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ABSTRACT
The incipient invasion o f epithelial tumour cells, characterised by disruption o f normal cell­
cell adhesion, marks the point o f transition to malignancy. Cadherins are a family o f calcium- 
dependent, transmembrane, cell-cell adhesion molecules whose function requires association 
with the actin cytoskeleton o f the cell through cytoplasmic proteins called catenins. Oral 
keratinocytes express E-cadherin, which is considered a regulator of the epithelial phenotype. 
Loss of E-cadherin commonly is seen in oral squamous cell carcinoma (OSCC), particularly 
in poorly differentiated tumours, allowing cells to detach from the tumour mass, invade and 
metastasise.
An E-cadherin negative OSCC cell line was identified where E-cadherin expression and 
function was restored through cDNA transfection resulting in functional cell surface 
expression o f the protein and the formation o f cell-cell attachments, with significant 
alteration in levels and distribution o f catenins. Alteration o f cell morphology, from a spindle 
to an epitheloid form, was observed. Additionally, restoration o f E-cadherin showed a 
marked inhibition o f the invasive potential o f this OSCC cell line. These effects were not 
observed in the control cell line transfected with the expression vector containing antisense 
E-cadherin cDNA.
Most findings in cell and molecular biology, presented in the literature, are based, primarily, 
on in vitro studies obtained from the culture o f cells growing in 2-dimensional (2-D) tissue 
culture dishes. In this study I have investigated if E-cadherin plays a role in modulating 
tumour cell growth in a 3-D, as opposed to a 2-D, environment. Results showed that the 
epitheloid-like morphology brought about by E-cadherin expression under 2-D conditions 
allows differences in density dependent inhibition to occur accompanied by enhancement in 
the apoptotic capacity o f the cells. However, where constraints o f 3-D culture are imposed, 
these variations between E-cadherin expressing and non-expressing lines disappear. To 
explore the basis o f these changes I have examined Western blot analysis o f proteins known 
to play a role in mediating cell proliferation or regulation o f apoptosis, such as Bcl-2, Akt-1, 
ILK and N-cadherin. I showed that changes in levels o f expression o f these proteins under 
2-D conditions is markedly affected when cells were implanted in 3-D collagen I cultures.
I also investigated the possible molecular cross talk between E-cadherin and the (34-integrin 
subunit. Results obtained from (34-knock-down experiments showed that (34-integrin plays a 
role in the maturation o f E-cadherin-dependent cell-cell contacts. I investigated the possible 
mechanisms o f this apparent cadherin-integrin cross-talk and preliminary results showed that 
the function o f (34-integrin was, potentially, executed through the Racl small Rho GTPase.
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CHAPTER 1
Introduction
1.1 Overview
Cancer is the second leading cause o f death in the Western world. Growth and proliferation 
o f normal cells at all levels (biochemical, genetic and cellular) usually are under strict control. 
Loss o f  control over these processes leads to the development o f malignancy; characterised 
by abnormal, non-stop cell divisions. Cancer usually starts as a primary tumour that is 
capable o f invading the surrounding tissues, and eventually metastasises to distant sites where 
it settles as a secondary lesion. Metastasis entails a series o f events involving adhesion and de­
adhesion where the transformed cells gain the ability to alter their cell-cell and cell- 
extracellular matrix interactions. For example, loss o f intercellular adhesion is a prerequisite 
for the cell to break away from the primary tumour mass.
Tumours arising from epithelial origin account for the majority o f human cancers, while E- 
cadherin is one o f the major cell-cell adhesion molecules in epithelial cells (and also is 
responsible for conveying signals in and out o f the cell), and is the molecule that I have 
chosen to study. Understanding the biological basis o f E-cadherin’s importance and the 
underlying signalling cues it triggers in tumours will, hopefully, provide the basis o f improved 
interventional therapeutic strategies.
1.2 Normal Oral Mucosa
The oral mucosa is divided into two components; an outer epithelial lining (equivalent to the 
epidermis o f the skin), and an underlying connective tissue support (equivalent to the dermis 
o f the skin). The two components are divided by a highly specialised basement membrane.
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1.2.1 Epithelium
The oral epithelium is o f a stratified squamous type, it forms a protective layer that shields 
the oral mucosa from the outer environment thus providing a barrier against environmental 
stresses, chemical damage, microorganisms and other noxious substances, as well as 
preventing excessive transepithelial loss o f body fluids. To maintain this critical barrier the 
oral epithelium undergoes programmed terminal differentiation, as well as continual 
desquamation, which establishes the basis o f epithelial homeostasis. Epithelial homeostasis 
implies that cell proliferation at the deeper layers is balanced by the loss o f cells from the 
surface.
Oral epithelium shows regionally distinctive patterns o f maturation. Depending on the 
presence o f keratinisation, the oral epithelium is divided into three main types: the 
keratinised, or comified, epithelium, parakeratinised epithelium and non-keratinised 
epithelium.
The keratinised epithelium, like that o f the epidermis o f the skin, covers the masticatory 
mucosa o f the hard palate, the gingiva and some areas of specialised mucosa on the dorsum 
of the tongue. The parakeratinised epithelium covers the remaining part o f the gingiva where 
superficial epithelial cells are nuclear, compared to the superficial anuclear cells o f the 
keratinised oral epithelium which contain flattened remnants o f nuclei (Scully et al., 2005). 
The non-keratinised epithelium forms the lining o f the distensible oral mucosa. It is generally 
thicker, but more permeable, than keratinised mucosa, covering areas that are subjected to 
the least mechanical stresses such as the floor o f the mouth, the ventral surface o f the 
tongue, the vestibule, the alveolar mucosa, the cheeks, and the inner lining o f the lips.
In general, the stratified squamous epithelium consists of multiple layers o f epithelial cells 
(keratinocytes). The proliferative basal layer (stratum basale), which lies adjacent to the 
basement membrane, consists o f a single layer of keratinocytes, cuboidal or columnar in
shape, that exhibit a mitotic potential. Basal keratinocytes are o f two types: the pluripotent 
stem cells, which maintain high capacity for self-renewal throughout adult life, and the transit 
amplifying cells, which a have lower capacity for self-renewal and possess the capability for 
undergoing terminal differentiation after few rounds o f cell division (Potten, 1981; Hall and 
Watt, 1989; Watt, 2001). These cells generate a post-mitotic cell population that irreversibly 
withdraws from the cell cycle; the cells increase in size and lose their proliferative capacity 
(Barrandon and Green, 1985). Cells committed to terminal differentiation become less 
adherent to the basement membrane as well as to one another (Watt, 1984), detach from the 
basement membrane, as a consequence o f inactivation and loss o f pi-integrin (Hotchin et al., 
1993), and express proteins associated with differentiation, such as envoplakin, periplakin, 
involucnn and new cytokeratins (Watt and Green, 1981; Watt and Green, 1982; Barrandon 
and Green, 1985; Fuchs, 1990, Steinert, 2000). Basal cells also are characterised by their 
cytokeratin profile, containing an intracellular cytoskeleton composed o f a relatively 
dispersed, but extensive, network of the keratin pair; keratin-5/keratin-14 (K5/K14) 
(Presland and Jurevic, 2002). In contrast stem cells were claimed to express K 15/K19 (Squier 
and Kremer, 2001) though this is not proven unequivocally.
The spinous, or prickle-cell, layer (stratum spinosum) is composed o f 3-5 layers of cells that 
show a gradient in shape, size and orientation with their protein synthesising machinery 
devoted to the manufacture o f new pairs o f keratins; K 1/K 10 in epidermal and gingival 
tissue and K 4/K 13 in non-keratinised epithelium such as the buccal and soft palate mucosa 
(Presland and Jurevic, 2002). At histological levels it can be seen that the spines (which give 
this layer its name) correspond to the insertion of the keratin tonofilament bundles into 
neighbouring cells. As the cells move towards the surface they gradually become larger, 
flatter and contain more kertain bundles.
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The granular cell layer (stratum granulosum) lies superficial to the spinous cell layer and is 
characterised by irregularly shaped cells, condensed with 0.5-5pm keratohyaline granules, 
which become progressively larger as the keratinocytes move into the outermost granular 
layer. In this layer cells stop generating keratin and envelope proteins, that become uniformly 
deposited at the inner surface o f the cell membrane to serve as a scaffold or template for 
subsequent maturation and assembly o f the comified envelope (CE) (stratum comeum), and 
start producing a new set o f reinforcement proteins such as loricrin, filaggnn and the small 
proline rich (SPR) family o f proteins (Fleckman et al., 1985; Mehrel et al., 1990; Steinert, 2000; 
Kalinin et al., 2001). In oral epithelium, reinforcement proteins are composed o f ~70% SPRs 
and ~10% loricrin (Steinert, 2000). These proteins mediate the cross-linking o f the structural 
proteins that together form the comified envelope of the stratum comeum. Also present in 
these cells are the lipid-rich cytoplasmic lamellar granules, which release their contents into 
the intercellular space to form lamellae between the granular and first comified layer. The 
lamellar granule-derived sheet contributes to the protective barrier properties o f the 
epithelium (Elias and Menon, 1991).
The stratum comeum is a 15nm multilayered zone o f terminally differentiated keratinocytes, 
in keratinised epithelium. It is composed o f flattened cells with the proteinaceous envelope 
cross-linked to the keratin cytoskeleton inside the cells and to lamellar granule-derived lipids 
on the surface (Presland and Jurevic, 2002). Keratinising epithelial cells are anuclear and are 
devoid o f organelles. Proteins in the CE are o f two types. They are either proteins that are 
produced exclusively in epithelia to be incorporated into the CE, such as loricrin, involucrin, 
the small proline-rich proteins (SPRs) and a new family of proteins, called the late envelope 
proteins (LEPs) (Nernes and Steinert, 1999; Kalinin et al., 2001; Marshall et al., 2001), or they 
are proteins that are known to regulate other functions in epithelial cells, such as
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desmosomal proteins (for example, envoplakin, plakoglobin, desmogleins) or proteins 
associated with differentiation and /o r cytoskeletal functions (for example, filaggrin) (Nernes 
and Steinert, 1999; Presland and Dale, 2000).
In non-keratinised stratified epithelium, the most superficial cells become flatter and larger 
but retain their nuclei and a variety o f organelles and do not form a CE (Presland and 
Jurevic, 2002).
Beside keratinocytes the stratified squamous epithelium harbours a variety o f other cells, 
such as Langerhans cells, lymphocytes, melanocytes and Mercle cells but such cells comprise 
only a small proportion o f the total cellular content.
1.2.2 Basement membrane
Basement membranes (basal laminae) are complex, delicate, lace-like structures, often 
characterised by undulated appearance over connective tissue papillae, and composed o f a 
mixture o f collagenous and non-collagenous glycoproteins and proteoglycans, which separate 
cells from underlying connective tissue. They form cell-associated, sheet-like extracellular 
matrices under epithelial cells and around endothelial cells, and surrounding individual 
muscle, fat and peripheral nerve cells. Bone osteoid and cartilage are among the few tissues 
that lack basement membranes completely. Basement membranes act as a selective barrier 
between tissue compartments and provide a mechanical scaffold to the overlying cellular 
component, as well as being critically involved in regulation of cellular biological activities 
such as differentiation, morphogenesis, survival and migration (Adams and Watt, 1990; 
Adams and Watt, 1993; Erickson and Couchman, 2000; Miner and Yurchenco, 2004). The 
basic constituents o f basement membranes are type IV collagen, laminin, the glycoprotein 
nidogen/entactin and proteoglycans o f the perlecantype (Timpl and Brown, 1996; Erickson 
and Couchman, 2000). Recently new components have been described such as agrin and type
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XVIII collagen which have been classified as heparan sulphate proteoglycans (Erickson and 
Couchman, 2000). The laminin family recently has been expanded to include new isoforms 
with new functions elucidated (Miner and Yurchenco, 2004), with laminin-1 being the most 
abundant non-collagenous protein in the basement membrane (Sasaki et al., 2004). A small 
amount o f fibronectin also is present within the basement membrane (Fleischmajer and 
Timpl, 1984) along with other proteoglycans and these molecules are capable o f binding to 
growth factors and presenting them at the cell surface (Aviezer et al'., 1994). Basement 
membrane proteins are synthesised by both keratinocytes and fibroblasts (Marinkovich et a l, 
1993).
Under conventional electron microscopy, the basement membrane comprises the lamina 
lucida, lamina densa and the reticular layer (Briggaman and Wheeler, 1975).
The lamina lucida is a 10-50nm thick electron-lucent layer that lies adjacent to the epithelium 
and which is traversed by bundles o f anchoring filaments, running from the basal 
keratinocytes to the lamina densa. Laminin-5 (also known as kalinin, epiligrin and nicein) 
constructs the anchoring filaments that run from the hemidesmosomes into the basement 
membrane and which play an important role in maintaining the epithelial-ECM junction 
(Verrando et al., 1991). The extracellular domain o f the a6(34 integrin interacts with 
components o f the basement membrane such as laminin-1 and -5 (Niessen et al., 1994).
The lamina densa is a 55nm thick electron-dense collagen IV-rich layer, which lies between 
the lamina lucida and the reticular layer.
The reticular layer is an electron-lucent layer traversed by collagen IV connecting the dermis 
to the hemidesmosomes.
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1.2.3 Connective tissue
The connective tissue component, the corium or the lamina propria, o f the oral mucosa 
consists o f a dense network o f collagen and elastin embedded in a viscoelastic ground 
substance o f proteoglycans and glycoproteins. It forms a papillary layer that is made of 
connective tissue papillae and a dense fibrous region comprising the bulk o f the lamina 
propria (Moss-Salentijn, 1980; Gage, 1989). In adult oral mucosa, type I collagen constitutes 
the bulk o f the connective tissue proper and represents 80-90% o f the total collagen content, 
type III collagen represents 10-15% and type IV and V less than 5%. Type I collagen is 
found throughout the lamina properia, in contrast, type III is localised mainly to the papillae 
and adjacent to blood vessels. In addition, other components, like elastin, tenasdn and 
fibronectin, and vitronectin, are found associated with the dermal elastic fibres (Dahlback et 
al., 1989; Yamada, 1989; Chiquet-Ehrismann, 1991).
Connective tissue also contains sparse cell populations o f fibroblasts, macrophages, Mast 
cells, and migrating cells such as polymorphonuclear leukocytes, lymphocytes and plasma 
cells (Moss-Salentijn, 1980; Gage, 1989).
Connective tissue o f the non-keratinised epithelium is more elastic and flexible than that of 
the keratinised epithelium.
1.3 Malignant oral mucosa
1.3.1 Oral cancer
Oral cancer refers to malignancies that include cancer o f the Up ((9th International 
Classification) ICD9 140), cancer o f the tongue (ICD9 141) and cancer o f the mouth (ICD9 
143-145) (Parkin, 1993). Oral cancer is the sixth most common solid cancer accounting for 
about 5% of all malignancies (Parkin, 1993), with squamous cell carcinoma (SCC) o f the
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covering epithelium being the m ost common type of oral cancer and accounting for more 
than 90% o f cases (Thomas and Speight, 2001).
World-wide, the incidence o f oral cancer shows remarkable geographical variations. 
Generally the highest rates are found in the developing countries, such as India and Sri 
Lanka, where oral cancer accounts for as many as 50% of all malignancies. In Saudi Arabia 
oral cancer happens to be relatively common accounting for about 5% o f all malignancies 
(WHO report, 1997), particularly in the Jizan area (Allard et al., 1999), where oral cancer was 
found to be the most common cancer accounting for about one-fifth o f all cancers, probably 
due to the widespread use o f oral tobacco preparations (Tandon, 1995).
Despite the rapid advances in treatment modalities o f oral sqamous cell carcinoma (OSCC) 
as well as improvements in the early detection o f oral cancer, the overall 5-year survival of 
patients remains poor, with it being estimated as approximately 50%; a figure which has not 
improved over the past 25 years (Greenlee et al., 2001). Mortality from oral and pharyngeal 
cancer has shown increased rates over the past three decades in the European Community 
(EC) countries (Johnson and Wamakulasuriya, 1993), with 50% o f the cases expected to die 
within a period o f 5 years (OPCS, 1994). In the United State an estimated 29,370 new cases 
of oral cancer are expected to be diagnosed in 2005 and approximately 7,320 people will die 
of the disease (ASC, 2005). The poor prognosis is thought to be attributable to the fact that 
over 60% of patients presenting with oral cancer have tumours greater than 2cm in diameter, 
and prognosis is known to be worse for larger lesions (Platz, 1986). Moreover, prognosis is 
affected adversely by the occurrence o f distant metastatic lesions; a situation which appears 
to be increasing (Carr and Langdon, 1989).
The ventral and lateral surfaces o f the tongue are the most common sites o f oral cancer 
(Scully, 2005). The floor o f the mouth, the retromolar area and the posterior lower alveolus
24
come next in order o f frequency o f involvement followed by the buccal mucosa. 
Involvement o f the other areas o f the oral-pharyngeal region showed a lesser incidence.
1.3.2 Characteristics of oral cancer
1.3.2.1 Development and proliferation
Cancer involves disruption o f the normal developmental programmes o f the cell, both in 
terms o f proliferation and in terms of differentiation, hence the term “development 
disorder” (Dean, 1998). The transformed cell escapes these developmental restraints and 
gives rise to a malignant cell population that is, in a sense, immortal and exhibits many 
characteristics which appear to be quite foreign to the mature differentiated cell. However, it 
should be noted that the morphological identification o f many tumours is based on their 
expressing a repertoire o f differentiated functions.
Oral carcinogenesis is a complex multi-step process in which the basic cellular functions are 
being disturbed by multiple genetic alterations with progressively increasing capacity for 
proliferation, survival, invasion and metastasis. The first step in the process is “tumour 
initiation” which includes activation o f oncogenes and inactivation of tum our suppressor 
genes. An accumulated body of evidence suggests that there are at least 6 to 10 genetic 
events required for the development o f full-blown oral carcinogenesis (Williams, 2000). 
Oncogenes encode proteins which normally activate and drive cell proliferation and several 
oncogenes have been implicated in oral carcinogenesis, for example overexpression o f the 
proto-oncogene epidermal growth factor receptor (EGFR) has been detected frequently in 
oral cancers (Partridge et al., 1988), and was found to be due to gene amplification in almost 
30% of oral cancers (Scully, 1993). Members o f the ras oncogene family, together with other 
genes like c-myc, int-2, hst-1, PRAD-1 and bcl-1, are also found to be implicated in the
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development o f oral cancer (For review see: Williams, 2000). Oncogenes however only act as 
initiators for carcinogenesis and their activation alone is not sufficient for the development 
o f a tumour. In general, for any malignancy to develop activation o f oncogenes must be 
coupled with the inactivation o f tumour suppressor genes. Tum our suppressor genes encode 
proteins which normally suppress cell proliferation. The p53 gene, the m ost widely studied 
tum our suppressor gene, has been shown to be functionally inactivated in oral cancer 
(Schantz, 1993; Partridge et al., 1999). O ther tumour suppressor genes, such as doc-1, the 
retinoblastoma (Rb) gene, and the adenomatous polyposis coli (APC) gene, have been 
mutated frequently in oral cancers (For review see: Williams, 2000). In general, oncogenes 
and tumour suppressor genes feed into common cellular regulatory systems, implicated in 
proliferation and /o r differentiation, which change the structure and behaviour of 
transformed cells. Continuous efforts have been made to identify new genes that are 
expressed differentially in oral cancers (Arora et al., 2005). However, further studies are 
required to determine the biological importance o f these newly discovered genes to assess 
their validity as future biomarkers and as targets for new therapeutic strategies.
The second step in cancer evolution is “tumour progression” where additional mutations 
continue to occur within the transformed cells giving rise to more rapid-growing and 
increasingly malignant cell populations.
Oral squamous cell carcinoma (OSCC) is the most common malignant neoplasm o f the oral 
cavity, and it is considered that here the cancer cells are less stringently regulated by cell-cell 
and cell-matrix interactions. Contact-inhibition is a characteristic o f normal epithelial cells, 
where normal cells proliferate until they reach a finite cell density and become quiescent. 
Contact inhibition is lost in oral squamous cell carcinoma, where transformed cells are no 
longer subjected to the density-dependent inhibition o f cell proliferation. These changes are 
attributed to the downregulation or loss o f the E-cadherin-dependent cell-cell contacts in
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oral carcinoma (Li et a l 1998), where re-expression o f E-cadherin conferred density- 
dependent growth inhibition. However, on the other hand, E-cadherin was found to confer 
survival advantage, in other OSCC cell lines, for detached cell growing in suspension (Kantak 
and Kramer, 1998).
1.3.2.2 Growth and survival
The growth o f a malignant tumour is dependent upon the balance between cell growth and 
cell death (Carson and Ribeiro, 1993). Programmed cell death, or apoptosis, is an integral 
part o f normal tissue homeostasis. Failure of neoplastic cells to undergo apoptosis 
contributes substantially to tumour growth and development. Among other regulating 
effectors, the B cell leukaemia/lymphoma-2 (Bcl-2) family o f proteins is implicated in 
regulation o f apoptosis (Adams and Cory, 2001). In oral cancers over-expression o f Bcl-2 
protein was reported in poorly differentiated tumours (Jordan et al'., 1996; Badaracco et al., 
2000; Chen et al., 2000; Teni et al., 2002; Loro et al., 2003). In normal epithelial cells, 
apoptosis is initiated by loss o f cell anchorage, i.e. cell-cell and cell-matrix interactions (Frisch 
and Francis, 1994; Hermiston and Gordon, 1995). However, transformed cells are resistant 
to the loss o f cell anchorage and exhibit anchorage-independent survival capabilities, a 
phenom enon which, it is thought, enables malignant cells to survive and metastasise to 
distant sites (Grossmann, 2002). E-cadherin has been implicated in regulation o f anchorage- 
independent growth and in survival o f tumour cells in oral squamous cell carcinoma (Kantak 
and Kramer, 1998).
1.3.2.3 Differentiation
There generally has been an inverse relation between tumour growth and differentiation 
(Harris, 1987). Dedifferentiation (or loss o f the differentiated phenotype) is an important
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step in carcinogenesis and often correlates with poor prognosis. Dedifferentiation involves 
morphological alterations to the cell-cell structures and to the cytoskeleton o f the 
transformed cell, as well as changes to the cell-matrix organisation and gene expression 
profile (Thiery, 2003); such a change, manifested by alterations in morphology, often is 
referred to as Epithelial-Mesenchymal Transition (EMT) where the carcinoma cells are 
thought to lose their epithelial characteristics at the invasive front and to express a new set of 
mesenchymal-specific genes (Boyer et al., 2000). In sqamous cell carcinoma, E-cadherin, an 
epithelial marker which mediates cell-cell interactions, frequently is lost in oral squamous cell 
carcinoma and its loss is implicated in EM T (Behrens et al., 1993; Bagutti et al., 1998; 
Williams et al\, 1998; Lo Muzio et al., 1999).
1.3.2.4 Invasion and metastasis
OSCC is characterised by its ability to spread locally and regionally, where malignant 
keratinocytes break through the underlying basement membrane and move through the 
connective tissue stroma. Alteration in the expression and /o r function of cell adhesion 
molecules results eventually in tumour invasion and metastasis. In OSCC, loss or aberrant 
function o f the E-cadherin (invasion-suppressor) cell adhesion molecule has been correlated 
with invasion and metastasis o f tumour cells (Behrens et a l, 1993; Mattijssen et al., 1993; 
Bagutti et al., 1998; Shinohara et a l, 1998; Hoteiya et al., 1999; Kudo et al., 2004). Also, 
thinning and discontinuity of the basal lamina were observed in OSCC and such changes are 
thought to prom ote invasion (Kannan et al., 1994; Cheng and Hudson, 2002). The ability of 
the malignant cells to degrade ECM components, mediated by matrix metalloprotease 
(MMP) enzymes, is an im portant determinant o f the invasive potential o f any tumour. The 
Gelatinases (MMP-2 and -9), Stromelysins (MMP-3, -10, -11), Collagenases (MMP-1 and -13) 
and membrane-bound MMP (MT1-MMP) are all expressed in oral cancer where they may
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contribute to tumour progression (Polette et a l, 1991; Polette et al., 1993; Gray et al., 1992; 
Pyke et al., 1992; Kusukawa et al., 1992; Kusukawa et al., 1993; Kusukawa et al., 1995; Muller et 
al., 1993; Okada et al., 1995; Yoshizaki et al., 1997; Charous et al., 1997; Airola et al., 1997; 
Johansson et al., 1997; Thomas et al., 1999).
1.4 Cell adhesion Molecules
Eukaryotic cells communicate with their extracellular environment, both cellular and 
acellular, through a variety o f cell surface located cell adhesion molecules (CAMs). A t the 
present time there are six major subfamilies o f CAMs: integrins, syndecans, selectins, 
immunoglobulin superfamily members, cadherin superfamily members, and those which fall 
into a separate group, such as the hyaluronan receptor CD44, with little resemblance to the 
other five specific categories (Skubitz, 2002).
In general, broad terms it may be viewed that interactions with the extracellular matrix 
(ECM) are carried out by integrins and syndecans while interactions with neighbouring cells, 
via heterophilic or homophilic binding, are attributable to the members o f the cadherin, 
selectin and immunoglobulin (Ig-CAM) families (Aplin et al., 1999).
The CAMs do not serve simply as “inert” molecules binding a cell to the recognised ligand. 
Rather they function in a dynamic fashion to control a number o f cellular events, such as 
proliferation, survival, differentiation and migration, by participating in cellular signal 
transduction pathways (Juliano, 2002). The ultimate outcome o f the generation o f these 
signal transduction pathways are changes in gene expression and, consequendy, changes in 
cell behaviour (Juliano, 2002).
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1.4.1 Epithelial cell-cell and cell-matrix adhesion
Formation o f a polarised epithelium is dependent upon a high-order organisation involving 
formation o f cell-cell and cell-matrix adhesive structures.
Epithelial cell-cell adhesion is mediated by a variety o f membrane proteins that accumulate to 
form different adhesive structures; tight junctions (TJs), adherens junctions (AJs) and 
desmosomes. Collectively they form the intercellular junctional complexes (for review see: 
Kowalczyk et al., 1999; Tsukita et al., 2001; Perez-Moreno et al., 2003). Tight junctions and 
adherens junctions are both connected to the actin cytoskeleton o f the cell, desmosomes, in 
contrast, are linked to the intermediate filament network. Tight junctions are formed mainly 
by glycoproteins, such as claudin/occluding and nectin. However, adherens junctions and 
desmosomes are cadherin-dependent adhesive structures.
The AJs play a key role in synchronising cellular organisation and movements within 
epithelia. Moreover, they are directly involved in conveying information from the 
surrounding to the interior o f the cell (Perez-Moreno et al., 2003).
Epithelial cell-matrix adhesion is mediated by integrins which cluster to form organised 
adhesive structures, such as focal adhesions and hemidesmosomes. Focal adhesive 
complexes connect components o f the extracellular matrix (ECM) to the actin cytoskeleton 
and are made mainly by the [31 -containing members o f the integrin family (Clark and Brugge, 
1995). In contrast, hemidesmosomes are multi-protein complexes that are dependent upon 
a6[34 integrin and link the intermediate filament (keratin) network o f the cell with the ECM 
(Borradori and Sonnenberg, 1996; Green et al., 2005)
The work described in this report has focused primarily on E-cadherin, a classical member of 
the cadherin superfamily, and thus a brief review o f the characteristics o f these molecules is 
presented.
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Introduction
1.4.2 Cadherins
The cadherin superfamily represents a family of adhesion molecules that are structurally 
related. Sequence similarities among members of the cadherin superfamily provide the basis 
for their assignment into four main groups: classical cadherins (type I, II, and III), 
desmosomal cadherins (desmocollins and desmogleins), protocadherins, and other cadherin 
related proteins (Angst et al, 2001; Truong and Ikura, 2002). The cadherin superfamily, and 
its known members, is presented in Table 1.1 (also see Figure 1.1)
Table 1.1: Cadherin Superfamily
Superfamily Members
Classical cadherins E-, N-, P-cadherin
VE-cadherin
Desmosomal cadherins Desmocollin
Desmoglein
Proto-cadherins p-Protocadherin
CNR-cadhenn
Seven transmembrane (7TM) Flamingo
T-cadherin T-cadherin
FAT family Dachsous
Fat
Taken from (Angst et al., 2001)
Cadherins are calcium-dependent (hence the name calcium-dependent-adherins) intercellular 
adhesion molecules described originally by Takeichi (1977). These molecules generally bind 
in an homophilic (i.e. like-binding-like) fashion though an heterophilic interaction between 
the E-cadherin molecule and integrin ocEJ37 has been demonstrated (Higgins et al, 1998). 
Also, it has been reported that E-cadherin can interact directly with a2(31 (Whittard et al,
2002). These generally transmembrane molecules (T-cadherin is unique in being linked to the
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plasma membrane via a glycosyl-phosphatidylinositol “G PI” anchor) link through to 
elements of the cytoskeleton (Figure 1.1). Indeed it is the nature o f the filaments to which 
the cytoplasmic tail binds, eventually, which places some o f the cadherins into their 
appropriate sub-families. Thus the desmosomal cadherins bind to intermediate filaments 
whereas the classical cadherins bind to actin filaments (Figure 1.1). VE-cadherin, a classical 
cadherin expressed in endothelial cells, is unusual in being able to bind both actin filaments 
and intermediate filaments (Angst et al., 2001). Much that is known about the functions of 
the cadherins comes from studies on the classical cadherins (Wheelock and Johnson, 2003b; 
Wheelock and Johnson, 2003a).
In general, the cadherins play an important role in histogenesis and maintenance o f the 
normal tissue architecture, where they contribute to the formation o f intercellular organised 
adhesive structures. Classical cadherins constitute the adherens junctions (AJs) whereas 
desmosomal cadherins; the desmocollins (Dsc) and desmogleins (Dsg), form the spot-like 
desmosomes.
1.4.2.1 Classical Cadherins
These may be regarded as the prototype o f all cadherins. Named for the tissue from which 
they first were isolated (epithelial, E-cadherin Yoshida-Noro et al., 1984; placental, P- 
cadherin Nose et al., 1987; neuronal, N-cadherin Hatta et al., 1988; vascular endothelial, VE- 
cadherin Lampugnani et al., 1995).
E- and P-cadherins as well as desmosomal cadherins are the primary cadherins expressed by 
the stratified squamous epithelium (Thomas and Speight, 2001; Wheelock and Johnson, 
2003b). E-cadherin is the molecule we are interested in.
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1.4.2.2 Epithelial-cadherin (E-cadherin)
E-cadherin, the predominant intercellular adhesion molecule o f epithelial cells, is a 5758 
amino acid, transmembrane protein with a molecular mass o f 120 kDa; formed by the 
enzymatic cleavage o f a 135 kDa precursor in a step which is thought to be crucial for a 
mature, functional adhesive molecule (Figure 1.2). It is also known as uvomorulin, L-CAM, 
cell-CAM 120/80 or Arc-1 (Bremnes et al'., 2002). E-cadherin is, arguably, the prototypic 
member o f the classical cadherins.
The gene encoding human E-Cadherin (CDH1) recently has been cloned and characterised 
and found to be situated on chromosome 16q22.1, within a large conserved linkage group 
that includes loci for haptoglobin, chymotrypsinogen B, metaUothionine-1, metallothionine-2 
and tyrosine aminotransferase (Bremnes et al., 2002).
Like the other members o f the type I classical cadherins, E-cadherin consists o f three main 
domains: extracellular domain, transmembrane domain and an intracellular highly conserved 
domain.
The extracellular region o f these molecules consists of five repeats (EC1-EC5; amino to 
carboxyl terminus) o f negatively-charged unique calcium-binding motifs. Calcium is essential 
for cadherin-mediated adhesion and also serves to protect the cadherins from degradation by 
trypsin (Hyafil et al., 1981). It is thought that the HAV (histidine-alanine-valine) amino acid 
triplet displayed on the EC1 sub-domain at the N-terminus acts as a recognition sequence 
essential for the homophilic binding o f the cadherin molecules (Noe et al., 1999a; Noe et al., 
1999b). In order for cadherins to bind they must dimerise; first a parallel dimer is formed 
between two adjacent cadherin molecules on the same cell and then an antiparallel dimer is 
formed between cadherin dimers o f adjacent cells; the so-called “adhesion zipper” (Shapiro 
et al., 1995; Yap et al., 1997; Vasioukhin et al., 2000).
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1.4.2.2.1 E-cadherin in normal oral mucosa
E-cadherin is expressed during embryonic life as early as the two-cell stage (Larue et al, 1994; 
Riethmacher et al., 1995), where E-cadherin was shown to play an important role in 
development, regulation o f morphogenesis and tissue formation. Epithelial differentiation 
and polarisation occurs early during the morula stage, during which E-cadherin plays an 
important role (Fleming et a l, 1992). In normal adult epithelial tissue, E-cadherin’s function 
lies primarily in the formation of adherens junctions. E-cadherin is also involved in 
maintenance o f epithelial tissue homeostasis, by being part o f the signal transduction 
pathways which not only regulate adhesion but regulate other cellular process such as cellular 
differentiation, migration, proliferation and apoptosis (Barth et al., 1997; Pedna-Slaus, 2003; 
Wheelock and Johnson, 2003a). E-cadherin is implicated in the regulation of growth of 
normal ginigival epithelium in a density-dependent manner (Kandikonda et al., 1996).
1.4.2.2.2 Adherens junctions (AJs)
In epithelial tissue, AJs are E-cadherin-dependent adhesive structures that are knotted to the 
actin cytoskeleton o f the cell. In order for functional adhesive activity to occur it also is 
essential that the cytoplasmic domain o f E-cadherin molecule interacts with the actin 
cytoskeleton. Linkage to this structure is via a series of cytoplasmic plaque proteins, known 
as catenins; a- (102 kDa, chromosome 5q21-22), (3- (88 kDa, chromosome 3q21), y-catenin 
(82 kDa, chromosome l l q l l ) ,  and the catenin p l20ctn (120 kDa, chromosome 12ql3). The 
(3-catenin is homologous to the Drosophila segment polarity gene armadillo (Gumbiner,
1995) and binds direcdy to the E-cadherin molecule at the C-terminal end o f the cytoplasmic 
domain (Ozawa et al., 1990). The (3-catenin leads a dual life in that, through binding to E- 
cadherin, it plays a role in AJ formation (Gumbiner, 1996), and also, it acts as a 
transcriptional factor when stimulated by the Wnt signal transduction pathway (Ben-Ze'ev
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and Geiger, 1998). The a-catenin shares sequence homology with vinculin (Herrenknecht et 
a l 1991) and binds the E-cadherin/(3-catenin complex either directly to the actin 
cytoskeleton (Rimm et a l 1995) or via a-actinin (Knudsen et al., 1995). Clustering o f E- 
cadherin/catenin complex and formation o f proper AJ are highly dependent on a-catenin. 
Transformed cells lacking a-catenin showed disturbed cell-cell adhesion (Shimoyama et al, 
1992) and restoration o f a-catenin restored the normal cell-cell contacts (Hirano et a l, 1992). 
a-catenin complexes with (3-catenin (or y-catenin) and other cytoskeletal proteins, including 
vinculin, to organise the cadherin/catenin complex at the AJ o f the polarised cell (Perez- 
Moreno et al., 2001). a-catenin can also bind to proteins involved in actin polymerisation 
such as VASP (vasodilator-stimulated phosphoprotein) and Mena (Vasioukhin et a l, 2000); 
an association thought to be necessary for maturation o f E-cadherin-dependent AJs 
(Vasioukhin and Fuchs, 2001). a-catenin also possesses a binding region for ZO-1 (Imamura 
et a l, 1999). The y-catenin bears homology to (3-catenin and is identical to the desmosomal 
plakoglobin. The (3- and y-catenins appear to form mutually exclusive complexes with the E- 
cadherin cytoplasmic domain, where the two catenins can substitute for one another when 
one is missing. Like (3-catenin, p l20ctn binds directly to defined, and distinct, portions of the 
E-cadherin cytoplasmic domain (Yap et al, 1998).
An intact cadherin-catenin complex is crucial for the development o f a functional adherens 
junction.
1.4.2.2.3 Regulation of adherens junction formation
Theoretically the life o f a cadherin junction can be divided into three stages: formation, 
maintenance and disassembly. Junction formation is further subdivided into three phases 
involving the formation o f initial contacts, which then grow and mature and, eventually, 
form clusters o f cadherins and associated molecules that can be recognised ultrastructurally
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as AJs. Sometimes, cadherin is recruited from intracellular stores following initiation o f cell­
cell contact formation (Mary et al., 2002). AJs are dynamic in nature; the turnover of 
molecules in and out o f the adhesive contacts is marked while internalisation and recycling of 
cadherins can affect junction formation and maintenance substantially (Le et al., 2002). 
Disassembly could result from the extensive breaking of contacts, for example by proteolysis 
while different cell types may not share identical mechanisms o f how junctions are initiated 
and maintained; thus formation o f AJs appears to be cell-type-specific as well as cadherin- 
specific (Wheelock and Johnson, 2003b).
The process o f AJ formation (assembly and disassembly) is vital for certain biological 
processes such as growth, wound healing and differentiation, as well as during pathological 
conditions such as tumourigenesis. Several mechanisms are known to be implicated in the 
regulation o f AJs, including: tyrosine phosphorylation/dephosphorylation o f components of 
the AJs, ubiquitination (internalisation and degradation of plasma membrane proteins) and 
endocytosis o f E-cadherin, and regulation o f AJs by members o f the Rho family GTPases.
In epithelial cells, tyrosine kinases induce tyrosine phosphorylation o f components o f the AJs 
(Takata and Singer, 1988). Activation o f various tyrosine kinases, such as the src kinase 
family (Tsukita et al., 1991), the protein tyrosine phosphatase PTPp family (Brady-Kalnay et 
al., 1995)), the epidermal growth factor (EGF) receptor (Hazan and N orton, 1998), the 
hepatocyte growth factor (HGF) receptor “c-met” (Hiscox and Jiang, 1999) and the 
oncogene product c-erbB-2 (Shibata et al., 1996b), all induce tyrosine phosphorylation of 
adhesion molecules such as E-cadherin and (3-catenin, with subsequent scattering of 
epithelial cells and the adoption o f a fibroblast-like morphology (Weidner et al., 1990; 
Fukuyama and Shimizu, 1991; Behrens et al., 1993; Hoschuetzky et al., 1994; Shibata et al., 
1996b). Moreover, inhibition o f tyrosine phosphatases, using sodium pervanadate for
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example, resulted in increased tyrosine phosphorylation o f E-cadherin, [3- and y-catenins, 
with the occurrence o f incomplete junctions and scattering o f the treated keratinocytes (Soler 
et al'., 1998). These findings suggest that tyrosine phosphorylation and dephosphorylation 
play an important role in regulation o f the cadherin-dependent AJs.
E-cadherin trafficking (dynamic recycling and endocytosis) play an im portant role in control 
o f AJs disassembly (Le et al., 2002). It has been reported that E-cadherin molecules were 
internalised following Ca2+ depletion (Kartenbeck et al., 1991). Several mechanisms have been 
proposed to explain this phenomenon. However, this aspect o f cadherin biology has not yet 
been thoroughly investigated. Le et al. (2002) showed that recycling o f the E-cadherin 
molecule was dependent upon activation o f the protein kinase C (PKC) family (Le et al.,
2002). Hakai, a novel E-cadherin binding protein, is found to mediate E-cadherin 
endocytosis through enhancement o f cell-cell adhesion disassembly (Fujita et al., 2002; Pece 
and Gutkind, 2002).
In addition to the potential role o f kinases in regulation o f adherens junctions, the Rho 
family of GTPases (Rho, Rac, and Cdc42) also have been implicated in remodelling actin for 
regulation o f cell-cell contacts (for review see: Hall, 1998; Van Aelst and D'Souza-Schorey, 
1997; Bishop and Hall, 2000; Braga, 2000). Blocking the activity o f Rho or Racl resulted in 
the removal o f cadherin adhesion complexes and prevention of cell-cell contact assembly in 
epithelial cells (Braga et al., 1997). Conversely the introduction o f constitutively active Racl 
accumulates cadherins, catenins, and actin at junctions; resulting in the formation o f E- 
cadherin-mediated cell-cell adhesion contacts (Ridley, 1995; Braga et al., 1999). In contrast, 
the expression of dominant negative Racl showed disruption in the E-cadherin-dependent 
cell-cell contacts (Lambert et al., 2002).
37
1.4.2.2.4 E-cadherin signalling
E-cadherin is thought to play an important role in the in-out cellular signalling. There are 
several models that have been used to study signals downstream of cadherin engagement 
(Wheelock and Johnson, 2003a). The best studied signalling  pathway involving cadherin is 
the (3-catenin/Wnt (or wingless) pathway. Activation o f this signalling pathway, by the Wnt 
ECM-associated growth factor, triggers the synthesis o f proteins involved in cell growth, 
such as myc and cyclin D l, with unbound (3-catenin being a co-activator (Conacci-Sorrell et 
al., 2002). Over-expression o f E-cadherin decreases the total amounts o f unbound (3-catenin 
available for signalling, and thus provided strong evidence that E-cadherin is involved in 
modulating the W nt signal transduction pathway.
E-cadherin also has been linked recently to the Rho family GTPases signalling pathways 
(Braga, 2002; Yap and Kovacs, 2003) with Racl being reported to be activated following E- 
cadherin engagement. Moreover, p l20ctn, one o f the catenin proteins that interact directly 
with E-cadherin’s cytoplasmic domain, is involved in Rho GTPase signalling pathway; a 
pathway which is implicated in the regulation of cell morphology, migration and gene 
transcription (Noren et al., 2000, Anastasiadis and Reynolds, 2001; Perez-Moreno et al., 2003). 
E-cadherin is thought to play a major role in controlling cell fate and survival through its 
interaction with the Epidermal Growth Factor Receptor (EGFR) and the subsequent 
activation o f the MAP kinase pathway. E-cadherin was found to induce a ligand-independent 
activation o f the EG F receptor (Pece and Gutkind, 2000).
1.4.2.2.5 Loss of E-cadherin function during carcinogenesis
It has been well accepted that the E-cadherin molecule functions as an invasion-suppressor 
(for review see: Behrens, 1999; Guilford, 1999; Wijnhoven et al., 2000; Wheelock et al., 2001; 
Thiery, 2002; Wheelock and Johnson, 2003a). Loss o f E-cadherin expression leads to
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epithelial tumourigenesis (Perl et a l, 1998) and disruption o f the cadherin-catenin complex. 
Such decreased E-cadherin expression often is observed in many advanced, poorly 
differentiated carcinomas (Berx and Van Roy, 2001; Hajra and Fearon, 2002).
Multiple mechanisms o f inactivation o f the E-cadherin/catenin complex in epithelial 
tumours have been proposed; including transcription and genomic regulation o f E-cadherin 
expression where either transcription o f E-cadherin is reduced through binding of 
transcription factors, like Snail, to the E-boxes sites o f the E-cadherin promoter (Batlle et al., 
2000; Cano et al., 2000; Comijn et al., 2001; Perez-Moreno et al., 2001; Yokoyama et al., 2003), 
or through DNA hypermethylation o f the E-cadherin promoter, thereby making the 
promoter inaccessible for transcription (Graff et al., 2000; Nass et al., 2000; Nojima et al.,
2001).
Switched expression of different types o f cadherins, the so-called “Cadherin switch” where 
N-cadherin is expressed instead of E-cadherin, has been reported as one o f the main causes 
for E-cadherin suppression in human squamous carcinoma cells (Tomita et al., 2000; Hazan 
et al., 2004). Mutation or deletions o f cadherin or catenin genes is another mechanism where 
E-cadherin expression and function are compromised in epithelial tumours (reviewed by: 
Berx et al., 1998; Nollet et al., 1999).
Also inhibition o f E-cadherin function where both cadherin and catenins molecules are 
expressed and intact has been attributed either to the shedding o f its ectodomain (Vallorosi et 
al., 2000), as a result o f cleavage by metalloproteinases, like matrilysin, stromelysin-1 
(Steinhusen et al., 2001; Noe et al., 2001) and plasmin (Ryniers et al., 2002), or through the 
cleavage o f its cytoplasmic domain by caspases (Steinhusen et al., 2001). The cleaved soluble 
fragments of the E-cadherin molecule (sE-cadherin) have been found in patients diagnosed
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with cancer (Katayama et al., 1994). These sE-cadherin fragments were reported to 
downregulate E-cadherin function in a paracrine manner (Noe et al., 2001).
Alteration o f adhesive functions by intracellular signalling pathways, such as growth factor 
receptors, oncogenes and small GTPases, may change cadherin adhesive properties (Lozano 
et al., 2003).
Mutation o f the E-cadherin gene (CDH1) has been reported in familial gastric carcinoma 
(Guilford et al., 1998), however the majority o f carcinomas appear to lack mutations in this 
gene. Nevertheless, immunohistochemical studies show that loss o f E-cadherin is common 
in many tumours (Behrens, 1999) and it is thought that tumour cells must downregulate E- 
cadherin in order to invade surrounding tissues (Hajra and Fearon, 2002). In many cases, E- 
cadherin frequently is lost or rendered dysfunctional by mechanisms that do not involve 
irreversible, genetic alterations. Hypermethylation of 5’ CpG islands, which is another 
mechanism by which the E-cadherin gene is silenced in normal cells as well as during the 
process o f carcinogenesis, has been demonstrated in many human cancers (Graff et al., 2000; 
Nass et al., 2000; Kanazawa et al., 2002; Ribeiro-Filho et al., 2002) including oral cancer (Saito 
et a l, 1998; Nakayama et al., 2001b; Chang et al., 2002; Chen et al., 2004).
Frequently in tumours, it has been shown that loss o f E-cadherin is transient and shows a 
heterogeneous and unstable dynamic pattern (Mareel et al., 1995); where, in some tumours, 
E-cadherin was absent in the primary tumour but re-expressed in the metastatic lesions of 
the same patient (Schipper et al., 1991). It is proposed that the microenvironment at the 
invasive front transiently downregulates E-cadherin and it is thought that this facilitation 
might contribute to the dynamic heterogeneity that drives metastatic progression (Berx and 
Van Roy, 2001). Similar mechanisms also might be responsible for the occurrence o f the 
cadherin switch (Chen et al., 2004). Regardless o f the precise mechanism, it appears that loss 
o f E-cadherin, indeed is required for the tumour cells to detach from the primary tumour,
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invade and metastasise and that there might well be re-expression o f E-cadherin, enhancing 
tumour-host adhesion, at the metastatic site (Guilford, 1999).
Disruption of the cadherin/catenin complex, as a result o f any o f the proposed mechanisms, 
has been demonstrated in a wide range o f carcinomas and was found to be correlated with 
various pathological and clinical features, such as de-differentiation, infiltrative growth, 
lymph node metastasis and poorer patient prognosis (Berx and Van Roy, 2001).
1.4.2.2.6 E-cadherin and Oral Squamous Cell Carcinoma (OSCC)
Up to date there have been a limited number o f studies which have correlated the expression 
o f E-cadherin with the behaviour o f head and neck tumours. In oral squamous cell 
carcinoma (OSCC) loss o f cadherin expression also has been shown to be associated with 
tumourigenicity and tumour progression (Thomas and Speight, 2001). In different tumour 
cell lines, restoration o f E-cadherin expression resulted in reduced invasiveness (Miyaki,
1995), growth suppression (St Croix et a l, 1998), and terminal differentiation (Zhu and Watt,
1996).
In an attempt to correlate the expression o f E-cadherin and (3-catenin with the clinical 
progression and prognosis o f cancer, Bankfalvi et al (2002) found that there is a perturbed 
expression o f E-cadherin and (3-catenin during the stepwise course of OSCC, dysplastic 
lesions showed general transient increase in the immunoreactivity o f all adhesion molecules 
and only some showed restricted loss o f E-cadherin and (3-catenin; indicative o f at least two 
possible mechanisms that could be involved in the malignant transformation o f oral 
epithelial cells: expansion o f the germinative basal cell layer, which normally express high 
levels o f E-cadherin and (3-catenin, and the de novo inactivation o f the respective genes by 
mutation (Bankfalvi et al., 2002). As tumours acquire an invasive phenotype, there was a 
marked reduction o f both E-cadherin and (3-catenin especially in poorly differentiated
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tumours which was consistent with the findings o f others (Sakaki et al., 1994; Sorscher et al., 
1995; Yamada et al., 1997; Williams et al., 1998; Lo Muzio et al., 1999). Loss of E-cadherin in 
poorly differentiated OSCC lesions usually is accompanied by loss o f P-cadherin, a- and y- 
catenins and (31 -integrin (Bagutti et al., 1998; Williams et al., 1998). In the majority o f OSCC 
lesions, E-cadherin was lost at the advancing front o f the tumour; localisations which play a 
role in determining the aggressiveness o f oral tumours (Downer and Speight, 1993; Bankfalvi 
and Piffko, 2000; Bankfalvi et al., 2002). Alternatively it could be that this is suggestive of the 
possible molecular cross-talk between the tumour cell and the surrounding micro- 
enviroment o f the host (Bryne et al., 1998; Bankfalvi and Piffko, 2000; Bankfalvi et al., 2002). 
However, in general E-cadherin has shown an heterogeneous distribution patterns. Thus 
Downer and Speight (1993) found varied expression with no correlation between the pattern 
of staining and the histological grade o f the tumour. However some infiltrative islands and 
tumour cells were found to be negative suggesting, perhaps, that E-cadherin could be 
implicated in the infiltrative process (Downer and Speight, 1993). Similarly, Kudo et al. (2004) 
had also observed an heterogeneous downregulation o f E-cadherin within metastatic areas 
and at the invasive front o f OSCC resulting from hypermethylation o f the E-cadherin 
promoter (Kudo et al., 2004). Indeed methylation of the E-cadherin promoter is accountable 
for about 67% of nodal metastasis in OSCC (Chang et al., 2002).
Reduction or loss o f E-cadherin expression has been associated with poor differentiation and 
higher metastatic potential o f OSCC (Mattijssen et al., 1993; Shinohara et al., 1998; Hoteiya et 
al, 1999), as well as the development o f the malignant phenotype, characterised by loss of 
the epithelial morphology and the acquisition o f mesenchymal characteristics (Yokoyama et 
al., 2003).
Regional and lymph node metastasis has been the most important diagnostic factor in 
predicting OSCC outcome (Jones et al., 1993). Schipper et al. (1991) found that metastatic
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lymph node deposits, whether they were derived from well or poorly differentiated tumours, 
were generally E-cadherin negative (Schipper et a l 1991). In contrast to these findings, 
Bowie et al. (1993) and Sorscher et al. (1995) had found that metastatic tumour deposits in 
lymph nodes showed the same pattern o f staining as the primary tumour (Bowie et al., 1993; 
Sorscher et al., 1995). E-cadherin expression also has been used in attempts to predict patient 
survival. In OSCC loss o f E-cadherin has been correlated with clinical stage and the 
increased incidence o f occurrence o f metastatic lesions (Yamada et al., 1997; Tanaka et al.,
2003) which in itself is associated with poor survival. Mattijssen et al. (1993) found significant 
correlation between strong E-cadherin expression and improved patient survival whereas 
others found no such correlation (Mattijssen et al., 1993).
Epithelial-mesenchymal transition has not been well studied in OSCC, however, it has been 
suggested the activation o f the W nt family, in OSCC, might be a contributory factor to such 
changes (Lo Muzio, 2001; Uraguchi et al., 2004).
In OSCC there is a strong correlation between reduced E-cadherin expression, or loss, and 
increased invasiveness, where the E-cadherin molecule is considered to act as a tumour- 
suppressor (Mattijssen et al., 1993; Birchmeier and Behrens, 1994; Andrews et al., 1997; 
Hoteiya et al., 1999; Kudo et al., 2004). However, Kinsella et al. (1994) found no correlation 
between E-cadherin expression and invasiveness when commencing invasion assays on cell 
lines derived from tongue SCC (Kinsella et al., 1994).
E-cadherin however often is considered to function as a tumour suppressor gene. The 
interference o f E-cadherin-mediated cell-cell contact formation by using anti-E-cadherin 
antibodies (St Croix et al., 1998), incubation o f cells in a low-calcium culture medium (Kantak 
and Kramer, 1998), or by modulation of cell density (Takahashi and Suzuki, 1996) has 
abrogated the growth-inhibitory effects mediated by E-cadherin.
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Inappropriate expression o f the non-epithelial/mesenchymal cadherin (N-cadherin) was 
shown in OSCC (Islam et al., 1996; Chen et al., 2004). These cell lines exhibited a fibroblastic 
phenotype and showed reduced expression of E-cadherin. The actual mechanism by which 
this cadherin-switch takes place is still not known. However, Chen et al. (2004) showed that 
hypermethylation of the E-cadherin promoter is a possible mechanism (Chen et al., 2004).
1.4.3 Integrins
Integrins are a large family o f heterodimeric, cation-dependent, transmembrane cell-surface 
proteins. Each integrin consists o f an a and (3 glycoprotein subunit non-covalently associated 
(Hynes, 1992; Sonnenberg, 1993). There are about 19 a and 8 (3 subunits which have been 
identified. Many integrin a and (3 subunits have the ability to associate with more than one 
partner, resulting in redundancy o f integrin heterodimerisation. For example, the p i subunit 
can dimerise with about 12 a subunits and the a6 subunit can dimerise with pi and p4 
subunits. About 24 integrin receptors have been recognised and each exhibits a different 
ligand profile (for review see: Hynes, 2002). Integrins also express a high degree of 
redundancy in ligand binding. Most integrin heterodimers recognise several ECM proteins, 
whereas the a5pi integrin binds only to fibronectin (Wehrle-Haller and Imhof, 2003). Figure
1.3 illustrates the known ap integrin combinations with their ligand interactions.
In the epidermis o f the skin, integrin expression mostly is confined to the basal layer. The 
most abundant integrins expressed by normal keratinocytes are a2pi, a3pi and a6p4 
((Bagutti et al., 1998)). Basal cells have also been reported to express other integrins such as 
a8pi and a9pi (Bossy et al., 1991; Ojakian and Schwimmer, 1994). Reports on a5pi integrin 
expression in the epidermis have been contradictory. Klein et al. (1990) found that a5pi was 
not expressed, however, on the other hand Hertle et al. (1991) found weak pericellular 
expression in the basal keratinocytes (Klein et al., 1990; Hertle et al., 1991). There is some
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evidence suggesting that the oc5(31, if present, may not be fully functional (Guo et a l, 1991). 
Moreover, Hertle et al (1991) also demonstrated weak pericellular expression of ocv(35 in basal 
keratinocytes (Hertle et al., 1991).
a2(31 and a3(31 are components of focal contacts in keratinocytes (Carter et a l, 1990) and 
they both have a pericellular distribution (Zambruno et al, 1991; Watt and Jones, 1993). High 
levels o f a2(31 have been demonstrated in proliferating epithelium; indicative o f a possible 
role for this integrin in promoting cell proliferation (Zutter and Santoro, 1990). 
a6(34 integrin is a component of the hemidesmosomes and is expressed at the basal aspect of 
the basal cells with lower expression at the lateral aspects o f the cell (Hertle et a l, 1991).
In oral epithelium, integrin expression showed a similar pattern. Oral keratinocytes showed 
strong expression of a2(31, a3(31 and a6(34 with weaker and more variable expression o f a5(31 
and av(35 (Jones et a l, 1993). a6(34 is relatively confined to the basal aspects of the basal cells 
whereas the other integrins have a uniform pericellular distribution in the basal cells. In 
gingival epithelium a6(34 showed a strong linear staining along the basement membrane zone 
(Hormia et a l, 1990). Larjava (1991) reported strong pericellular expression of a2, a3 and (31 
in the basal layer with low expression o f a5(31 (Larjava, 1991).
In contrast to the epidermis o f the skin where integrin expression largely is confined to the 
basal cells, oral epithelium showed an extensive suprabasal staining, particularly in the floor 
o f the mouth and lateral borders o f the tongue (Jones et a l, 1993, Jones et a l, 1995). In these 
areas integrin expression is seen to be as high as in the prickle cell layer, possibly indicative of 
the increased turnover rate o f the oral epithelium.
In tissue culture, keratinocytes were shown to express a2(31, a3(31, a5(31, a6(34, av(35 and 
av(36 (Adams and Watt, 1991; Haapasalmi et a l, 1996).
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Table 1.2: Epithelial integrins
Integrin Ligand Reference
a2pi Collagen type I (Wayner and Carter, 1987)
Collagen type IV (Carter et al., 1990)
Laminin 1 (Languino et al., 1989)
oe3|31 Laminin 1 (Carter et al., 1990)
Laminin 5 (Carter et al., 1991)
oc5(31 Fibronectin (Adams and Watt, 1991)
a6£4 Laminin 1 (Niessen et al., 1994)
Laminin 5 (Niessen et al., 1994)
a9pl Tenascin (Yokosaki et al., 1994)
Vitronectin (Weinacker et al., 1995)
av{35 Vitronectin (Adams and Watt, 1991)
avj36 Fibronectin (Busk et al., 1992)
Vitronectin (Thomas et al., 2002)
Tenascin (Thomas et aL, 2002)
Latency-associated peptide (LAP) (Thomas et al., 2002)
All integrins, except for a6{34, mediate adhesion via the actin cytoskeleton of the cell.
1.4.3.1 Integrin signalling
In addition to their role as cellular mechanical anchors, integrins also mediate bi-directional 
intracellular signalling (for review see: Hynes, 2002; Lee and Juliano, 2004).
Engagement of cells with the ECM proteins via integrins is crucial for transduction of a 
variety of signal events that serve to modulate many biological processes, including cell 
adhesion, spreading, cell shape, polarity, proliferation, differentiation, migration, 
survival/apopotosis and gene induction, contributing to maintenance of tissue integrity,
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embryogenesis, wound healing and the metastasis o f tumour cells (Hynes, 2002; Juliano, 
2002).
Interaction of integrins with ECM proteins initiates clustering o f integrins and recruitment of 
intracellular signalling molecules and actin filaments (Hynes, 2002). Integrins interact with 
different intracellular sigalling molecules, such as focal adhesion kinase (FAK), Erk and c-Jun 
kinase QNKs), MAP kinases, and Rho GTPase family members (RhoA, Racl and Cdc42) 
(Juliano, 2002; Lee and Juliano, 2004).
One o f the major functions o f an integrin is to link ECM proteins to the actin cytoskeleton 
o f the cell by virtue o f interactions o f the integrin cytoplasmic tail with actin binding 
proteins, such as talin, filamin, integrin-linked kinase (ILK), and a-actinin (Pozzi and Zent,
2003). Through these interactions, integrins mediate actin filament reorganisation (Coppolino 
and Dedhar, 2000), as well as mediating signals critical for cell growth, survival, migration 
and cell polarity. Also, integrin-mediated cell adhesion regulates formation, turnover, and 
linkage o f the actin cytoskeleton via stimulation o f the Rho small GTPase family members 
including RhoA, Racl and Cdc42 (Lee and Juliano, 2004). During early stages o f adhesion, 
integrins mediate the protrusion o f the cell membrane through activation o f Racl and Cdc42, 
followed by the adhesion/spreading phase which involves RhoA activation and increased 
contractility. O n the other hand, assembly o f integrins and associated proteins in focal 
adhesion contacts is mediated by members o f the Rho small GTPases (Hotchin and Hall, 
1995; Hotchin and Hall, 1996). Mechanisms o f integrin-dependent activation o f the Rho 
GTPases are being actively studied.
A nother major function o f integrins is promoting cell survival in an anchorage-dependent 
manner, whereby engagement o f the integrin with ECM proteins mediates survival signals in 
the cell (Frisch and Screaton, 2001). Cells that lose integrin-mediated attachment with the 
ECM undergo apoptosis. Adhesion o f integrin receptors with ECM generates survival signals
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and blocks apoptosis via PI3-kinase and Akt (King et al., 1997) and stimulates cell cycle 
progression via ERK  and cyclin D1 (Hynes, 2002). In tumours, anchorage-z/zdependent 
survival is a hallmark o f neoplastic transformation and is critical for tumour progression. In 
transformed cells survival signals generally are mediated by oncogenes or by loss o f tumour 
suppressor genes (Lukashev and Werb, 1998).
1.4.3.2 Integrals in tumours
There is a large body o f literature providing evidence that integrins dictate the malignant 
behaviour o f tum our lesions. In general, integrins are implicated in different biological 
processes o f great significance to tumourigenesis, such as migration, proliferation, protease 
production, apoptosis and angiogenesis (Marshall, 2000). Different tumours show different 
integrin expression profiles, probably reflecting the biological activity o f each tumour. 
Variable loss o f a2(31, a3(31, av^5 and a6(36 has been reported in many carcinomas (Pignatelli 
and Bodmer, 1990; Koretz et al., 1991). Loss o f polarised integrin expression has been 
observed constantly in all tumours, for example a6(31 and a6(34, normally expressed at the 
basolateral domain o f epithelial cells, showed a uniform distribution and loss o f polarity in 
transformed malignant cells (Keely et al., 1998). Increased expression o f av(33 and av(36 has 
been reported in several carcinomas and the presence o f these heterodimers has been 
thought to contribute to the development o f a more malignant phenotype (Albelda et al., 
1990; Felding-Habermann et al., 1992; Seftor et a l, 1993; Agrez et al., 1994; 1996; Thomas et 
al., 2001). The a5(31 integrin plays a complex role in tumour progression. Restoration of a5(31 
integrin expression was shown to inhibit anchorage-independent growth o f malignant cells 
(Giancotti and Ruoslahti, 1990). However, it also was reported that a5(31 integrin plays an 
im portant role in cell survival and inhibition o f apoptosis (Zhang et al., 1995).
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So as a general rule, tumours tend to retain or express integrins that support the malignant 
phenotype, for example those involved in increased cell migration, and lose expression of 
integrins known to maintain tissue organisation and stable adhesion.
1.4.3.3 Integrins in OSCC
In OSCC, integrins show variable expression between tumours and within different areas of 
the same tum our (Jones et a l, 1993; Jones et al., 1997; Cortesina et a l 1995; Thomas et a l,
1997). As with other carcinomas, focal and extensive loss o f a2(31, a3(31, av(35 and a6f36, has 
been associated with the poorly differentiated OSCC lesions and loss o f the a6(34 correlated 
with the loss o f basement membrane integrity (Downer et a l, 1993). However, others 
reported retained expression o f the a6(34 integrin in highly malignant head and neck 
carcinoma (Cortesina et a l, 1995), probably indicative o f a failure o f the transformed cells to 
differentiate rather than a true upregulation o f the a6(34 (Thomas and Speight, 2001). 
Moreover, in vitro studies showed high expression of a6(34 integrin consistent with epithelioid 
colonies in head and neck carcinoma (Tomson et a l, 1996). Alterations in localisation and 
expression o f a6-integrin were also observed, with a relative increase in a6-integrin 
expression compared to the (34-integrin subunit, in both premalignant and malignant oral 
mucosa (Garzino-Demo et a l, 1998). Also, strong expression o f a2-, a3-, a4-, a5- and a6- 
integrin subunits have been oberved in metastatic OSCC cell lines as compared to non­
metastatic cell lines (Shinohara et a l, 1999).
Alteration o f av-integrin has also been observed in OSCC (Jones et a l, 1997). Thus the avj36 
integrin, which normally is not expressed by normal epithelium, was expressed in OSCC and 
was correlated with increased motility and invasiveness (Breuss et a l, 1995; Jones et a l, 1997), 
whereas av^5 integrin showed a reduced expression in OSCC as compared to the normal 
epithelial cells (Jones et al, 1993; Jones et a l, 1997). The av-integrin might be o f significant
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importance in OSCC as it has been reported that re-expression o f this particular integrin has 
reversed the malignant phenotype (Jones et al., 1996b; Thomas et al., 1997; 2001).
1.5 Synergy and cross-talk between E-cadherin and integrins
Molecular cross-talk is a term used to refer to the concept o f two different classes of 
adhesion molecules signalling to each other. There is growing indication o f cross-talk 
between different CAM families. In a multicellular environment, the collaborative actions of 
multiple CAMs are essential to maintain tissue balance and homeostasis.
In cultured keratinocytes, inhibition o f E-cadherin-mediated cell-cell contacts resulted in 
decreased integrin expression in proliferating cells and de novo expression by differentiating 
cells (Hodivala and Watt, 1994). Moreover, downregulation o f E-cadherin levels in 
keratinocytes showed a concomitant decrease in the expression o f a2(31 and a3(31 integrins 
and enhancement o f cell motility (Zhu and Watt, 1996). Recently, Hintermann et al. (2005) 
provided evidence o f a potential cross talk between E-cadherin and the a6f34 integrin, where 
activation o f the a6(34 integrin resulted in an augmentation o f the E-cadherin-dependent cell­
cell contacts and a concomitant decrease in cell motility (Hintermann et al., 2005).
Evidence o f cross-talk between adhesion receptors has a particular relevance to malignant 
epithelial cells that show decreased levels o f adhesion molecules complemented with 
increased motility and invasiveness potential. In malignant lesions there is a strong 
suggestion that loss o f E-cadherin and integrins are closely related. Bagutti et al. (1998) found 
that E-cadherin, but not P-cadherin, strongly associated with integrin expression and tumour 
differentiation; indicative that downregulated expression levels o f E-cadherin and integrins 
are likely to confer selective growth advantage in squamous cell carcinoma and possibly are 
correlated with poor prognosis (Bagutti et al., 1998).
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One possible mechanism pertaining to the cross-talk between cadherins and integrins 
involves ILK. ILK interacts with the cytoplasmic domain o f (31 and (33 integrins (Dedhar et 
al., 1999). It has been reported that epithelial cells overexpressing ILK showed additional 
activation o f the W nt signalling pathway, and dramatic reduction in E-cadherin expression 
accompanied by loss o f cell-cell contacts and increased invasion (Novak et al., 1998; 
Huttenlocher et al., 1998; Wu et al., 1998). Thus, such findings provide an interesting 
potential connection between cadherins and integrins.
Decoding the underlying mechanisms by which this adhesion molecules cross-talk may 
provide a better understanding o f mechanisms relevant to tumour differentiation, invasion 
and metastasis.
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Figure 1.1
Schem atic representation of the Cadherin Superfamily
a-cat: a-catenin; {3-cat: (3-catenin; PG: plakoglobin; PP: plakophilin; Vine: vinculin; IF: 
intermediate filaments; DP: desmoplakin. Desmosomal cadherins (Desmocollins and 
Desmogleins) can bind DP via PG or PP. Classical and desmosomal cadherins are 
represented as dimers, while other cadherins are represented as monomers because of 
lack of evidence as to how they bind. VE-cadherin is known to bind to both the actin 
cytoskeleton and to the intermediate filament network; for simplicity only one interaction is 
illustrated (Angst et al., 2001).
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Figure 1.2
Schem atic rep resen ta tion  o f the m ature E -C adherin  m olecule
E-cadherin molecules in one cell appear as dimers interacting with E-cadherin molecules on 
adjacent cells forming the “Adhesion Zipper”. Intracellularly, E-cadherin interacts with the 
actin cytoskeleton o f the cell via cytoplasmic plaque proteins named the catenins (a-, (3-, y- 
catenin and p!20ctn).
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Figure 1.3
Schem atic representation  o f the in tegrin  family and ligands
The figure illustrates the mammalian integrin subunits and their a(3 associations, which are 
subdivided further into groups according to their ligand-specificity (adapted from Hynes,
2002).
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CHAPTER 2 
Materials and Methods
2.1 Cell Culture
Routine tissue culture provides a core facility for the development, maintenance and 
provision o f cultured cells. Cultured cells must be provided with an appropriate surface for 
attachment, promoting cell seeding and spreading, presence o f exogenous serum containing 
the necessary nutrients and culture conditions that enable an adequate mass transfer of 
nutrients and oxygen along with waste removal.
2.1.1 General principles
Cell culture was carried out in a laminar flow hood which provided a sterile environment. 
The hood was decontaminated with 70% ethanol before and after each work session. All 
tissue culture reagents were filter- sterilised using a 0.22pm syringe-driven or vacuum driven 
filters (MILLIPORE, Watford, UK) and stored in a sterile container at 4°C. Upon use, media 
were pre-warmed in a 37°C water bath. Cells were grown in an humidified atmosphere and 
8% CO , at 37°C in incubators. Closed-front lab coats and gloves were worn routinely.
2.1.2 Cell lines and growth requirements
All cell lines used were derived from oral squamous cell carcinomas. H357 is an OSCC line 
derived from the lateral border o f the tongue and H376 is an OSCC line derived from the 
floor o f the mouth. Both lines were provided by Professor S. Prime (Prime et al!, 1990). 
H376(34 is an H376 cell line previously transfected with the [34-integrin subunit (Jones et al 
1996a).
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Cells were grown in either full- or antibiotic-supplemented keratinocyte growth medium 
(KGM) (Appendix I). The cell lines and their growth requirements are shown in Table 2.1.
Table 2.1: Cell Lines: Origin and growth requirem ents
Cell Origin M edium Supplements
lines
H357 Oral keratinocytes derived from a squamous cell 
carcinoma of the tongue (Prime et al., 1990)
KGM Nil
H376 Oral keratinocytes derived from a squamous cell 
carcinoma of the tongue (Prime et al., 1990)
KGM Nil
H376(34 H376 transfected with (34 integrin subunit (Jones 
et al., 1996a)
KGM G418 
1 mg/ml
IA2 H376 transfected with empty vector KGM G418
1 mg/ml
2.1.3 Cell Culture
2.1.3.1 Cells growing on tissue culture plastic
Cells were grown as adherent monolayers in sterile, serum-coated tissue culture flasks 
(Nunc/Falcon) in an humidified atmosphere and 8% C 0 2 at 37°C in incubators. Cells were 
subcultured, when they were 80-90% confluent, 1-3 times a week, at a ratio 1:2 to 1:10 
depending on the growth rate. After removal of the spun medium, cells were washed once 
with PBS washing buffer (Appendix I), then 2ml of trypsin/EDTA (0.05% trypsin (w/v) /  
5mM EDTA) were added to the cells for 3-5 minutes at 37°C. Once the cells had been 
detached from the plastic, the trypsin was inactivated by serum-containing medium. Cells 
were spun at 1,200 rpm for 3 minutes, supernatant was discarded, and then cells were 
resuspended in fresh medium and transferred to new flasks.
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2.1.3.2 Cells growing in 2-D/3-D collagen I cultures
2-dimensional (2-D) and 3-dimensional (3-D) Type I collagen cultures were established as 
illustrated in Figure 2.1. Collagen I, rat tail (Upstate Cell Signalling Solutions, Milton Keynes, 
UK) mix was prepared at a final concentration o f 2.9 m g/m l. K ept on ice, the collagen I was 
mixed with lOx MEM (ICRF, Clare Hall Labs., South Mimms, UK), 0.34N N aO H  and 
Foetal calf serum (FCS) in an 8:1:1:1 ratio.
For formation o f the 2-D substrate, 25pl o f the collagen I mix was spread evenly, with the 
aid o f a pipette tip to ensure an even lining, on the bottom  of each well in a 24-well plate. 
The plates were incubated for 45 minutes at 37°C; to allow for the collagen I mix to set. 
Then 2x104 cells were seeded on top o f the set matrix and fed with 2ml selection medium. 
For 3-D cultures, 2x104 cells were embedded in 500pl o f the collagen I mix prior to setting. 
The plates were incubated for 45 minutes at 37°C before adding 2ml selection medium. Cells 
in both 2-D and 3-D collagen I cultures were allowed to grow until harvested using 
collagenase 1 enzyme (Worthington Biochemical Corporation, Lakewood, NJ, USA) for 
counting or for obtaining total cell lysates.
2.1.4 Storage and recovery of liquid nitrogen stocks
2.1.4.1 Cryopreservation of cell culture
Cultures can be preserved effectively in the presence o f a cryoprotectant, such as
dimethylsulphoxide (DMSO), which reduces the damage from ice crystals (Brown, 2000).
Cells to be stored were harvested in log phase growth. Following trypsinisation, cells were 
washed in complete medium and resuspended in medium containing 10% DMSO (Sigma- 
Aldrich, Dorset, UK) at l-2x !06 cells per ml. One ml o f cell suspension was placed in a Nunc
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cryotube in an insulated container and placed at —80°C for 8 hours, before transferring vials 
to —196°C liquid nitrogen for long-term storage.
2.1.4.2 Thawing cell stocks
Cryopreserved cells are fragile and require quick thawing and immediate retrieval into full 
medium. Vials to be recovered from liquid nitrogen were placed in a water bath at 37°C to 
thaw rapidly. As soon as the vial contents were thawed they were transferred to 15ml tubes 
(Falcon) containing 10ml o f pre-warmed KGM  and centrifuged at 1,200 rpm  for 3 minutes. 
The supernatant was removed to get rid o f cryopreservative and cells were resuspended in 
lm l o f KGM  and transferred to a 75cm2 flask containing fresh medium. If  cells required 
drug selection pressure, selection medium was used once growth in culture was re­
established.
2.1.5 Cell counting
As a part o f standardising a proper experiment, cell counting is the commonly used method 
to quantify cells in a cell culture. There are two methods used to count cells: the 
haemocytometer and the automated cell counter.
2.1.5.1 Cell counting using an haemocytometet
Cell count was obtained by placing harvested cell suspension under a girdded, optically flat 
chamber viewed under the microscope. Different defined fields o f cells, within the confines 
of the grid, were counted. The cell concentration was obtained from the count. Along with 
this m ethod “Trypan blue exclusion” was used to determine cell viability. Viable cells are 
impermeable to trypan blue dye, while non-viable cells, characterised by breakdown o f the 
cell membrane, uptake the dye and appear blue under the microscope. 0.4% (w/v) Trypan
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blue dye (Sigma-Aldrich) was added 2 minutes prior to counting a time just enough to allow 
for staining o f non-viable, but not viable, cells.
2.1.5.2 Cell counting using an automated cell counter
Harvested cells were counted on a CASY automated cell counter (Sharfe System, Reutlingen, 
Germany). Basically, cells suspended in isotonic buffer (Coulter Euro Diagnostics GMBH, 
Buckinghamshire, UK) were passed through a fine orifice changing a current flow which 
produces a series o f pulses that are sorted and counted.
2.2 Analysis of the whole cell
2.2.1 Flow cytometry (FACS analysis)
Flow cytometry is a commonly used method for characterising and separating individual
cells. It provides a technology that can deliver rapid, quantitative, multi-parameter analyses
on a single cell based on measurement o f fluorescent light emission intensity, produced by 
fluorescent-labelled antibody bound to a specific cell-associated molecule, using a flow 
cytometer.
2.2.1.1 FACS analysis for E-Cadherin
Cells to be labelled with E-Cadherin monoclonal antibody “H ECD -1” (M. Takeichi, Tokyo, 
Japan) were allowed to reach confluence, washed twice in PBSA containing ImM  calcium 
chloride, ImM  magnesium chloride (PBSABC) (Appendix I) and incubated in EDTA free 
trypsin (0.1% (w/v) (Sigma-Aldrich) supplemented with ImM  calcium chloride for 25-30 
minutes (adapted from Takeichi, 1997), conditions which minimise the proteolysis o f the 
extracellular domain o f E-Cadherin. Antibodies used were diluted in PBSABC containing
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10%FCS, which also was used as a washing buffer. Dissociated cells were incubated with 
primary antibody for 60 minutes at 4°C and washed twice with 10%FCS-PBSABC washing 
buffer. Alexa 488-conjugated goat anti-mouse IgG secondary antibody (Molecular Probes, 
Paisley, UK) was applied to the cells for 45-60 minutes at 4°C. The cells were then washed 
three times with 10%FCS -PBSABC washing buffer and resuspended in 0.5ml PBS 
containing 10% FCS. Control samples were labelled with Mouse IgG l negative control 
(DakoCytomation Ltd., Cambridgeshire, UK). Labelled cells were scanned on a FACScaliber 
Cytometer (BD Bioscience, Oxford, UK) connected to an Apple Macintosh computer fitted 
with Cellquest software, acquiring lxlO 4 events. With each cell line, the same settings were 
used for each experiment.
2.2.1.2 FACS analysis for Integrins
Subconfluent cells were washed twice with PBSA and harvested by trypsin/ED TA  (0.25% 
w /v , 5mM). The cells were washed once in PBSA 0.1% heat-inactivated BSA and 0.1% 
Azide (0.1/0.1 blocking/washing buffer), incubated with primary antibody for 60 minutes at 
4°C and washed twice with 0.1/0.1 washing buffer. Alexa 488-conjugated goat anti-mouse 
IgG secondary antibody (Molecular Probes) or FITC-conjugated Rabbit anti-Rat 
Immunoglobulin secondary antibody (DakoCytomation Ltd.) were applied to the cells for 45 
minutes at 4°C (a complete list o f antibodies used in this experiment is given in Appendix II, 
Table 2). The cells were then washed three times with 0.1/0.1 blocking buffer and 
resuspended in 0.5ml PBSA containing 10% FCS. Control samples were labelled with Mouse 
or Rat IgG l negative control (DakoCytomation Ltd.). The procedure was as described 
previously in Section 2.2.1.1.
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2.2.2 Indirect immunocytochemical staining
A suspension o f 2x104 cells was plated on uncoated 13mm glass coverslips in 24-well plates 
and cells were allowed to grow for 48 hours in complete medium. Cells were rinsed twice in 
PBSABC, fixed for 15 minutes in 4% formaldehyde (BDH Laboratories, Poole, UK), rinsed 
once with PBSA. Cells were then permeabilised using 0.1% Triton X-100 (Sigma-Aldrich) for
3-4 minutes at room  temperature, rinsed once with PBSA and blocked with PBSA containing 
0.1% heat-inactivated BSA and 0.1% Azide (0.1/0.1 blocking/washing buffer) for 30 
minutes at room  temperature. Antibodies used (Appendix II, Table 2) were diluted in 0.1 /0.1 
blocking buffer. 200pl o f the diluted primary antibody was used to cover one coverslip in 24- 
well plate; otherwise, the coverslip was inverted on a 20pl drop placed on parafilm (a cost- 
effective method). The coverslips were incubated with the primary antibody for 60 minutes 
at 4°C. Then, the cells were washed three times with 0.1/0.1 blocking buffer. The coverslips 
must not be allowed to dry at any time. Secondary antibody, also diluted in 0 .1 /0A blocking 
buffer, was added for 60 minutes at 4°C. F-actin was visualised using phalloidin- 
tetramethylrhodamine isothiocyanate “phalloidin-TRITC” 50 ng/m l (Sigma-Aldrich: 
5ng/ml), or using Alexa Fluor ® 647 phalloidin (Molecular probes: Invitrogen Ltd., Paisley, 
UK) while nuclei were detected with 4 \  6-a diamidino-2-phenylindole dihydrochloride 
“D API” (Polyscience Inc., Warrington, PA, USA). The coverslips were incubated with the 
counterstains for 10 minutes at room  temperature. The coverslips were washed three times, 
for 5 minutes each, in washing buffer and mounted with M OW IOL 4-88 (O.lg/ml dissolved 
in 25% (v/v) Cidfluor AFI (Citifluor Ltd, London, U K )/ 100 mM Tris-HCL pH 8.5) and 
viewed with a confocal inverted laser scanning microscope (Zeiss Axiovert 200M: Welwyn 
Garden City, UK).
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2.3 Analysis of cellular proteins by Western blotting (WB)
Western blot analysis is used to determine some im portant characteristics o f a protein 
antigen, including: the presence, the quantity and the molecular weight. Polyacrylamide gel 
electrophoresis separates individual proteins based on their size, shape and charge. 
Transferring separated proteins allows for detection o f specific proteins using specific 
antibodies.
2.3.1 Preparation of whole cell lysates of cells growing on plastic
Confluent and subconfluent cells were washed twice in PBSABC. A 1ml solution o f RIPA 
buffer containing Protease inhibitor (Appendix I), was added to each 75cm2 flask and the 
cells were scraped into a microcentrifuge tube, and incubated on ice for 1 hour. Lysates were 
cleared by centrifugation for 10 minutes at 13,000 rpm. Samples were stored at —70°C until 
use.
2.3.2 Preparation of whole cell lysates of cells growing in 2-D/3-D collagen I 
cultures
Cells were plated as described in Section 2.1.3.2 but with the cultures instead being set in 6- 
well plates. For the 2-D cultures 60pl o f the collagen I mix was spread on the bottom  of 
each well in a 6-well plate and a starting number o f 6x104 cells were seeded on top o f the set 
matrix and fed with 6ml selection medium. For 3-D cultures the same number o f cells was 
added to 1.5ml o f the collagen I mix prior to setting and 6ml selection medium were added 
after setting. Cells were allowed to grow for 5 days, until cells growing in 2-D collagen I 
cultures were about confluent and cells growing in 3-D collagen I cultures were sufficient to 
provide appropriate levels o f protein lysate as determined in preliminary experiments. Cells
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were retrieved from the collagen I culture prior to lysing, as follows: After washing the 
cultures, twice, with PBSABC, 500pl of collagenase 1 (Worthington Biochemical 
Corporation) were added to the 2-D cultures and 2ml to the 3-D cultures and incubated for 
about 1-2 hours at 37°C before cells were collected in 15ml Falcon tubes and spun down and 
the supernatant was discarded. To get rid of excess collagenase, the cell pellet was washed 
twice with PBSA. After the second wash the supernatant was discarded carefully and excess 
was removed using a 200pi pipette. RIPA buffer, containing Protease inhibitor, was added to 
the cell pellet and mixed. The lysates were transferred into a microcentrifuge tube, and 
incubated on ice for 1 hour. Lysates were cleared by centrifugation for 10 minutes at 4,000 
rpm. Samples were stored at —70°C until use.
2.3.3 Estimation of protein concentration
Protein concentration was estimated using the Bio-Rad DC protein assay (Bio-Rad, Hercules, 
Hertfordshire, UK), a colorimetric assay based on the Lowry assay, according to the 
manufacturer’s instruction. The assay depends on the reaction between protein and copper in 
an alkaline medium, and the subsequent reduction of Folin reagent by the copper-treated 
protein. A blue colour develops which is read at absorbance 650nm.
BSA protein standard solutions were set up at protein concentrations o f 0, 125, 250, 500, 
750, 1000, 1500 and 2000 pg/m l. 1ml reagent B was added, first, into 2.5ml SM Cuvettes 
(Kartell Plastics U K Ltd., Cambridge, UK), followed by 25pi o f standard solutions and lysate 
samples. 125pl o f reagent A' were added last. The tubes were incubated at room  temperature 
for 15 min and read at O D  650nm on a spectrophotometer (SLT Labinstruments GmbH, 
Salzburg, Austria) and the unknown protein concentration determined against the standard 
curve using UV WinLab software (PerkinElmer™ Molecular SPECTROPSCOPY, Boston, 
USA)
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2.3.4 Sodium Dodecyl Sulphate polyacrylamide gel electrophoresis (SDS-PAGE)
Cellular proteins were separated using a polyacrylamide gel m ounted on a vertical gel 
electrophoresis apparatus system (Xcell SureLock™ Novex Mini-Cell system: Ivitrogen Ltd.) 
and the 1mm thick gels assembled according to the manufacturer’s instructions.
The desired percentage o f acrylamide resolving gel (Appendix I) was poured into the gel 
cassette and covered with propan-2-ol to eliminate the air interface (which inhibits 
acrylamide polymerisation). The gel was allowed to polymerise for about 45 minutes, the 
propan-2-ol was poured o ff and the space on top o f the set gel was rinsed with 0.5M Tris 
(pH 6.8). 4% stacking gel (Appendix I) was poured, and allowed to polymerise for about 30 
minutes before placing the gel into the electrophoresis tank. The chamber was filled with 
SDS-running buffer (Appendix I). Samples were diluted in loading buffer (Appendix I), 
boiled for 10 minutes; the contents were collected by centrifugation and loaded using 
capillary disposable pipette tips. The gel was run for 10 minutes at 120 volts, then 140 volts 
for about 1 hour, until sufficient protein migration had occurred, as judged by the migration 
o f the loaded Molecular weight markers (Amersham Life Science, Buckinghamshire, UK) 
and the dye in the loading buffer.
After running the gel the assembly was dismanded and the gel carefully removed and 
equilibrated in transfer buffer (Appendix I).
2.3.5 Immunoblotting
After separation o f the protein sample on the polyacrylamide gel, the proteins were 
transferred to either a supported nitrocellulose membrane or a polyvinylidene difluoride 
(PVDF) membrane (Hybond™-C extra or Hybond™-P: Amersham Life Science), in a 
pattern reproducing the separation seen on the gel. The resolved gel was laid on the blot 
membrane and sandwiched between two 3MM Whatman Chromatography papers
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(Whatman Int., Maidstone, UK). Using a transfer cassette unit, the sandwiched gel was 
compressed in the cassette and assembled according to the m anufacturers instructions 
(XCell II™  Blot Module: Ivitrogen Ltd.). The cassette was immersed in transfer buffer. 
Proteins were transferred at 26 Volts for 2 hours.
Once the transfer was complete, depending on the primary antibody used, each blot was 
processed differently to generate an optimum signal. In general each blot was incubated in 
blocking solution, to minimise non-specific binding, for 1-2 hours with agitation. The blot 
was then incubated with the primary antibody diluted in a buffer with agitation for a variable 
length o f time. Then the blot was washed several times in washing buffer before incubation, 
with the appropriate HRP-conjugated secondary antibody diluted in a buffer, and then the 
blot was again washed for several times (a list o f primary antibodies used in this experiment 
is given in Appendix II, Table 3).
Specifically bound antibody was detected using enhanced chemiluminescence (ECL™, ECL 
plus™ or ECL™  advance: Amersham Life Science) on Kodak X-Omat film (Sigma-Aldrich). 
Images were scanned, and densitometry was performed by comparing treatment and control 
band densities using the image analysis program N IH  Image (NIH, USA).
2.3.5.1 General blocking protocol
To generate optimal signal the following blocking protocol was used with all antibodies listed 
in Table 2.4 (Appendix II), except when blocking for phospho-Akt (Thr 308), Racl and 
Cdc42. Protein was transferred to nitrocellulose membrane. After the transfer was complete, 
the membrane was rinsed once with ddLLO, then was incubated in 5% milk in PBSA 
blocking buffer (blocking buffer 1: Appendix I) for 2 hours at room temperature. Then, the 
blot was incubated with the primary antibody in blocking buffer over night, with agitation, at 
4°C. Then, the membrane was washed for four times in 0.05% PBSA-Tween (washing buffer
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1: Appendix I), 5 minutes for the first two washes and 10 minutes for the second two 
washes. The blot was then incubated with 1:1000 goat-anti-mouse HRP secondary antibody 
(BioSource United Kingdom, Nivelles, Belgium) diluted in 5% milk-PBSA blocking buffer 
for one hour at room  temperature. Finally, the blot is washed for five times in 0.05% PBSA- 
Tween, 5 minutes each, then developed using either ECL™  or ECL plus™ (Amersham Life 
Science).
2.3.5.2 Blocking for phospho-Akt (Thr 308)
50pg reduced sample protein were loaded in 12.5% polyacrylamide gel. Proteins were then 
transferred into nitrocellulose membrane which was washed in 0.05% TBS-Tween (washing 
buffer 2: Appendix I) for three times, 5 minutes each. The blot was incubated, with 1:1000 
primary antibody diluted in 1% BSA in 0.05% TBS-Tween blocking buffer (blocking buffer 
2: Appendix I), overnight at 4°C. Subsequently, the blot was washed for three times in 0.05% 
TBS-Tween, 5 minutes each, and then incubated with 1:1000 the goat-anti-Rabbit secondary 
antibody (BioSource United Kingdon) diluted in 5% milk-0.05% TBS-Tween blocking buffer 
(blocking buffer 3: Appendix I). To wash off excess secondary layer the blot was washed for 
three times in 0.05% TBS-Tween, 5 minutes each, then developed using ECL plus™ 
(Amersham Life Science).
2.3.5.3 Blocking for Racl
Sample were run in 15% polyacrylamide gel, the proteins were then transferred to 
polyvinylidene difluoride (PVDF) membrane. The membrane was rinsed twice with ddFLO, 
then was incubated in 3% milk in PBSA blocking buffer (blocking buffer 4: Appendix I) for 
2 hours at room  temperature. Subsequently, the blot was incubated with the primary 
antibody (anti-Racl “23A8” monoclonal antibody: Upstate Cell Signaling Solutions), diluted
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1:1000 in 3% milk-PBSA, with agitation, over night at 4°C, followed by two washes with 
ddH 20 ,  5 minutes each, and a final wash with PBSA for 10 minutes. The blot was then 
incubated with the 2° antibody diluted in 3% milk-PBSA, with agitation, for 1.5 hour at 
room  temperature. To minimise the high back ground, the blot was washed extensively. The 
blot was first rinsed, once, with ddH 20 ,  followed by three washes in ddH 20 ,  5 minutes each. 
Additionally, it was washed twice using 0.05% TBS-Tween for 10 and 5 minutes, 
respectively. Prior to development, using ECL plus, the blot was quickly rinsed using ddH20 .
2.3.5.4 Blocking for Cdc42
Sample were run in 15% polyacrylamide gel, the proteins were then transferred to 
polyvinylidene difluoride (PVDF) membrane. The membrane was rinsed twice with ddH 20 ,  
and then was incubated in 5% milk in 0.05% TBS-Tween blocking buffer for 1 hour at room 
temperature. Subsequently, the blot was incubated with the primary antibody (anti-Cdc42 
“3707” monoclonal antibody: diluted 1:250 in 0.01% TBS-Tween- no blocking reagent was 
added), with agitation, over night at 4°C. The blot was rinsed twice in 0.01% TBS-Tween and 
then washed using the same buffer for three times, 5 minutes each. The blot was then 
incubated with the 2° antibody diluted in 3% milk-PBSA, with agitation, for 1.5 hour at 
room temperature. Using 0.05% TBS-Tween, the blot was first rinsed twice, and then 
washed three times, 10 minutes each. Prior to development, using ECL plus the blot was 
quickly rinsed using ddH 20 .
2.3.6 Western blot recycling
To re-probe the same blot with different antibody (or to correct errors in incubation with the 
wrong antibody) the bound antibodies can be removed effectively from the membrane 
without affecting the immobilised proteins using stripping buffer (Re-Blot™ Western blot
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recycling kit: CHEMICON® international, Hampshire, UK). The blots were incubated with 
stripping buffer (diluted in distilled water at 1:10 ratio) at room temperature for 7 minutes 
with agitation. Following stripping the blots was blocked for 1 hour before incubating with 
primary antibody.
2.4 Molecular biology
Several molecular biological techniques were used in an attempt to isolate and clone E- 
cadherin cDNA to create a cell line, originally E-cadherin negative, that expresses functional 
E-cadherin molecules and further study the effect o f E-cadherin expression on the function 
o f this particular cell line.
2.4.1 RNA isolation and RT-PCR
2.4.1.1 RNA isolation
Total cellular RNA was extracted from the E-Cadherin positive H357 cell line (Sugiyama et 
al., 1993), using RNA STAT-60™ total RN A/m RN A  isolation reagent (Tel-Test “B” Inc., 
Friendswood, Texas, USA). Briefly, confluent cells in a 75cm2 flask were washed once with 
whole medium (KGM) and trypsinised using 3ml o f trypsin/EDTA . The trypsin was 
inactivated by 7ml fresh medium and cells were centrifuged at 1,200 rpm  for 3 minutes. 
Supernatant was removed completely and the pellet kept on ice for immediate use. 2ml of 
RNA STAT-60 (phenol and guanidinium thiocyanate in mono phase solution) were added 
and mixed to homogenise the cells, and the homogenate was stored at room temperature for 
5 minutes. 0.2ml o f chloroform per 1ml o f RNA STAT-60, was added, and the tube was 
shaken vigorously for 15 seconds, and then was incubated at room temperature for 3 
minutes. The mixture was centrifuged at 13,000 rpm for 15 minutes at 4°C, after which the
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homogenate was separated into two phases: colourless upper aqueous phase, containing total 
RNA, and a red lower organic phase, containing DNA and proteins. The aqueous phase was 
carefully transferred into a sterile microcentrifuge tube. 0.5ml isopropanol per 1ml RNA 
STAT-60 was added and the sample incubated at room temperature for 5-10 minutes, then 
centrifuged at 13,000 rpm  for 10 minutes at 4°C, to allow the RNA precipitate to form as a 
white pellet at the bottom  of the tube. The supernatant was removed completely, and the 
RNA pellet was washed by adding 1ml o f 75% ethanol, vortexed and centrifuged at 13,000 
rpm for 5 minutes at 4°C. The washing buffer was removed completely and the pellet was 
left to dry for 5-10 minutes. Then the RNA pellet was resuspended in 20pl ddH 20 ,  
incubated on ice for 30 minutes and vortexed every 5 minutes to dissolve RNA completely. 
The concentration and purity o f RNA was determined by absorbance at 260 and 280nm. A 
solution with an optical density O D 260 o f 1.0 contains 40pg RN A /m l, and the ratio O D 260 
/O D 280 o f ~ 1.8 specifies a clean preparation. Contamination with protein or salts leads to a 
lower ratio.
5pl o f sample were added to 995pl ddH 20 ,  and the concentration o f RNA was calculated 
using the following equation:
Final concentration o f RNA = Spectrophotometer reading at 260nm x dilution factor x 
conversion factor
Where: Dilution factor = 1000/5 = 200
Conversion factor = 40 pg/m l
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2.4.1.2 Reverse transcription of RNA to make complementary DNA (cDNA)
DNA complementary to the total RNA was synthesised using the SUPERSCRIPT First- 
Strand Synthesis System (GIBCO BRL®: Invitrogen Ltd.) that has been engineered to 
eliminate the RNAse activity that degrades mRNA during the first-strand reaction, 
lp l total RNA (2.34 pg/pi), 9pl DEPC-treated distilled water, lp l (0.5pg) o f oligo(dt)12_18 and 
lp l o f lOmM dN TP mix were added to a nuclease-free 0.5ml tube. The mix was incubated at 
65°C for 5 minutes, and then was chilled on ice for 2 minutes. The contents were collected 
by brief centrifugation. 4pl o f (5x) first-strand buffer, 1 pi RNAseOUT RNAse inhibitor and 
2pl o f 0.1 M D TT were added to the mix, mixed gendy and the contents were collected by 
centrifugation and incubated at 42°C for 1 minute, lp l o f SUPERSCRIPT II RT was added 
and the contents were mixed, and further incubated at 42°C for 1 hour. The reaction was 
terminated at 70°C for 15 minutes, followed by 2 minutes incubation on ice. The contents 
were collected by brief centrifugation. To increase the sensitivity o f PCR, the RNA template 
was removed by adding lp l o f RNAse H before proceeding to PCR, , and the mix was 
incubated at 37°C for 20 minutes.
2.4.2 Purification of cDNA product
cDNA was purified with a Microcon-100 column (MILLIPORE). The column was placed in 
a tube and 400pl ddH 20  with 2pg oil-free RT-product product was added. The column was 
spun at 2,200 rpm in a microfuge for 15 minutes, and two washes were performed. The 
column was then inverted in a new sterile Microcon tube, and the product was eluted by 
centrifugation at 2,200 rpm for 2 minutes, and ddH 20  was added to make up to lOpl 
solution.
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2.4.3 Amplification of cDNA using the polymerase chain reaction (PCR)
For cDNA amplification, 5pl of purified RT product was incubated in the presence of 100 
ng/pi of two specific primers (see below), lOmM of each of the four dNTPs (Sigma-Aldrich) 
and lp l of (6x) pfuTurbo®DNA polymerase (Stratagene, Cambridgeshire, UK) with 5pl 
reaction buffer (GeneSys Ltd., Surrey, UK). The mixture was made up to 50pl with ddH20 . 
The reaction mixture was thermal cycled in the DNA Thermal Cycler (Perkin Elmer, 
Wellesley, MA, USA) using the following setting parameters:
Segments Cycles Tem perature Tim e
1 1 95°C 5 minutes
95°C 1 minutes
2 30 63°C ^ 1 minutes
72°C 4 minutes
3 1 72°C 10 minutes
4 1 4°C Hold
The PCR product was purified with a Microcon-100 column prior to DNA restriction 
digestion.
Following amplification, lOpl of PCR products were added to 2pl DNA loading buffer 
(Appendix I) and electrophoresed as described below in Section 2.4.5.
The primers for determination of the E-Cadherin cDNA were obtained from the ICRF 
Oligonucleotide Synthesis Laboratory at Clare Hall (South Mimms, UK). The primer 
sequences were as follows
GCGCCCGGGCTCGAGTCGGCGTCCCCGGCCAGCCATGG E l (forward primer)
GCGCCCGGGCTCGAGGCATTTCCCAGCACATGGGTCTGG E2 (reverse primer)
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2.4.4 Preparation of the plasm id
The pIRES-puro plasmid was digested with Xho I restriction endonuclease (New England 
Biolabs, Hitchin, Hertfordshire) at the Multiple Cloning Site (MCS) (Figure 2.2) and was 
prevented from religation by dephosphorylation with alkaline phosphatase (New England 
Biolabs) as follows
Plasmid DNA was digested using 1 unit of Xho I restriction endonuclease enzyme per 1 pg 
of DNA at 37°C overnight (New England Biolabs) and used with the appropriate buffers 
supplied by the manufacturers. Xho I restriction enzyme is supplied in an inactive form and, 
to activate it, it has to be diluted to 1:10 dilution, and the volume of each reaction was 
adjusted accordingly as follows:
pIRES-puro Vector
Plasmid DNA (0.75 pg/p l)
DNA lOpl 7 pi
Xho I 6pi 8 pi
Buffer #  2 6pl 8pl
ddH 20  38pl 57pl
Total 60 pi 80 pi
Religation was prevented by dephosphorylation using alkaline phosphatase enzyme (New 
England Biolabs). 2pl alkaline phosphatase enzyme was added to the 80pl sample of the 
digested vector, incubated at 37°C for 30 minutes, then, another 2pl alkaline phosphatase 
enzyme was added, and the mix was incubated for another 30 minutes at 37°C, chilled on ice. 
The reaction was terminated by the addition of loading buffer.
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2.4.5 Agarose gel electrophoresis
Samples were run on 1% agarose gels prepared by adding lg  o f agarose (Amresco: NBS 
Biologicals, Huntingdon, UK) to 100ml o f lxT A E buffer (National Diagnostics, Hassle, 
Hull, UK) (Appendix I) and boiled in a microwave oven until the agarose was dissolved. On 
cooling for a few minutes 1 pg ethidium bromide (Sigma-Aldrich) was added and the solution 
poured into a flat gel former with a well-comb in place. Once the gel had set it was 
transferred to an electrophoresis tank and immersed in TAE buffer. Loading buffer 
(Appendix I) was added to the DNA solutions which were then loaded into the wells and 
electrophoresed at 100 V for 30 minutes. 5pl o f H inD III digested X. phage DNA ladder 
(New England Biolabs) were loaded in the first lane to enable DNA fragment size to be 
determined. The gel was transilluminated with ultraviolet (UV) light and the DNA bands 
were visualised and photographed using an EagleEye II camera, monitor and printer 
(Stratagene).
2.4.6 DNA recovery from agarose gel
The amplified gene o f interest (Section 2.4.3) and the linearised pIRES-puro plasmid (Section 
2.4.4) were recovered from the agarose gel and purified using the Q IAEX II kit (QIAGEN 
Ltd, Crawley, UK), according to the manufacturer’s instructions. DNA, contained in either 
aqueous solution or in an agarose gel in TAE buffer, was solubilised in a high salt buffer 
containing a chaotropic salt, which dissociates DNA from DNA binding proteins and 
solubilises agarose. DNA was adsorbed onto silica particles, any agarose was washed off with 
the original buffer, and salts were washed off in two washes with an ethanol-containing 
buffer. The silica particles were allowed to air-dry thoroughly, and the DNA was eluted with 
ddH 20 .
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2.4.7 Ligation of DNA fragment into vector
The purified cDNA and pIRES-puro plasmid were ligated using T4 D NA ligase enzyme 
(New England Biolabs). Ligation reaction comprised 1 unit T4 DNA ligase enzyme, lp l 
(lOx) T4 ligase buffer, a mixture o f insert and linearised vector DNA, made up to lOpl with 
dH 20 .  Reaction was carried out overnight at 16°C.
2.4.8 Transformation of bacteria
Plasmid DNA was chemically transformed into One Shot® Top 10 Chemically Competent E. 
coli (Invitrogen Ltd.), 2pl o f each ligation reaction were added directly into the competent 
cells and mixed by tapping gendy, and incubated on ice for 30 minutes. The vials were then 
incubated in the pre-heated water bath at 42°C and for exacdy 30 seconds, and then chilled 
on ice for 2 minutes. 450pl o f pre-warmed SOC medium (rich L-broth medium) were added 
to each vial. The vials were incubated at 37°C for exacdy 1 hour at 225 rpm in a shaking 
incubator. 100-200pl o f each transformation from the vials were spread onto 9cm Petri 
dishes containing LB agar (L-Broth with 1.5% (w/v) agar) with ampicillin at a final 
concentration of 100 pg/m l. The plates were inverted and allowed to dry, then incubated at 
37°C overnight.
2.4.9 Small-scale preparation of DNA (“minipreps”)
For preliminary analysis, plasmid DNA was prepared from bacteria, using QIAprep® 
Miniprep plasmid D NA purification system (QIAG EN Ltd.), the microcentrifuge spin 
procedure, according to the manufacturer’s instructions. In this protocol, plasmid DNA is 
extracted from bacterial cells using alkaline lysis, and is then selectively adsorbed onto silica- 
based resin in the presence o f high salts.
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Single colonies o f transformed bacteria were picked from plates using sterile yellow Gilson 
pipette tips, inoculated into 5ml o f L-Broth containing ampicillin 100 pg/m l, and incubated 
overnight in a shaking incubator at 37°C. O n the next day, 1.5ml o f each culture were 
centrifuged at 13,000 rpm  for 2 minutes, and the bacterial pellets resuspended in 250pl o f PI 
buffer and transferred to a microcentrifuge tube. 250pi o f buffer P2 were added and the tube 
was gendy inverted 4-6 times to mix the contents. 350pl o f buffer N3 were added and the 
tube was immediately, but gendy, inverted to avoid localised precipitation. This inversion was 
repeated for 4-6 times. The tube was centrifuged at 13,000 rpm  for 10 minutes, and the 
cleared supernatant was transferred to a QIAprep column, that had been centrifuged at 
13,000 rpm for 30-60 seconds, before the flow-through was discarded. The QIAprep spin 
column was then washed with 0.5ml buffer PB, to remove trace nuclease activity, centrifuged 
for 30-60 seconds and the flow-through was discarded. The QIAprep spin column was 
further washed by adding 0.75ml buffer, centrifuged for 30-60 seconds and the flow-through 
was discarded. The QIAprep spin column was centrifuged for another 1 minute to remove 
the residual wash buffer, and placed in a clean 1.5ml microcentrifuge tube. The DNA was 
eluted by the addition o f 50pl buffer EB (10 mM Tris-Cl, pH 8.5) to the centre o f the 
QIAprep spin column. After 1 minute the column was centrifuged for 1 minute and the 
flow-through, containing the DNA, was collected and analysed by restriction enzyme 
digestion and agarose gel electrophoresis as described above.
Xho I restriction digestion (New England Biolabs) was used to determine the presence o f the 
plasmid in the selected colony, while EcoR I restriction digestion (New England Biolabs) was 
used to verify the direction o f insertion of the PCR-generated cDNA within the plasmid.
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2.4.10 Medium-scale preparation of DNA (“maxipreps”)
The identified sense and antisense constructs were built up for large scale DNA preparation 
using the QIAGEN® Plasmid Maxi Kit (QIAGEN Ltd.). A modified alkaline lysis procedure 
was performed, followed by binding o f plasmid DNA to an anion exchange resin under 
appropriate low salt and pH  conditions. Impurities (RNA, proteins etc.) were washed away 
by a medium salt wash. Plasmid DNA  was eluted by a high salt buffer and concentrated and 
desalted by isopropanol precipitation.
5pl o f bacterial culture, shown to have the correct plasmid insert, were added to 100ml L- 
Broth containing ampicillin 100 pg/m l and incubated overnight at 37°C in a shaking 
incubator. The bacterial cells were harvested by centrifugation at 3,840 g for 15 minutes at 
4°C (J2-HS centrifuge, Beckman, Palo Alto, CA, USA), and the bacterial pellet resuspended 
in 10ml o f chilled buffer PI (50mM Tris-HCL, pH 8.0; lOmM EDTA; 100 pg/m l RNAse 
A). The bacteria were lysed by the addition o f 10ml buffer P2 (200mM NaO H; 1% SDS) 
and, as soon as lysis was complete, the lysate was neutralised by the addition o f 10ml of 
buffer P3 (3.0 M potassium acetate, pH 5.5). The mixture was filtered through a QIAfilter 
cartridge, incubated at room temperature for 10 minutes, and the flow-through was poured 
into a Q IA G EN -tip containing the anion exchange resin which had been equilibrated with 
10ml buffer QBT (750mM NaCl; 50mM MOPS, pH 7.0; 15% ethanol; 0.15% Triton X-100). 
The cell lysate was allowed to flow through under gravity, and the resin was then washed 
twice with 30ml buffer QC (1.0 M NaCl; 50mM MOPS, pH 7.0; 15% ethanol). Plasmid 
D NA  was eluted from the column by the addition o f 15ml buffer QF (1.25 M NaCl; 50mM 
Tris-HCL, pH 8.5; 15% ethanol). The plasmid DNA was precipitated and desalted by adding 
10.5ml isopropanol and recovered by centrifugation at 15,000 g for 30 minutes. The pellet 
was washed twice in 5ml 70% ethanol, air dried for 20 minutes, and re-dissolved in 200fil TE 
buffer, incubated at room temperature for 10 minutes and the DNA solution was transferred
'Mu re dais? and M ethods
into a clean microcentrifuge tube. To ensure that the DNA was completely dissolved, the 
sample was further incubated at 4°C before measuring the yield.
DNA concentration was measured using a Spectrophotometer. The concentration of DNA 
was determined by absorbance at 260 and 280nm.
A solution with 4pl of the sample was added to 396pl ddH20 ,  and the concentration of 
DNA was calculated using the following equation:
Final concentration of DNA = Spectrophotometer reading at 260nm x dilution factor x 
conversion factor
Where: Dilution factor = 400/4 = 100
Conversion factor = 50 pg/ml
2.4.11 Sequencing of DNA
Primers were obtained from the ICRF Oligonucleotide Synthesis Laboratory at Clare Hall 
(Appendix III), and diluted to 3.2 pmol/pi.
For the sequencing reactions, the following 20pi reaction mixture were made using ABI 
PRISM® BigDye® Terminator v l.l Cycle Sequencing Kit (Applied Biosystem, Foster City, 
CA, USA):
Test reaction Control reaction
Purified PCR product 200-500ng 2pl
Prim er (3.2 pm ol/p i) ltd 4pl
Stock mix (Big dye*) 8nl 8 pi
ddH 20 Make up to 20 pi 6pl
The Terminator Ready Reaction mix contains: A, C, T and G terminators labelled with high- 
sensitivity dyes; deoxynucleoside triphosphatase; MgCl2; and Tris-HCL buffer, pH 9.0.
The mixture was overlaid with 20 pi mineral oil and thermal cycled in the DNA Thermal 
Cycler (Perkin Elmer) using the following setting parameters:
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Segments Cycles Tem perature Tim e
1 1 94°C 4 minutes
94°C C 30 seconds
2 17 60°C J 30 seconds
72°C 5 minutes
3 1 72°C 5 minutes
4 1 15°C Hold
The results were analysed using ABI Prism sequencer software (Perkin Elmer).
2.5 Gene transfer into eukaryotic cells
2.5.1 Introduction of E-cadherin cDNA, RacV12 and RacN17 into OSCC cell line 
using Fugene 6 transfection reagent
FuGENE 6 Transfection reagent (Roche Diagnostic Corporation, East Sussex, UK) is a 
proprietary blend of lipids and other components supplied in 80% ethanol. Transfection was 
done using FuGENE 6 reagent: pg DNA at a 3:1 ratio.
On the day prior to transfection, 5 x 105 cells were seeded into 10cm petri-dishes, and 
allowed to grow in KGM to 50-60% confluency, which is optimal for transient transfection. 
On the day of transfection, the transfection complex was prepared in a small sterile tube, 
where 500pl Opti-MEM was added, and directly into the medium 30pl of FuGENE 6 
reagent was added (undiluted FuGENE 6 reagent should not be allowed to come in contact 
with plastic surfaces other than the pipette tip). For E-cadherin cDNA, 10pg of DNA were 
added to the mix, and the tube was gently tapped. However, for constitutively active Racl 
variant (Racvl2-GFP) and the dominant negative Racl variant (RacN17-GFP), lpg was added 
to mix. The transfection complex was incubated at room temperature for 15-20 minutes.
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Meanwhile, KGM  was removed and the cells were washed once with Opti-MEM®I “serum- 
free medium” (GIBCO™ : Invitrogen Ltd.). 10ml Opti-MEM  were added to the adherent 
cells. The transfection complex was added dropwise to the cells and then they were 
incubated in 8% C 0 2 at 37°C in an humidified incubator for 5-6 hours. Transfection 
complex was removed and the cells were washed once with KGM, and 12ml KGM  were 
added, and the cells were allowed to grow to confluency.
For transient transfection, the transfection was terminated after 48 hours at which time the 
transfected cell lines (Table 2.2, Figure 2.3) were analysed using FACS analysis, western blot 
and indirect immunostaining.
For stable transfection, the transfected cell lines were allowed to grow in KGM  for 1-2 weeks 
before being drug-selected or magnetic bead-sorted.
Table 2.2: Transfected Cell Lines
Origin 
(Parental cell lines) 
H376 
H376(34
IA2
cDNA plasmid 
Orientation 
E-Cadhenn Sense
E-Cadherin Anti- Sense 
E-Cadherin Sense 
E-Cadherin Anti- Sense 
E-Cadherin Sense 
E-Cadherin Anti- Sense
Transfected Cell line
H376 E-cadherin
H376 AS
H376p4 E-cadherin 
H376(34 AS 
IA2 E-cadherin
IA2 AS
2.5.2 Introduction of siRNA duplexes into OSCC cell line using Oligofectamine™ 
transfection reagent
Oligofectamine™ reagent (Invitrogen Ltd.) interacts efficiendy with oligonucleotides to form 
transfection complexes. A 6-well plate format was used according to the manufacturer’s 
instructions.
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The (34 integrin siRNA oligonucleotides were supplied as a pool o f four siGEN OM E 
duplexes (siGENOM E SMARTpool: Dharmacon RNA technologies, Chicago, IL, USA) 
provided in a desalted form at 50nM concentration (see Appendix III for oligonucleotide 
sequences). The SMARTpool reagent was resuspended in (lx) siRNA buffer (lOOmM KC1, 
30mM H EPES-pH  7.5, l.OmM MgCl2) to a 40pM stock solution then stored at -20°C until 
use.
24 hours before transfection, 2 x 104 cells were plated in each well o f a 6-well plate, and 
allowed to grow in an antibiotic-free KGM  medium up to 40-50% confluency, which is 
optimal for transfection. O n the day o f transfection, for each well in a 6-well plate the 
following oligo solutions were prepared. 2.5pi o f SMARTpool stock solution was diluted in 
182.5pl Opti-MEM®I “serum-free medium” (GIBCO™: Invitrogen Ltd.) to form 185pl 
duplex solution (solution A). 3pi Oligofectamine™ reagent was diluted in 12pl Opti-MEM®I, 
forming 15pl transfection solution (solution B). Both solution A and B were incubated for 15 
minutes at room temperature. Then both diluted solutions were added and mixed gently to 
form a 200pl mix (solution C), that was incubated at room temperature for 20 minutes. 
Meanwhile, cells were washed once with Opti-MEM®I and, for each well containing cells, 
800pl o f Opti-MEM®I was added. 200pl o f solution C was then added dropwise onto each 
well. Cells were incubated at 37°C in an 8% CO, humidified incubator for 4 hours. 
Transfection was terminated by adding 500pl (3x) antibiotic-free KGM  into each well. Gene 
expression was assayed at 48-72 hours post-transfection.
2.5.3 Selection
Puromycin acts as an analogue o f aminoacyl-tRNA thus causing premature chain 
termination; it therefore inhibits protein synthesis in eukaryotic cells. Streptomyces alboniger 
contains the puromycin-N-acetyl transferase gene which can be expressed in mammalian
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cells and can be used as a selectable marker for puromycin resistance. The puromycin 
(Sigma-Aldrich) concentration required to kill each parental cell line was determined by a 
“Kill Curve”, and the minimum concentration o f puromycin required to kill all parental cells 
after 1 week was used to select transfected cells.
2.5.4 Magnetic bead sorting of cells
E-Cadherin expressing cells were selected by two rounds o f magnetic bead sorting 
(Dynabeads®, Dynal Ltd, Norway) using Anti-E-Cadherin Antibody HECD-1 (M. Takeichi). 
Cells were washed twice in PBSABC and incubated in EDTA free trypsin/ calcium (0.1% 
(w/v) trypsin (Sigma-Aldrich)/ Im M  CaCL) for 25-30 minutes. Detached cells were spun 
down and resuspended in 1ml cold PBSABC containing 10%FCS. Cells were incubated with 
primary antibody HECD-1 (1:200 dilution) on ice for one hour. Then, cells were washed 
three times in PBSABC containing 10%FCS, and incubated on ice with prewashed beads 
coated with goat anti-mouse antibody (107 beads/m l) for 30 minutes with frequent 
resuspension. To isolate labelled cells, cells and the coated beads were placed in a 
microcentrifuge tubes in a Dynal magnet, and left for 2 minutes. The unlabelled cells were 
removed by gentle pipetting. The tubes were removed from the magnet, and cells were gently 
resuspended in wash buffer. This was repeated for 6-7 times, until no further enrichment was 
possible. Selected cells were incubated in KGM  in 6-well plates and, once they were 
adherent, KGM  was replaced by selection medium. Selected cells naturally shed the magnetic 
beads over a period o f seven days.
Stable expression o f E-Cadherin was achieved after 2 sorts. Cells were grown continually in 
KGM  supplemented with puromycin (Sigma-Aldrich) (0.5 pg/ml).
81
2.6 Functional Assays
2.6.1 Cell Growth Assays
2.6.1.1 Cell Growth Assay of cells growing on plastic
2x104 cells were seeded into 6-well plates with a well diameter o f 35mm and grown as 
described in Section 2.1.3.2. Cells were fed every 3 days. Every 24 hours cells were removed 
from triplicate wells by trypsinisation with 1ml o f trypsin/ED TA . Once the cells had 
detached, the trypsinisation was stopped with 1ml of KGM  and the cells were pipetted 
vigorously to disrupt any cellular aggregates. The wells were examined to ensure that no cells 
remained. Between 50-500pl o f cell suspension, depending on cell confluency, was added to 
Isoton solution (Coulter Euro Diagnostics GMBH) to make a total volume o f lOmls. The 
cells were counted on a Casy I counter (Sharfe System) and the total number of cells per well 
was calculated. Readings were recorded every day for 5 days, and the experiment was 
repeated 3 times for each cell line.
2.6.1.2 Cell Growth Assay of cells growing in 2-D/3-D collagen I cultures
Cells were grown as described in Section 2.1.3.2 and allowed to grow for 10 days. Cells were 
harvested for the growth assay, at two day intervals, as follows. After washing the cultures, 
twice, with PBSABC, 200pl o f collagenase 1 (Worthington Biochemical Corporation) were 
added to the 2-D cultures and 1ml to the 3-D cultures and incubated for about 1-2 hours at 
37°C before cells were collected and spun down and the supernatant was discarded. A 
measured amount o f Trypsin was added to the cell pellet and incubated at 37°C for about 15 
minutes to break the cell clumps. Prior to cell counting, the cell aggregates were further 
broken down by gentle pipetting o f the supernatant. Cell number was determined by 
haemocytometer counting using Trypan blue exclusion to monitor cell viability.
2.6.2 Invasion Assay
Cell invasion was measured using Transwells divided into upper and lower chambers by a 
Matrigel-coated polyethylene tetraphthallate (PET) membrane with 8pm pores (BD 
Bioscience). 1 x 103 cell/well were plated in the upper chamber, incubated for 48 hours and 
allowed to invade through the membrane and into the lower chamber towards full 
keratinocyte growth medium which was used as a chemoattractant.
Inserts were coated with 70pi o f growth factor reduced-Matrigel (BD Bioscience) (diluted 
1:2 in a-MEM) and allowed to set for 60 minutes at 37°C. Cells approaching confluency were 
washed twice with PBSABC and harvested using the E-cadherin preserving technique as 
described in Section 2.2.1.1. Detached cells were collected in PBSABC, spun down at 1,200 
rpm for 3 minutes and resuspended in a-MEM. Cells were plated in quadruplicate with lxlO 3 
cells seeded in the upper chamber o f each Transwell. 0.5ml full KGM  was used as a 
chemoattractant in the lower chamber.
After incubating for 48 hours at 37°C the KGM  in the lower chamber was removed, and the 
chamber was washed with PBSA. Cells at the bottom  of the lower chamber and at the 
undersurface o f the Transwell insert were harvested by the addition of 0.5ml trypsin/ED TA  
into the lower chamber and, with the Transwell insert in place, incubated at 37°C for 45-60 
minutes. The undersurface o f the Transwell was washed twice carefully using trypsin in the 
lower chamber. The whole amount o f trypsin (0.5ml) with the detached cells was pipetted up 
and added to 9.5ml Isotone solution, and the tubes were incubated on ice, in preparation for 
counting. Cells were counted using the CASY counter.
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2.6.3 TUNEL Assay for biochemical detection of apoptotic DNA fragmentation
DNA fragmentation is one o f the defining characteristics o f apoptosis (Bursch et al!, 1990). 
The TU N EL assay, one o f the methods used to detect apoptosis, is based on a procedure in 
which the ApopTag® Fluorescein Apoptosis Detection kit (CHEMICON® international) 
specifically detects D NA  cleavage using indirect immunostaining.
Transfected cell lines (H376 E-cadherin and H376 antisense) were plated, in triplicate, at an 
initial density o f 2x l04 cell/well, either atop 2-D, or within 3-D, collagen I cultures, and 
allowed to grow for 5 days.
At day 5, cells growing on 2-D collagen I- coated cover slips were washed once using PBSA. 
Residual PBS was then removed and cells were fixed using 1% paraformaldehyde (in PBSA) 
for 10 minutes at room  temperature. Excess liquid was drained off and the cells were washed 
twice in PBSA (5 minutes each). Cells were permeabilised using Ethanol:Acetic acid (at a 
ratio o f 2:1) for 5 minutes at —20°C. Excess liquid was drained off and cells were washed 
twice in PBSA (5 minutes each). Working strength Terminal deoxynucleotidyl Transferase 
(TdT) enzyme was added to the pre-equilibrated cells (using the supplied Equilibration 
Buffer) and incubated for 1 h at 37°C. Stop/W ash Buffer was added to the slide and agitated 
for 15 sec followed by 10 minutes incubation at room temperature. After washing three 
times with PBS for 1 minute each, Anti-Digoxigenin Fluorescein (1:100 dilution: Roche 
Diagnostic Corporation) conjugate was added to the slides and incubated for 30 min. After 
cells were washed for four times with PBSA, cover slips were mounted in M OW IOL 4-88, 
containing 1 pg /m l o f Propidium Iodide, for counterstaining.
In contrast cells, growing in 3-D collagen I were fixed in Formol Saline and were embedded 
in paraffin and sectioned in the Histopathology Lab (Cancer Research UK  Central Services). 
Sections were deparaffinised by washing in three changes of Xylene (5 minutes each). The
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sections were washed twice in 2 changes of Absolute Ethanol (5 minutes each), followed by 
one wash in 95% Ethanol and a final wash in 70% Ethanol (3 minutes). Lastly, the section 
was washed once in PBSA for 5 minutes. Sections were pretreated with a Proteinase-K 
digesting enzyme (20 pg/m l) for 15 minutes and then washed twice with PBSA (2 minutes 
each). Then slides were treated, as described for cells growing in 2-D, from the equilibration 
step onwards.
Detached cell populations were evaluated by the Trypan blue dye exclusion test using a Vi- 
CELL™ XR Viability Analyser (BECKMAN COULTER, Buckinghamshire, UK).
2.6.4 Racl and Cdc42 Pull-down Assay
The Rho switch functions by alternating between an active, G TP-bound state and an 
inactive, G D P-bound state (discussed in Chapter 6). This assay is based on the fact that p21 
activated kinase 1 (PAK), a downstream effector of both Racl and Cdc42 members o f the 
Rho family GTPAses, specifically recognises the GTP bound form o f the protein, thus 
monitoring the activity o f Racl and Cdc42 proteins (Lim et al., 1996). The assay uses the 
Cdc42/Rac Interactive Binding (CRIB) region (also called the p21 Binding Domain, PBD) of 
the Cdc42 /  Rac effector protein, p21 activated kinase 1 (PAK). The CRIB/PBD  protein 
m otif has been shown to bind specifically to the G TP-bound form o f Rac and /o r Cdc42 
proteins. The PAK-PBD is also in the form o f a glutathione i ’-transferase (GST) fusion 
protein which allows one to "pull-down" the PAK-PBD /G TP-Rac (or GTP-Cdc42) 
complex with glutathione affinity beads (Lim et al., 1996; Sells et al., 1997).
Racl and Cdc42 activity assay is called (GST)-PAK-CRIB pull-down assay. Active Racl and 
Cdc42 were pulled down with the GST-PAK-CRIB fusion protein.
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5x105 cells were plated in 10cm Petri dishes in full KGM medium and allowed to grow for 48 
hours, where it was about 80-90% confluent. As for the [34-integrin knock-down experiment, 
an RNAi experiement was carried out 24 hours later and cell lysates for all cell lines were 
obtained altogether. Cells were washed in ice-cold PBSABC saline and lysed on ice in 800 pi 
o f lysis buffer (Appendix I). Total lysates were cleared by centrifugation at 13,000 rpm for 2 
minutes at 4°C. Each sample o f cleared lysate was incubated for 40-60 minutes, in a rotor, at 
4 °C with 5 pi GST-PAK-CRIB domain (PAK-CD) pre-coupled to glutathione-Sepharose 
beads (prepared in the Lab by D. McCulloch). Subsequently, the beads were spun down by 
centrifugation at 13,000 rpm for 1 minute at 4°C, and supernatant, containing inactive Racl, 
was aspirated into a fresh Eppendorf. Precipitated complexes were washed three times in an 
ice-cold washing buffer (Appendix I). After the final wash, the supernatant was discarded, 
leaving about 15pi on top o f the precipitated complexes, and 5pi of 4x Laemmli sample 
buffer (Appendix I) was added to the beads. Samples were boiled for 5 minutes, spun down 
briefly at 4°C to sediment the beads, and the entire volume was loaded into a 15% 
polyacrylamide gel. Amounts o f active versus inactive proteins were assessed with Western 
blot analysis using human monoclonal antibodies against Racl and Cdc42 (as described in 
Section 2.3.4.3 and 2.3.4.4).
2.7 Statistical Analysis
Data are expressed as the standard error o f mean (sem) o f a given number o f observations. 
Where appropriate, samples o f equal variance of paired groups were analysed using Student’s 
t-Test. Comparison was set at 5% significance. A p value of £  0.05 was considered to be 
significant.
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a) b)
□□
Collagen I matrix 
Selection KGM medium
Figure 2.1
2-D /3-D  collagen I cultures
a) cells growing atop of a thin layer of collagen I matrix.
b) cells growing within a thick layer of collagen I matrix.
Cells were fed with complete selection medium.
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Figure 2.3
Schem atic representation of the transfected cell lines
siRNA/RISC  
 Complex
1 Protein
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D N A
Figure 2.4
Schem atic representation of RNAi technology
Synthetic small interfering (si) RNA nucleotides can be introduced into Eukaryotic 
cells. siRNA nucleotides interact with RNA-induced silencing complex (RISC) which 
uses the attached siRNA sequence as a template to seek out and destroy the single 
stranded mRNA with a matching sequence, thus inhibiting the production of the 
protein of interest.
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CHAPTER 3
Introduction of Full-Length E-cadherin cDNA Into Oral Squamous 
Cell Carcinoma Cells and Their Characterisation
3.1 Introduction
Cell-cell association often is disorganised in tumours thus allowing malignant cells to detach 
from the tum our mass, invade into the underlying stroma and metastasise. The role o f E- 
cadherin in cell-cell adhesion has led to the suggestion that it acts as an ‘invasion suppressor’ 
molecule (Berx et al., 1995). Cadherin expression (mainly E-cadherin because o f the 
prevalence o f carcinomas) has been studied in many human cancers where levels can vary 
between tumours o f the same type and even between areas o f the same tumour. Generally, 
however, reduced or aberrant expression o f E-cadherin is seen in aggressive, poorly 
differentiated tumours, with an infiltrative histological growth pattern (for an overview, see 
Mareel et al., 1995). These clinical observations, with their implication that E-cadherin has a 
role to play in modifying invasion, were supported by in vitro assays where transfection o f E- 
cadherin cDNA into adhesion molecule-deficient cells converted E-cadherin-negative, 
fibroblastic, invasive cell lines to an epithelial and non-invasive phenotype (Frixen et al., 
1991). Conversely, blocking E-cadherin function in epithelial cells was shown to induce an 
invasive phenotype (Behrens et al., 1989; Takeichi, 1993). However, it is not only normal 
levels o f E-cadherin but also correct localisation and proper cadherin-catenin interactions, 
which are necessary for the adherens junctions to be functional (Navarro et al., 1993; Bullions 
et al., 1997).
While these general comments appear applicable to many carcinomas, their relevance to head 
and neck cancer seems much more equivocal. Attempts to correlate E-cadherin expression
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with tum our behaviour in head and neck SCC largely have been unsuccessful. Most 
carcinomas show variable degrees o f loss o f expression although this often is most 
prom inent in poorly differentiated tumours or at the advancing front o f lesions (Williams et 
al., 1998).
My goal was to develop an oral squamous cell carcinoma (OSCC) model to study the effect 
o f the E-cadherin molecule on the behaviour o f epithelial cells in OSCC. This was achieved 
by the introduction o f full length E-cadherin cDNA into the E-cadherin-negative OSCC line 
using a bicistronic vector “pIRES-puro” (Chapter 2, Figure 2.5). Such a vector has allowed 
both the recom binant cDNA and the puromycin resistance gene to be transcribed as a single 
message. In this system, therefore, clones that are resistant to puromycin express high levels 
o f the protein encoded by the cloned cDNA. The internal ribosome entry site (IRES) 
ensures efficient translation o f the second gene (Hobbs et al., 1998).
In this Chapter, I describe the production and characterisation o f this E-cadherin model 
system derived from OSCC.
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3.2 Results
3.2.1 Characterisation of the primary OSCC lines
Two starting lines, derived from oral squamous cell carcinomas, were used. H357 is an 
OSCC line derived from the lateral border o f the tongue and H376 is an OSCC line derived 
from the floor o f the mouth. Both lines were kindly provided by Professor S. Prime o f the 
University o f Bristol (Prime et al., 1990).
H357 OSCC cell line as an E-cadherin positive control:
As reported previously (Sugiyama et al., 1993) the H357 line proved positive for E-cadherin 
expression. E-cadherin expression was determined by FACS analysis and Western blotting. 
Cells used for assessment o f E-cadherin expression were allowed to grow to confluency. As 
described in Chapter 2 Section 2.2.1.1, cells were harvested using a procedure adapted from 
Takeichi (1997), which minimises the proteolysis o f the extracellular domain o f the E- 
Cadherin molecule (Takeichi, 1977). Using anti-E-cadherin (HECD-1) monoclonal antibody 
(M. Takeichi), FACS analysis and Western blotting results confirmed that the H357 cell line 
was E-cadherin positive (Figure 3.1). Accordingly this line was used both as the source of 
total RNA, from which the full length E-cadherin cDNA was purified, and as a constitutively 
positive control for E-cadherin expression throughout the rest of the study.
Characterisation ofH 376 OSCC cell line for E-cadherin expression:
As described above, the H376 cell line was examined for the presence and expression of the 
E-cadherin molecule. Figure 3.1 shows the lack of E-cadherin expression, as assessed by 
FACS analysis and Western blotting, in cell populations from this line.
Accordingly, it was determined that the H376 line would be a suitable recipient for 
transfection with E-cadherin cDNA.
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Characterisation ofH 376 OSCC cell line for catenin expression:
Prior to introducing E-cadherin cDNA into recipient cells (H376 OSCC cell line) it was 
thought necessary to check that they expressed the appropriate catenins, to ensure that a 
functional cadherin/catenin complex could be formed. Using Western blot analysis, the 
H376 cell line was checked for the expression o f a-, (3- and y-catenins. Results showed that 
the H376 line appears to express the 102 kDa a-catenin, the 88 kDa (3-catenin and the 82 
kDa y-catenin (Figure 3.2: a). Several attempts were made to blot for p l2 0 ctn, another catenin 
member, all o f which failed. Had I had the time to recheck for its presence, I would have 
done so since I believed this result m ost likely was attributable to technical problems rather 
than to absence o f this specific catenin. Differences in apparent levels o f expression o f these 
proteins may be a consequence o f variations in protein loading, as no consistent patterns of 
dramatic alterations emerged from the replicate experiments.
Characterisation o f H376 OSCC cell line for other cadherins:
The H376 line was also checked for the expression o f other cadherins. Western blot analysis, 
using anti-P-cadherin (clone 56) monoclonal antibody (BD Transduction Laboratories), 
showed that the H376 cell line was negative for P-cadherin as compared to the H357 control 
cell line (Figure 3.2: b). As for the expression o f N-cadherin, using Western blot analysis and 
the anti-N-cadherin (clone 32) monoclonal antibody (BD Transduction Laboratories), when 
loading the same amount o f protein, the H376 parental cell line was strongly positive for N- 
cadherin as compared to the H357 control cell line (Figure 3.2: b).
The starting cell lines, H376 and H357, also were checked for the expression o f Desmoglein, 
one o f the desmosomal cadherins, using Western blot analysis and the monoclonal antibody 
against desmoglein (BD Transduction Laboratories), both cell lines were found to be almost 
equally positive for this molecule (Figure 3.2: b).
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3.2.2 Introduction of full length E-cadherin cDNA into recipient starting cell lines
As mentioned above, the H357 cell line was used as the source of total RNA and this was 
extracted using RNA STAT-60IM isolation reagent (Tel-Test “B” Inc.) (Figure 3.3). The 
concentration and purity o f RNA was determined by measuring absorbance at 260 and 
280nm. A solution with an optical density O D 260 o f 1.0 contains 40pg R N A /m l, and the 
ratio O D 260/O D 280 o f ~ 1.8 specifies a clean preparation. Contamination with protein or 
salts leads to a lower ratio and resulted in the preparation being discarded.
DNA complementary to the total RNA was synthesised using the SUPERSCRIPT First- 
Strand Synthesis System (GIBCO BRL®).
Using two E-cadherin specific primers (Chapter 2, Section 2.4.3), the purified cDNA was 
amplified using polymerase chain reaction (PCR). The PCR product (Figure 3.4) was purified 
with a Microcon-100 column (MILLIPORE) prior to DNA restriction digestion.
The isolated E-cadherin gene was sequenced using PRISM® BigDye® Terminator v l . l  Cycle 
Sequencing Kit (Applied Biosystem) and specific primers obtained from the ICRF 
Oligonucleotide Synthesis Laboratory at Clare Hall, South Mimms (Appendix III). The 
results were analysed using ABI Prism sequencer software (Perkin Elmer). Using sequence 
matching software, Lalign, supplied by the GeneStream network server where the nucleic 
acid sequence o f the isolated E-cadherin gene was matched with the E-cadherin gene 
sequence template obtained from EM BL/G enbank Data Libraries under the accession 
number Z13009. Point mutations, resulting from substitution o f Cytosine (C) with 
Thymidine (T), were detected at two different locations (Appendix IV). However both point 
mutations were found to be ‘silent mutations’ because the resultant codons encoded for the 
same amino acid. (AAC and AAT codons both encode for Tyrosine).
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The pIRES-puro plasmid was digested with Xho I restriction endonuclease (New England 
Biolabs), prevented from religation by dephosphorylation with alkaline phosphatase (New 
England Biolabs) and the full length E-cadherin cDNA was ligated into the Xho I site of the 
pIRES-puro plasmid.
The plasmid DNA was digested with Xho I and EcoR I restriction endonucleases (New 
England Biolabs) to verify the direction o f insertion o f the PCR-generated E-cadherin 
cDNA (Figure 3.5). The identified sense and anti-sense constructs were expanded for large 
scale DNA preparation using the QIAGEN® Plasmid Maxi kit (QIAG EN  Ltd.).
The E-cadherin negative cell line (H376) either was transiendy or stably transfected, using 
FuG E N E im 6 Transfection reagent (Roche). Figure 2.6 (Chapter 2) shows a schematic 
illustration o f the transfection plan and outcome.
3.2.3 D e novo expression of E-cadherin in H376 Oral Squamous Cell Carcinoma 
Cell line
In order to verify the ability o f the various constructs to cause E-cadherin expression in 
recipient cells originally I used transient transfection o f both murine N IH  3T3 cells and 
H376 cells.
That expression o f the transfected E-cadherin cDNA resulted in expression of the molecule 
on the cell surface was confirmed by flow cytometry using anti-E-cadherin (HECD-1) 
monoclonal antibody. In Figure 3.6, D ot plots showed that both transiendy transfected cell 
lines, H376 and N IH  3T3, contained populations o f cells positive for E-cadherin expressed 
at the cell membrane. The efficiency o f expression was almost similar in both cell types with 
about 25.56% o f the transfected N IH  3T3 cells being positive for surface E-cadherin 
(represented by cells in the upper right quadrant) and about 29.96% o f the H376 E-cadherin
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transfected cells being positive for surface E-cadherin. Control cell lines, transfected with the 
antisense construct, were negative for E-cadherin.
Expression o f the E-cadherin molecule was further confirmed by Western blot analysis. 
Whole cell RIPA lysates from the transiently transfected cell lines and 28.6pg protein/lane 
were probed for E-cadherin using the anti-E-cadherin (HECD-1) monoclonal antibody. As 
can be seen from Figure 3.6, a strong E-cadherin band at 120kDa was apparent in both these 
lines after transfection with the E-cadherin sense, but not the antisense, construct. H357 was 
used as a positive control, while N IH  3T3 cells and pEG FP transfected-3T3 cells were used 
as negative controls.
Since the transient transfection experiments indicated that the constructs were functioning 
correctly and producing protein o f the correct si2e, I then established stable lines. 
Transfection studies with the E-cadherin sense and antisense plasmids were repeated on the 
H376 cell line. The E-cadherin expressing cells were selected by two rounds o f magnetic 
bead sorting and the resulting cell populations were grown in puromycin-supplemented 
KGM  “Selection Medium”, with a concentration o f 0.5pg/m l; a value previously determined 
with preliminary “kill curve” experiments. Isolated positive colonies, capable o f growing in 
this selection medium, were pooled as a means o f avoiding clonal heterogeneity.
Over the next 24 months o f continuous culture, expression was checked on a routine basis 
using both FACS and Western blot analyses, so that confirmatory results were obtained at 
different times over this period. Representative results are illustrated in Figure 3.7.
3.2.4 Immunocytochemical localisation of E-cadherin in transfected lines
For indirect immunofluorescence experiments, cells were grown on coverslips in the 
presence o f 10% FCS for 48 hours in order to allow for the formation o f mature adherens
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junctions. Cells were fixed with 4% formaldehyde, and stained for E-cadherin using anti-E- 
cadherin (HECD-1) monoclonal antibody. Triton X-100 was used to permeabilise cell 
membranes and permit access o f antibodies to the cytoplasm. It was also used as an indirect 
assessment o f the strength o f association of the transfected E-cadherin molecule with the 
actin cytoskeleton, as molecules not associated with the actin cytoskeleton were removed by 
Triton X-100 (Ozawa et al,1, 1989). Antibodies were visualised with fluorochromes linked to 
second layer antibodies. Actin cytoskeleton and nuclei were counterstained in some 
experiments using Phalloidin and DAPI respectively.
Images from H376 transfected cell lines were taken using confocal laser scanning 
microscopy. In Figure 3.8 (Panels A-C), it can be seen that the antisense transfected lines, as 
expected, demonstrated no detectable definite positive staining for E-cadherin. In contrast 
the cells into which the sense E-cadherin cDNA had been introduced (Panels D-F) exhibited 
strong cell surface positivity, mostly evident at sites o f cell-cell contact. Actin filaments 
evident in the antisense transfected line (Panel B) appeared to be re-distributed into bundles 
in the E-cadherin positive cells (Panel E), and these co-localised with the cell surface E- 
cadherin molecule (Panel F). Moreover it was apparent that the E-cadherin positive lines had 
a more epithelial morphotype, compared to the antisense controls, with the cells coming 
together in close cell-cell apposition (Figure 3.8). However the actin belt, which is 
characteristic o f epithelial cells, is missing as compared to the control cell line, H357, which 
has perfect epithelial morphology with a well-formed, E-cadherin-dependent, cell-cell 
junction (Figure 3.9).
From  subjective morphological assessment alone the formed E-cadherin cell-cell junction 
appeared as a stitched zipper-like junction rather than as a straight line (marked by open 
arrows in Figure 3.8); what I referred to as ‘immature’ junctions with the formation being
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stuck somewhere at the adhesion zipper phase, a phase described by Vasioukhin et al. (2000) 
as an intermediate step in Adherens junction formation (Vasioukhin et al., 2000).
Under the phase-contrast microscope the E-cadherin transfected cell lines did not attain a 
typical epithelial morphotype although they certainly looked more epithelial than their 
antisense-transfected counterparts (Figure 3.10).
3.2.5 Effect of E-cadherin re-expression on catenin levels
E-cadherin is linked, via (3- catenin or y-catenin, to a-catenin which mediates the anchorage 
o f the E-cadherin/catenin complex to the actin cytoskeleton (Kemler, 1993). Having 
established that there is a significant amount o f E-cadherin expressed in the transfected cell 
lines, it was necessary to examine if  there was any alteration in catenin expression and 
distribution in such lines, after de novo expression o f E-cadherin, using Western blot analysis 
and indirect immunostaining. Whole cell lysates from the transfected cell lines and their anti­
sense controls were used to blot for the various catenins. Figure 3.11 shows a representative 
Western blot analysis o f a-, [3-, and y-catenin in transfected cell lines. Densitometric analysis 
o f three independent experiments showed that E-cadherin re-expression resulted in about a 
2-fold increase in total a-catenin levels in the H376 E-cadherin cell line as compared to the 
antisense control (p value £  0.01). (3-catenin levels increased by about 1.8-fold in H376 E- 
cadherin cell line as compared to the antisense control (p value £  0.02). However, total y- 
catenin was downregulated in the E-cadherin positive cell lines by about 1.4-fold, apparently 
trivial but statistically significant (p value < 0.02).
Cellular catenins ((3- and y-catenin, but not a-catenin) also were examined with confocal laser 
scanning microscopy. Figure 3.12 shows confocal images o f the H376 transfected cell lines 
stained for (3- and y-catenin. Figures demonstrated positive staining for ^-catenin in both E- 
cadherin positive transfected cell lines (Panel A) and in its antisense-transfected counterpart
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(Panels B). However there appeared to be stronger positivity in the E-cadherin positive line 
for this molecule. In the H376 E-cadherin cell line more o f the (3-catenin was redirected to 
the cell-cell junction.
In Figure 3.12, the Panel D  showed that the stained y-catenin appeared to be cytoplasmic in 
the H376 antisense-transfected cell line and was recruited to the cell-cell junction in the 
H376 E-cadherin cell line (Panel C) only. Inconsistent with the Western blot results, which 
showed downregulation o f the total y-catenin in the E-cadherin positive cell line, was the 
confocal image o f the H376 E-cadherin cell line which showed stronger positivity for E- 
cadherin and for the y-catenin.
3.2.6 Effect of E-cadherin re-expression on levels of other cadherins
Western blot analysis was used to assess changes in levels o f previously identified cadherins 
(N-cadherin and Desmoglein) as a consequence o f de novo E-cadherin expression. Using anti- 
N-cadherin (clone 32) monoclonal antibody showed that there is a marked reduction o f total 
N-cadherin expressed in the E-cadherin transfected cell line (H376 E-cadherin) as compared 
to the antisense-transfected control (Figure 3.13) (Levels were re-assessed in Chapter 4). 
Although the H376 parental cell line was marked positive for Desmoglein (Section 3.3.1, see 
Figure 3.2), I failed to blot for this molecule in both descendant cell lines (H376 E-cadherin 
and H376 antisense counterpart). I believe that this was attributed to technical problems and 
since investigation in this area was not my primary interest, I decided not to pursue it further.
3.2.7 Effect of E-cadherin re-expression on the differentiation potential of the 
transfected OSCC cell lines
K14 and involucrin are epithelial cell markers. H376 cells are known to express very low 
levels o f involucrin (Sugiyama et al., 1993), suggestive o f a low level o f differentiation. To
100
determine whether re-expression o f E-cadherin had any effect on the ability o f  the cells to 
differentiate, immunoblotting with both anti-involucrin (Abeam Ltd.) and anti-K14 
antibodies (Abeam Ltd.) was carried out on whole cell RIPA lysates. Protein extracts from 
HaCaT (normal keratinocyte cell line) were used as a positive control. Neither involucrin nor 
K14 was detected in either the parental cell line or the transfected descendant cell lines. The 
restoration o f E-cadherin expression had no apparent effect on the capacity of 
differentiation o f the H376 cell line as monitored by measuring involucrin (data not shown).
I next conducted functional assays to monitor the invasive and growth capacity o f these cell 
lines in order to determine what effect, if there was any, the re-expression o f E-cadherin had 
on these parameters.
3.2.8 Effect of E-cadherin re-expression on the invasive potential of the transfected 
OSCC cell lines
Cell invasion was measured using Transwells divided into upper and lower chambers by a 
Matrigel-coated polyethylene tetraphthallate (PET) membrane with 8pm pores (Becton- 
Dickinson). 1 x 103 cell/well were plated, in quadruplicates, in the upper chamber, incubated 
for 48 hours and allowed to invade through the membrane and into the lower chamber 
towards full keratinocyte growth medium which was used as a chemoattractant. Results 
showed that the E-cadherin positive line (H376 E-cadherin) was 60-80% less invasive than 
its antisense counterpart (Figure 3.14).
In an attempt to further assess the effect o f E-cadherin re-expression on the invasive 
potential o f the cells I tested my cells for the expression of MMP-2 and MMP-9 using 
zymographic analysis. Both cell lines were shown to be negative for both MMP’s (data not 
shown).
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3.2.9 Effect of E-cadherin re-expression on the proliferative potential of the 
transfected OSCC cell lines
Similar experiments on the proliferative activities o f these cells were conducted where the 
growth rates o f the transfected cell lines were compared on plastic.
2 x 104 cell/well were plated onto 24-well plates and cells were harvested at at least five time 
points over a five day period, where triplicate wells were counted for each reading. 
Experiment was repeated three times and results showed that there was no apparent 
difference between the growth rates o f the E-cadherin expressing cells and the antisense 
control cell line (Figure 3.15).
3.2.10 Integrin profile of transfected H376 cell lines
Because o f the increasing evidence o f co-ordinated regulation or, ‘cross-talk’, between 
different families o f adhesion molecules, such that changes in the functional capacity o f one 
class o f receptor has an impact on the activity o f another class o f receptor, I decided to 
monitor integrin expression by my various cell lines. Weaver et al. (1997) observed that 
tumourigenic variants o f a breast carcinoma cell line could be induced to re-express 
functional E-cadherin by using antibodies to block (31 -integrin (Weaver et a l 1997). 
Moreover, integrins and E-cadherin cooperate with insulin-like growth factor to induce 
migration in colon tum our cells (Andre et al., 1999). Therefore, I thought it would be relevant 
to investigate the integrin profile o f my transfected cell lines. Flow cytometry can provide a 
relative measure o f cell surface integrin levels. In order to compare expression in different 
cell lines, the mean fluorescence intensity o f each integrin subunit in each cell line was 
determined by subtracting the fluorescence value o f cells labelled with control antibody. The 
integrin flow cytometry results are summarised in Figure 3.16 grouped by cell line. In general, 
FACS analysis o f the surface expression o f a l ,  a2, a3, a4, a5, a6, a9, av, (31, av(33, av(35 and
av(36, showed that there was no significant difference in expression at the cell surface of the 
integrins tested. The two exceptions to this observation were that there was a hint that E- 
cadherin re-expression might have resulted in alteration o f (31- and (34-integrin expression 
(Figure 3.17). Thus in the Figure shown there is a change in the levels o f (31- and [34-integrin 
expressed after transfection with E-cadherin. Upon E-cadherin restoration in the H376 
transfected cell line there was about 1.8-fold, statistically significant, increase in the level of 
the pi-integrin subunit (p value < 0.01) (Figure 3.17). Among the different a integrin 
subunits that were being tested, only a2-integrin subunit showed a concomitant 1.7-fold 
increase in the H376 E-cadherin cell line as compared to the antisense counterpart, which 
was consistent in three independent experiments (p value £  0.04) (Figure 3.17). This 
particular cell line (H376) was previously characterised as expressing a very low basal level of 
(34-integrin (Sugiyama et al., 1993). E-cadherin re-expression resulted in about a 2.5-fold 
increase in (34-integrin levels. The increase was, although apparently relatively trivial, 
statistically significant (p value < 0.01) (Figure 3.17). H376 transfectants were also found to 
be negative for av(36 (data not shown).
These early results later were expanded to form the basis of Chapter 5 o f my thesis.
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3.3 Discussion
Loss o f cell-cell adhesion is considered to be a main determinant o f the invasive properties 
and metastasising capacities o f tum our cells (Hajra and Fearon, 2002).
In the present Chapter I found that E-cadherin essentially was lacking in H376 OSCC cells. 
The membrane localisation o f (3-catenin in the E-cadherin-negative cell line (H376), as it 
appeared in preliminary immunocytochemical staining experiments (data not shown), 
presumably indicates the presence o f a catenin-binding protein, probably N-cadherin, as 
suggested by other groups (Husmark et al'., 1999; Islam et al\, 1996). Accordingly, I tested for 
the expression o f N-cadherin, and found that, in the H376 cell line, cell-cell adhesion, 
instead, was mediated by N-cadherin. There is a large body o f data suggesting that the 
inappropriate expression o f non-epithelial cadherins, such as N-cadherin and cadherin-11, 
either in association with or even instead o f E-cadherin loss, may play a significant role in 
invasion and metastasis o f cancer cells (Shibata et al., 1996a; Tomita et al., 2000). 
Concomitant upregulation o f N-cadherin and downregulation o f E-cadherin has been 
termed “cadherin switching” and this phenom enon has been demonstrated in primary 
tumours (Hajra and Fearon, 2002).
Since N-cadherin was not detected in normal epithelium (Christofori, 2003), E-cadherin may 
be replaced by N-cadherin in poorly differentiated OSCC. In support o f this possibility is the 
finding o f Islam et al. (1996) that N-cadherin is expressed in SCC but not in the surrounding 
normal tissue. The presence o f N-cadherin appears to correlate with the loss o f epithelial 
differentiation in breast carcinoma cell lines (Hazan et al., 1997). In addition, N-cadherin 
transfected into squamous epithelial cells resulted in tumour cells which manifested a 
scattered phenotype (Islam et a l, 1996). N-cadherin therefore may be one o f several 
aberrantly expressed molecules determining the malignant properties o f epithelial tumours. 
O ne proposed mechanism (Hazan et al., 1997) is that N-cadherin, present at the surface of
tumour cells, mediates adhesion to stromal cells, thereby facilitating the local and metastatic 
spread o f the tumour. Re-expression o f E-cadherin in my cell lines resulted in the down- 
regulation o f N-cadherin and this might account, at least partially, for why invasion was 
markedly inhibited in the E-cadherin-transfected cell line.
Under the microscope, cells o f the H376 line exhibited a fibroblastic morphotype. Navarro et 
al (1991) reported that the complete absence o f P-cadherin was only observed in fibroblast­
like cells or among different epidermal keratinocyte cell lines representative o f different 
stages o f carcinogenesis. Moreover these authors also suggested that loss o f both E-cadherin 
and P-cadherin could be associated with the final stage o f carcinogenesis; that is the 
development o f spindle cell carcinomas (Navarro et al., 1991). Therefore I checked for the 
expression o f P-cadherin in my primary H376 cell line. Figure 3.2, shows that the H376 cell 
line was negative for P-cadherin as compared to the H357 control.
Apart from the fact that the starting H376 cell line was found to be positive for Desmoglein, 
a desmosomal cadherin considered as an epithelial marker (Figure 3.2), the characterisation 
o f these lines by others for other epithelial markers provided evidence that these cells are not 
fibroblasts (as might be thought from their absence o f E-cadherin and their fibroblastic 
morphology) but rather are unusual epithelial cells.
Thus, for example, the H376 cell line has been characterised as expressing Epidermal 
Growth Factor Receptor (EGFR), a cell surface receptor even though the cells showed poor 
patchy staining for the EGF-receptor with the majority o f cells being negative or weakly 
positive (Prime et al., 1994). Sugiyama et al. (1993) used Western blot analysis to detect the 
total amount o f involucrin, a marker for terminal differentiation, in 8 different OSCC cell 
lines among which both the H376 and H357 cell lines expressed very low total involucrin 
levels compared to other cell types and the results were consistent with immunohistological 
sections which were stained for involucrin (Sugiyama et al., 1993).
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Thus it appears that the H376 cell line does express markers of epithelial origin, albeit at a 
low level, suggesting it represents a poorly-differentiated example o f this histiotype.
As a consequence o f de novo E-cadherin expression, the H376 cells attained a more epithelial 
morphotype; although not typically epithelial in appearance they certainly were more 
epithelial than the antisense counterpart cell line, with the cells coming together in close cell­
cell apposition (Figure 3.8 and Figure 3.10). These changes in cellular morphology are very 
similar to those reported by others who have transfected E-cadherin cDNA into various cell 
lines (e.g. Navarro et al., 1991).
However, solely by morphological criteria, the formed E-cadherin cell-cell junctions looked 
immature. From  subjective visual assessment alone the formation o f adherens junctions 
appeared to be stuck somewhere at the adhesion zipper phase, a phase described by 
Vasioukhin et al. (2000) and believed to be an intermediate step in adherens junction 
formation. This phase manifested itself as a stage between the formation o f the E-cadherin- 
dependent punctata at sites of cell-cell contact prior to their merging fully into a single line 
(Vasioukhin et a l, 2000). In this study several actin-binding proteins, and other proteins that 
reside at the cell-cell border, were studied for effect o f cadherin function. The authors 
suggested that VASP/M ena-dependent reorganisation and the calcium-dependent directed 
polymerisation o f actin were implicated as providing the necessary physical force to push the 
stabilised two rows o f punctata together to further seal the cell-cell membrane (Vasioukhm et 
al, 2000). Had I had more time available I would have explored the possibility o f incomplete 
adherens junction formation in my transfected cell lines by using this elegant study as a guide 
for further experiments I might have conducted. This is one line o f thought. Based on my 
results in this Chapter I could suggest other molecules that might be involved in the 
maturation o f the E-cadherin-dependent cell-cell junctions in my model system, such as 
p!20ctnand Keratin-14 (K14).
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In vitro studies demonstrated that p l2 0 ctn acts as a regulatory molecule o f the adhesive 
function o f E-cadherin, binding to the same region of this molecule as the rest o f the 
catenins (Shibamoto et al,., 1995). Moreover, some studies have suggested that p l2 0 ctn 
positively regulates cadherin clustering in the cell membrane (Yap et a l, 1998) and cell-cell 
junction formation (Yap et al., 1998; Thoreson et al., 2000; Grosheva et al., 2001). These 
pieces o f evidence made me think that p l2 0 ctn might be a key role player in the formation 
and maturation o f E-cadherin-dependent adherens junctions. The fact that, despite my 
continuous efforts, I failed to blot for p l2 0 ctn in my cell lines, made the role o f p l2 0 ctn in the 
maturation o f the E-cadherin-dependent cell-cell junction in my model system obscured, or 
non-discemible, in the results presented in this thesis.
K14 and involucrin are epithelial cell markers. Thus K14 is a keratin o f the basal cells o f all 
stratified squamous epithelia (Moll et al., 1982; Quinlan et al., 1985; Galvin et al., 1989), while 
involucrin is a protein precursor o f the cross-linked envelope that forms late in the terminal 
differentiation o f keratinocytes (Rice and Green, 1979). In contrast to K14, involucrin is 
made only in suprabasal cells (Banks-Schlegel and Green, 1981; Watt and Green, 1982). I 
tested my primary and transfected cell lines for the expression o f these two 
epithelial/differentiation markers. Whole cell RIPA lysates from all cell lines, were probed 
for K14 using anti-K14 monoclonal antibody (Abeam Ltd.) and a strong K14 band at 50 
kDa was apparent only in the control lane (HaCaT, normal keratinocyte cell line), while 
H376 primary and transfected cell line lanes were negative for K14. The same negative result 
was obtained when blotting for involucrin. From these rather preliminary results I have 
considered it is possible that the lack o f some o f the differentiation markers in my cells might 
have impaired maturation o f the cell-cell junction. I would suggest that in the future this idea 
should be considered and experiments designed to address this question. Again, had I had 
more time, this is an area I would have explored.
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Concomitantly re-expression o f the E-cadherin molecule in the H376 OSCC cell line resulted 
in the upregulation o f both a- and (3-catenin. O n the other hand, y-catenin was 
downregulated as a result o f the de novo E-cadherin expression in this particular cell line 
(Figure 3.11).
It has been reported that E-cadherin is required for the efficient translation o f the a-catenin 
mRNA (Takahashi et a l, 2000). Jamora and Fuchs (2002) argued if this was true, then in 
cases where E-cadherin is downregulated, like wound healing and tumour progression, there 
should be a concomitant decrease in levels o f a-catenin (Jamora and Fuchs, 2002). Therefore, 
it is only logical to think that a-catenin levels were upregulated simultaneously with E- 
cadherin re-expression in my OSCC model system.
It is known that two distinct complexes can be found in the same cell, either E-cadherin 
complexing with (3-catenin or E-cadherin complexing with y-catenin but not with both 
occurring at the same time (Butz and Kemler, 1994). Moreover, from analysis o f the 
interaction o f purified recombinant cadherin and catenins in combinatorial protein-protein 
interactions, it is known that E-cadherin interacts with a higher affinity with (3-catenin as 
compared to y-catenin (Aberle et al., 1994). This might explain why, upon E-cadherin re­
expression, y-catenin levels dropped down while levels o f (3-catenin increased, as determined 
by Western blot analysis.
Husmark et al. (1999) tested the role o f E-cadherin and the catenins in the progression of 
human anaplastic thyroid-carcinoma cell lines and showed that there was a correlation with 
the amount o f cytokeratin present in the same cell line. They suggested that, since cytokeratin 
is an epithelial marker, this finding supports the idea that y-catenin is closely associated with 
the epithelial phenotype (Husmark et al., 1999). Using the MNF 116 antibody (Dakopatts, 
Denmark) which recognises cytokeratins 5,6,8,17 and 19, the H376 primary cell line showed 
a very weak staining for cytokeratin (Thompson M., MSc thesis, University o f London,
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1993). In repeated experiments with my transfected cell lines and using a cocktail o f two pan 
cytokeratin antibodies (clone A E1/A E3) to detect at least 19 o f the major human 
cytokeratins (DakoCytomation), they consistently appeared negative for cytokeratin in 
paraffin sections (data not shown). In Western blot analysis, using the monoclonal antibody 
against Keratin-14 (Abeam Ltd.), my transfected cell lines appeared to be negative for that 
particular molecule (data not shown). In light o f this, such observations might explain why, 
upon transfection with E-cadherin, the E-cadherin expressing cells in my studies did not 
restore the typical epithelial morphotype completely and still showed a downregulation o f y- 
catenin.
The invasive potentials o f the transfected cell lines were measured and it showed that upon 
E-cadherin transfection invasion was gready inhibited in the H376 E-cadherin cell line as 
compared to the H376 antisense control cell line (Figure 3.14). This finding is consistent with 
those o f others (e.g. Behrens et al.y 1989). In an attempt to further assess the effect o f E- 
cadherin re-expression on the invasive potential o f the cells I tested my cells for the 
expression o f MMP-2 and MMP-9 using zymographic analysis. Both cell lines were shown to 
be negative for both MMP’s (data not shown). However, Barbletz et al. (2000) showed a 
marked activation o f MMP-1 and MMP-7 by (3-catenin in colorectal carcinoma. And with 
further time, I would have tested my transfected cell lines for the expression o f other 
MMP’s, especially including these.
It has been acknowledged that normal cells growing as a monolayer in tissue culture become 
quiescent when they reach confluency by a process known as “contact inhibition” (Aoki et 
al!, 1991; Kandikonda et al!, 1996; Takahashi and Suzuki, 1996). Loss o f contact inhibition is 
considered one o f the hallmarks o f cancer, yet, many tumour cells were shown to maintain a 
certain degree o f contact inhibition that has been referred to as “contact-dependent growth
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inhibition/suppression” (St Croix et al., 1998). E-cadherin was shown to contribute to 
contact-dependent growth inhibition (Aoki et al., 1991; Kandikonda et al., 1996; Takahashi 
and Suzuki, 1996). E-cadherin expression was shown to reduce tumour cell growth rate 
(Navarro et al., 1991; Miyaki et al., 1995; H su et al., 2000; Fricke et al., 2004). However, it has 
been suggested that contact-dependent growth suppression in tumour cells, growing as a 
monolyer, was incomplete as compared to normal cells which might explain the reduced 
sensitivity o f tumour cells to undergo contact-dependent growth suppression (St Croix et al.,
1998). However, cells growing in three-dimensional tissue culture showed a significant, 
although still incomplete, reduction in cell growth (St Croix et al., 1998). In my transfected 
cell lines (the H376 E-cadherin and the H376 antisense control), E-cadherin seems not to 
affect the growth rates (Figure 3.15).
This unremarkable finding did however cause me to re-think the direction o f my project and 
stimulated me to embark on what will constitute a large section o f the remainder o f my 
studies. That is that one assay (the invasive assay) monitors the behaviour o f cells in a 3-D 
situation, i.e. passaging through a Matrigel layer, whereas, generally, m ost investigators have 
confined their assessment o f growth to that which occurs under conditions o f 2-D 
constraint, as I have done here. Accordingly I determined to examine the proliferative and 
survival characteristics of the matched lines under 3-D conditions. These results will be 
presented in the subsequent Chapter.
There is a growing body o f data suggesting that there is a kind o f synergistic ‘cross-talk’ 
interaction between different CAM families (Aplin et al., 1999). In some instances the 
expression levels o f cadherins and integrins are linked. For example, in primary myoblasts, 
over-expression o f either a5- or (31-integrin subunits leads to the increased expression o f N- 
cadherin (Huttenlocher et al., 1998). One possible mechanism in connection with the ‘cross­
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talk’ between cadherins and integrins involves the serine/threonine kinase; integrin-linked 
kinase (ILK) (Delcommenne et al., 1998; Novak et al., 1998; Wu et al., 1998; Dedhar et al.,
1999).
The ^1-integrin subunit dimerises with various a integrin subunits to assemble into about 12 
integrins (Chapter 1, Figure 1.3) (Hynes, 2002). Upon E-cadherin re-expression in my H376 
transfected cell line, there was about a 1.8-fold (statistically significant) increase in the level of 
pi-integrin subunit (p value £  0.01) (Figure 3.17). Among the different a integrin subunits 
that were being tested, only a2-integrin subunit showed a concomitant 1.7-fold increase, in 
the H376 E-cadherin cell line as compared to the antisense counter part, which was 
consistent in three independent experiments and statistically significant (p value £  0.04) 
(Figure 3.17). In keratinocytes, downregulation o f E-cadherin was shown to decrease the 
expression o f a2pi and a3pi integrins (Zhu and Watt, 1996). The MCF-7 breast carcinoma 
cell line was transformed, under the effect o f melatonin, into a less invasive phenotype 
through upregulation o f E-cadherin and pi-integrin subunit, which further prom oted cell 
differentiation (Cos et al., 1998), suggesting the both E-cadherin and pi-integrin subunit 
contribute to invasion and differentiation in a similar manner. Furthermore, in breast 
carcinoma, poorly differentiated cancer cells were able to differentiate into gland-like 
structures when a2pi integrin expression was restored (Zutter et al., 1995). This might 
explain why de novo E-cadherin expression in this particular OSCC cell line resulted in 
upregulation o f pi-integrin subunit and perhaps, more specifically, a2pi integrin. 
a6p4 integrin is expressed in stratified epithelia and cultured keratinocytes adhering to 
basement membrane substrates (De Luca et al., 1990; Marchisio et al., 1991; Jones et al., 
1993). In poorly differentiated oral squamous cell carcinomas loss o f a6 and p4 was detected 
at the advancing edges o f the tum our lesion (Jones et al., 1993). The p4-integrin subunit 
previously has been reported to be expressed 10-fold less in the H376 primary cell line
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compared to normal keratinocytes (Sugiyama et al., 1993). De novo E-cadherin expression, in 
this particular cell line, resulted in about a 2.5-fold increase in [34-integrin levels (Figure 3.17), 
suggesting that there might be a ‘cross-talk’ between these two epithelial adhesion molecules 
which will be investigated further in Chapter 5.
Based on the results that I achieved so far, in the work described in this Chapter, I dedicated 
the next two years work to investigate two major areas. Firsdy, I chose to examine the 
possible cross-talk between E-cadherin and the (34-integrin subunit. For this reason, I utilised 
the FI376(34 cell line, an H376 cell line previously transfected with [34-integrin subunit by 
J.Jones (Jones et al., 1996a), and its control counterpart cell line, IA2, which was transfected 
with the empty vector. The plan was to transfect these cell lines with my E-cadherin 
construct and then to study the possible cross talk between E-cadherin and the (34-integrin 
subunit.
Secondly the E-cadherin molecule is one o f the most extensively studied adhesion molecules 
and my initial functional assay results showed not much difference than similarly published 
observations. However, in my opinion, m ost of these tests have a major limitation. That is 
they were conducted on cells under 2-D conditions in tissue culture; a non-physiological 
state for mammalian cells. In an effort to give my studies greater in vivo relevance I chose to 
expand the basis o f my investigations by adapting some of these assays to 3-D culture 
conditions using my E-cadherin OSCC model cell lines. These findings constitute the basis 
o f the next Chapter.
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Figure 3.1 
E-cadherin profile of the H376 parental cell lines using FACS analysis and Western 
blotting
a) F A C S analysis: Cells were allowed to grow to confluency. Harvested using E-cadherin 
preservation method (Chapter 2, Section 2.2.1.1). FACS results showed E-cadherin surface 
expression o f the parental cell lines, the black histogram represents the negative control 
labelled with Mouse IgG l negative control (DAKO), while the blue histogram represents the 
positive cell population expressing E-cadherin labelled with and-E-cadherin antibody 
“HECD -1” (M. Takeichi). H357 cell line was used as a positive control and shown to express 
high levels o f E-cadherin, while H376 is shown to be an E-cadherin negative line.
b) W estern b lo t analysis: Equal cell numbers o f each cell line were plated for 48 hours in 
KGM prior to lysing. Whole cell RIPA lysates were obtained, and equal protein was 
determined by the BCA protein assay. Proteins (25 pg/lane) were resolved by SDS-PAGE 
and blotted onto nitrocellulose membrane. The blot was probed for E-cadherin using 
HECD-1 antibody and shows a 120 kDa band in relation to H357 line “positive control”, 
whereas H376 cell line was negative for E-cadherin. The bottom  blot was probed for (3-actin 
used as a loading control.
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Figure 3.2 
Catenins and other cadherins profile of the H376 parental cell lines using Western 
blot analysis
Equal cell numbers o f each cell line were plated for 48 hours in KGM  prior to lysing. Whole 
cell RJPA lysates were obtained, and equal protein was determined by the BCA protein assay. 
Proteins (25 pg/lane) were resolved by SDS-PAGE and blotted onto nitrocellulose 
membrane.
a) Catenin Profile: The top blot was probed with monoclonal antibody to a-catenin (BD 
Transduction Laboratories) and shows a 102 kDa a-catenin band in relation to both cell 
lines, H357 and H376.
The second blot was probed with monoclonal antibody to (3-catenin (BD Transduction 
Laboratories) and shows a 92 kDa j3-catenin band in relation to both cell lines, H357 and 
H376.
The third blot was probed with monoclonal antibody to y-catenin (BD Transduction 
Laboratories) and shows a 82 kDa y-catenin band in relation to both cell lines, H357 and 
H376.
b) Cadherin profile: The top blot was probed using monoclonal antibody to Desmoglein (BD 
Transduction Laboratories) and shows a 165 kDa band in relation to both H357 and H376 
lines.
The second blot was probed with monoclonal antibody to N-cadherin (BD Transduction 
Laboratories) and shows a 130 kDa N-cadherin band in relation to both cell lines, H357 and 
H376, with strong expression in the H376 lane.
The third blot was probed with monoclonal antibody to P-cadherin (BD Transduction 
Laboratories) and shows a 120 kDa P-cadherin band in relation to the H357 cell line, 
whereas the H376 cell line was negative for P-cadherin.
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Figure 3.3
Total RNA purification from the H357 cell line
Total RNA o f O D 260/280 1.8 ratio was isolated from the E-cadherin- expressing H357 cells 
using the RNA STAT-60™ total RN A/m RN A isolation reagent (Tel-Test “B” Inc.). The 
bands were resolved using 1% agarose gel electrophoresis. The image shows the ribosomal 
RNA bands.
Figure 3.4
Amplification of the E-cadherin gene
E-cadherin cDNA was amplified using pfuTurbo®DNA polymerase (Stratagene) and 
specific primers. Electrophoresis image shows a band o f 2700 bp.
Figure 3.5
Miniprep restriction digestions
Colonies were selected for small scale minipreparation
The template was identified using X hol restriction digestion and fragments o f 5284 bp and 
~2700 bp were expected to appear in the 1% agarose gel electrophoresis image.
The orientation o f the insert was identified using EcoRI restriction digestion, and the sense 
orientation was expected to give fragments o f ~6234 bp, 1350 bp and 500 bp, while the 
antisense orientation was expected to give fragments o f ~5934 bp, 1350 bp and 800 bp.
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Figure 3.6
E-cadherin expression in transiently transfected cell lines using FACS analysis and 
Western blotting
a) F A C S analysis: N IH /3T 3 and H376 cell lines were transiendy transfected with E- 
cadherin sense and anti-sense cDNA, using FuG E N E  6 Transfection reagent. The 
transfected cells were labelled for E-cadherin using HECD-1 antibody. The negative control 
was labelled with Mouse IgG l negative control (DAKO), and the positive control was 
labelled for pEG FP. D ot blots showed total surface E-cadherin expression o f 25.56% of 
cells in the N IH /3T 3 transfected cell line and 29.96% of cells in H376 transfected cell line.
b) W estern b lo t analysis: Whole cell RIPA lysates (28.6 pg/lane) were resolved by SDS- 
PA G E and blotted onto nitrocellulose membranes. The blot was probed for E-cadherin 
using HECD-1 antibody and shows an E-cadherin band o f 120kDa detected in N IH /3T 3 
and H376 cell lines transfected with the E-cadherin sense construct. The H375 cell line was 
used as a positive control
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Figure 3.7
Determination of E-cadherin expression in H376 stably transfected cell lines
a) F A C S analysis: H376 cell line was transfected with E-cadherin sense and anti-sense 
constructs. Positive cell populations expressing E-cadherin were sorted using magnetic beads 
(Dynabeads®), and were selected using 0.5 pg/m l puromycin. FACS results showed E- 
cadherin surface expression of the transfected cell lines, the black peak represents the 
negative control labelled with Mouse IgG l negative control (DAKO), while the blue peak 
represents the positive cell population expressing E-cadherin labelled with HECD-1 
antibody. H376 antisense cell line showed no expression o f E-cadherin while the H376 E- 
cadherin cell line expressed high levels of E-cadherin.
b) W estern b lo t analysis: Whole cell RIPA lysates (38 pg/lane) were resolved by SDS- 
PA G E and blotted onto nitrocellulose membranes. The top blot was probed for E-cadherin 
using HECD-1 antibody and shows a 120 kDa band in relation to the “positive control” 
H357 line and the H376 cell line transfected with the E-cadherin sense construct (H376 E- 
cadherin). In contrast H376 cell line transfected with the anti-sense construct (H376 
antisense) was negative for E-cadherin. The bottom  blot was probed for (3-actin which was 
used as a loading control.
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Figure 3.8
Determination of E-cadherin expression in H376 stably transfected cell lines using 
indirect immunostaining
2 x 104 cells were plated onto 13mm coverslips in a 24-well plate and allowed to grow for 48 
hours with selection medium. Cells were examined on a confocal laser scanning microscope, 
and images collected digitally.
Panels A-C are confocal images of the H376 cells transfected with the anti-sense construct 
(H376 antisense).
Panels D-F are confocal images of the H376 cells transfected with the sense construct (H376 
E-cadherin).
In Panels A and D, E-Cadherin, “green”, was detected by HECD-1 antibody. H376 
antisense cell line was negative for E-cadherin (Panel A). H376 E-cadherin cell line was 
positive for E-cadherin (Panel D) which appeared on the cell surface at cell-cell junctions but 
the junctions appeared to be morphologically immature (as denoted with open arrows).
In Panels B and E, actin cytoskeleton, “red”, was detected with phalloidin-TRITC, and 
showed that the actin filaments co-localised with E-cadherin and redistributed into bundles 
in the H376 E-cadherin cell line (Panel E).
Panels C and F are composite confocal images showing E-cadherin, “green”, actin 
cytoskeleton, “red” , and nuclei, “blue” , detected by DAPI.
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Figure 3.9
Indirect immunostaining for E-cadherin in the H357 cell line
2 x 104 cells were plated onto 13mm coverslips in a 24-well plate and allowed to grow for 48 
hours, stained and examined on a confocal laser scanning microscope, and images collected 
digitally.
In Panel A, E-Cadherin, “green”, was detected by HECD-1 antibody, and appeared on the 
cell surface at cell-cell junctions forming a mature junction. In Panel B, Actin cytoskeleton, 
“red”, was detected with phalloidin-TRITC, and showed that the actin filaments formed an 
actin belt parallel to the circumference o f the cell; a feature o f cells with an epithelial 
morphology.
Panel C, is an image o f H357 cells visualised under “contrast phase” microscopy, showing 
typical epithelial morphological presentation.
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Figure 3.10
Microscopic images of the stably transfected cell lines
Under “contrast phase” microscopy the E-cadherin positive cell lines exhibited a more 
epithelial morphology (Panel A) than the more spindly anti-sense control cells (Panel B).
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Figure 3.11
Catenin profile of the stably transfected cell lines using Western blot analysis
Equal cell numbers o f each cell line were plated for 48 hours in KGM  prior to lysing. Whole 
cell RIPA lysates were obtained and 25 pg protein/lane were resolved by SDS-PAGE and 
blotted onto nitrocellulose membrane. Densitometric analysis: values were obtained and 
corrected for loading. Error bars represent standard error o f the mean.
a) Histogram obtained from results o f densitometric values o f three independent 
experiments shows that E-cadherin transfection resulted in an increase in the total level o f a- 
catenin (p value < 0.01). The top blot is a representative Western blot probed with 
monoclonal antibody to a-catenin (BD Transduction Laboratories) and shows a 102 kDa a- 
catenin. (3-actin has been used as a loading control.
b) Histogram obtained from results o f densitometric values o f three independent 
experiments shows that E-cadherin transfection resulted in an increase in the total level o f (3- 
catenin (p value £  0.02).The top blot is a representative Western blot probed with 
monoclonal antibody to (3-catenin (BD Transduction Laboratories) and shows a 92 kDa (3- 
catenin. (3-actin has been used as a loading control.
c) Histogram obtained from results o f densitometric values o f five independent experiments 
shows that y-catenin was downregulated as a consequence o f E-cadherin re-expression (p 
value 5: 0.02). The top blot is a representative Western blot probed with monoclonal 
antibody to y-catenin (BD Transduction Laboratories) and shows a 82 kDa y-catenin. (3-actin 
has been used as a loading control.
129
Densitometric value 
(Arbitrary units)
8 £ ! C v
Densitometric value 
(Arbitrary units)
Densitometric value 
(Arbitrary units)
w
>
c/ j
O vn
*
i
ii
o
oto
W
I
H376 E-cad
H376 AS
to p 
6 § -
O Clto £
0  1- M 3
H376 E-cad
H376 AS
oto tO p tO p
H376 E-cad
H376 AS
Figure 
3.11
Figure 3.12
Indirect immunostaining for (3- and Y-catenin in the H376 transfected cell lines
2 x 104 cells were plated onto 13mm coverslips in a 24-well plate and allowed to grow for 48 
hours.
Panels A and B are confocal images o f H376 transfected cells probed with monoclonal 
antibody to (3-catenin (BD Transduction Laboratories) and show that H376 E-cadherin cells 
(Panel A) exhibit a stronger posirivity for (3-catenin with more (3-catenin recruited to the cell­
cell junctions, as compared to cells transefected with the antisense construct (Panel B).
Panels C and D are confocal images o f H376 transfected cells probed with monoclonal 
antibody to y-catenin (BD Transduction Laboratories) and show that H376 E-cadherin cells 
(Panel C) exhibit a stronger positivity for y-catenin which was recruited to the cell membrane 
(apparently not consistent with the Western blot results that showed downregulation o f the 
total y-catenin in the E-cadherin positive cell line), as compared to cells transefected with the 
antisense construct (Panel D).
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Figure 3.13 
Expression of other Cadherins in the H376 transfected cell lines
Whole cell RIPA lysates were obtained, and equal protein was determined by BCA protein 
assay. Proteins (25 pg/lane) were resolved by SDS-PAGE and blotted onto nitrocellulose 
membranes.
The top blot was probed with monoclonal antibody to N-cadherin (BD Transduction 
Laboratories) and shows a 130 kDa N-cadherin band in all lanes, positive control, H376 E- 
cadherin and H376 antisense cell lines. With the same amount o f protein loaded there 
appeared to be a marked downregulation o f the total N-cadherin in the H376 E-cadherin cell 
line.
The bottom  blot was probed for Hsc-70 which was used as a loading control.
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Figure 3.14 
Invasion Assay
Cell invasion was measured using Matrigel-coated polyethylene tetraphthallate (PET) 
membranes. Full keratinocyte growth medium was used as a chemo-attractant in the lower 
chamber. After 48 hours cells were detached with ED TA /trypsin and counted using the 
CASY counter.
A representative experiment showed that invasion was greatly inhibited (60-80%) (p value £  
0.0004) in H376 E-cadherin cell line as compared to the H376 antisense control cell line. 
Error bars represent standard error o f the mean.
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Figure 3.15 
Growth assay
2 x 104 cells were plated onto 3cm wells. Triplicate wells were counted at 5 time points up to 
120 hours. Cells were counted using the CASY counter. Figure shows one representative 
experiment out of three. Error bars represent standard error o f the mean.
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Figure 3.16
Integrin Profile of the H376 transfected cell lines (Geometric mean fluorescence 
histogram)
Flow cytometric analysis of expression of various integrins on the cell surface o f the 
transfected cell lines; H376 E-cadherin and H376 antisense. Geometric mean fluorescence 
(arbitrary units, log scale) as measured by flow cytometry o f cells labelled with anti-integrin 
antibodies.
Figure shows a representative experiment. The mean fluorescence intensity (MFI) o f each 
integrin subunit in each cell line was determined by subtracting the fluorescence value o f cells 
labelled with the appropriate IgG control antibody.
Antibody FB12 recognises the a l  subunit; P1E6 recognises the a2 subunit; P1B5 recognises 
the a3 subunit; 7.2 recognises the a4 subunit; P1D6 recognises the a5 subunit; G O H 3 
recognises the a 6 subunit; Y9A8 recognises the a9 subunit; L230 recognises the av subunit; 
AIIB2 recognises the pi subunit; 3E1 recognises the (34 subunit; LM609 recognises the av(33 
integrin; P1F6 recognises the av(35 integrin.
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Figure 3.17
(31, p4 and a2 integrin subunit analysis in the H376 transfected cell lines (Geometric 
mean fluorescence histogram)
Flow cytometric analysis o f expression o f p i, (34 and a2 integrin subunits on the cell surface 
o f the transfected cell lines; H376 E-cadherin and H376 antisense. Geometric mean 
fluorescence (arbitrary units, log scale) as measured by flow cytometry o f cells labelled with 
anti-(31 integrin antibodies (AIIB2), anti-(34 integrin antibodies (3E1) and anri-a2 integrin 
antibodies (P1E6).
Figure shows histogram blotted against the mean value o f three independent experiments for 
p i integrin (a), p4 integrin (b) and a2 integrin (c). The mean fluorescence intensity (MFI) was 
determined by subtracting the fluorescence value o f cells labelled with the appropriate IgG 
control antibody. Error bars represent standard error o f the mean (sem).
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Figure 3.17
Pl-integrin subunit
■  H376 E-Cadherin
■  H376 antisense
[34-integrin subunit
■  H376 E-Cadherin
■  H376 antisense
a 2  -integrin subunit
■  H376 E-Cadherin 
IB H376 antisense
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CHAPTER 4
E-cadherin Regulation of Cell Proliferation Under 2-D or 3-D 
Collagen I Culture Conditions
4.1 Introduction
Tumour cells may be regarded as being like “cynical criminals” in their behaviour in that they 
defy the body’s normal social restraints; one of these restraints being the restriction o f cell 
growth when cells find themselves outside o f their correct anatomical location. During the 
initial phase o f the neoplastic process the transformed tumourigenic epithelial cells 
proliferate at accelerated rates on top o f the underlying basement membrane in what, 
effectively, is a “two dimensional” (2-D) environment. As tumour evolution progresses the 
transformed epithelial cells acquire the ability to penetrate the basement membrane and 
invade the adjacent stromal matrix (see Figure 4.1 for an illustration o f the metastatic 
process). The expression o f this tissue-invasive phenotype occurs in conjunction with 
adaptation o f the tumour cells to survive an abm pt transition in growth environments. No 
longer confined to the planar surface of the extracellular matrix (ECM), where they were 
located on a contiguous basement membrane, the invading cells are forced to proliferate 
within a dense three-dimensional (3-D) matrix composed largely o f type I collagen or 
crosslinked fibrin (for an overview, see Hanahan and Weinberg, 2000).
In normal epithelium, the physical interactions o f the epithelial cells with each other and with 
the underlying ECM are termed “cell-cell anchorage” and “cell-matrix anchorage”, 
respectively (Grossmann, 2002).
Cell anchorage molecules not only act as a cellular “glue” and mechanical scaffolding to 
maintain the integrity o f a given tissue, but also they are known to provide necessary signals 
that promote cell growth and survival (Meredith et a l , 1996; Assoian, 1997). Loss of cell
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anchorage forces the detached cells to undergo programmed cell death, or apoptosis; a 
phenom enon found to be o f relevance for development, differentiation, maintenance of 
tissue homeostasis and disease (Grossmann, 2002). In principle, every living cell inherits the 
capacity to commit suicide through different programmed cell death pathways. For normal, 
adherent, non-transformed cells a synergistic activation o f apoptotic pathways follows loss of 
cell anchorage, whereas transformed tum our cells have the potential to grow in the absence 
o f cell adhesion to the underlying ECM in an ‘anchorage ///dependent’ manner; such an 
acquired potential allows tum our cells to grow at inappropriate sites in vivo as occurs during 
invasion and metastasis (Grossmann, 2002).
Apoptosis following loss o f cell anchorage is referred to as “Anoikis” ; a term adopted from 
Greek, meaning ‘state o f homelessness’ (Frisch and Francis, 1994). Alternatively, the survival 
o f tum our aggregates away from their homeland, through adhesion mediated cell-cell 
contact, was referred to as “Synoikis” (Shen and Kramer, 2004) (Figure 4.2).
It is believed that specific cell-cell and cell-matrix contacts regulate cell growth in epithelial 
cells, and that disruption o f these contacts induces apoptosis (Ruoslahti and Reed, 1994; 
Hermiston and G ordon, 1995). O n the other hand, it also has been reported that cadherin- 
mediated cell-cell adhesion plays a critical role in the complex network o f survival signalling. 
There is a growing body o f literature supporting the fact that E-cadherin plays a key role 
during the induction and progression o f epithelial cancers (e.g. Cavallaro and Christofori, 
2004), while its loss and malfunction contributes to increased invasiveness and proliferation 
in epithelial carcinomas (Margulis et al., 2003). It is rather interesting that, in some tumours, 
cadherins seem to enhance not only cell growth but also cell survival. Engagement of 
detached epithelial cells via E-cadherin-mediated adhesion complexes was shown to generate 
anchorage-independent survival signals rendering the aggregated epithelial cellular masses
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anoikis-resistant/synoikotic (Miller and Moon, 1996; Kantak and Kramer, 1998; Day et al, 
1999; Shen and Kramer, 2004).
The expression o f this homophilic adhesion molecule, E-cadherin, has been linked to several 
pathways that control cell proliferation, survival and apoptosis, through the interaction with 
some downstream pathway effectors such as Bcl-2, A kt/PK B  and ILK, and /o r another cell 
adhesion molecule that has been reported to play an anti-apoptotic role; namely N-cadherin.
Bcl-2 (B cell leukaem ia/lym phom a-2) protein:
This anti-apoptotic member o f the apoptosis-regulating family o f proteins (Adams and Cory,
2001), has been shown to confer a survival advantage on cells by inhibiting apoptosis. In 
epithelial cells, Bcl-2 expression is associated with proliferation, tissue development and 
morphogenesis (Lu et a l 1996). High levels, or irregular patterns, o f Bcl-2 expression occur 
in various carcinomas (Reed et al., 1996; Reed, 1998; 1999). For example, Lu et al. (1995) 
showed that overexpression o f Bcl-2, in a mammary epithelial cell line, increased survival of 
tumour cells but also prom oted epithelial-mesenchymal conversion; a conversion which was 
accompanied by a reduction in levels o f the E-cadherin molecule expressed at the cell surface 
(Lu et al., 1995). Li et al. (2003) obtained similar results using MCF-7, a poorly invasive breast 
carcinoma cell line exhibiting a typical epithelial morphotype. They showed that Bcl-2 
overexpression in this cell line led to decreased cell surface E-cadherin and disrupted the 
membrane localisation o f all junctional markers, while interfering with junction assembly (Li 
et al., 2003). Conversely, Sasaki et al. (2000) reported that re-expression o f E-cadherin, in a 
rat breast carcinoma cell line, reduced Bcl-2 expression and resulted in the redistribution of 
(3-catenin. This has led to the suggestion o f a possible cross-talk between E-cadherin and 
Bcl-2 molecules (Sasaki et al., 2000).
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Serine/threonine kinase Akt:
Also known as protein kinase B (PKB), Akt is a proto-oncogene and a downstream effector 
o f phosphatidylinositol 3-kinase (PI 3-kinase); an enzyme known for its vital regulatory role 
in diverse cellular processes, including cell changes propelling cancer progression. The three 
Akt isoforms (Aktl, Akt2 and Akt3) mediate many o f the downstream events regulated by 
PI-3 kinase (PI3K) such as cell growth, cell proliferation and cell survival (Brazil et al., 2002; 
Cantley, 2002; Vivanco and Sawyers, 2002). Furthermore, A kt/PK B  activation has been 
reported to occur in many human epithelial cancers. For example, total A kt/PK B  kinase 
activity is increased in non-small cell lung cancer, squamous cell carcinoma o f the oral cavity 
as well as breast and prostate carcinoma (Nakayama et al., 2001a; Sun et al., 2001; Brognard et 
al., 2001). Additionally, Akt-2 overexpression has been found to be associated with an 
undifferentiated histological pattern and more aggressive clinical behaviour in ovarian cancer 
(Bellacosa et al., 1995); perhaps suggesting that A kt/PK B  actually can contribute to tumour 
progression.
In oral squamous cell carcinoma, this kinase also was shown to induce epithelial- 
mesenchymal transition (EMT); a phenotypic change characterised by the downregulation of 
epithelial cell-specific proteins, including E-cadherin and (3-catenin, and the upregulation of 
the mesenchymal cell-specific protein, vimentin (Grille et al., 2003). This EM T was 
accompanied by increased motility and invasiveness o f the engineered squamous carcinoma 
cell line (Grille et al., 2003). These findings suggested that A kt/PK B  kinase may be an 
im portant therapeutic target for the control o f tumour cell invasion and, eventually, for the 
control o f the metastatic behaviour o f malignant cancers.
It has been reported that homophilic E-cadherin-mediated adhesion initiates the activation 
o f PI 3-kinase followed by downstream activation o f the A kt/PK B  protein (Pece et al., 1999; 
Kovacs et al., 2002). Activation o f Akt protein requires phosphorylation on both threonine
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308 (Thr-308) and serine 473 (Ser-473). Phosphorylation o f Thr-308 occurs when Akt is 
recruited to the cell membrane but it is not sufficient for activation o f the kinase activity, 
which requires further phosphorylation o f Ser-473 (Alessi et al., 1996). Activated Akt further 
phosphorylates several substrates that can result in suppression o f apoptosis and stimulation 
o f cell growth (Datta et al., 1999). Again the inference from these diverse studies is that there 
is some connection, or interaction, between E-cadherin and A kt/PK B; at least at the 
functional level.
Integrin Linked Kinase (ILK):
ILK is a PI-3 kinase-dependent serine/threonine kinase, originally identified as a (31 integrin- 
binding protein (Hannigan et al., 1996) that binds to the (3- cytoplasmic domains of both (31 
and (33 integrins, and phosphorylates the pi cytoplasmic domain in vitro (Hannigan et al., 
1996). It is thought to play a role in mediating interactions between integrins and the actin 
cytoskeleton, through interaction with multiple different proteins, in a variety o f cell types 
(Zervas et al., 2001; Wu and Dedhar, 2001; Nikolopoulos and Turner, 2001).
It has been reported that ILK is a major contributor to the phenotypic alteration of 
transformed epithelial cells, such that cells overexpressing ILK exhibit an induced epithelial- 
mesenchymal transition (Somasiri et al., 2001; Lee et al., 2004). Added to this role, several 
studies have suggested that ILK also plays a vital role in the control o f cell survival (Fukuda 
et al., 2003; Friedrich et al., 2004). ILK overexpression was shown to disrupt cell-cell adhesion 
and has been suggested to induce anchorage-independent cell survival in the transfected cells 
(Hannigan et al., 1996). It also has been reported that the crucial contribution o f ILK to cell 
survival is conferred via its ability to activate A kt/PK B protein optimally which, as outlined 
above, is an im portant signalling mediator for the cell survival pathway (Persad et al., 2000; 
Fukuda et al., 2003; Troussard et al., 2003; Friedrich et al., 2004).
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A number o f studies have incriminated ILK in the regulation o f E-cadherin expression (Wu 
et al., 1998; Somasiri et al., 2001; Li et al., 2003; Oloumi et al., 2004). ILK over expression has 
been shown to result in the disruption of cell-cell adhesion, loss o f E-cadherin expression 
and the acquisition o f a fibroblastic morphotype (Hannigan et al., 1996; Somasiri et al., 2001; 
Li et al., 2003). Such findings were further supported by the observation that inhibiting ILK 
activity in human cancer cell lines has resulted in upregulation o f E-cadherin expression (Tan 
et al., 2001). In contrast, Vespa et al. (2003) showed there was a substantial reduction o f ILK 
activity associated with Ca2+-induced keratinocyte differentiation, although the exogenous 
expression o f ILK in their model system did not induce EM T or even E-cadherin 
degradation and loss o f intercellular adhesion (Vespa et al., 2003). Such findings though are in 
contrast to other model systems which have used different epithelial cells (Wu et al., 1998; 
Somasiri et al., 2001; Lee et al., 2004) and this may be indicative o f the possibility that there is 
considerable variation between different cell types.
The Cadherin switch:
Associated with the metastatic progression o f epithelial tumour cells is the dynamic 
regulation o f cadherin expression. Loss, or reduced expression, o f E-cadherin has been 
detected in the majority of carcinomas, and often has been correlated with increased 
invasiveness and poorer survival (Dorudi et al., 1993; Bringuier et al., 1993; Kawakita et al., 
1994; Lipponen and Eskelinen, 1995; Miyazaki et al., 1995; Mialhe et al., 1997). O n the other 
hand, the upregulation o f other members o f the cadherin family in carcinomas, particularly 
N-cadherin, was found to function in cancer progression and contribute to the invasive 
phenotype (Islam et al., 1996; Tran et al., 1999; Hazan et al., 2000; Li et al., 2001). It has been 
documented that, associated with the loss of E-cadherin in some human cancers, there was 
an increased expression o f other mesenchymal cadherins, like N-cadherin and cadherin-11
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(Li and Herlyn, 2000; Tomita et al., 2000), thus suggesting that N-cadherin, and perhaps 
other mesenchymal cadherins, have an opposite effect as compared to E-cadherin. This 
cadherin conversion has been referred to as the “Cadherin switch”; a phenom enon thought 
to support the transition from a benign to an invasive, malignant tumour phenotype (Tomita 
et al., 2000; Hazan et al., 2004). This switching of cadherin subtypes recapitulates a well 
known phenom enon that occurs during development; where epiblast cells switch from 
expressing E-cadherin to expressing N-cadherin, to ingress the primitive streak (Edelman et 
al., 1983; Hatta and Takeichi, 1986). Also, the differential expression pattern o f E- and P- 
cadherin during hair follicle development, skin morphogenesis and tooth formation, is 
another example of cadherin switch in normal tissues (Hardy and Vielkind, 1996; Jamora and 
Fuchs, 2002).
E-cadherin and N-cadherin are both classical cadherins and, as a first impression, they might 
seem likely to be implicated in similar mechanisms o f cell-cell adhesion. Yet, unlike E- 
cadherin, N-cadherin is unable to support the epithelial phenotype, and as polarity is lost, N- 
cadherin has been proposed to promote a dynamic adhesion state in tumour cells, allowing 
not only dissociation o f tumour cells from the tum our mass and enhancement o f invasion 
and migration o f tum our cells, but also allowing for their interaction with fibroblasts, 
vascular endothelial cells, and other stromal components (Hazan et al., 2000; Li and Herlyn, 
2000; Tomita et al., 2000). Thus, this switching o f cadherin subtypes might affect tumour- 
host cell adhesion, tumour cell invasion and tumour cell migration.
N-cadherin also has been suggested to function as an anti-apoptotic protein. Thus Tran et al. 
(2002) demonstrated a signal transduction cascade that linked the N-cadherin-catenin 
adhesion complex to upregulation o f the anti-apoptotic protein, Bcl-2. It also was proposed 
that N-cadherin-mediated homophilic adhesion, in the same model system, can initiate anti-
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apoptotic signalling through the activation o f A kt/PK B  (Tran et al., 2002); results somewhat 
similar to reports that E-cadherin ligation also is implicated in the regulation of the PI-3 
kinase signalling pathway (Pece et al., 1999; Kovacs et al., 2002; Rieger-Christ et al., 2004). 
Thus, the consensus o f all these findings is that both E-cadherin and N-cadherin have the 
potential to activate the Akt signalling pathways.
Potential fate o f the E-cadherin molecule in apoptosis:
In addition to (3-catenin and plakoglobin, E-cadherin also is reported to be cleaved in 
epithelial cells as part o f the changes which occur during the execution phase o f programmed 
cell death; otherwise known as apoptosis. It has been suggested that simultaneous cleavage of 
the intracellular and extracellular domains o f E-cadherin provides an highly efficient 
mechanism to disrupt cell-cell cohesion enabling apoptotic cells to round up and exit from 
the epithelium (Steinhusen et al., 2001). Different types o f proteolytic cleavage o f the E- 
cadherin molecule have been documented. For example, it has been shown that caspase-3 
mediates a cleavage that releases the cytoplasmic domain o f the E-cadherin molecule, and 
that metalloproteinase sheds the extracellular domain from the cell surface during apoptosis 
(Steinhusen et al., 2001). In support o f the theory that E-cadherin may play a central role in 
adhesion-dependent survival and dissociation-induced apoptosis, are the findings of 
Vallorosi et al. (2000), who associated the loss o f cell-cell adhesion with the rapid truncation 
of the (Tcatenin binding domain o f the E-cadherin molecule. This resulted in the generation 
of two cleavage products, one o f 97 kDa, specified as the membrane-bound fragment, and 
another o f 35 kDa, specified as the cytoplasmic-free fragment, whose activity was shown to 
be correlated with reduced cell-cell adhesion (Vallorosi et al., 2000).
Solid tumours usually grow as three-dimensional masses. A substantial body o f literature has 
emphasised the importance o f the physical three-dimensional nature of the ECM; a
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condition more relevant to the in vivo milieu encountered by tissue invasive cells. The impact 
of this physical structure in regulating normal cell behaviour, including cell proliferation, has 
been considered by a number o f authors (Bissell and Radisky, 2001; Cukierman et al!, 2001; 
Walpita and Hay, 2002; Grinnell, 2003).
Hotary et al. (2003) adopted the idea o f studying this aspect o f cell behaviour in the context 
of 3-D culture conditions. They compared tumour cell proliferation in 2-D and 3-D collagen 
type I cultures, and reported that the 3-D physical restraints were able to prevent 
proliferation in tumour cells. They found that some o f these cells exhibited a compact, 
spherical morphotype with the actin filaments assembled at the cell periphery (Hotary et al., 
2003). However when such tumour cells were producing the membrane-anchored matrix 
metalloproteinase (MT1-MMP), they exhibited a stretched-out morphotype with actin 
filaments reorganised into centrally located robust stress fibres (Hotary et a l 2003). In 
previous work Chen et al (1997) showed that cell shape, and the associated organisation of 
the cytoskeleton, played a role in cell growth and apoptosis (Chen et al., 1997). A possible 
interpretation o f the Hotary et al. (2003) results would be that the capacity o f tumour cells to 
grow is linked to their ability to alter cell shape. Such results further support the importance 
of utilising a 3-D microenvironment when conducting different biochemical experiments on 
cellular growth parameters.
Much o f the data which I have discussed above actually have been derived from studies on 
tumour cells growing within the confines o f two-dimensional tissue culture dishes. Because 
solid tumours usually grow as three-dimensional masses, I have been interested in 
understanding the impact o f E-cadherin re-expression on the growth properties o f my 
tumour cells in the context o f three-dimensional collagen I culture conditions; a system more
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likely to simulate the normal physiological milieu of the human biological environment than 
two-dimensional growth.
The main aim o f this chapter was to detect any differences in the cells, in relation to E- 
cadherin expression, to any o f the previously listed cell survival molecules and to assess such 
differences in the context o f 3-D collagen I culture conditions.
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4.2 Results
4.2.1 Analysis of expression of proteins associated with cell survival in E- cadherin 
transfected cell lines growing on tissue culture plastic
Cells were allowed to grow as a monolayer on serum-coated tissue culture plastic for 5 days. 
When cells had just reached confluency, total RIPA cell lysates were prepared, as described 
in Chapter 2 Section 2.3. Using the appropriate antibody concentration (Appendix II, Table 
II.3), Western blots for both the H376 E-cadherin cell line and its antisense counterpart 
(H376 antisense) were probed for proteins that have been linked to cell survival, such as Bcl- 
2, Akt-1, phospho-Akt, ILK and N-cadherin proteins.
Western blot analysis, using Anti-Bcl2 (clone 100) monoclonal antibody (Upstate), 
consistently, showed a two-fold decrease in Bcl-2 expression associated with de novo 
expression o f E-cadherin in my OSCC cell lines. Figure 4.3 (a) shows a representative 
Western blot analysis and a histogram, obtained from results o f four independent 
experiments, illustrating a statistically significant reduction of Bcl-2 levels in the H376 E- 
cadherin cell line as compared to the antisense counterpart (p value < 0.004).
Using monoclonal anti-Akt-1 (clone 2H10) antibody (Cell Signaling) the Western blot results 
showed a slight, yet significandy different, reduction (p value < 0.001), in total Akt-1 levels 
associated with re-expression o f the E-cadherin molecule in my OSCC cell lines. Figure 4.3 
(b) shows a representative Western blot and a histogram summarising data obtained from 
three different experiments.
At the same time, Western blot analysis also was used to evaluate the levels of 
phosphorylation o f the A kt/PK B  protein at the Thr-308 location as a consequence o f the de 
novo expression o f the E-cadherin molecule. There was nearly a 1.5 fold, statistically 
significant, increase in levels o f phospho-Akt (Thr-308) in the H376 E-cadherin cell line as
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compared to the antisense counterpart (p value < 0.001) (Figure 4.3: c). Figure 4.3 (c) shows 
a representative W estern blot that has been probed with monoclonal anti-phospho-Akt 
(Thr308) antibody (Cell Signaling), and histogram representing data of three different 
individual experiments.
Previous work has linked the E-cadherin molecule to ILK in that ILK  overexpression was 
shown to result in the loss o f E-cadherin expression (Somasiri et al., 2001; Li et al., 2003). 
Conversely it also was shown that ILK was reduced substantially upon Ca2+-induced E- 
cadherin-dependent cell-cell junction assembly and keratinocyte differentiation (Vespa et al., 
2003). This ‘cross-talk’-like interaction between the E-cadherin molecule and ILK was 
investigated in my OSCC model system. Western blot results, obtained from four 
independent experiments using an anti-ILK monoclonal antibody (BD Transduction 
Laboratories), consistently showed a slight reduction, that was not statistically different (p 
value 5: 0.2), in ILK levels associated with the re-expression o f E-cadherin in my OSCC cells 
(Figure 4.3: d).
Preliminary results from the previous chapter suggested that de novo E-cadherin expression in 
my OSCC cell lines resulted in the downregulation o f N-cadherin; a previously observed 
phenom enon that has been referred to as the “Cadherin switch” (Tomita et al., 2000; Hazan 
et al., 2004). The N-cadherin molecule also has been proposed to play an anti-apoptotic role, 
which made me think it would be sensible to investigate the expression o f this protein 
further in my system. Western blot results, from three independent experiments, using anti- 
N-cadherin antibody (BD Transduction Laboratories), consistently showed about a two-fold 
reduction in N-cadherin levels as a consequence o f de novo expression o f the E-cadherin 
molecule. Results were significantly different between the H376 E-cadherin cell line and the 
antisense counterpart (p value < 0.03) (Figure 4.3: e).
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4.2.2 E-cadherin transfected OSCC cell lines in the context of 2-D and 3-D collagen
I culture conditions
4.2.2.1 Gross morphology of E-cadherin transfected cell lines in 2-D/3-D collagen 
I cultures
A number o f papers have reported that E-cadherin positive cells adopted a rounded 
morphology when implanted in 3-D cultures (St Croix et al., 1998; Hotary et al., 2003; Shen 
and Kramer, 2004). Somewhat in contrast to these findings, and as observed under contrast- 
phase microscopy, my transfected cell lines (both the E-cadherin sense and the antisense) 
manifested the same morphological appearance and formed spherical aggregates when they 
were implanted in 3-D Matrigel cultures though not when they were implanted in 3-D 
collagen I cultures (Figure 4.4). In fact in the 3-D collagen I cultures my transfected cell lines 
exhibited a more stretched fibroblastic morphotype and formed ‘net-like’ colonies with 
strands o f communicating cells (Figure 4.4). There was no apparent difference between the 
E-cadherin positive and E-cadherin negative cell lines; clearly indicating that expression o f 
this molecule had no impact on the gross appearance o f my cells.
4.2.2.2 Growth assay in 2-D/3-D collagen I cultures
In order to study the role o f the E-cadherin molecule in modulating cell growth and survival 
in 3-D culture conditions the growth o f my transfected cell lines (H376 E-cadherin and 
H376 antisense) was assessed under both 2-D and 3-D collagen I culture conditions over a 
10 day period (as described in Chapter 2, Section 2.6.1.2). Results showed that under 2-D 
collagen I culture conditions there was a marked difference between the sense and antisense 
cell lines. Starting with 2x104 cells, for each experimental well, H376 antisense cells were able 
to grow to up to 6.4 x 103 cells by day 10. In contrast, H376 E-cadherin cells grew to only 3.3
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x 103cells within the same time (Figure 4.5). Under 3-D collagen I culture conditions, these 
differences were abrogated. Starting with the same cell number as in 2-D cultures (2x104 cells 
per experimental well), H376 E-cadherin cells grew to 7 x 103 cells by day 10, versus 7.9 x 
103 cells for the H376 Antisense line (Figure 4.5).
By growing my transfected cell lines in three-dimensional culture, as compared to cells 
growing in two-dimensional collagen I culture, and during the first 10 days o f my growth 
assay, I could not observe any contact-dependent growth inhibition.
Having conducted these experiments it occurred to me that the 1-2 hour incubation period, a 
predetermined period o f time required to free all cells from 2-D and 3-D collagen I culture 
using 6m g/m l collagenase 1 (Worthington), might be rather harsh on the cells and also might 
affect the cell viability. Consequently, I tested this possibility and I found (data not shown) 
that for cells growing for 8 days in 2 -D /3-D  collagen I cultures that after 2 hours incubation 
with collagenase 1, only 2-5% o f cell were not viable (as tested with trypan blue exclusion) in
2-D cultures, compared to 0.7-0.9% of non-viable cells growing in 3-D cultures. Accordingly 
I concluded that the viability o f the cells was not affected dramatically by culture conditions 
nor by the harvesting methods.
4.2.2.3 Apoptosis and cell vitality Assay
Apoptosis was assessed in 2-D and 3-D collagen I cultures using the immunostaining-based, 
dUTP nick-end labelling (TUNEL) assay. Because apoptosis in adherent cultures involves 
the detachment o f cells from the substrate, supernatant was collected from each sample and 
the viability o f detached cells was tested using Trypan blue exclusion. Results showed that, 
under 2-D collagen I culture conditions, E-cadherin restoration was associated with an 
increased apoptotic response in the H376 E-cadherin cell line as compared to the H376 
antisense control cell line. TU N EL assay results showed that re-expression o f E-cadherin
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increased the apoptotic response by 4.1%, p value < 0.03 (Experiment I) and by 3.7%, p 
value < 0.02 (Experiment II) (Table 4.1). Moreover, the detached H376 E-cadherin cells 
showed 30.9% viability as com pared to 52.8% viability in the H376 antisense cells (p value < 
0.003), in Experiment I, similar results were obtained in Experiment II, where the H376 E- 
cadherin cells showed 31.3% viability as com pared to 51.4% viability in the H376 antisense 
cells (p value < 0.001) (Table 4.2). However, in the 3-D collagen I culture conditions, the 
apoptotic profile o f both the H376 E-cadherin cell line and the H376 antisense counterpart 
cell line did not show any statistical significance (Experiment I, p value < 0.2; Experiment II, 
p value <• 0.1) (Table 4.3), suggesting that E-cadherin restoration in 3-D collagen I 
conditions had no effect on the apoptotic potential o f the transfected cell line.
Table 4.1: Enumeration of Apoptotic cells in 2-D collagen I cultures
H376 E-cadherin H376 antisense
Field
No.
Total N o. 
o f
cells/F ield
N o. of 
apoptotic 
cells
Apoptosis
%
Total N o. 
of
cells/F ield
N o. of 
apoptotic 
cells
Apoptosis
%
1 30 2 6.7 30 0 0.0
Experiment 2 40
2 5.0 30 0 0.0
3 33 1 3.0 33 0 0.0
I 4 33 0 0.0 34 0 0.0
5 35 2 5.7 40 0 0.0
Mean 34.2 1.4 4.1 33.4 0 0.0
1 41 0 0.0 28 0 0.0
Experiment 2 25 1 4.0 25 0 0.0
3 32 2 6.3 40 0 0.0
II 4 35 2 5.7 37 0 0.0
5 28 1 3.6 33 0 0.0
Mean 32.2 1.2 3.7 32.6 0 0.0
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Table 4.2: Viability of detached cells from 2-D collagen I cultures
Sample
No.
H376 E-cadherin H376 antisense
Viable cells 
N o. (x 106)
Total cells 
N o. (x 106)
Viability
%
Viable cells 
N o. (x 106)
Total cells 
N o. (x 106)
Viability
%
Experiment
I
1 0.018 0.064 28.1 0.029 0.055 52.9
2 0.019 0.061 31.2 0.030 0.064 47.5
3 0.015 0.045 33.3 0.039 0.081 48.0
4 0.013 0.044 29.6 0.031 0.066 47.1
5 0.020 0.065 30.0 0.031 0.067 46.2
6 0.019 0.055 34.1 0.046 0.061 75.0
Mean 0.019 0.056 30.9 0.034 0.066 52.8
Experiment
II
1 0.025 0.066 37.5 0.034 0.057 58.8
2 0.013 0.049 27.5 0.036 0.067 53.8
3 0.019 0.067 29.0 0.031 0.066 47.1
4 0.013 0.044 30 0.027 0.055 48.9
5 0.020 0.065 31.1 0.028 0.064 44.5
6 0.018 0.055 32.7 0.045 0.081 55.0
Mean 0.018 0.058 31.3 0.033 0.065 51.4
Table 4.3: Enumeration of Apoptotic cells in 3-D collagen I cultures
Field
No.
H376 E-cadherin H376 antisense
Total N o. 
of
cells/F ield
N o . of 
apoptotic 
cells
Apoptosis
%
Total N o. 
of
cells/F ield
N o. of  
apoptotic 
cells
Apoptosis
%
1 24 2 8.3 23 4 17.4
2 20 1 5.0 10 2 20.0
3 34 2 5.9 17 1 5.9
Experiment 4 19 0 0.0 17 2 11.8
I 5 20 1 5.0 30 1 3.3
6 30 2 6.7 25 3 12.0
7 23 1 4.3 35 1 2.9
8 23 2 8.7 33 0 0.0
Mean 24.13 1.38 5.7 23.75 1.75 7.4
1 22 1 4.5 33 2 6.1
2 31 1 3.2 18 2 11.1
3 24 2 8.3 11 1 9.1
Experiment 4 21 0 0.0 25 1 4.0
II 5 19 0 0.0 15 2 13.3
6 19 1 5.3 22 2 9.1
7 17 2 11.8 25 2 8.0
8 24 2 8.3 29 2 6.9
Mean 22.13 1.13 5.1 22.25 1.75 7.9
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D o any o f the proteins involved in cell survival, previously shown to be affected by de novo E- 
cadherin expression in my OSCC cell line, growing on tissue culture plastic, contribute to the 
apoptosis-resistant phenotype?
4.2.2.4 Analysis of expression of proteins associated with cell survival in 2-D/3-D
collagen I cultures
In order to analyse the proteins, discussed earlier, in the context o f  2-D /3-D  collagen I 
culture conditions, cells were allowed to grow in either condition, for 5 days. Again, total 
RIPA cell lysates were obtained, as described in Chapter 2 Section 2.3.2, when cells growing 
in 2-D collagen I culture conditions were just about confluent and when the cells growing in 
3-D collagen I cultures had expanded just enough to provide sufficient protein for the 
subsequent analyses.
D ifferent parameters were tested prior to monitoring protein expression in my collagen I 
model system, which included:
M onitoring the effect o f  the extended exposure tim e to different collagenases: Cells 
growing on tissue culture plastic were exposed to collagenase 1 or collagenase 3 for varying 
lengths o f time, and the results showed that up to 2 hours exposure time, the time required 
to free all cells o ff the collagen I matrix, resulted in cells exhibiting over 95% viability (data 
not shown).
M onitoring the difference between collagenase 1 and 3: Results showed that there was 
no difference in the length o f time required for the collagenase 1, or collagenase 3, solutions 
to dissolve the collagen I matrix. Both enzyme preparations required from 1 to 2 hours to 
dissolve collagen I matrix completely. N or was there a difference in the Western blot results 
when either o f these collagenases was used (data not shown).
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Having established the working parameters I then used Western blot analysis to m onitor the 
effect o f de novo E-cadherin expression in the context o f 2-D and 3-D collagen I cultures, in 
my OSCC model system, on the expression o f Bcl-2, Akt-1, Phospho-Akt and ILK proteins; 
as discussed previously these all are proteins that have been linked to cell survival, by other 
investigators.
4.2.2.4.1 Effect of E-cadherin on Bcl-2 expression in 2-D/3-D collagen I cultures
De novo E-cadherin expression in my OSCC cell lines resulted in a maintained trend, as 
compared to the results obtained from preliminary W estern blot analysis, in 2-D collagen I 
cultures but not in 3-D cultures, where restoration o f E-cadherin expression in my 
transfected cell line has resulted in downregulation o f total Bcl-2 levels. Figure 4.6 (b) 
presents a representative W estern blot result, while Figure 4.6 (a) shows a histogram 
illustrating results obtained from four independent experiments. Data show that E-cadherin 
re-expression downregulated Bcl-2 levels in the H376 E-cadherin cell line, growing in 2-D 
collagen I cultures, as compared to the antisense counterpart (p value < 0.01). However, that 
effect was not significandy different when cells were plated in 3-D collagen I culture (p value 
<  0 .1).
4.2.2.4.2 Effect of E-cadherin re-exptession on Akt/PKB expression and activation 
in 2-D/3-D collagen I cultures
I have utilised my 2 -D /3 -D  collagen I model system to determine whether E-cadherin may 
play a role in the activation o f the PI3-K  pathway. First I analysed the effect o f E-cadherin 
re-expression on total levels o f A kt/PK B  protein, and secondly I examined the 
phosphorylation o f  a downstream substrate o f Akt.
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Figure 4.7 (b), shows a representative Western blot o f total Akt-1 levels in my transfected cell 
lines, both in 2-D and 3-D collagen I culture conditions. While, Figure 4.7 (a) shows a 
histogram that illustrates results obtained from three independent experiments, showing that 
E-cadherin re-expression was associated with a reduction in total Akt-1 levels in the E- 
cadherin positive cells (H376 E-cadherin) growing in 2-D collagen I cultures. W hen this 
reduction was compared to the antisense counterpart (F1374 antisense) the change, though 
small, was significantly different (p value < 0.04). O n the contrary, this downregulation was 
not observed in cells growing in 3-D collagen I culture conditions, where, instead, E- 
cadherin re-expression showed a reversal o f  this finding and resulted in upregulation o f total 
Akt-1 levels. However, upregulation o f total Akt-1 levels, in the transfected cell lines, 
appeared to be solely a consequence o f their maintenance under 3-D growth conditions 
rather than a consequence o f the de novo expression o f E-cadherin. Thus, in 3-D collagen I 
culture, there was no significant difference between H376 E-cadherin and the antisense 
counterpart (p value £  0.1) in terms o f Akt-1 levels.
Western blot analysis also was used to evaluate the levels o f phosphorylation o f the 
A kt/PK B  proetin at the Thr-308 location and how this varied as a consequence o f the de novo 
expression o f the E-cadherin molecule in 2-D versus 3-D collagen I culture conditions. 
Figure 4.8 (b) shows a representative Western blot o f phospho-Akt (Thr-308) levels in my 
transfected cell lines. Figure 4.8 (a) illustrates results from three independent experiments, 
plotted on a histogram, showing a significant 7-fold increase in phosphorylation o f Akt in 
the H376 E-cadherin cell line growing in 3-D collagen culture as compared to the antisense 
counterpart cell line (p value < 0.01). Cells growing on a 2-D collagen I matrix showed no 
significant difference in phospho-Akt (Thr-308) levels between E-cadherin sense and 
antisense cells (p value < 0.2).
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4.2.2.4.3 Effect of E-cadherin re-expression on ILK expression in 2-D/3-D collagen 
I cultures
Using W estern blot analysis, I showed that growing my cells in either 2-D or 3-D collagen I 
culture conditions was associated with the upregulation o f ILK  levels in E-cadherin positive 
cell lines as com pared to the antisense control cell lines. Figure 4.9 (b) shows a representative 
Western blot analysis o f ILK expression in my transfected cell lines growing under 2-D and 
3-D collagen I culture conditions. Figure 4.9 (a) shows a histogram illustrating results 
obtained from four independent experiments, showing a statistically significant increase in 
ILK levels in H376 E-cadherin cell lines in both 2-D collagen I cultures (p value £  0.05) and 
in 3-D collagen I cultures (p value < 0.002), as compared to the antisense counterpart cell 
lines.
4.2.2.4.4 Effect of E-cadherin re-expression on N-cadherin expression in 2-D/3-D  
collagen I cultures
Western blot results showed that the downregulation o f N-cadherin, as a consequence o f de 
novo FLcadherin expression in my OSCC cell lines, was reversed when cells were embedded 
in 3-D collagen I culture. Figure 4.10 (b) illustrates a representative Western blot experiment, 
while Figure 4.10 (a) shows a histogram, obtained from one o f two identical experiments, 
denoting a two-fold decrease in N-cadherin levels in the H376 E-cadherin cell line, growing 
on serum-coated tissue culture plastic, as compared to its antisense counterpart. These 
findings are consistent with the reports o f others (Chen et al.!, 2004).
O n the other hand, this difference in N-cadherin expression was hardly noticeable when cells 
were grown atop o f collagen I in 2-D cultures. In contrast to these findings, cells growing in 
3-D collagen I cultures actually showed a reversal o f this result such that the N-cadherin level
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was increased by about 1.7 fold in the H376 E-cadherin cell line as compared to the 
antisense control cell line.
4.2.2.5 E-cadherin expression as a consequence of growth conditions in 2-D/ 3-D 
collagen I cultures
While conducting Western blot analysis in my model system, where I grew my transfected 
cell lines under three different culture conditions, (serum-coated tissue culture plastic, atop 
o f collagen I in what I termed 2-D cultures and embedded in a collagen I milieu termed 3-D 
cultures), I also assessed the expression o f the E-cadherin molecule. As shown in Figure 4.11 
(a), using the monoclonal anti-E-cadherin antibody (HECD-1), the following features were 
observed:
The E-cadherin molecule appeared as double bands, a thick band o f 120 kDa molecular 
weight and a faint band o f 79 kDa molecular weight, when the H376 E-cadherin cell line was 
grown on serum-coated tissue culture plastic.
The E-cadherin molecule appeared as only the lower molecular weight band, 79 kDa in size 
when the H376 E-cadherin cell line was grown in collagen I cultures, whether under 2-D or
3-D growth conditions.
Regarding the first observation, the E-cadherin double band appearance, I investigated the 
cause and showed it to be as a result o f the increased confluence o f the cell cultures. Figure 
4.11 (b) showed that, when cells were allowed to grow to only about 60-70% confluency, E- 
cadherin appeared as a single band o f 120 kDa molecular weight. In contrast when cells were 
allowed to grow to 100% confluency or more I started to detect a double band o f 79 kDa 
molecular weight.
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I doubted that this would be the reason why cells growing in 2-D or 3-D collagen I cultures 
gave rise to the cleaved version o f the E-cadherin molecule, because such cells never were 
allowed to grow to such high confluency before obtaining cell lysates.
In the literature, it has been reported that matrix metalloproteinases have the ability to cleave 
the extracellular domain o f the E-cadherin molecule (Noe et al., 2001; Steinhusen et al., 2001). 
This made me think that treating my cells with collagenase 1 or collagenase 3, in order to 
retrieve them from the collagen I prior to cell lysis, might contribute to this E-cadherin 
cleavage. In an attem pt to investigate this finding, I grew my transfected cell lines on tissue 
culture plastic to about 80% confluency, before I treated them with either collagenase 1 or 
collagenase 3, for the same length o f time as the cells in collagen I cultures had been exposed 
to, and then I obtained total RIPA cell lysates. Figure 4.11 (c) shows that cells treated with 
collagenase 1 or collagenase 3 expressed a cleaved E-cadherin molecule o f 79 kDa molecular 
weight, as compared to the 120 kDa E-cadherin molecule expressed by the un-treated cells.
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4.3 Discussion
In an elegantly written review, Schmeichel and Bissell (2003) described a series of 
experimental models for maintaining cultured cells in 3-dimensional microenvironments 
sufficiently long enough to make cellular and molecular biological assays possible. The 
models they described ranged in complexity from a monotypic 3-D culture system to 
multicellular ‘humanised’ organs in vitro (Schmeichel and Bissell, 2003). Apart from 
considering any difficulties that can be encountered by experimental intervention, a 3-D 
model design ideally should recapitulate both the 3-D organisation and the particular 
function for any given organ. Some 3-D models will, o f necessity, represent compromises 
between the theoretical requirements and the practical realities.
The model I used to conduct my experiments consisted o f a 3-D monotypic collagen I 
culture, that was composed o f single cell type, hence the name ‘monotypic’, but nonetheless 
appeared to allow replication o f the minimum unit of differentiated tissues required for 
tissue-specific function (Cultierman et al., 2002). Because epithelial cancer cells have acquired 
an ability to penetrate the basement membrane and invade the sub-adjacent stromal matrix,, 
which is largely composed o f collagen I (Hanahan and Weinberg, 2000), I have chosen 
collagen I as my matrix substrate in order to study the effect o f E-cadherin re-expression on 
growth and survival o f OSCC within the context o f 3-D physical constraints.
It has been reported that epithelial cells in 3-D culture environments were able to form nests 
of E-cadherin-dependent three-dimensional aggregates, which have been referred to as 
multicellular aggregates (MCAs) (Kantak and Kramer, 1998; St Croix et al., 1998; Hotary et 
al, 2003; Shen and Kramer, 2004). Moreover, studies o f 3-D collagen I culture o f cell lines 
that are transfected with E-cadherin cDNA showed MCAs (Jiao et al., 2001). Preliminary 
results showed that my transfected cell lines (H376 E-cadherin and H376 antisense), 
regardless o f their E-cadherin expression status, appeared as multicellular spherical
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aggregates (MCAs) only when they were implanted in 3-D Matrigel culture , but not in 3-D 
collagen I cultures. W hen the same cells were grown in 3-D collagen I culture, they showed 
altered morphology and abnormal polarity, exhibiting a more stretched, fibroblastic 
morphotype (Figure 4.4). These results lead me to the conclusion that it is primarily the 
growth conditions, in particular the nature and composition o f the substrate, and not 
expression o f the E-cadherin molecule per se that contributed to the formation o f MCAs in 
my cell lines. This result is compatible with the findings o f Howlett et al. (1995) and 
Gudjonsson et al. (2002); by altering the growth conditions and allowing the same cell line to 
grow in an interstitial ECM, such as collagen I, as compared to cells growing in 3-D laminin- 
rich basement membrane substrata, these authors found, that the cells showed altered 
integrin expression coupled with abnormal polarity and organisation (Howlett et al., 1995; 
Gudjonsson et al., 2002). Hotary et al. (2003) found that when growing in 3-D collagen I 
cultures their cells, unless they produced MT1-MMP, manifested a compact spherical 
morphology, otherwise, they exhibited a “stretched-out” morphotype which was attributed 
to MT1-MMP activity (Hotary et al., 2003). Based on their findings, I suspect that my OSCC 
cell line is an MT1-MMP producer, since the 3-D constrained cells appeared more like 
fibroblastic cells. Expression o f this metalloproteinase should be considered in future work 
to check for the validity o f this suggestion and, had I had the reagents available, I would have 
tested this possibility.
Also had I had more time, I would have considered comparing the results obtained from 
experiments conducted on 2 -D /3 -D  collagen I model systems with results obtained from 
analogous experiments using Matrigel as a 2-D or 3-D substratum. Alternatively I might have 
considered utilising a more complex organotypic co-culture model system. Such co-cultures 
have been shown to allow for epithelial stratification; a differentiated appearance that 
replicates many o f the morphological and functional features o f an epithelium in vivo (Watt,
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1988; K opan and Fuchs, 1989; Smola et al., 1998; Schmeichel and Bissell, 2003). Thus, using 
such culture systems, it is possible to conduct experiments to study the biological events 
associated with malignancy in light o f the interaction o f transformed cells with normal cells 
(Fusenig et al., 1983; Fusenig et al., 1994; Mackerme, 2004; Stark et al., 2004). Taking into 
consideration the experimental difficulties that could be encountered when trying to retrieve 
cells out o f these cultures, for W estern blot analysis, I might also have considered using a 
modified organotypic co-culture system. The modification that I would suggest is presented 
in Figure 4.12, and includes both the deposition o f a laminin-rich basement membrane 
beneath the epithelial cells and on top o f a set collagen matrix with a nylon filter placed 
within the collagen matrix with pores, o f 2-4pm diameter, small enough to prevent the 
fibroblasts growing underneath from mixing with epithelial cells living above but, at the same 
time, large enough to allow for any soluble growth factor or signalling molecules to pass 
through. This would permit epithelial-fibroblastic interaction to occur yet would still allow 
the investigator to obtain cellular lysates from either o f the two cellular subtypes. 
Furthermore, the epithelial cells would benefit from a more physiological interaction with the 
underlying laminin-rich basement membrane leaving them with the entire sub-adjacent 
collagen I-rich substratum to invade once they have penetrated this basement membrane.
As delineated in the Introduction o f this chapter, the E-cadherin molecule, besides being 
involved in multiple critical cellular events during the organisation o f the epithelium, also has 
been reported to play a vital role in controlling individual epithelial cell fate. A researcher 
might find two ‘sets’ o f literature about this matter. One ‘set’ would support the fact that the 
engagement o f the epithelial cells in E-cadherin dependent cell-cell complexes (or the 
formation o f MCAs) initiates anchorage-independent survival pathways (Miller and Moon, 
1996; Kantak and Kramer, 1998; Day et al., 1999). In some contrast the other ‘set’ of
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literature, suggests that formation o f E-cadherin-dependent cell-cell complexes induces 
contact-inhibidon (or density-dependent) inhibition o f growth; suggesting that when 
epithelial cells reach confluency in vitro, a number o f energy-demanding activities, such as 
growth and motility, are contact-inhibited (Chen and Obrink, 1991; Kandikonda et al., 1996; 
Tsukatani et al., 1997; Li et al., 1998; St Croix et al., 1998). Even more interestingly the 
induction o f apoptosis has been reported to occur in relation to increased density, 
characterised by overexpression o f E-cadherin and other apoptotic signalling molecules, in 
K -ras m utant cell lines (Guerrero et al., 2000). However the work o f Guerrero et al. (2000) 
was conducted on an N IH  3T3 cell line; a line that is well characterised to be a fibroblast 
and, to my surprise, they reported an increased expression o f E-cadherin. However it is well 
known this molecule is not expressed by this subtype of cells. I suspect that perhaps the 
reagent they used, to blot for E-cadherin, possessed the potential to interact with a similar 
peptide present in a cell adhesion molecule, possibly N-cadherin, which these cells do 
express. This means that probably this latter report is not to be accepted completely as being 
correct in all its findings (Guerrero et a l, 2000).
As mentioned earlier, several molecules involved in the induction and control o f different 
cell survival signalling pathways, also have been linked to the E-cadherin adhesion molecule, 
including Bcl-2, A kt/PK B , ILK and N-cadherin.
In an attempt to test the effect o f E-cadherin re-expression, in my OSCC model system, on 
levels o f expression o f these molecules when cells were growing under 3-D collagen I 
cultures, I used Western blot analysis to analyse the levels o f these proteins in both E- 
cadherin expressing cells and in their antisense control counterparts. First, I have tested the 
levels o f these proteins when cells were growing in the traditional serum-coated tissue culture 
plastic dishes to provide a base line data for subsequent experiments. I then tested the effect
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of de novo E-cadherin expression on the same survival molecules under 2-D /3-D  collagen I 
culture conditions.
W hen cells were growing on serum-coated tissue culture plastic dishes, my results showed 
that de novo expression o f the E-cadherin molecule in the H376 OSCC cell line resulted in 
downregulation o f the Bcl-2 molecule. In general terms this result was consistent with the 
findings o f Sasaki et al. (2000), in that these authors also observed that, upon re-expression of 
the E-cadherin molecule in rat breast carcinoma cells, those cells showed a downregulation 
o f Bcl-2 levels (Sasaki et al., 2000).
In order to measure the relative level o f Akt phosphorylation in each cell line, the ratio of 
phospho-Akt (Thr-308) to the total Akt-1 levels was measured using the densitometric values 
o f W estern blots from three independent experiments (Figure 4.13). In my OSCC cell line, de 
novo E-cadherin expression showed a statistically significant increase in phosphorylation of 
the Akt (Thr-308) as compared to the antisense control (Figure 4.13). These results were, 
also, consistent with those o f others, where the engagement o f epithelial cells into E- 
cadherin-dependent adhesion complexes led to increased PI3-Kinase-dependent Akt 
phosphorylation (Pece et al., 1999; Kovacs et al., 2002; Munshi et al., 2002).
My results, also, showed that in four independent experiments, there was a consistent, but 
not significant, downregulation o f ILK as a consequence o f E-cadherin re-expression in my 
OSCC line. This result was somewhat similar to the findings obtained by Vespa et al. (2003) 
who showed that there was a marked reduction in the ILK activity associated with the 
increased keratinocyte differentiation (Vespa et al., 2003). Moreover, these data were further 
supported by the observations o f others, who suggested that ILK is implicated in the 
regulation o f E-cadherin expression (Hannigan et al., 1996; Somasiri et al., 2001; Tan et al., 
2001; Li et al., 2003; Oloumi et al., 2004).
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Added to all this, there was a downregulation o f N-cadherin, known to act as an anti- 
apoptotic molecule (Tran et al., 2002), in my E-cadherin positive cell line as compared to the 
antisense control cell line.
Taken altogether, these data provide evidence that there is an interplay between the pathways 
regulating cell adhesion and cell death and that this type o f ‘cross-talk’ or interaction does 
occur between the E-cadherin and the survival molecules.
These initial findings were then expanded by altering the tissue culture conditions, so that 
cells were grown on, or in, collagen I as an extracellular matrix in both 2-dimensional and 3- 
dimensional milieus. In these two modified culture conditions, I tested both the growth 
capacities and the apoptotic profile o f my transfected OSCC cell lines. Results showed that, 
over a 10 day period, under 2-D collagen I culture conditions there were marked differences 
between the H376 E-cadherin sense cell line as compared to the antisense control cell line; 
thus E-cadherin re-expression seemed to induce contact-dependent growth suppression; 
quite possibly through the induction o f apoptosis. However, when growing the same cells 
under 3-D collagen I culture conditions, these differences were abrogated, and the E- 
cadherin positive cell line seemed to manifest an apoptosis/anoikis-resistant phenotype. This 
result fits well with the results obtained from other studies, where E-cadherin has been 
shown to regulate anchorage-independent growth and survival pathways and where 
engagement o f cells into E-cadherin-dependent complexes generates compensatory survival 
signalling (Kantak and Kramer, 1998; Shen and Kramer, 2004).
The findings, obtained from the growth and apoptosis assays, provided a good basis for me 
to study previously examined molecules associated with cell survival and cell death pathways, 
but in the context o f 2-D and 3-D collagen I culture conditions.
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Because growing my OSCC transfected cell lines in 2-D collagen I cultures seemed to 
indicate that E-cadherin re-expression triggered contact-dependent growth suppression, 
associated with enhanced apoptosis, this made me think that such findings might be 
attnbutable to the effect o f E-cadherin on Bcl-2 and other molecules associated with cell 
survival. This molecule was, at first sight, apparently downregulated slightly but still it shows 
a significant difference between the H376 E-cadherin cell line and its antisense counterpart; a 
finding that mimics results obtained from experiments conducted on tissue culture plastic 
and agrees with previously published data (Sasaki et al.^  2000). However, in 3-D collagen I 
cultures these differences were abrogated. Based on these findings, and results obtained from 
the apoptosis assays, in my transfected OSCC cell line model system it seems that E- 
cadherin-dependent growth suppression and increased apoptosis could, possibly, be due to 
Bcl-2 suppression.
In 3-D, but not 2-D, collagen I cultures, there was a consistent, statistically significant, 
increase in the phosphorylation o f the Akt (Thr-308) as a consequence o f de novo E-cadherin 
expression in my OSCC (Figure 4.13). These results did not appear to be in accord with the 
results obtained from cells plated on tissue culture plastic, and even seemed to run counter to 
this scenario, but the PI3-kinase pathways are known to play a central role in many cellular 
processes, such as mitogenic signalling and cell survival, cytoskeletal remodelling, metabolic 
control and vesicular trafficking (Wymann and Pirola, 1998), so I can not know for certain if 
E-cadherin re-expression in my OSCC transfected cell line activates the same signalling 
pathways when varying the culture conditions. This could be verified by detailed examination 
o f other key role players in each pathway.
With regard to ILK expression in my transfected cell lines, under both 2-D and 3-D 
collagen I culture conditions, de novo E-cadherin expression upregulated ILK levels in H376 
E-cadherin cell line as compared to the antisense control cell line (Figure 4.13).
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Because ILK is an integrin-linked kinase that has been reported to interact with both  (31 and 
(33 integrins (Hannigan et a l, 1996), and knowing that the a2(31 integrin is a well characterised 
receptor for collagen I (Siljander et al., 2004), I thought it very likely that growth in a collagen 
I environment could have a substantial impact on ILK  expression. From  comparing these 
results with results obtained from my transfected cells growing on tissue culture plastic, I 
would say that the influence o f collagen I binding, with its impact upon ILK levels, is more 
the reason for changes in growth signals rather than a consequence o f  the effect o f the 3- 
dimensional microenvironment. Results from Chapter 3 (Figure 3.17) showed that E- 
cadherin re-expression resulted in a consistent, though slight, upregulation o f the (31 -integrin 
subunit. Upregulation o f ILK might accompany the increased pi-integrin subunit levels 
simultaneously as a consequence o f E-cadherin re-expression in my OSCC model system; 
but only when cells are allowed to bind to collagen I, thus accounting for my observed results. 
I would also like to believe that E-cadherin, in the context o f collagen I culture conditions, 
favours the ILK-related cell survival pathway in order to induce cell survival. These findings 
should be thoroughly studied, and should be tested in future work.
E-cadherin-dependent downregulation o f N-cadherin has been observed in cells growing on 
tissue culture plastic. This modifying effect seems to be blocked when my transfected OSCC 
cells were plated atop o f collagen I matrix in 2-D cultures, where the E-cadherin effect on 
the expression o f N-cadherin seems to fade away. W hen cells were embedded in 3-D 
collagen I culture, E-cadherin re-expression, appeared to upregulate N-cadherin rather than 
reduce its expression.
In 3-D collagen I cultures, there was an upregulation o f N-cadherin levels, an upregulation of 
ILK levels and an increase in Akt phosphorylation as a consequence o f E-cadherin re­
expression in my OSCC model system. Furthermore, E-cadherin-dependent suppression of
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Bcl-2 seems to be blocked when cells were embedded in 3-D collagen I cultures, as 
compared to cells growing in 2-D culture conditions (both on tissue culture plastic, or atop 
collagen I). This seems to suggest that, under 3-D collagen I culture conditions, the E- 
cadherin molecule results in an apoptosis/anoilds-resistant phenotype.
Several mechanisms by which cadherins alter cell survival have been reported. In prostate 
and mammary epithelial cells, E-cadherin was shown to promote cell survival through the 
Retinoblastoma (Rb) cell-cycle control pathway (Day et al., 1999). This putative mechanism 
was supported by the fact that E-cadherin was shown to induce cell survival through 
activation o f the PI3-ltinase/Akt pathway in the Madin-Darby canine kidney (MDCK) cell 
line (Pece et al., 1999), In prostate carcinoma cells N-cadherin was shown to activate the 
same pathways; an activation which led to a subsequent elevation o f Bcl-2 levels (Tran et al.,
2002). In human OSCC cells, E-cadherin was shown to prom ote aggregation-dependent cell 
survival through the activation o f the epidermal growth factor receptor (EGFR) and the 
downstream MAPK pathway; a biochemical step further shown to control Bcl-2 levels (Shen 
and Kramer, 2004). Also, in some cell types the ‘balance o f life and death’ will not easily ‘tip 
towards cell death’ nor will it ‘tip towards cell survival’ as a consequence o f changes in 
cellular adhesion although there might be a key regulator that adjusts the balance between 
these extremes o f cell fate. If  this scenario was correct then my results might suggest that the 
E-cadherin molecule seems to function as just such a ‘regulator’ molecule. This could explain 
why on the one hand, E-cadherin favoured cells to undergo apoptosis through 
downregulation o f Bcl-2 and upregulation o f N-cadherin, while on the other hand, it 
maintained cell growth and survival through activation/phosphorylation o f A kt/PK B. 
Because transformed cells will have altered their growth characteristics considerably though 
it might be more im portant to consolidate these results by performing similar experiments in
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non-transformed, putatively ‘normal’ epithelial cells; this I would have done had I had more 
time available.
My results indicate that, in my OSCC model system, the E-cadherin molecule controls cell 
survival through different pathways, depending on, first, the ECM  substrate and second, the 
encountered physical restraints provided by the third dimension o f this particular type of 
tissue culture. W hen cells were growing on the conventional tissue culture plastic dishes, E- 
cadherin appeared to control cell survival mainly through activation o f  the PI3-kinase/Akt 
pathway. However when cells were embedded in 2-D collagen I cultures, E-cadherin was 
shown to activate another survival pathway, i.e. through the upregulation o f  ILK. Finally in 
3-D collagen I cultures, E-cadherin enhanced the activation o f the PI3-kinase/Akt pathway 
and, it seems, it might also have utilised an additional pathway to prom ote cell survival, 
through the ILK signalling pathway. This effect was augmented further by upregulation of 
the anti-apoptotic cell adhesion molecule, N-cadherin.
Shen and Kramer (2004) ingeniously argued that, in contrast to many tumours such as breast, 
colon and prostate which mosdy tend to be anchorage-independent, head and neck SCCs are 
known generally to be anchorage-dependent (Rheinwald and Beckett, 1980). This might 
explain why assembly o f tum our cells into MCAs provides a survival benefit in this particular 
type o f carcinoma (Shen and Kramer, 2004).
In summary, taken all together, results in this chapter lead to the conclusion that the 
adhesion status o f the cells may control individual cell fate, including cell survival or death by 
apoptosis. Furthermore, changes in cellular events observed in 2-D tissue culture conditions 
might not necessarily be the same when cells are growing under 3-D culture conditions. 
From  my results it is evident that I was able to repeat and verify some o f the results reported 
by others. However when I tried to test these findings under 3-D conditions the results often
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came out diametrically opposite to those described previously in the litrature. Given that the 
same cell line was used throughout, it is clear that it was the growth conditions which 
changed the results and not the fact that I was using a different cell line from other 
investigators. Such results suggest a need for caution when studying tumour cell growth 
exclusively in monolayer cultures. Perhaps, at a fundamental level, the biological functions o f 
individual molecules should be investigated within the context o f different 
microenvironments, because cross-talk between cells as well as communication between cells 
and the extracellular matrix exert profound effects on cellular functions.
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Figure 4.1
Schematic representation of the metastatic process
The metastatic process consists o f multiple, highly complicated steps, all o f which must be 
completed successfully to give rise to a metastatic tum our mass (adapted from (Marshall, 
1999; Christo fori and Semb, 1999) .
a) Cells in primary tum our lose their capacity for cell-cell adhesion.
b) Downregulation o f E-cadherin and loss o f E-cadherin-dependent cell-cell 
cohesiveness takes place and cells begin to dissociate and depart from the primary 
tum our mass.
c) Integrin-dependent proteolysis o f the basement membrane and initiation of 
migration and invasion o f tumour cells through stroma towards blood or lymph 
vessels.
d) Initiation o f co-ordinated signalling pathways to provide the necessary signals for 
growth and survival o f the tum our mass at distant secondary metastatic site, perhaps 
through the formation o f E-cadherin-dependent multi cellular aggregates (MCA’s).
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Figure 4.1
M etastatic process
a) Benign epithelial tumour 
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b) Malignant transformation 
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c) Malignant invasive tumour
d) Tumour metastasis to distant 
sites
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Figure 4.2 
Cell adhesion-mediated cell survival
Cell-cell and cell-matrix interactions anchor the epithelial cells and provide necessary signals 
for survival. Loss o f both leads to rapid initiation o f cell death through “anoikis” . Tumour 
cells survive this loss o f anchorage through formation o f organised colonies through a 
process termed “synoikis” (Shen and Kramer, 2004).
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Figure 4.3 
Western blot analysis of cell survival proteins in E-cadherin transfected cell lines 
growing on tissue culture plastic dishes
Equal cell numbers for each cell line were plated on serum-coated tissue culture T-75 flasks 
for 48 hours, in selection medium, prior to lysis. Whole cell RIPA lysates were obtained, and 
equal protein was determined by the BCA protein assay. Proteins (25pg/lane) were resolved 
by 12.5% SDS-PAGE and blotted onto nitrocellulose membrane.
a) Bcl-2 levels. Results are representative o f four independent experiments. Student’s t 
test showed a p value 5~ 0.004 between H376 E-cadherin (H376 E-cad) and H376 
antisense (H376 AS) cell lines.
b) Total Akt-1 levels. Results are representative o f three independent experiments. 
Student’s t test showed a p value < 0.001 between H376 E-cadherin (H376 E-cad) 
and H376 antisense (H376 AS) cell lines.
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Figure 4.3 (cont.)
Western blot analysis o f cell survival proteins in E-cadherin transfected cell lines growing on 
tissue culture plastic dishes.
c) Phospho-Akt (Thr-308) levels. Results are representative o f three independent 
experiments. Student’s t test showed a p value £  0.001 between H376 E-cadherin 
(H376 E-cad) and H376 antisense (H376 AS) cell lines.
d) ILK levels. Results are representative o f four independent experiments. Student’s t 
test showed a p value < 0.2 between H376 E-cadherin (H376 E-cad) and H376 
antisense (H376 AS) cell lines.
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Figure 4.3 (cont.)
Western blot analysis o f cell survival proteins in E-cadherin transfected cell lines growing on 
tissue culture plastic dishes.
e) N-cadherin levels. Results are representative o f three independent experiments. 
Student’s t test showed a p value < 0.03 between H376 E-cadherin (H376 E-cad) and 
H376 antisense (H376 AS) cell lines.
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Figure 4.3 (cont.)
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Figure 4.4 
Gross appearance of E-cadherin transfected cell lines growing in 3-D cultures
Cells were embedded in either Matrigel or collagen I 3-D culture as described in Chapter 2, 
Section 2.3.2 and allowed to grow for 8 days, then cells were fixed using formol saline and 
were embedded in paraffin. Parrafin sections were stained with HandE stain by 
Histopathology lab (Cancer Research UK Central Cell Services). Cells were viewed under 
contrast phase microscopy.
a) E-cadherin transfected cells (H376 E-cadherin) growing in 3-D Matrigel culture formed 
spherical multicellular aggregates (left), while the same cell line formed ‘net-like’ colonies 
and exhibited a fibroblastic morphology when grown in collagen I 3-D cultures (right).
b) Schematic representation of E-cadherin transfected cells in both  cultures.
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Figure 4.4
a)
H376 E-cadherin (Matrigel) H376 E-cadherin (collagen I)
b)
J Matrigel | | Collagen I
188
Figure 4.5
Growth curves of E-cadherin transfected cell lines growing in 2-D and 3-D collagen I
cultures
Transfected cell lines (H376 E-cadherin and H376 antisense) were plated, in triplicates, at an 
initial density o f 2x l04 cell/well, either atop 2-D or within 3-D collagen I cultures, and 
allowed to grow for 10 days. At 2-day intervals, cells were harvested after treatment with 6
m g/m l collagenase 1 and trypsin, then counted using an haemocytometer. Cell viability was
determined using “Trypan blue exclusion” and results were plotted into a growth curve 
histogram.
a) G rowth curve o f cells growing in 2-D collagen I culture
b) Growth curve o f cells growing in 3-D collagen I culture
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Figure 4.6
Western blot analysis of the Bcl-2 cell survival protein in E-cadherin transfected cell 
lines growing in 2-D and 3-D collagen I cultures
Equal numbers o f cells (6x104 cell/well) were plated in 6-well plates, either atop 2-D or 
within 3-D collagen I cultures, and allowed to grow for 5 days. Cells were retrieved from the 
collagen I culture prior to lysis, as described in Chapter 2, Section 2.3.2. Whole cell RIPA 
lysates were obtained, and equal protein was determined by the BCA protein assay. Proteins 
(25pg/lane) were resolved by 12.5% SDS-PAGE and blotted onto nitrocellulose membrane.
a) Bcl-2 levels. Results are from densitometric values from four independent Western 
blot analyses. In 2-D collagen I cultures, E-cadherin transfection (2DE) resulted in 
downregulation o f Bcl-2 relative to the antisense counterpart (2DAS) (p value £ 
0.02). This effect was abrogated when cells were em bedded in 3-D collagen I 
cultures.
b) Representative Western blot analysis from one o f four independent experiments used 
to generate the graph in Figure a). Heat Shock Protein (Hsc-70) has been used as a 
loading control.
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Figure 4.7
Western blot analysis of the Akt-1 cell survival protein in E-cadherin transfected cell 
lines growing in 2-D and 3-D collagen I cultures
Equal numbers of cells (6x104 cell/well) were plated in 6-well plates, either atop 2-D or 
within 3-D collagen I cultures, and allowed to grow for 5 days. Cells were retrieved from the 
collagen I culture prior to lysis, as described in Chapter 2, Section 2.3.2. Whole cell RIPA 
lysates were obtained, and equal protein was determined by the BCA protein assay. Proteins 
(25|Lig/lane) were resolved by 12.5% SDS-PAGE and blotted onto nitrocellulose membrane.
a) Akt-1 levels. Results are from densitometric values from three independent Western 
blot analyses. In 2-D collagen I cultures, E-cadherin transfection (2DE) resulted in 
downregulation o f Akt-1 relative to the antisense counterpart (2DAS) (p value < 
0.04). This effect was abrogated when cells were em bedded in 3-D collagen I 
cultures.
b) Representative Western blot analysis from one o f three independent experiments 
used to generate the graph in Figure a). Heat Shock Protein (Hsc-70) has been used 
as a loading control.
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Figure 4.8
Western blot analysis of the phosphorylation of Akt cell survival protein at threonine- 
308 in E-cadherin transfected cell lines growing in 2-D and 3-D collagen I cultures
Equal numbers o f cells (6xl04 cell/well) were plated in 6-well plates, either atop 2-D or 
within 3-D collagen I cultures, and allowed to grow for 5 days. Cells were retrieved from the 
collagen I culture prior to lysis, as described in Chapter 2, Section 2.3.2. Whole cell RIPA 
lysates were obtained, and equal protein was determined by the BCA protein assay. Proteins 
(25pg/lane) were resolved by 12.5% SDS-PAGE and blotted onto nitrocellulose membrane.
a) Phosphor-Akt (Thr-308) levels. Results are from densitometric values from three 
independent Western blot analyses. In 3-D collagen I cultures, E-cadherin 
transfection (3DE) resulted in substantial upregulation o f phosphor-Akt (Thr-308) 
levels relative to the antisense counterpart (3DAS) (p value < 0.02). This difference 
was abrogated when cells were grown on top o f 2-D collagen I matrix.
b) Representative Western blot analysis from one o f three independent experiments 
used to generate the graph in Figure a). Heat Shock Protein (Hsc-70) has been used 
as a loading control.
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Figure 4.9
Western blot analysis of the ILK cell survival protein in E-cadherin transfected cell 
lines growing in 2-D and 3-D collagen I cultures
Equal numbers o f cells (6x104 cell/well) were plated in 6-well plates, either atop 2-D or 
within 3-D collagen I cultures, and allowed to grow for 5 days. Cells were retrieved from the 
collagen I culture prior to lysis, as described in Chapter 2, Section 2.3.2. Whole cell RIPA 
lysates were obtained, and equal protein was determined by the BCA protein assay. Proteins 
(25pg/lane) were resolved by 12.5% SDS-PAGE and blotted onto nitrocellulose membrane.
a) ILK levels. Results are from densitometric values from four independent Western 
blot analyses. In both 2-D and 3-D collagen I cultures, E-cadherin transfection (2DE 
and 3DE) resulted in upregulation o f ILK levels relative to the antisense counterpart 
(2DAS and 3DAS) (p value < 0.05 and 0.002 respectively).
b) Representative Western blot analysis from one o f four independent experiments used 
to generate the graph in Figure a). Heat Shock Protein (Hsc-70) has been used as a 
loading control.
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Figure 4.10 
Western blot analysis of N-cadherin levels in E-cadherin transfected cell lines 
growing in 2-D and 3-D collagen I cultures
Equal numbers o f cells (6x104 cell/well) were plated in 6-well plates, either atop 2-D or 
within 3-D collagen I cultures, and allowed to grow for 5 days. Cells were retrieved from the 
collagen I culture prior to lysis, as described in Chapter 2, Section 2.3.2. Whole cell RIPA 
lysates were obtained, and equal protein was determined by the BCA protein assay. Proteins 
(25(0.g/lane) were resolved by 12.5% SDS-PAGE and blotted onto nitrocellulose membrane.
a) N-cadherin levels. Result represents one o f two Western blot analyses. In 3-D 
collagen I cultures, E-cadherin transfection (3DE) resulted in upregulation o f N- 
cadherin levels relative to the antisense counterpart (3DAS). This effect was not 
evident between cells growing in 2-D collagen I cultures.
b) Representative Western blot analysis from one o f two independent experiments used 
to generate the graph in Figure a). Heat Shock Protein (Hsc-70) has been used as a 
loading control.
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Figure 4.11
E-cadherin expression as a consequence of growth conditions in 2-D/3-D collagen I
cultures
a) Equal cell numbers, o f transfected cell lines H376 E-cadherin and H376 antisense, 
were grown on tissue culture plastic (E and AS), on 2-D collagen I (2DE and 2D AS) 
and within 3-D collagen I matrix (3DE and 3DAS), and allowed to grow for 5 days. 
Cells growing on tissue culture plastic were retrieved as described in Chapter 2, 
Section 2.3.1, while cells growing on 2-D and 3-D collagen I cultures were retrieved 
from the collagen I culture prior to lysis, as described in Chapter 2, Section 2.3.2. 
Western blot analysis shows E-cadherin expression in all three culture conditions.
b) Transfected cell lines H376 E-cadherin and H376 antisense (E and AS) were grown, 
for 48 hours up to different confluencies, on tissue culture plastic. Total RIPA cell 
lysated were obtained and assessed for expression o f E-cadherin molecule.
c) Equal cell numbers, o f  transfected cell lines H376 E-cadherin and H376 antisense, 
were grown on tissue culture plastic (E and AS). Cells were treated, with either 
collagenase 1 or collagenase 3 (W orthington Biochemical Corporation), prior to lysis. 
Total RIPA cell lysates were assessed for E-cadherin expression using Western blot 
analysis.
201
Figure 4.11
a)
RIPA
A
r
Collagenase/RIPA 
 ^ ----------
2DE 2DAS 3DE 3DAS
b)
60-70% 100% over­
confluent confluent confluent
E  AS E AS E AS
-------------- — St
c)
Collagenase/RIPA
S '
AS AS AS
202
Figure 4.12
Proposed model of a modified organotypic co-culture
A model adapted from the organotypic co-culture system described by Fusenig et al. (1983), 
being modified to be used to extract cellular protein from the cultured cell populations. The 
modifications include: separating the collagen-embedded fibroblast population from being 
mixed with the epithelial cells via the use o f  a nylon filter and the addition o f a separate 
laminin-rich basement membrane (as illustrated in Figure).
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Figure 4.13
Level of phosphorylation of Akt in E-cadherin transfected cell lines growing on tissue 
culture plastic, 2-D collagen I and in 3-D collagen I cultures
Histogram representing the ratio o f phospho-A kt/total Akt. In cultures where cells were 
growing on serum-coated plastic, E-cadherin expressing cells (E) showed a substantial 
increase o f phosphorylation o f Akt (Thr-308) as compared to the antisense control cell line 
(AS) (p value £  0.01). In 3-D collagen I cultures, E-cadherin transfection (3DE), also 
resulted in increased phosphorylation o f Akt (Thr-308) levels relative to the antisense 
counterpart (3DAS) (p value £  0.05). This difference was abrogated when cells were grown 
on top o f 2-D collagen I matrix (p value < 0.1).
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Figure 4.13
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CHAPTER 5 
Cross-Talk between Integrin oc6(34 and E-cadherin
5.1 Introduction
The a6- and (34-integrin subunits are transmembrane proteins with the cytoplasmic domain 
o f the {34-integrin subunit being unusually large. It is composed o f about 1000 amino acids, 
as compared to the average 50 amino acids for the other integrin [3 subunits, and is distinctly 
different from any other known integrin in that it interacts with the intermediate filament 
network o f the cell rather than the actin cytoskeleton (Hogervorst et al., 1990; Suzuki and 
Naitoh, 1990). Tamura et al. (1990) suggested that the unique structure o f the (34-integrin 
subunit is indicative o f its involvement in distinctive cytoskeletal interactions (Tamura et al., 
1990).
The integrin a6(34 is expressed predominantly on tissues o f epithelial origin, where it can be 
located in the hemidesmosomes (see Chapter 6) (Kajiji et al., 1989; Sonnenberg et al., 1990; 
Hynes, 1992; Kennel et al., 1992), as well as in some peripheral nerves and in a few subsets of 
endothelial cells (Sonnenberg et al., 1990). Stratified epithelia and cultured keratinocytes 
adhering to basement membrane substrates were also found to express a6{34 (De Luca et al., 
1990; Marchisio et al., 1991; Jones et al., 1993). Although hemidesmosomes occur only in cells 
that express a6(34 integrins, not all o f the cells expressing a6(34 integrin possess 
hemidesmosomes (Owaribe et al., 1990; Sonnenberg et al., 1990; Natali et al., 1992).
Loss o f this pattern o f expression is seen in carcinomas in situ and there is a consistent 
alteration involving oc6(34 integrin expression in carcinomas in general (Natali et al., 1992; 
Carico et al., 1993; Juliano and Vamer, 1993). Both decreased and increased expression of the 
a6(34 integrin have been observed in epithelial tumours (Gomez et al., 1992; Tennenbaum et 
al., 1992; Tennenbaum  et al., 1993; Carico et al., 1993; Downer et al., 1993; Juliano and
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Vamer, 1993; Cress et al., 1995; Liebert and Seigne, 1996; Rabinovitz and Mercurio, 1996; 
Allen et al., 1998; Schofield et al., 1998; Lo et al., 2001). In head and neck squamous cell 
carcinoma, some workers have reported an increase in a6(34 expression (Wolf et al., 1990; 
Carey et al., 1992), while others have observed reduced expression o f a6(34 in poorly 
differentiated oral squamous cell carcinomas (Downer et al., 1993; Jones et al., 1993).
Loss o f a6(34 in OSCC was found to be most evident at the leading edge o f tumours and in 
the poorly differentiated lesions (Jones et al., 1993). It also has been reported that the 
decrease in a6(34 integrin levels observed in carcinoma was not a part o f a general alteration 
o f other integrin levels but rather was specific for this particular integrin (Witkowski et al., 
2000).
The biochemical changes behind the altered expression o f the a6(34 integrin, during tumour 
progression, in carcinomas are unknown. Witkowski et al. (2000) have investigated the 
expression o f a6(34 in a multi-step mouse model o f skin carcinogenesis comprised of normal 
keratinocytes, benign papillomas and malignant undifferentiated carcinoma cells. Results 
revealed that there was about a 75% reduction in the surface expression o f  oc6(34 integrin in 
the undifferentiated carcinoma cells as compared with the normal keratinocytes and 
papilloma cell lines (Witkowski et al., 2000). They also showed that the remaining a6(34 
integrin heterodimers lost their polarised expression and were distributed diffusely around 
the cell membrane in carcinoma cells and showed about a 2.5-fold increase in turnover as 
compared with the turnover in normal keratinocytes (Witkowski et al., 2000).
The loss o f both hemidesmosome-associated structures and basal cell differentiation has 
been associated with early stromal invasion in prostate cancer (Bonkhoff, 1998) indicating 
that such associations are not restricted to tumours of a single lineage.
Recent studies suggest that the a6(34 integrin plays a critical role in transducing signals from 
the extracellular environm ent to the interior of the cell, significantly modulating the
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organisation o f the cytoskeleton, cell proliferation, apoptosis and differentiation (Borradori 
and Sonnenberg, 1999). O ther studies indicate that the a6(34 integrin can function in 
migration through its ability to promote the formation and stabilisation o f motility structures 
(Rabinovitz and Mercurio, 1997). Geuijen and Sonnenberg (2002) found that oc6(34 integrin 
induces hemidesmosome formation and slowed down migration o f epithelial cells, in 
response to wound healing when the (34-integrin subunit was allowed to bind to its ligand, 
laminin-5, through the interaction o f (34 with plectin (Geuijen and Sonnenberg, 2002). 
Conversely, it was found that, in carcinoma cells, the a 6(34 integrin promotes cell migration 
and invasion (Shaw et a l 1997). Thus suggesting that a6(34 may play a binary, and apparently 
paradoxical, role both in maintaining the normal epithelial cell’s stationary status and in 
promoting its migration after transformation.
The formation o f hemidesmosomes, as well as cadherin-dependent adherens junctions, is 
dependent upon extracellular Ca2+ ions (Trinkaus-Randall and Gipson, 1984; Braga, 2000), 
possibly indicating a relationship between the divalent-dependent a6(34 integrin and the 
cadherin proteins (Collins et a l, 1991). Because o f their need for co-ordinated changes during 
neoplastic transformation I considered it possible that there might be a connection/cross- 
talk between E-cadherin and a6(34 integrin in epithelial cells and that these interactions might 
play a role in carcinoma development and prognosis.
Results from Chapter 3 were suggestive for the existence o f a possible “cross-talk” 
interaction between E-cadherin and (34-integrin. The H376 OSCC line showed a low surface 
level o f (34 expression (Prime et al., 1990). This cell line had been transfected previously with 
cDNA for the human (34-integrin subunit (Jones et al., 1996a) to investigate the role o f this 
molecule in the behaviour o f malignant keratinocytes. As assessed by FACS analysis (Jones 
J., PhD  thesis, University o f London, 1996) the derived Clone B6 showed a substantial level
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of (34-integrin subunit expression. This line, which I used, is referred to as the “H376(34” cell 
line. IA2 cells were transfected with the empty vector and were used as a negative control 
(Jones J., PhD  thesis, University o f  London, 1996).
The aim was to use these m atched cell lines, expressing and not expressing (34-integrin, and 
transfect them  with my E-cadherin plasmid to produce stable transfectants that could then 
be used to study the possible cross-talk interactions between E-cadherin and the (34-integrin 
subunit.
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5.2 Results
5.2.1 Characterisation of the H376J34 and IA2 primary cell lines
The H376J34 and IA2 cell lines were examined for the presence and the expression o f both 
E-cadherin and the (34-integrin subunit using FACS analysis and Western blotting. Figures
5.1 and 5.2 showed that H376(34 and IA2 lines were both, E-cadherin negative. Moreover, 
only the H376(34 cell line, but neither the IA2 nor the H376 parental cell lines, expressed the 
(34-integrin subunit.
Knowing that both the H376(34 and the IA2 cell lines express the necessary catenins (data 
not shown), they became suitable candidates for transfection with E-cadherin cDNA.
5.2.2 Establishment of E-cadherin/§4-integrin positive stable transfectants 
(Introduction of E-cadherin cDNA into the H376(34 cell line)
The H376J34, as well as the IA2, cell lines were stably transfected with the E-cadherin sense 
and antisense constructs using F u G E N E IM 6 Transfection reagent (Roche) to generate four 
transfected cell lines: H376(34 E-cadherin cell line, H376J34 antisense control cell line, IA2 E- 
cadherin cell line and IA2 antisense cell line (Chapter 2, Figure 2.3). As with my previous 
transfection studies (Chapter 3) the E-cadherin expressing cells also were selected by two 
rounds o f magnetic bead sorting and the resulting cell populations were grown in 
puromycin-supplemented KGM  “Selection Medium”, with a concentration o f 0.5 pg/m l; a 
value previously determined with preliminary “kill curve” experiments. Again, the isolated 
positive colonies, capable o f growing in this selection medium, were pooled as a means of 
avoiding clonal heterogeneity.
Over the next 12 m onths o f continuous culture expression o f the molecules o f interest were 
checked at different times on a routine basis using both FACS and Western blot analysis.
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Representative results are illustrated in Figure 5.3, where the stable cell lines “H376(34 E- 
cadherin” and “IA2 E-cadherin” expressed high levels of E-cadherin as compared to their 
antisense control counterpart cell lines, ”H376(34 antisense” and “IA2 antisense”, which were 
negative for E-cadherin.
5.2.3 Characterisation of stably transfected cell lines
All transfected cell lines were characterised for the expression o f catenins, other cadherins, 
and integrins. Characterisation was carried out in exactly the same way as previously 
conducted on H376 E-cadherin and H376 antisense transfected cell lines. Similar results 
were obtained, where a- and (3-catenin upreguladon and y-catenin downregulation appeared 
concomitant with the de novo E-cadherin expression, as compared with the negative antisense 
control (Appendix IV). The E-cadherin positive clones showed a marked downregulation o f 
N-cadherin (Appendix IV) and an integrin profile presented similarly as the H376 E-cadherin 
cell line, when each clone was compared to its antisense control (Appendix IV).
5.2.4 Effect of E-cadherin te-expression on the total levels of {34-integrin subunit in 
the transfected cell lines
Results from Chapter 3 had shown that E-cadherin re-expression in the H376 OSCC cell line 
resulted in about a 2.5-fold increase in the surface (34-integrin levels in the H376 E-cadherin 
cell line as compared to the antisense control counterpart (p value 5: 0.01) (Chapter 3, Figure 
17). Consistent with this result, when similar experiments were conducted on the new stable 
transfectants, both the H376(34 E-cadherin and IA2 E-cadherin cell lines showed an 
upregulation in the cell surface levels o f the (34-integrin as a consequence o f de novo E- 
cadherin expression. Figure 5.4 shows histograms illustrating results from three independent 
FACS experiments, using anti-(34-integrin (clone 3E1) monoclonal antibody (CHEM ICON
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international), where there was about a 5-fold increase in the levels o f [34-integrin subunit in 
the IA2 E-cadherin cell line as compared to the IA2 antisense control (p value < 0.04). In the 
H 376(34 E-cadherin cell line there was a statistically highly significant 17-fold increase in the 
levels o f (34-integrin as a consequence o f E-cadherin re-expression (p value < 0.003).
The effect o f E-cadherin re-expression on the total levels of the (34-integrin was further 
investigated using W estern blot analysis.
Western blot results, using anti-(34-integrin (clone 7) monoclonal antibody (BD Transduction 
Laboratories), showed that, upon re-expression o f E-cadherin there was about a 6-fold 
increase in the total [34-integrin levels in the H376J34 E-cadherin cell line as compared to the 
H376(34 primary cell line (Figure 5.3). Moreover, de novo E-cadherin expression resulted in the 
re-expression o f the (34-integrin in the IA2 E-cadherin cell line as compared to the IA2 
primary cell line and to the antisense negative control (Figure 5.4).
FACS and Western blot analyses however showed that the H376(34 antisense cell line, 
unexpectedly, did not express (34. This was a repeatable observation that I considered might 
be because this particular cell line was the most difficult to select for using ‘puromycin’. After 
being transfected with the E-cadherin antisense construct, it could have been that the 
previously introduced (34-integrin subunit was lost during the subsequent selection 
procedure. Alternatively it could be that the E-cadherin ‘antisense’ cDNA acts as a “silencing 
gene” though I have performed no experiments to address these issues directly.
Moreover, despite continuous effort, I could not obtain a similar result with the H376 E- 
cadherin cell line. Contrary to the FACS results presented in Figure 3.17 (Chapter 3), the 
H376 E-cadherin cell line was found to be negative for the (34-integrin subunit when tested 
with W estern blotting. A few possibilities were considered in an attempt to interpret this 
finding:
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First it may have been that the signal was very weak and that more protein needed to be 
loaded before detecting any signal. Consequently other Western blots were carried out with 
50 pg o f protein being loaded per lane; but still no (34-integrin was detected in relation to the 
H376 E-cadherin cell line (data not shown).
Second it was considered possible that this cell line, transfected with E-cadherin constructs 
more than a year before this W estern blot experiment was carried out and grown in selection 
medium throughout, may have had its entire integrin profile changed. However on going 
back to an early passage, recovered from the liquid nitrogen freezer, I still could not detect 
any signal (data not shown).
Third it was thought possible that the results I obtained might be a consequence of 
unexpected technical problems. However it was a repeatable finding (three independent 
experiments), with both the H376 and the IA2 cell line.
Lastly it was considered possible that I might, inadvertently, have contaminated this 
particular cell population with another cell line. To rule out the possibility o f contamination, 
DNA fingerprinting o f the various lines was carried out next.
In Western blots, there appeared to be cleavage or processing of the (34-integrin, as it was 
represented by double bands; 200 and 185 kDa, which have been previously reported in this 
particular cell line (Jones J., PhD  thesis, University of London, 1996) and in other cell lines 
(Giancotti et al., 1992; Potts et al., 1994; Witkowski et al., 2000).
5.2.5 DNA fingerprinting of the transfected cell lines
To exclude the possibility o f cell contamination and to ensure that all the transfected cell line 
clones originated from the same parental cell line (the H376 OSSC line), DNA fingerprinting 
was carried out by the Cell Production Unit at Cancer Reasearch-UK, Clare Hall. DNA was
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collected from all clones and “fingerprinted” by this department. As shown in Figure 5.5, all 
clones came from the same origin.
5.2.6 Immunocytochemical assessment of p4-integrin expression in the H376(34 E- 
cadherin OSCC cell line
J. Jones reported that the (34-integrin subunit transfected into the H376 OSCC cell line failed, 
together with the endogenously expressed a6-integrin, to form stable anchoring contacts 
(SACs) (Jones et al., 1996a). She claimed that the inability of a6(34 integrin to be expressed as 
SACs, in her transfected cell lines, might be attributable to the low level of expression of 
a6(34 integrin as compared to the levels expressed by normal keratinocytes (Jones J., PhD 
thesis, University o f London, 1996). De novo E-cadherin expression into the H376J34 cell line 
resulted in a significant increase in a6(34 integrin (as assessed by FACS analysis and Western 
blot, Figure 5.4) and thus the ability o f the transfected cell line to present (34-integrin at SACs 
was checked using indirect immunocytochemical staining. The H 376(34 E-cadherin and CA1 
cell lines were plated on laminin-5-coated 13mm coverslips and allowed to grow for 48 hours 
in full KGM  medium. Cells were fixed with 4% formaldehyde, permeabilised using Triton X- 
100 and stained for (34-integrin subunit using anti-(34 integrin (clone 7) monoclonal antibody 
(BD Transduction Laboratories). Images were taken using confocal laser scanning 
microscopy.
Compared to the CA1 cell line the (34-integrin subunit in the H376(34 E-cadherin cell line 
failed to form the highly organised SAC-like structures. Rather it assembled into a reticular- 
like cytoplasmic network patterned throughout the entire cell (Figure 5.6).
Another difference was observed in the nuclei of the FI376(34 E-cadherin cell line. They 
exhibited a lobular appearance and, when staining with anti-(34-integrin monoclonal antibody, 
(34-integrin was shown to localise between those lobules (Figure 5.6).
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5.2.7 Immunocytochemical localisation of E-cadherin in transfected lines
For indirect immunofluorescence experiments, H376 E-cadherin, H376|34 E-cadherin and 
IA2 E-cadherin cell lines were grown on coverslips for 48 hours in order to allow for the 
formation o f mature adherens junctions. Cells were fixed with 4% formaldehyde, 
permeabilised using Triton X-100 and stained for E-cadherin using HECD-1 antibody. 
Antibodies were visualised with fluorochromes linked to second layer antibodies. The actin 
cytoskeleton and nuclei were counterstained in some experiments.
Images from all transfected cell lines were taken using confocal laser scanning microscopy. In 
Figures 5.7, 5.8 and 5.9 (the Panels A), all E-cadherin positive cell lines (the FI376 E- 
cadherin, 14376(34 E-cadherin and IA2 E-cadherin cell lines) exhibited strong cell surface 
positivity for E-cadherin, as compared to their negative antisense counterparts (images not 
shown). However, there were marked morphological differences, in terms o f E-cadherin 
localisation, between the three cell lines. Thus the H376 E-cadherin cell line manifested what 
I term “zipper-like” appearance at sites of cell-cell contact (Figure 5.7; structures designated 
by arrows) indicative o f relative immaturity. In contrast the H376(34 E-cadherin cell line had 
a more mature “straight line” contact (Figure 5.8; arrows). I considered that the appearance 
o f the IA2 E-cadherin cell line also was consistent with the “zipper-like” appearance of 
immature junctions (Figure 5.9; arrows).
I also observed changes in the actin organisation, such that the H376(34 E-cadherin cell line 
showed disrupted actin filaments and less stress fibres as compared to both the H376 E- 
cadherin cell line and the IA2 E-cadherin cell line. In both these latter lines the actin 
filaments re-distributed into bundles co-localising with the cell surface E-cadherin molecule 
(Figures 5.7, 5.8 and 5.9, Panels B and C).
Taken together, these morphological changes suggest that the [34-integrin might be involved 
in the maturation o f the E-cadherin-dependent cell-cell junction.
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Because the initial aim o f this Chapter was to detect any sort o f E-cadherin/(34-integrin 
cross-talk interaction, based on results from Sections 5.2.3 and 5.2.4, I decided to carry out 
the rest o f my experiments with only 2 cell lines, the H376 E-cadherin and the H376(34 E- 
cadherin lines. The fact that they had been proven to originate from the same parental cell 
line, and that the only difference between them appeared to be the lack o f the (34-integrin 
subunit in the H376 E-cadherin cell line, meant I considered they would provide a good 
model to study the effect o f (34-integrin on the maturation o f the E-cadherin-dependent cell­
cell junction.
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5.3 D iscussion
The primary H376 OSCC cell line was shown to express low surface levels o f the (34-integrin 
subunit (Sugiyama et al., 1993) and was characterised as being E-cadherin negative (Chapter 
3). Later the H376 cell line was transfected with human (34-integrin cDNA by J. Jones (Jones 
et al., 1996a) and the H376(34 (G418-resistant clone 6) stable transfectant was shown to 
express substantial levels o f (34-integrin subunit at the cell surface (Jones J., PhD thesis, 
University o f London, 1996). However these levels still were less than those expressed by 
normal keratinocytes (Sugiyama et al., 1993). The IA2 cell line was used as a negative control 
since it had been transfected with the empty vector only (Jones et al., 1996a). FACS and 
Western blot analyses showed that the primary H376 and IA2 cell lines were negative for the 
(34-integrin subunit, while the H376(34 cell line was confirmed as positive (Figure 5.1). E- 
cadherin sense and antisense cDNA was stably transfected into all three primary cell lines 
(H376, H376(34 and IA2) and as a consequence o f de novo E-cadherin, three main findings 
occurred:
1) Failure o f the (34-integrin subunit to assemble into hemidesmosome-like 
structures in (34-integrin-transfected cell lines.
2) Limited to large, yet always significant, increases in the basal level o f (34- 
integrin expression in all three E-cadherin positive transfectants.
3) Occurrence o f a mature form o f E-cadherin-dependent adherens junctions in 
the H 376(34 E-cadherin cell line as compared to the zipper-like cell-cell 
contacts in the H376 E-cadherin ((34-negative) cell line.
The (34-integrin subunit dimerises with the a6- integrin subunit and plays an im portant role 
in the assembly o f hemidesmosomes (Jones et al., 1991) such that antibodies directed against 
a6(34 integrin inhibited hemidesmosome assembly (Jones et al., 1991; Kurpakus et al., 1991).
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In the literature, cultured keratinocytes expressing a6(34 integrin have been reported as 
manifesting two different hemidesmosome-like structures. First, the hemidesomosomal 
proteins formed patch-like structures, which were referred to as “SACs” (Carter et al., 1990), 
or they assembled into lines which were referred to as “cat-paw arrays” (Tsuruta et al., 2003). 
In the primary H 376(34 line the [34-integrin subunit failed to assemble into either structure; 
rather it assembled into reticular network-like arrays, as appeared in Figure 5.6; a result 
previously described by J. Jones (Jones et al., 1996a), such an arrangement I found, mostly, to 
mimic the microscopic presentation o f the keratin intermediate filament system (Ghosh et a l, 
2002).
J. Jones claimed that the inability o f the transfected cell line to show hemidesmosomal SACs 
may be due to its inability to express normal levels o f (34 integrin. De novo E-cadherin 
expression in this particular cell line, “H376(34”, resulted in markedly increased (34-integrin 
levels, as established by FACS and Western blot analyses (Figure 5.4) but this elevation of the 
(34-integrin level did not alter the ability o f the transfected cell line to assemble 
hemidesmosomal SAC-like structures.
It is known that the oc6(34 integrin binds the cell to ECM via the laminin-5 protein (Niessen et 
al, 1994) and such binding triggers clustering o f other hemidesmosomal proteins and 
induces hemidesmosome formation (Mainiero et al., 1995; Spinardi et a l, 1995). However, 
Nievers et al. (1998) showed that (34-integrin alone was able to induce hemidesmosome 
assembly in a ligand-independent manner (Nievers et al., 1998). The ability o f  the H376[34 E- 
cadherin cell line to form (34-integrin-dependent hemidesmosomal structures after binding to 
laminin-5 was tested with the cells plated atop laminin-5-coated cover slips. Using indirect 
immunofluorescence, confocal images showed that (34-integrin-to-laminin-binding did not 
induce hemidesmosomal structure formation in this particular cell line (Figure 5.6).
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Classical hemidesmosomes are formed by clustering o f multiple transmembrane and 
cytoplasmic proteins. a6(34 integrin together with the bullous pemphigoid antigen 180 
(BP180 or BPAG-2) constitute the transmembrane component o f the hemidesmosome 
(Jones et al., 1991; Li et al., 1993). In the cytoplasm, a6(34 integrin and BP180 are associated 
with the cytoplasmic components o f the hemidesmosome which include the H D l/p lec tin  
protein (Hieda et al., 1992), the bullous pemphigoid antigen 230 (BP230 or BPAG-1) (Tamai 
et al., 1993) and the intermediate filament associated protein (IFAP300) (Skalli et al., 1994) 
(see Chapter 6; Figure 6.1 for an illustration). The presence or absence o f these proteins, 
together with their distribution, should be monitored in my FI376(34 E-cadherin cell line 
since the lack o f any o f these accessory proteins might provide an explanation for the failure 
of this line to form SACs.
The <x6(34 integrin is expressed in various epithelial tissues that are controlled by Epidermal 
G rowth Factor (EGF) and it has been reported that activation o f EG F receptors causes 
disassembly o f the hemidesmosomes by obstructing the association o f the activated a6(34 
integrin with the cytoskeleton (Mainiero et al., 1996). My OSCC cell was grown in KGM 
enriched with E G F and this too might explain why de novo (34 expression in this particular cell 
line failed to result in it being organised into hemidesmosomal structures.
It is known that in order to build the protective layer that is stratified squamous epithelium, 
epithelial cells m ust be bound tightly to each other and collectively they must adhere firmly 
to the underlying basement membrane.
In general, cell-cell and cell-ECM adhesion are mediated by different adhesion receptor 
systems among which cadherin and integrins, respectively, play a major role (Juliano, 2002). 
Adherens junctions, with E-cadherin being the main adhesive receptor, in conjunction with 
the actin cytoskeleton, “zip” the apposing cell surfaces together in an homophilic manner
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and seal them  into a cohesive well-protected sheet of cells (Vasioukhin and Fuchs, 2001). 
Concurrently the hemidesmosomes, harbouring the major a6(34 epithelial integrin (laminin 
receptor), connect the intermediate filament system to laminin-5; a major constituent of the 
basement membrane (Fuchs et a l, 1997; van der Flier and Sonnenberg, 2001; Watt, 2002).
In tandem with the E-cadherin-mediated intercellular adhesion, the a6(34 integrin is known 
to contribute to the development o f a stable adhesion phenotype with a non-motile 
morphotype (Carter et al., 1990; Fukata et al., 1999b).
It seems logical to think that these two major epithelial adhesive receptors complement each 
other in allowing a stable integration of cells into a multicellular tissue.
In the literature there is little solid evidence to suggest that such “cross-talk” does exist. Thus 
Hintermann et al (2005) provided proof that the oc6(34 integrin possesses the ability to 
upregulate E-cadherin-mediated cell-cell adhesion through the activation o f erbB2 
(Hintermann et a l, 2005). O n the other hand, disruption o f a6 (34-dependent 
hemidesmosomal cell anchorage was shown to trigger a rapid loss o f E-cadherin from cell­
cell contacts (Fouquet et a l, 2004).
In this Chapter I have provided preliminary evidence that E-cadherin and (34-integrin ‘cross­
talk’. De novo E-cadherin expression in all transfected cell lines resulted in an increase in the 
expression o f the (34-integrin subunit. In Chapter 3, H376 E-cadherin transfectants showed 
about a 2.5-fold increase in (34-integrin levels. The increase was, although apparendy 
relatively trivial, statistically significant (p value < 0.01) (Chapter 3, Figure 3.21). Two years 
later when I used these same cell lines again these results were not-repeatable (which could 
be attributable to a potential artefactual change in integrin expression as a consequence of 
the selection procedure and the continuous propagation o f the tumour cell line). However, 
re-expression o f E-cadherin in an other two primary cell lines, the H376(34 and IA2 lines, 
which were proved, using D N A  finger-printing, to originate from the same parental cell line
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as well as the H376 cell line, resulted in the same effect. Accordingly there was about a 5-fold 
increase in the levels o f (34-integrin subunit in the IA2 E-cadherin cell line as compared to 
the IA2 antisense control (p value < 0.04). In the H376(34 E-cadherin cell line there was a 
significant 17-fold increase in the levels o f (34-integrin as a consequence o f E-cadherin re­
expression (p value < 0.003) (Figure 5.4). This independent experiment supports my first 
observation that restoration o f  E-cadherin expression can lead to an increase in the basal 
surface levels o f the (34-integrin.
In Chapter 3, I showed that restoration o f E-cadherin into the H376 OSCC cell line resulted 
in the formation o f E-cadherin-dependent cell-cell contacts. Visual evaluation, under the 
confocal microscope, led me to conclude that these were incompletely formed cell-cell 
contacts in that they appeared as stitched “zipper-like” contacts rather than straight line cell­
cell contacts. These “zipper-like” cell-cell contacts represented an intermediate step in 
adherens junction formation preceding the full merger o f the neighbouring cell membrane 
into a single line, as described by Vasioukhin et al. (2000). Suprisingly, this was not the case 
when E-cadherin cDNA was introduced into the H376(34 cell line. The resultant transfected 
cell line, the H376(34 E-cadherin line, exhibited typical mature E-cadherin-dependent cell-cell 
contacts (Figures 5.7 and 5.8). Moreover, under the microscope, compared to the H376 E- 
cadherin transfectants, the H376(34 E-cadherin cell line, certainly, exhibited a more epithelial 
morphotype.
It is known that the re-expression o f the (34-integrin subunit has rescued the epithelial 
phenotype through restoration o f the ability of the epithelial cells to form hemidesmosomes 
(Gagnoux-Palacios et al., 1997; Schaapveld et al., 1998; van der Neut et al., 1999) suggesting 
that some o f these changes might be mediated through E-cadherin activity.
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In conclusion, there is increasing evidence that molecules mediating cell-cell and cell-ECM 
adhesion “cross-talk” to each other. In OSCC, loss or perturbed expression o f both the E- 
cadherin molecule and epithelial integrins are closely related (Bagutti et al., 1998). In cultured 
keratinocytes it has been shown that inhibition of E-cadherin-mediated cell-cell adhesion 
resulted in a decrease in integrin expression by proliferating cells and their de novo expression 
by differentiating cells (Hodivala and Watt, 1994; Zhu and Watt, 1996). In this Chapter I 
provide evidence that restoration o f the E-cadherin molecule in this particular OSCC cell 
line, a cell line that was proved to normally lack E-cadherin, resulted in an increase in the 
expression o f the (34-integrin subunit. There also is a strong suggestion that the (34-integrin 
subunit is involved in the maturation o f E-cadherin-dependent cell-cell adherens junctions. 
This latter observation is investigated more comprehensively in the next Chapter.
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Figure 5.1
Detection of E-cadherin and (34-integrin expression in the parental cell lines using 
FACS analysis
For E-cadherin detection, cells were harvested as described in Chapter 2, Section 2.2.1.1. 
FACS results showed E-cadherin surface expression o f the parental cell lines, the black 
histogram represents the negative control labelled with Mouse IgG l negative control 
(DAKO), while the blue histogram represents the positive cell population expressing E- 
cadherin labelled with anti-E-cadherin antibody “H EC D -1”. H357 cell line was used as a 
positive control and shown to expresses high levels o f E-cadherin, while H376 cell line was 
used as a negative control and was shown to be E-cadherin negative. Both H376(34 and IA2 
cell lines were characterised as E-cadherin negative.
For (34-integrin detection, cells were harvested as described in Chapter 2, Section 2.2.1.2. 
FACS results showed (34-integrin surface expression o f the parental cell lines, the black 
histogram represents the negative control labelled with Mouse IgG l negative control 
(DAKO), while the red histogram represents the positive cell population expressing (34- 
integrin labelled with anti-(34-integrin antibody “3E1”. H357 cell line was used as a positive 
control and shown to express high levels o f (34-integrin. Both H376 and IA2 cell lines were 
found negative for (34-integrin subunit, while H376(34 cell lines appeared positive.
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Figure 5.2 
Detection of E-cadherin and (34-integrin expression in the parental cell lines using 
Western blot analysis
Equal cell numbers o f each cell line were plated for 48 hours in KGM  prior to lysing. Whole 
cell RIPA lysates were obtained, and equal protein was determined by BCA protein assay. 
Proteins (25 pg/lane) were resolved by SDS-PAGE and blotted onto nitrocellulose 
membrane.
a) For E-cadherin detection, the blot was probed using HECD-1 antibody and shows a 
120 kDa band in relation to H357 line “positive control”, whereas H376, H376(34 
and IA2 parental cell lines were negative for E-cadherin. The bottom  blot was 
probed for Hsc-70 and used as a loading control.
b) For (34-integrin detection, the blot was probed using “clone 7” anti-(34-integrin 
monoclonal antibody and shows a 200 kDa band in relation to the H376(34 cell line, 
only. In contrast, both H376 and IA2 parental cell lines were negative for (34-integrin. 
The bottom  blot was probed for Hsc-70 and used as a loading control.
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Figure 5.3
Determination of E-cadherin expression in stably transfected cell lines using FACS 
analysis and Western blotting
F A C S analysis: Cells were allowed to grow to confluency then harvested using the E- 
cadhenn preservation m ethod (Chapter 2, Section 2.2.1.1). FACS results showed E-cadherin 
surface expression o f the transfected cell lines, the black histogram represents the negative 
control labelled with Mouse IgG l negative control (DAKO), while the blue histogram 
represents the positive cell population expressing E-cadherin labelled with HECD-1 
antibody. H376 antisense, H376(34 antisense and IA2 antisense cell lines showed no 
expression o f E-cadherin while the H376 E-cadherin, H376(34 E-cadherin and IA2 E- 
cadherin cell lines expressed high levels o f E-cadherin.
W estern b lo t analysis: Whole cell RIPA lysates (25 pg/lane) were resolved by SDS-PAGE 
and blotted onto nitrocellulose membranes. The top blot was probed for E-cadherin using 
HECD-1 antibody and shows a 120 kDa band in relation to the H376 E-cadherin, H376(34 
E-cadherin and IA2 E-cadherin cell lines transfected with the E-cadherin sense construct. In 
contrast cell lines transfected with the anti-sense construct (H376 antisense, H376(34 
antisense and IA2 antisense) were negative for E-cadherin. The bottom  blot was probed for 
Hsc-70 which was used as a loading control.
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Figure 5.4
Determination of (34-integrin expression in stably transfected cell lines using FACS 
analysis and Western blotting
F A C S analysis: Surface expression o f the (34-integrin subunit in the transfected cell lines; 
H376(34 E-cadherin, H376[34 antisense, IA2 E-cadherin and IA2 antisense, was assessed 
using anti-(34 integrin antibodies (3E1). Geometric mean fluorescence (arbitrary units, log 
scale) as measured by flow cytometry was used to plot the histogram. Figure 5.4 shows 
histogram plotted against the mean value o f three independent experiments for (34-integrin. 
The mean fluorescence intensity (MFI) was determined by subtracting the fluorescence value 
o f cells labelled with the appropriate IgG control antibody. Error bars represent standard 
error o f the mean (sem). Results showed that de novo E-cadherin expression in transfected cell 
lines had resulted in a statistically significant increase in surface expression o f (34-integrin as 
compared to the antisense control cell lines.
W estern b lo t analysis: Whole cell RIPA lysates (25 pg/lane) were resolved by SDS-PAGE 
and blotted onto nitrocellulose membranes. The top blot was probed for (34-integrin using 
“clone 7” anti-(3 4-integrin monoclonal antibody and shows a 200 kDa band in relation to the 
H376(34 parental cell line, as well as the H376(34 E-cadherin cell line and the IA2 E-cadherin 
cell line. The bottom  blot was probed for Hsc-70 which was used as a loading control. The 
(34-integrin was represented by double bands o f  200 kDa and 185 kDa molecular weight.
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Figure 5.6
Immunocytochemical assessment of p4-integrin expression in OSCC cell lines
2 x 104 cells were plated onto laminin-5-coated 13mm coverslips in a 24-well plate and 
allowed to grow for 48 hours. Cells were examined on a confocal laser scanning microscope, 
and images collected digitally.
Panels A and C are confocal images o f H376J34 E-cadherin cell line. Panels B and D are 
confocal images o f CA1 cell line.
Panels A and B show (34-integrin, “green”, detected by anti-(34-integrin monoclonal antibody 
(BD Transduction Laboratories). Panel A shows reticular distribution o f (34-integrin in 
H376(34 E-cadherin transfectans and Panel B the (34-integrin SAC-like structures.
Panels C and D  are composite confocal images showing (34-integrin, “green”, actin 
cytoskeleton, “red”, detected with phalloidin-TRITC and nuclei, “blue”, detected with DAPI.
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Figure 5.7 
Determination of E-cadherin expression in H376 E-cadherin transfected cell line
2 x 104 cells were plated onto 13mm coverslips in a 24-well plate and allowed to grow for 48 
hours with selection medium. Cells were examined on a confocal laser scanning microscope, 
and images collected digitally.
In Panel A, E-Cadherin, “green”, was detected by HECD-1 antibody and showed E- 
cadherin-dependent “zipper-like” cell-cell contacts (as denoted with open arrow).
In Panel B, actin cytoskeleton, “red”, was detected with phalloidin-TRITC, and showed that 
the actin filaments co-localised with E-cadherin and redistributed into stress fibres.
Panel C is composite confocal a image showing E-cadherin, “green”, actin cytoskeleton, 
“red”, and nuclei, “blue” , detected with DAPI.
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Figure 5.8 
Determination of E-cadherin expression in H376(34 E-cadherin transfected cell line
2 x 104 cells were plated onto 13mm coverslips in a 24-well plate and allowed to grow for 48 
hours with selection medium. Cells were examined on a confocal laser scanning microscope, 
and images collected digitally.
In Panel A, E-Cadherin, “green”, was detected by HECD-1 antibody and showed E- 
cadherin-dependent “straight-line” cell-cell contacts, “green”,(as denoted with arrows).
In Panel B, actin cytoskeleton, “red”, was detected with phalloidin-TRITC, and showed 
redistribution o f the actin filaments.
Panel C is composite confocal a image showing E-cadherin, “green” , actin cytoskeleton, 
“red”, and nuclei, “blue”, detected with DAPI.
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Figure 5.9
Determination of E-cadherin expression in IA2 E-cadherin transfected cell line
2 x 104 cells were plated onto 13mm coverslips in a 24-well plate and allowed to grow for 48 
hours with selection medium. Cells were examined on a confocal laser scanning microscope, 
and images collected digitally.
In Panel A, E-Cadherin, “green”, was detected by HECD-1 antibody and showed E- 
cadherin-dependent “zipper-like” cell-cell contacts (as denoted with open arrow).
In Panel B, actin cytoskeleton, “red”, was detected with phalloidin-TRITC, and showed that 
the actin filaments co-localised with E-cadherin and redistributed into stress fibres.
Panel C is composite confocal a image showing E-cadherin, “green”, actin cytoskeleton, 
“red”, and nuclei, “blue”, detected with DAPI.
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CHAPTER 6
(34-integrin and Maturation of E-cadherin-Dependent Adherens
Junctions
6.1 Introduction
A polarised epithelium is composed o f epithelial cells that possess a cuboidal morphology 
with their nuclei localised at the basal aspect o f the cell, and with their cellular proteins 
distributed asymmetrically along well-defined membrane domains; the apical and the 
basolateral domains. A polarised epithelial phenotype provides one of the primary examples 
o f how cell shape and function essentially are dependent on each other. The maintenance of 
polarisation is vital to ensure an intact structural integrity and physiological function o f the 
epithelium.
The efficiency and stability of this epithelial barrier is maintained through the interaction of 
specialised adhesive complexes that either interact with similar structures on neighbouring 
cells, to form intercellular junctions (Nelson, 2003), or interact with the underlying 
extracellular matrix, through hemidesmosomes, to anchor the overlying epithelial cells to the 
basement membrane (Borradori and Sonnenberg, 1999) (Figure 6.1). These adhesive 
complexes are involved directly in the organisation o f the cytoskeleton and provide 
im portant spatial cues to generate cell polarity and enable cells to sense and respond to 
adjacent cells and to the surrounding environment (Borradori and Sonnenberg, 1999; 
Nelson, 2003).
Intercellular junctions include: tight junctions, adherens junctions, and desmosomes. The 
cadherin-rich adherens junctions and desmosomes provide tight adhesion and mediate 
strong cell-cell contact while tight junctions, the most apical o f these junctional complexes,
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seal the epithelial cells together rendering the epithelial front impermeable to ions and small 
solutes (Fleming et al., 2000).
C adherin -dependen t A d h eren s ‘C ell-C ell’Junctions:
Adherens junctions are formed by cadherin molecules that mediate calcium-dependent cell­
cell adhesion. They have a common structural organisation, and their junctional complexes 
consist o f extracellular components, transmembrane components and cytoplasmic domains 
that interact with adaptor proteins, collectively known as the catenins, which all together 
assemble to form a cytoplasmic cell adhesion complex (CCC), that provides a direct, or an 
indirect, link to the actin cytoskeleton (Christofori and Semb, 1999).
Epithelial cells express at least two types o f classical cadherin molecules, E- and P-cadherin. 
In contrast to other cadherin molecules expressed in other cell types, adhesion mediated by 
E-cadherin triggers the development o f epithelial morphology (Gumbiner, 1996). Loss o f E- 
cadherin function, either through inhibition by different experimental methods or naturally, 
such as during tumourigenesis, has been shown to result in the loss o f the epithelial 
morphotype (Gumbiner, 1996; Christofori and Semb, 1999).
Although cell-cell adhesion might, at first, seem static it is in fact a dynamic process and the 
reorganisation o f these adhesion complexes triggers a wide range o f vital physiological 
processes, starting from the early days of embryonic development and continuing throughout 
tissue development (Takeichi, 1995; Adams and Nelson, 1998; Gumbiner, 2000; Tepass et al.^  
2000). Similar reorganisation also is implicated during pathophysiological processes such as 
wound-healing and tum our metastasis (Fukata and Kaibuchi, 2001). Cellular polarity in 
earliest stages o f vertebrate development is thought to be mediated by E-cadherin (Wheelock 
and Johnson, 2003b).
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Cell-cell adhesion complexes rearrange constantly by remodelling o f the cadherin-catenin 
complexes. It has been estimated that half o f the E-cadherin molecules in any individual cell 
are engaged with the actin cytoskeleton to form cell-cell adhesion complexes, while the 
remainder remain in the cytoplasm, unattached (Sako et a l, 1998).
The oc6(24-integrin-dependen t H em idesm osom al ‘Cell-ECM’Junctions:
The hemidesmosome is a complex structure, consisting o f several proteins that assemble 
collectively to form an attachment site for the intermediate (Keratin) filament network in 
epithelial cells and contributes to the attachment o f epithelial cells to the underlying 
basement membrane (Jones et a l, 1991; Borradori and Sonnenberg, 1999). The integrin a6(34 
is an essential component o f  the hemidesmosome (Stepp et al., 1990; Jones et al., 1998; 
Borradori and Sonnenberg, 1999) which uses as a substrate laminin-5 anchoring filaments to 
anchor the epithelial cells tighdy to the underlying basement membrane (Carter et al., 1991; 
Rousselle et a l, 1991; Geuijen and Sonnenberg, 2002).
Recent studies suggest that the a6(34 integrin plays a critical role in transducing signals from 
the extracellular environment to the interior o f the cell; significantly modulating the 
organisation o f the cytoskeleton, cell proliferation, apoptosis and differentiation (Borradori 
and Sonnenberg, 1999). The bullous pemphigoid antigen BP180 (BPAG-2) hemidesmosomal 
component, also known as collagen XVII (Jones et a l, 1998), interacts directly with the a6(34 
integrin and was found to play a role in establishing cell-cell interaction via actinin, a 
com ponent o f the actin cytoskeleton; thus suggesting a “cross-talk” interaction between the 
cell-ECM and cell-cell adhesion systems (Gonzalez et a l, 2001).
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Formation o f the cadherin-dependent cell-cell junctions:
Cadherin molecules exist as parallel dimers at the surface o f expressing cells (Chapter 1, 
Figure 1.2); a phenom enon thought to be mediated solely by the extracellular domains of the 
cadherin molecules; additionally Ca2+ ions are thought not to play a role in this dimerisation 
process (Chitaev and Troyanovsky, 1998).
Cadherin-dependent cell-cell adhesion is an highly organised process that consists of 
sequential steps o f increasing complexity (Figure 6.2), that contribute to the generation o f the 
polarised, fully differentiated, epithelial cell (Braga, 2000; 2002):
Step 1 (Homophilic binding): In the presence o f Ca2+ ions, an ‘homophilic interaction’,
between cadherin dimers on neighbouring cells, is initiated. This is followed by:-
Step 2 (Clustering): Clustering o f the adhesion complexes at sites o f cell-cell contacts.
Step 3 (Stabilisation of the adhesion complexes): Adhesion molecules cluster at cell-cell 
contacts and are further stabilised through the formation o f the CCC and its subsequent 
interaction with the cytoskeletal proteins. Homophilic binding generates weak adhesive 
forces that are further strengthened via clustering o f the adhesion complexes and the 
cytoskeletal interaction (Gumbiner, 1996). However, association with the actin filaments was 
shown not to affect the homophilic binding, per se, o f the cadherin molecules (Yap et al., 
1997).
Step 4 (Remodelling of the cytoskeleton): Remodelling and reorganisation of the 
cytoskeleton, with the recruitment o f new actin to the junction, follows and results in the 
generation o f the necessary mechanical forces that are utilised for epithelial compaction and 
polarisation.
Step 5 (Generation of a polarised epithelial phenotype): Simultaneously, three other key 
processes take place: change in cell shape, formation o f other adhesive structures, and
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formation o f distinct cell membrane domains, that collectively contribute to the formation of 
a polarised epithelial phenotype.
The actual machinery for the development of cell-cell adhesion and regulation o f the 
polarised epithelial phenotype is still far from being completely understood. Recently, the 
signalling pathway regulated by Rho small GTPases has emerged as a key regulator that 
controls the cell membrane and actin cytoskeleton dynamics (Van Aelst and D'Souza- 
Schorey, 1997; Kaibuchi et al., 1999; Bishop and Hall, 2000; Braga, 2000). Three members of 
the Rho small GTPases family (Rho, Rac, and Cdc42) have been implicated comprehensively 
in the process o f epithelial morphogenesis and differentiation (Eaton et a l, 1996; Strutt et al., 
1997; Raich et al., 1999; Stappenbeck and Gordon, 2000). It also has been shown that these 
members o f the Rho small GTPases family play a major role in the regulation o f adherens 
junctions and the development o f epithelia (Takaishi et al., 1997; Kodama et al., 1999; Braga, 
1999; Fukata and Kaibuchi, 2001).
Following identification o f the regulator and effector molecules o f the small GTPases 
subfamily, signalling pathways running both ways, from cadherin-dependent adhesion 
complexes to Rho GTPases and from Rho GTPases back to cadherin adhesion complexes, 
are beginning to be clarified (Fukata and Kaibuchi, 2001; Braga, 2002).
Rho GTPases act like molecular switches; they cycle between an inactive, G DP-bound 
variant, and an active, G TP-bound variant. There are several mechanisms by which Rho 
family GTPases can affect the E-cadherin-dependent cell-cell junctions. For example, Rho 
GTPases have been reported to directly affect E-cadherin-catenin complex. When Racl and 
Cdc42 are inactive their effector protein, IQGAP1, binds to both the E-cadherin cytoplasmic 
domain and to (3-catenin, apparently causing a subsequent dissociation o f the a-catenin/ actin 
from the E-cadherin-catenin complex and loss of cell adhesion (Kuroda et al., 1998; Fukata et
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al., 1999a). O n the other hand, when Racl and Cdc42 are active, they interact with IQGAP1; 
therefore preventing its interaction with the E-cadherin-catenin complex (Figure 6.3). 
Interchange between the active and inactive variants of Rho GTPases family proteins is 
tightly regulated by associated protein. The exchange of bound G D P for GTP and the 
subsequent activation o f the GTPases is controlled by Guanine nucleotide exchange factors 
(GEFs), while the inactivation is stimulated by intrinsic hydrolysis of GTP by GTPase- 
activating proteins (GAPs) (for review see: Van Aelst and D'Souza-Schorey, 1997). Tiam-1 is 
a Rac-specific G EF and is one im portant regulator o f Rho GTPases functions in tumour 
cells (Mertens et al., 2003). It has been reported that Tiam-1 expression promotes cadherin- 
mediated adhesion o f fibroblasts and epithelial cells (Hordijk et al., 1997; Sander et al., 1998; 
Engers et al., 2001). Knock-down o f Tiam-1, using siRNA technology, in M DCK cells 
resulted in the acquisition o f a migratory and mesenchymal phenotype, with disruption of the 
E-cadherin-dependent cell-cell contacts (Malliri et al., 2004).
Results from the previous Chapter suggested that maturation o f E-cadherin-dependent cell­
cell junctions, in this particular OSCC cell line, was dependent upon the presence o f the (34- 
integrin subunit. In this Chapter I decided to investigate this finding by conducting further 
experiments on just two cell lines, the H376 E-cadherin and the H376(34 E-cadherin lines. 
The fact that they had been proven to originate from the same parental cell line and that the 
only difference between them appeared to be the lack o f the (34-integrin subunit in the H376 
E-cadherin cell line made them a good model with which to study the effect o f (34-integrin 
on the maturation o f the E-cadherin-dependent cell-cell junction.
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6.2 Results
6.2.1 Effect of the (34-integrin subunit on the maturation of the E-cadherin- 
dependent adherens junction
Using confocal microscopy the nature o f the E-cadherin-dependent cell-cell junctions, in 
both the H376 E-cadherin and the H376(34 E-cadherin cell lines, was investigated carefully. 
Figure 6.4 shows a close-up o f both E-cadherin-dependent cell-cell contacts. In the H376 E- 
cadherin cell line the E-cadherin molecules appeared to accumulate at the cell-cell border as 
punctata forming a “zipper-like” adhesion contact that failed to fuse into a linear contact. In 
contrast, E-cadherin-dependent cell-cell junctions in the H376(34E-cadherin cell line 
appeared as a “straight line” contact. This result suggests that the (34-integrin subunit plays a 
role in the maturation o f the E-cadherin-dependent adherence junction, by allowing the E- 
cadherin punctata to fully merge into a straight-line cell-cell contact. Attached (Appendix IV) 
is a CD with a movie illustrating 3-D images o f both types o f adhesion contacts.
6.2.2 (34-integrin knock-down in the H376(34 E-cadherin transfected cell line
Results from the immunocytochemical staining experiments suggested that the (34-integrin 
subunit contributes to the maturation o f the E-cadherin-dependent cell-cell contacts. If  this 
suggestion was true, then knock-down of (34-integrin should result in disruption o f these cell­
cell contacts. To test this hypothesis (34-integrin gene silencing was achieved using RNA 
interference (RNAi) technology on the H376(34 E-cadherin transfected cell line. In these 
studies (34-integrin mRNA was silenced specifically and (34-integrin expression was, 
consequently, inhibited. A pool o f synthetic small interfering (si) double stranded RNA 
sequences (Dharmacon) was used to knock-down (34 to test if this could convert the cell-cell 
contact from a mature straight-line into an immature zipper-like contact. As described in
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Chapter 2, Section 2.5.2, cells were grown in 6-well plates in an antibiotic-free KGM 
medium. W hen they were 40% confluent, they were transfected with either (34-integrin RNAi 
complex or scrambled oligonucleotides (positive control) using Oligofectamine™ 
transfection reagent (Invitrogen). Post-transfection, cells were allowed to grow for 48 hours 
before the efficiency o f the knock-down was tested using FACS analysis and Western 
blotting. Two positive controls were incorporated, the non-treated cells growing for 4 hours 
in OptiM EM  before being replaced with full KGM  medium and the cells being transfected 
with a scrambled oligonucleotide. FACS results, from five independent experiments, showed 
about a 93% knock-down as compared to the positive controls (Figure 6.5), where Western 
blot analysis, from five independent experiments, showed about a 90% knock-down (Figure
6.5). Concomitant with this expected reduction in (34 protein, there was a significant 
downregulation o f  E-cadherin by about 67% (Figure 6.5).
6.2.3 E-cadherin-dependent cell-cell junction formation as a consequence of {34- 
integrin knock-down
Indirect immunostaining was used to study the effect o f the [34 knock-down on the integrity 
o f the E-cadherin-dependent cell-cell contacts. For each knock-down experiment OptiMEM 
and scrambled control were used. (34-integrin knock-down was, first, carried out in 6-well 
plates (as described above). 24 hours post-transfection, cells were harvested and plated on 
top o f 13mm coverslips in 24-well plates and allowed to grow for another 24 hours in full 
K GM  medium. 48 hours post-transfection, cells were fixed using 4% formaldehyde, 
permeabilised with Triton X-100 then stained for E-cadherin with HECD-1 monoclonal 
antibody. Results showed that, compared to the positive control cells, when (34-integrin was 
knocked-out there was a disruption of the cell-cell junctions. Thus where the straight-line
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cell-cell contacts had been observed previously they now were reverted back to the less 
mature, zipper-like junctions with more stress fibres co-localising with the surviving E- 
cadherin molecules (Figure 6.6). Furthermore, as a consequence of (34-integrin knock-down, 
the H376(34 E-cadherin cell line exhibited what appeared to be a more fibroblastic phenotype 
as compared to their original, and the control, epithelial morphology (Figure 6.6). Perhaps 
even more interestingly lobulated nuclei were reverted back to an oval shape when (34- 
integrin was knocked-out indicating that (34-integrin was accountable for these changes in 
appearance detected in the previous chapter (see Chapter 5, Section 5.2.6)
6.2.4 (34-integrin knock-down in the CA1 OSCC cell line
I also studied this phenom enon in another cell line; the CA1 OSCC cell line (a kind gift of 
Professor Ian Mackenzie). As mentioned earlier, this particular cell line showed well-formed, 
SAC-like hemidesmosomal structures when it was stained for the (34-integrin subunit 
(Chapter 5, Figure 5.5). RNAi-mediated depletion of (34-integrin was carried out on the CA1 
cell line in exactly same way as described above. FACS and Western blot analyses confirmed 
an efficient (34-integrin knock-down o f about 96% (Figure 6.7). Concomitantly there was 
about a 42% downregulation o f the E-cadherin molecule which occurred when the (34- 
integrin subunit was knocked down (Figure 6.7). However, there was little difference in cell­
cell contact morphology as compared to the OptiMEM and scrambled control, with only 5- 
10% of the total population showing altered cell morphology and cell-cell contact (Figure 
6.8). Unfortunately, this experiment was conducted only once, so this phenomenon could 
not be generalised as occurring on other epithelial cells. Ideally I would have liked to test a 
range o f other (34-expressing cell lines, including normal epithelial cells, and this is something 
I would have done had I had more time available.
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6.2.5 In the H376(34 E-cadherin OSCC cell line the p4-integrin subunit induces the 
maturation of E-cadherin-dependent cell-cell contact in a Raci-dependent 
manner
De novo (34-integrin expression in the H376(34 E-cadherin cell line resulted in actin 
remodelling; thus this cytoskeletal protein was transformed, from bundles o f stress fibres co- 
localising with the E-cadherin surface molecules in the H376 E-cadherin transfectants, into 
apparently disintegrated structures in the H376(34 E-cadherin cell line (see Chapter 5, Figures 
5.7 and 5.8).
Members o f the Rho small GTPases family (Rho, Rac, and Cdc42) have been identified as 
regulators o f actin cytoskeleton dynamics (Braga, 2000). It was reported that the activation of 
Rac results in the formation o f more intermingled membrane junctioning between 
neighbouring cells (Takaishi et al., 1997; Stoffler et al!, 1998; Kodama et al!, 1999). Therefore, 
I thought that the Rho small GTPases, particularly Rac, most likely were serious contenders 
to be the down-stream effectors o f (34-integrin.
Endogenous Racl levels were assessed using indirect immunostaining. Cells were plated on 
top o f 13mm coverslips and allowed to grow for 48 hours, until they reached confluency, in 
full KGM  medium. Racl expression was stained for using human anti-Racl monoclonal 
antibody (Transduction Laboratories). Results showed that Racl was expressed in abundance 
in the cytoplasm o f the H376 E-cadherin cell line, but not at cell-cell contacts, denoting the 
apparent failure o f E-cadherin alone to recruit Racl to the cell-cell junctions (Figure 6.9). In 
contrast, Racl in the H376(34 E-cadherin cell line was localised both in the nuclei and at the 
cell-cell junctions; a shift in localisation that appeared to have occurred as a consequence of 
the de novo expression o f E-cadherin in the H376(34 cell line (Figure 6.9).
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Knock-down o f the (34-integrin subunit resulted in the translocation o f Racl from the cell­
cell contacts, and from the nuclei, to the cytoplasm (Figure 6.10). Furthermore, in almost 
30% of the cells, Racl accumulated into polarised large vesicles located near the cell 
membrane at the leading edge o f the cell (designated by arrows, Figure 6.10).
The effect o f levels o f (34-integrin subunit on the translocation o f Racl was tested in the CA1 
OSCC cell line and here also endogenous Racl was found to be located at the cell-cell 
junctions and in the nuclei (Figure 6.10). When the (34-integrin subunit was silenced using 
RNAi, the Racl translocated into the cytoplasm and to the free cell border (Figure 6.10). 
Taken altogether, these results suggest that the (34-integrin might affect the maturation o f the 
E-cadherin-dependent cell-cell adhesion through activation and /or recruitment o f Racl to 
the site o f the cell-cell junction. Also, this result might well suggest that Racl, in the H376 E- 
cadherin cell line, is expressed in an ‘inactive’ state, while in the FI376(34 E-cadherin cell line 
it is expressed as an ‘active’ variant o f Racl.
6.2.6 Pull-down activity assay
Racl and Cdc42 activity in H376E-cadherin was assessed using the GST-PAK-CRIB pull­
down assay (Chapter 2, Section 2.6.4). Active Racl and Cdc42 were pulled down with the 
GST-PAK-CRIB fusion protein. Amounts of active versus total proteins were assessed with 
Western blot analysis using human monoclonal antibodies against Racl and Cdc42 
(Transduction Laboratories). De novo E-cadherin expression in H376 E-cadherin cell line 
resulted in inactivation o f Racl as compared to the antisense negative control (Figure 6.11). 
This finding supports the previous results that the H376 E-cadherin cell line expresses an 
inactive variant o f Racl. In contrast E-cadherin re-expression has resulted in the activation 
o f Cdc42 as compared to the antisense control cell line (Figure 6.11). This result was
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consistent with the work o f others who concluded that E-cadherin-mediated cell-cell 
adhesion activates Cdc42 (Kim et al., 2000).
With the H376(34 E-cadherin cell line the results were inconclusive, as there was no activity 
detected, neither in relation to both the H376(34 E-cadherin cell line nor with the (34-knock­
down control (data not shown). I suspect this was because a large fraction of Racl activity 
was not detected because it was intra-nuclear. I suggest that this particular assay should be 
repeated using another lysis buffer to include the nuclear proteins.
6.2.7 Introduction of constitutively-active and dominant-negative Racl into H376 
E-cadherin and H376(34E-cadherin OSCC cell lines
To confirm that activation o f Racl is accountable for the maturation o f the E-cadherin- 
dependent cell-cell junction, dominant-negative (RacN17) or constitutively-active Racl (RacV12) 
variants were overexpressed transiently in both H376 E-cadherin and H376(34 E-cadherin 
cell lines, using F u G E N E IM 6 Transfection reagent (Roche) and transfectants were analysed 
using indirect immunostaining. Figure 6.12 shows a representative illustration of the H376 E- 
cadherin cell line transfected with the constitutively-active Racl (RacV12) construct. In the 
H376 E-cadherin cell line, contrary to the endogenously expressed cytoplasmic Racl, the 
GFP-tagged-RacV12 translocated to either the cell-cell junction, or to the nucleus or to both 
locations (Green: Figure 6.12) and these re-localisations have been associated with the 
maturation of the E-cadherin-dependent cell-cell contacts (Figure 6.12, Red: designated with 
solid arrow), whereas negative cells still showed the immature zipper-like cell-cell junctions 
(Figure 6.12, Red: designated with open arrow). Interestingly, activation of Racl in the H376 
E-cadherin cell line has lead to the occurrence o f a fan-shaped cells (Figure 6.12); a 
phenotype previously described by Sander et al (1998), where expression o f constitutively
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active T iam l/R ac in M DCK cells contributed to the development o f a fan-shaped motile 
phenotype in cells when grown on collagen I, whereas this effect was abrogated when cells 
were grown on laminin-1 or fibronectin (Sander et al., 1998).
Likewise the GFP-tagged-RacV12, in the H376J34 E-cadherin line also was translocated to the 
cell-cell junction and to the nucleus (Figure 6.13); a similar localisation to that observed with 
the endogenously expressed Racl in this cell line, supporting the previous suggestion that the 
H376|34E-cadherin cell line does, indeed, express an active variant o f Racl. In contrast to its 
effect in the H376 E-cadherin cell line, over expression o f RacV12 in the H376(34E-cadherin 
cell line did not result in altered cell morphology and the transfected cells remained epithelial 
in shape (Figure 6.13).
To further prove that activation o f Racl contributes to the maturation o f E-cadherin- 
dependent cell-cell contacts in this particular cell line a dominant-negative (RacN17) construct 
was introduced into the H376(34 E-cadherin cell line where it was shown to result in the 
disruption o f the original straight line contact and contributed to the development o f the 
immature zipper-like E-cadherin-dependent cell-cell contacts (Figure 6.13).
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6.3 D iscussion
Results from Chapter 3 and 5, when taken together provide evidence that, at least in this 
particular OSCC cell line, E-cadherin can cross-talk to [34-integrin. De novo E-cadherin 
expression in all transfected cell lines resulted in an increase in the expression o f the (34- 
integrin subunit. Moreover, visual assessment of the resultant E-cadherin cell-cell adherens 
junctions revealed there were marked differences between the ones which existed in the 
H376 E-cadherin cell line as compared to the ones expressed in the H376(34E-cadherin line. 
It appears therefore that the presence o f (34-integrin in the H376(34E-cadherin cell line has 
contributed to:
a) the formation of a mature phenotype o f E-cadherin-dependent cell-cell junctions.
b) the disruption o f actin stress-fibres formed in the H376 E-cadherin cell line.
c) the development o f a typical epithelial morphotype as compared to the less epithelial 
H376 E-cadherin cells.
In this Chapter I have provided evidence that the (34-integrin is accountable for all of the 
above changes. Silencing of (34-integrin mRNA and the consequent downregulation o f (34- 
integrin, resulted in the disruption of cell-cell adherens junctions and contributed to the 
reappearance o f E-cadherin-dependent zipper-like contacts together with the formation of 
stress fibres that co-localised with the E-cadherin molecules (Figure 6.4). Moreover, the 
knock-down o f expression o f the (34-integrin subunit in the H376(34 E-cadherin cell line has 
resulted in the reversion o f the appearance o f these cells from a more epithelial appearance 
into a more fibroblastic phenotype (Figure 6.6). Additionally, knock-down o f (34-integrin 
resulted in a significant (p value £  0.04 and 0.04) 67% downregulation o f E-cadherin (Figure
6.5). This result is strongly suggestive o f the existence o f an interactive cross-talk between E- 
cadherin and (34-integrin. In general terms, my findings further support the observations by
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Hintermann et al. (2005), where they report that a6(34 integrin increased E-cadherin- 
dependent cell-cell adhesion (Hintermann eta/., 2005).
In an attempt to find out if  this phenomenon could be generalised to another epithelial cell 
line, knock-down o f  (34-integrin by RNAi was carried out in the CA1 OSCC cell line. Results 
from a single experiment showed that there was about 5-10% of the total cell population 
with altered cell-cell contacts and altered morphology (Figure 6.8) and about a 42% reduction 
in total levels o f E-cadherin. Considering that this particular cell line showed well-formed 
SAC-like hemidesmosomal structures, when they were immunostained indirectly with anti- 
(34-integrin antibody (Figure 6.8), perhaps this is why knock-down o f (34-integrin did not 
have a similar impact as in my previous model. Unfortunately, this experiment was 
conducted only once rendering the results intriguing rather than totally unequivocal. 
Nonetheless it does appear that the phenomenon o f (34-integrin/E-cadherin crosstalk is 
applicable to more than just the model system utilised here.
Had I had more time available I would have repeated these experiments on CA1 cells and 
extended them to other cell lines, including normal epithelial cells.
Members o f the Rho small GTPases family (Rho, Rac, and Cdc42) have been categorised as 
regulators o f actin cytoskeleton dynamics (Braga, 2000). They were shown to play a 
significant role in adherens junction formation (Fukata and Kaibuchi, 2001; Braga, 2002) and 
are the most likely candidates to govern the phenom enon under study here. As mentioned 
above, activation o f Rac was shown to result in the formation o f a more intermingled 
membrane between neighbouring cells (Takaishi et al., 1997; Stoffler et al., 1998; Kodama et 
al., 1999). These data suggest that, in this particular cell line; the H376 OSCC, the effect of 
(34-integrin upon the maturation o f the E-cadherin-dependent cell-cell junction could, 
possibly, be mediated by Racl.
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Results showed that Racl was expressed in abundance in the cytoplasm o f the H376 E- 
cadherin cell line. In contrast, Racl was concentrated at cell-cell contacts and in the nuclei of 
the H376(34 E-cadherin cell line (Figure 6.9). This result suggested that (34-integrin is 
associated with the translocation o f Racl. Knock-down o f (34-integrin subunit, from the 
H376(34 E-cadherin cell line, resulted in the translocation o f Racl from the cell-cell contacts, 
and from the nuclei, to the cytoplasm (Figure 6.10). Furthermore, in almost 30% of the cells, 
Racl accumulated into polarised, large vesicles located near the cell membrane at the leading 
edge o f the cell (Figure 6.10; structures designated by arrows). Similarly, the specific knock­
down o f the (34-integrin subunit, from the CA1 cell line, also resulted in the translocation of 
Racl from the regions of cell-cell contact and the nuclei into the cytoplasm (Figure 6.10; 
structures designated by arrows). These results suggest that the (34-integrin might affect the 
maturation o f the E-cadherin-dependent cell-cell adhesion through recruitment o f Racl to 
the sites o f cell-cell junctions.
Because activation o f Rac was shown to result in the formation of a more intermingled 
membrane between neighbouring cells (Takaishi et a l 1997; Stoffler et al., 1998; Kodama et 
al., 1999). I considered it possible that Racl, in the H376 E-cadherin cell line, might be 
expressed in an ‘inactive’ state, while the H376(34 E-cadherin cell line might express an 
‘active’ variant o f  Racl. Pull-down activity assays showed that de novo expression o f E- 
cadherin in the H376 E-cadherin cell line resulted in the inactivation o f Racl, as compared to 
the antisense control cell line (Figure 6.11); a finding in support of the previous suggestion. 
This however, is somewhat in contradiction to previous suggestions that cell-cell junction 
formation, mediated by cadherins, is strictly required for Rac recruitment and activation, and 
that the activation o f Rac by itself cannot bypass this requirement (Braga et al., 1999;
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Nakagawa et a l, 2001). In my model system, E-cadherin restoration had, instead, lead to the 
activation o f Cdc42 (Figure 6.11); a result consistent with the findings o f Kim et al ( 2000).
It has been reported that, depending on the Rho GTPase effector involved, actin 
remodelling builds different structures. Activation of the Rho GTPase, Cdc42, was shown to 
induce the formation o f extended, linear, hair-like actin bundles. In contrast, Rac and Rho 
were shown to induce assembly o f circumferential actin and to result in cell spreading 
(Etienne-Manneville and Hall, 2002). Thus it might be that the formation o f actin stress- 
fibres in the H376 E-cadherin cell line is attributable to the activation o f Cdc42 as a 
consequence o f de novo E-cadherin expression.
Certainly it appears that, upon adhesion, cadherin receptors signal to other molecules that 
co-operate with Rac for the localised actin requirement at cell-cell junctions. Could it be that 
in this particular cell line; the H376 OSCC, that this ‘other’ molecule might be the (34-integrin 
subunit?
As mentioned earlier I had hypothesised that the H376|34 E-cadherin cell line might express 
an ‘active’ variant o f Racl. Unfortunately with the H376(34 E-cadherin cell line the results of 
the Racl pull-down assay were inconclusive, as there was no activity detected neither in the 
H376(34 E-cadherin cell line nor after the (34-knock-down control (Data not shown). I 
suspect, in retrospect, that this was because a large fraction of Racl activity was located in an 
intra-nuclear position. I suggest that this assay should be repeated but using a lysis buffer that 
would include the nuclear proteins.
I have, however, shown that activation o f Racl was, indeed, required for the maturation of 
E-cadherin-dependent cell-cell contacts in the H376 E-cadherin cell line. Using the 
constitutively-active Racl (RacV12), it appeared that cells which overexpressed the active
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variant exhibited a mature, straight E-cadherin-dependent, cell-cell contact as compared to 
those cells that did not express the RacV12. Moreover, RacV12 was expressed at sites o f cell-cell 
contact, as well as in the nuclei (Figure 6.12). Interestingly, expression o f RacV12 contributed 
to the occurrence o f fan-shaped cells (Figure 6.12); a phenotype previously described by 
Sander et al. (1998), after the expression o f constitutively active T iam l/R ac in MDCK cells. 
In these authors’ experiments such fan-shaped, motile cells occurred only when cells were 
grown on collagen I, whereas this effect was abrogated when cells were grown on laminin-1 
or fibronectin (Sander et a l 1998). Since a6(34 integrin is a known receptor for laminin-1 
(Niessen et al., 1994) and since the M DCK cell line is known to express (34-integrin, I am 
tempted to suggest that the changes observed by Sander et al. (1998) might be attributable to 
the a6(34 integrin. W hen both the H376 E-cadherin and the H376(34E-cadherin cell lines 
were transfected with the constitutively-active Racl (RacV12), only the H376 E-cadherin cell 
line, which lacks the (34-integrin subunit, showed these fan-shaped cells.
Similarly in the H376(34 E-cadherin cell line, the constitutively-active Racl (RacV12) also was 
translocated to the cell-cell junctions and to the nucleus (Figure 6.13); a similar localisation to 
the endogenously expressed Racl in this cell line. However, in contrast to the H376 E- 
cadherin line the expression o f the RacV12 did not appear to transform any o f the cells into 
fan-shaped variants; instead, they all retained their epithelial morphology.
From the literature, the effects o f Rho small GTPases in epithelial cells seem to be 
contradictory, since they have been shown to be required both for cell migration and also for 
cell-cell adhesion (Sander et al., 1998; Sander et al., 1999). This leads me to suggest that 
Tiam l/Rac-induced inhibition o f migration on laminin-1 is mediated via (34-integrin. The 
absence of (34-integrin in the H376 E-cadherin cell line has shifted the cellular response to 
produce the fan-shaped cells.
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Certainly it appears that, in this particular OSCC cell line, E-cadherin and (34-integrin ‘cross­
talk’ to each other and it is possible that the (34-integrin might be a key role player in the 
maturation o f E-cadherin-dependent adherens junction through either changes of location or 
change o f activity status o f the member o f the Rho small GTPase family, Racl.
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Figure 6.1
Diagrammatic illustration of the hemidesmosomal components
Hemidesmosomes consist o f two cytoplasmic cytoskeleton linkers; the 230 kDa human 
autoantigen named BP230 (BPAG-1) and Plectin, and two transm embrane proteins; the 180 
kDa human autoantigen named BP 180 (BPAG-2) and the a6(34 integrin (Figure adapted 
from Cox and Hardin, 2004).
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Figure 6.2 
Diagrammatic illustration of steps in the formation of E-cadherin-dependent cell-cell 
junctions and epithelial polarisation
Formation o f cadherin-mediated cell-cell contacts and the development o f the epithelial 
m orphotype is a complex process, which is believed to be under the control o f several 
signalling pathways; one o f most im portant being mediated by the Rho family GTPases 
(Figure adapted from Braga, 2000).
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Figure 6.2
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F igure 6.3 
Rho GTPases and the development of the E-cadherin-dependent cell-cell junctions
Digramatic illustration demonstrating the interchange between the active (GTP-bound) and 
inactive (GDP-bound) variants o f the Rho GTPases family proteins (Racl and Cdc42). 
Tiam-1, Rac-specific G EF, regulates the switch between the two variants. Inactivation of 
Rho GTPases releases IQGAP1 effector protein which competes for binding with the (3- 
catenin/E-cadherin complex and results in the dissociation o f a-catenin/actin complex and 
the subsequent disruption of cell-cell contacts.
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Figure 6.4 
Immunocytochemical assessment of E-cadherin-dependent cell-cell junctions in 
transfected OSCC cell lines
2 x 104 cells were plated onto 13mm coverslips in a 24-well plate and allowed to grow for 48 
hours with selection medium. Cells were examined on a confocal laser scanning microscope, 
and images collected digitally.
Panels A and C are confocal images o f H376 E-cadherin cell line.
Panels B and D are confocal images o f H376J34 E-cadherin cell line.
In Panels A and B, E-Cadherin, “green”, was detected by HECD-1 antibody and showed the 
the E-cadherin-dependent “zipper-like” cell-cell contacts in H376 E-cadherin cell line (Panel 
A: denoted with open arrow) as compared to the E-cadherin-dependent “straight-line” cell­
cell contacts in H376J34 E-cadherin cell line (Panel B: denoted with solid arrow).
Panels C and D are composite confocal images showing E-cadherin, “green”, actin 
cytoskeleton, “red” , was detected with phalloidin-TRITC and nuclei, “blue”, were detected 
with DAPI.
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Figure 6.5
(34-integrin knock-down in the H37604 E-cadherin OSCC cell line
RNA interference (RNAi) technology was used to knock-down (34-integrin expression in 
H376(34 E-cadherin cell line. Expression o f (34-integrin was assessed 48 hours post­
transfection using FACS and Western blot analyses.
For (34-integrin detection, cells were harvested as described in Chapter 2, Section 2.2.1.2. 
Figure (a) shows a representative flow cytometry experiment, o f  five independent 
experiments, with about 80% reduction in the level o f (34-integrin surface expression, labelled 
with anti-(34-integrin antibody “3E1”, as compared with the non-treated OptiM EM  control 
and the scrambled control.
For (34-integrin expression, 25 fig protein/lane were resolved by SDS-PAGE and blotted 
onto nitrocellulose membrane. The blot was probed using “clone 7” anti-(34-integrin 
monoclonal antibody. A histogram of data collected from five independent experiments 
shows about 90% reduction o f (34-integrin expression in the RNAi lane com pared to the 
OptiM EM  and scrambled control lanes (p value 5  0.02 when com pared to the OptiM EM  
control; p value £  0.002 when compared to Scrambled control).
For E-cadherin detection, the blot was probed using HECD-1 antibody. A histogram of 
data collected from five independent experiments shows a concom itant 67% reduction o f E- 
cadherin expression in the RNAi lane com pared to the OptiM EM  and scrambled control 
lanes (p value < 0.04 when com pared to the OptiM EM  control; p value 5: 0.04 when 
compared to Scrambled control).
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Figure 6.6
Effect of (34-integrin knock-down on the maturation of E-cadherin-dependent cell­
cell contacts in the H376(34 E-cadherin OSCC cell line
Expression o f (34-integrin and E-cadherin was assessed using indirect immunostaining.
Panels A, D, G and J are confocal images o f the H376(34 E-cadherin/O ptiM EM  control cell 
line.
Panels B, E, H and K are confocal images o f the H376(34 E-cadherin/Scram bled control cell 
line.
Panels C, F, I and L are confocal images o f the H376(34 E-cadherin/R N A i cell line. In Panels 
A-C: (34-integrin, “green”, was detected by clone 7 antibody and showed level o f reduction o f 
(34-integrin expression upon knock-down using RNAi (Panel C) as compared with the 
OptiM EM  and scrambled control lines (Panels A and B).
Panels D-F are composite confocal images o f  (34-integrin, “green”, actin cytoskeleton, “red”, 
was detected with phalloidin-TRITC and nuclei, “blue” , were detected with DAPI.
In Panels G-I: E-Cadherin, “green”, was detected by HECD-1 antibody and showed 
disruption o f E-cadherin-dependent cell-cell contacts as a consequence o f (34-integrin knock­
out (Panel I) as compared with the fully-formed, straight-line E-cadherin-dependent cell-cell 
contacts in the OptiM EM  and scrambled control lines (Panels G  and H).
Panels J-L are composite confocal images o f E-cadherin “green”, actin cytoskeleton, “red”, 
was detected with phalloidin-TRITC and nuclei, “blue” , were detected with DAPI. Panel L 
showed redistribution o f the actin filaments into stress fibres colocalising with E-cadherin 
molecule.
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Figure 6.7
(34-integrin knock-down in the CA1 OSCC cell line
RNA interference (RNAi) technology was used to knock-down (34-integrin expression in 
CA1 cell line. Expression o f (34-integrin was assessed 48 hours post-transfection using FACS 
and Western blot analyses.
For (34-integrin detection, cells were harvested as described in Chapter 2, Section 2.2.1.2. 
Figure (a) shows a flow cytometry experiment with about 96% reduction in the level o f (34- 
integrin surface expression, labelled with anti-(34-integrin antibody “3E1”, as compared with 
the non-treated OptiM EM  control and the scrambled control.
For (34-integrin expression, 25 pg protein/lane were resolved by SDS-PAGE and blotted 
onto nitrocellulose membrane. The blot was probed using “clone 7” anti-(34-integrin 
monoclonal antibody. A histogram, o f data collected from a single experiment, shows about 
100% reduction o f (34-integrin expression in the RNAi lane compared to the OptiM EM  and 
scrambled control lanes.
For E-cadherin detection, the blot was probed using HECD-1 antibody. A histogram, o f 
data collected from a single experiment, shows a concomitant 42% reduction o f E-cadherin 
expression in the RNAi lane compared to the OptiM EM  and scrambled control lanes.
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Figure 6.8 
Effect of {54-integrin knock-down on the maturation of E-cadherin-dependent cell­
cell contacts in the CA1 OSCC cell line
Expression o f  {34-integrin and E-cadherin was assessed, 48 hours post-transfection, using 
indirect immunostaining. Cells were examined on a confocal laser scanning microscope, and 
images collected digitally.
Panels A, D, G and J are confocal images o f the CA 1/O ptiM EM  control cell line.
Panels B, E, H and K are confocal images o f the CA1/Scrambled control cell line.
Panels C, F, I and L are confocal images o f the C A l/R N A i cell line.
In Panels A-C: (34-integrin, “green”, was detected by clone 7 antibody and showed level of 
reduction o f (34-integrin expression upon knock-down using RNAi (Panel C) as compared 
with the OptiM EM  and scrambled control lines (Panels A and B).
Panels D-F are composite confocal images o f p4-integrin, “green”, actin cytoskeleton, “red”, 
was detected with phalloidin-TRITC and nuclei, “blue”, were detected with DAPI.
In Panels G-I: E-Cadherin, “green”, was detected by HECD-1 antibody. Panel I represents 
about 5-10% o f the total population and shows disruption o f E-cadherin-dependent cell-cell 
contacts.
Panels J-L are composite confocal images o f E-cadherin “green” , actin cytoskeleton, “red”, 
was detected with phalloidin-TRITC and nuclei, “blue” , were detected with DAPI.
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Figure 6.9 
Assessment of endogenous Racl expression in H367 E-cadherin and H376{34 E- 
cadherin OSCC cell lines
2 x 104 cells were plated onto 13mm coverslips in a 24-well plate and allowed to grow for 48 
hours with selection medium.
Expression o f endogenous Racl and E-cadherin was assessed using indirect immunostaining. 
Cells were examined on a confocal laser scanning microscope, and images collected digitally. 
Panels A and C are confocal images o f the H376 E-cadherin cell line.
Panels B and D are confocal images o f the H376J34 E-cadherin cell line.
In Panels A and B: Racl, “green”, was detected by anti-Racl “clone 23A8” monoclonal 
antibody (Upstate Cell Signaling Solutions).
Panels C and D  are composite confocal images o f R acl, “green” , actin cytoskeleton, “red”, 
was detected with phalloidin-TRITC and nuclei, “blue” , were detected with DAPI.
Panels A and B show expression o f Racl in the H376 E-cadherin cell line, with Racl being 
expressed in abundance in the cytoplasm.
Panels C and D show expression o f Racl in the H376p4 E-cadherin cell line, with Racl 
being expressed at the nucleus, the cytoplasm and at the cell-cell junctions.
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Figure 6.10 
Effect of {34-integrin knock-down on localisation of endogenous Racl in H376{34 E- 
cadherin and CA1 OSCC cell lines
Expression and localisation o f Racl was assessed, 48 hours post-transfection, using indirect 
immunostaining. Cells were examined on a confocal laser scanning microscope, and images 
collected digitally.
Panels A-F are confocal images o f the H376J34 E,-cadherin cell line.
Panels G-L are confocal images o f CA1 cell line.
In Panels A-C and G-I: Racl, “green” , was detected by -Racl (clone 23A8) monoclonal 
antibody.
Panels D-F and J-L are composite confocal images o f  Racl, “green”, actin cytoskeleton, 
“red”, was detected with phalloidin-TRITC and nuclei, “blue”, were detected with DAPI. 
Panels A-F show H376[34 E-cadherin cell line with Racl expressed predominantly in the 
nuclei and at the cell-cell junction in OptiM EM  and scrambled control panels (Panels A and 
B). U pon (34-integrin knock down, Racl was relocalised to the cell periphery at the leading 
edge o f the cells (Panel C) forming vesicle-like structures (Panel C: designated by arrows). 
Panels G-L show CA1 cell line with Racl expressed predominantly in the nuclei and at the 
cell-cell junction in OptiM EM  and scrambled control panels (Panels G  and FI). Upon [34- 
integrin knock down, Racl was relocalised to the cell periphery at the leading edge o f the 
cells (Panel C: designated by arrows).
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Figure 6.11 
Pull-down of activated Racl and Cdc42
Activated R acl-G T P level was determined, in H376 E-cadherin cell line, by GST pull-down 
assay using the PAK binding domain (PBD), followed by Western blot analysis. Data shown 
are representative o f two independent experiments.
A ctivated/total Racl blotted using anti-Racl (clone 23A8) monoclonal antibody (Upstate). 
A ctivated/total Cdc42 blotted using anti-Cdc42 (clone 3707) monoclonal antibodies 
(CHEMICON® international).
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Figure 6.12 
Expression of constitutively-active Racl (Racvl2) in H376 E-cadherin OSCC cell line
Constitutively-active Racl (Racvl2-GFP) was introduced into H376 E-cadherin cell line. 
Expression and effect o f RacV12 was assessed 48 hours post-transfection using indirect 
immunostaining.
In Panels A and D: Racvi2-GEP appearing “green” .
In Panels B and E: E-cadherin, “red”, was detected with HEGD-1 antibody coupled to Cy3- 
and-mouse secondary layer.
Panels C and F are composite confocal images o f Racvl2-G FP, “green”, E-cadherin “red”, 
acdn cytoskeleton, “blue”, was detected with Cy5 and nuclei, “yellow”, were detected with 
DAPI.
Panels A-C show that H376 E-cadherin cells expressing Racvl2-G FP (Panel A) showed more 
mature E-cadherin-dependent cell-cell contacts (Panel B: designated by solid arrows) 
com pared with the immature ‘zipper-like’ contacts in cells that did not express Racvl2-GFP 
(Panel B: designated by open arrows).
Panels D -F show that H376 E-cadherin cells expressing Racv,2-G FP adopted a fan-shaped 
morphology.
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Figure 6.13 
Expression of constitutively-active Racl (RacV12) and dominant-negative (RacN17) in 
H37604 E-cadherin OSCC cell line
Constitutively-active Racl (Racvl2-GFP) or dominant-negative (RacN17-GFP) were introduced 
into H376J34 E-cadherin cell line. Expression and effect o f  Racvl2 or RacN1' was assessed 48 
hours post-transfection using indirect immunostaining.
Panels A-C are confocal images o f the H376(34 E-cadherin cell line transfected with RacV12- 
GFP.
Panels D-F are confocal images o f the H376(54 E-cadherin cell line transfected with RacN17- 
GFP.
In Panels A and D: Racvl2-G FP and RacN17-G FP appearing “green” .
In Panels B and E: E-cadherin, “red”, was detected with HECD-1 antibody coupled to Cy3- 
anti-mouse secondary layer.
Panels C and F are composite confocal images o f Rac-GFP, “green”, E-cadherin, “red”, 
actin cytoskeleton, “blue”, was detected with Cy5 and nuclei, “yellow”, were detected with 
DAPI.
Panels A-C show that H376(34 E-cadherin cells expressing Racvi2-G FP (Panel A) showed 
mature E-cadherin-dependent cell-cell contacts (Panel B: designated by solid arrows) with a 
typical epithelial morphology.
Panels D-F show that H376 E-cadherin cells expressing RacM7-G FP (Panel D) showed 
disrupted E-cadherin-dependent cell-cell contact (Panel E: designated by open arrow).
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CHAPTER 7
Discussion
7.1 Experimental approach
The purpose o f this study was to investigate the effect o f expression and function o f the E- 
cadherin cell-cell adhesion molecule on the behaviour of epithelial cells derived from an oral 
squamous cell carcinoma lacking endogenous expression of this particular molecule 
(Sugiyama et al., 1993). Three related starting cell lines were used to commence this study, the 
H376 (Prime et al., 1990), the H376J34 and the IA2 cell lines; the latter two cell lines being 
derivatives o f the H376 cell line, with the H376(34 line previously having been transfected 
with the (34-integrin human cDNA and the IA2 being its negative, or vector only, control 
(Jones et al, 1996a). All three cell lines were transfected with constructs expressing full-length 
E-cadherin cDNA. O n other occasions when E-cadherin cDNA was transfected into other 
model cell line systems it was shown to have a profound effect on subsequent cell behaviour 
(Miyaki, 1995; Hermiston et al., 1996; Gottardi et al., 2001; Jiao et al., 2001; Kohya et al., 2003). 
However, as far as I could ascertain, in OSCC studies on E-cadherin re-expression largely 
have been unsuccessful with few, if any, documented instances of successful manipulation of 
cellular adhesion and migration characteristics.
7.2 Production of E-cadherin positive stable clones
Transfection o f recipient cells with the E-cadherin cDNA was performed using a bicistronic 
vector “pIRES-puro”, with both the drug-resistance gene and the desired gene o f interest 
contained within a single transcription cassette; thus the clones that survived selection in 
antibiotic-containing medium expressed high levels of the transcribed protein o f interest 
(Hobbs et al., 1998). Cells were transfected either with full-length human E-cadherin cDNA
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in the sense orientation or with the full-length human E-cadherin cDNA in the antisense 
orientation
In order to produce the stable E-cadherin positive clones, transfected cells were put through 
a vigorous two rounds o f a magnetic bead sorting procedure (to select for high levels of cell- 
surface expression o f E-cadherin) and then were grown in the drug-selection medium. 
However, the antisense control clones were selected using drug-selection medium only. 
E-cadherin was highly expressed in all positive lines and clearly was able to induce 
morphological changes in the OSCC cells similar to those features exhibited by other 
epithelial cells expressing E-cadherin. Furthermore, I showed that E-cadherin in these cells 
was as capable o f inhibiting invasion as has been shown in other cells (Vieminckx et al, 1991; 
Takeichi et al., 1993; Moersig et al, 2002). Moreover, the endogenous (3-catenin protein was 
upregulated and redistributed to the cell-cell junctions as a consequence o f de novo E-cadherin 
expression in my OSCC model system, suggesting that the relationship o f E-cadherin and (3- 
catenin was restored back to what might be considered a normal epithelial phenotype. Similar 
findings were obtained with a-catenin, in terms o f its patterns o f re-distribution, but not with 
y-catenin which was, instead, dowregulated.
7.3 Effect of E-cadherin re-expression on the differentiation of an OSCC cell line
Because o f the fact that the primary H376 cell line was characterised previously as a low 
expresser o f involucrin (Sugiyama et al, 1993) and because all transfected cell lines were 
negative for this particular differentiation marker I concluded that the restoration o f E- 
cadherin expression had no apparent effect on the differentiation capacity o f the variant 
H376 cell lines; a similar finding was established by Jones et al (1996) where de novo 
expression o f the (34-integrin subunit into the H376 cell line was found not sufficient to 
induce terminal differentiation in this particular OSCC cell line (Jones et al, 1996a).
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7.4 Effect of E-cadherin re-expression on expression of other cadherins
N-cadherin is a mesenchymal cadherin (Li and Herlyn, 2000; Tomita et al., 2000). 
Upregulation o f N-cadherin in tumours o f epithelial origin has been associated with a poorly 
differentiated appearance (Islam et al., 1996; Nieman et al., 1999; Hazan et al., 2000; Tomita et 
al, 2000). All three OSCC primary cell lines used in this study were characterised as being 
negative for E-cadherin expression but were strongly positive for N-cadherin expression. 
Reciprocal downregularion o f N-cadherin was observed upon re-expression o f E-cadherin in 
these cell lines; simulating the phenom enon o f the “cadherin switch”, previously described as 
both a normal and a pathologic condition (Hatta and Takeichi, 1986; Hazan et al., 2000). 
Similar observations were made by Li et al. (1998) where the introduction o f L-CAM, a 
functional chicken homologue o f E-cadherin, into an OSCC cell line resulted in the 
downregulation o f N-cadherin and a subsequent loss o f the epithelial phenotype (Li et al., 
1998). This result suggests strongly that E-cadherin is accountable for reversion to the 
epithelial phenotype.
7.5 Effect of E-cadherin re-expression on the invasive potential of OSCC
Loss o f E-cadherin expression, or function, has been one o f the major hallmarks of 
malignant epithelial cancers and has been associated with increased invasion and metastasis 
o f low- or non-expressing tumours (Mareel et al., 1991; Birchmeier and Behrens, 1994). The 
precise role o f E-cadherin in modulating tumour invasion is still unclear though it most likely 
relates to the removal o f cells from the constraints of cell-cell adhesion; though it has rather 
been attributed to the abnormal expression of N-cadherin rather than loss o f E-cadherin 
(Nieman et al., 1999). De novo E-cadherin expression in my OSCC model system resulted in a 
marked inhibition o f invasion, as well as a substantial downregulation of N-cadherin. These 
results are suggestive o f the possibility that, in this particular model system, E-cadherin might
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have abrogated invasiveness through downregulation o f N-cadherin expression as much as it 
restricted cells through enhanced cell-cell interactions.
7.6 Growth and survival in 3-D collagen I cultures
Tum our cell invasion and mestastasis are three-dimensional processes. W hen transformed 
epithelial cells escape their normal anatomical location they are forced to proliferate within 
the dense three-dimensional collagen I-rich extracellular milieu; an environment which might 
be very different from their usual situation on a basement membrane.
I tried to mimic the conditions faced by proliferating, metastasising epithelial tumour cells 
by growing my transfected OSCC cell lines (H376 E-cadherin and H376 antisense cell lines) 
in a 3-D collagen I culture and, for direct comparison, under collagen I 2-D conditions; these 
latter conditions previously have been used by Hotary and colleagues (2003). By providing 
these various culture conditions I sought to test the effect o f de novo E-cadherin expression, 
in my model system, on tum our cell growth and survival. Under 2-D growth conditions, 
restoration o f E-cadherin suppressed tumour cell proliferation, suggesting that cancer growth 
suppression in the 2-D environment is an E-cadherin-dependent process. This type o f result 
has been reported previously in the literature (Tsukatani et al1, 1997; Li et al.y 1998). However, 
I found it difficult to detect any effect o f E-cadherin on inhibition o f cell growth in a 3-D 
environment; a result unlike those o f others whose studies have used normal epithelial cells 
and reported reduction in their growth capacities (Takahashi and Suzuki, 1996; Kandikonda 
et al.^  1996) or even others who also have used transformed cell lines (St Croix et al., 1998). 
My results might even suggest that expression of E-cadherin in a 3-D collagen I culture 
conferred a growth advantage on this particular OSCC cell line. Bcl-2 is an anti-apoptotic 
protein that protects cells from undergoing programmed cell death or apoptosis (Adams and 
Cory, 2001). Abrogation o f cell growth, as a consequence o f E-cadherin restoration in 2-D
cultures, was shown to be due to increased apoptosis. A similar observation was made by 
(Sasatomi et al\, 1996). Restoration o f expression of the E-cadherin molecule has been 
reported to reduce the expression o f Bcl-2 (Sasaki et al., 2000). In my model system, similar 
results were obtained when cells were growing under 2-D culture conditions however, in 
contrast, this effect was abrogated when cells were allowed to grow in 3-D collagen I 
cultures. I have interpreted these findings to suggest that, in 2-D culture systems, E-cadherin 
was able to confer a density-inhibidon o f growth on my OSCC cell line by downregulation of 
Bcl-2 causing a subsequent induction o f apoptosis. However, in 3-D cultures, E-cadherin 
seems almost to give preference to the development o f an apoptosis-resistant phenotype; 
this, perhaps, might be due to a higher exposure o f the embedded cells to survival signals 
mediated by other signalling pathways, such as integrin-ECM interactions (Meredith et al., 
1993). This suggestion was supported further by the fact that, in 3-D collagen I culture, E- 
cadherin re-expression concomitantly upregulated N-cadherin, phospho-Akt and ILK; all 
molecules that have been known for their anti-apoptotic effects in a range o f cell types 
(Datta et al., 1999; Tran et al., 2002; Friedrich et al, 2004).
The fact that, in certain tumours, partial E-cadherin function is maintained and is not 
selected against, despite its ability to inhibit growth under certain conditions implies that 
some level o f E-cadherin function may be advantageous to tumour cells. For example, 
expression o f E-cadherin has been shown to protect cells from undergoing apoptosis or 
programmed cell death (Hermiston and Gordon, 1995). Thus, in addition to growing more 
slowly (Navarro et a l, 1991; Miyaki et al, 1995) epithelial tumours with functional E-cadherin 
may also be resistant to apoptosis induced by environmental stress (Helmlinger et a l, 1997) 
or cytotoxic anticancer therapy (Dimanche-Boitrel et al, 1994; St Croix and Kerbel, 1997). 
Upregulation o f ILK in the E-cadherin positive OSCC cell lines was observed in both 2-D 
and 3-D collagen I culture conditions and, most likely, could be attributed to the
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upregulation o f the (31-integrin (as shown in Chapter 3, Section 3.2.10), a known collagen I 
receptor and ILK-linker protein, as a consequence of de novo E-cadherin expression in my 
OSCC model system.
Taken all together, these findings might suggest different mechanisms by which E-cadherin 
could provide an anti-apoptotic activity, and therefore mediate resistance to different 
therapeutic agents to cancer cells growing as 3-D multicellular aggregated masses in vitro and 
in vivo. This phenom enon previously has been described as “multicellular resistance” (Green 
et al., 2002), where formation o f E-cadherin-dependent MCAs contributed to the 
development o f therapeutic resistance. Knowing the underlying mechanisms which control 
this phenom enon might provide a clue as to what combination o f therapeutic agents could 
be used in order to inhibit the growth and expansion o f tumours once they have defeated 
their physical restaraints and expanded into the collagen I based surroundings.
7.7 E-cadherin/(3-4 integrin cross-talk
In my OSCC model system I provided evidence that these two epithelial adhesion molecules, 
E-cadherin and (34-integrin, do indeed cross-talk to each other. De novo E-cadherin 
expression in all three variant cell lines resulted in varying degrees o f upregulation or re­
expression o f the (34-integrin (results from Chapter 3 and 5). O n the other hand, de novo (34- 
integrin expression in the H376|34 E-cadherin cell line resulted in the maturation o f the E- 
cadherin dependent cell-cell contacts accompanied by derangement o f the actin cytoskeleton 
o f the cell and development o f an epithelial morphotype. In order to prove that (34-integrin 
was accountable for these changes, knock-down o f (34-inetgrin was carried out using RNAi 
technology. The subsequent downregulation of (34 resulted in the reversion o f the previous 
findings; where the E-cadherin-dependent cell-cell contacts were disrupted and showed a 
zipper-like appearance with the actin filaments reorganised into stress fibres. Moreover, there
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was down regulation o f E-cadherin molecules. The effect o f (34-integrin on E-cadherin- 
dependent adherence junction formation was tested in another cell line, the CA1 OSCC cell 
line. Similar results were obtained but only in 5-10% of the total population that showed 
alteration in the E-cadherin-dependent cell-cell junctions. E-cadherin was also subsequently 
downregulated as a result o f (34 knock down. These findings strongly support the idea that 
the (34-integrin is accountable for these changes, at least in this particular OSCC cell line. In 
general terms, my findings further support the observations by Hintermann et al. (2005), 
where they report that a6(34 integrin increased E-cadherin-dependent cell-cell adhesion 
(Hintermann et al., 2005).
In an attempt to establish how (34-integrin plays its role, members of the Rho small GTPases 
family (Rho, Rac, and Cdc42), which have been shown to play a significant role in adherens 
junction formation (Fukata and Kaibuchi, 2001; Braga, 2002) were examined and 
manipulated. Racl has been thought o f as a major role player in the formation o f a more 
intermingled membrane between neighbouring cells (Takaishi et al., 1997; Stoffler et al., 1998; 
Kodama et al., 1999). Also (34-integrin has been reported to signal via Racl (Russell et al., 
2003). Thus, the maturation o f the E-cadherin-dependent cell-cell junction, via (34-integrin, 
could possibly be mediated by Racl.
Results showed that (34-integrin was accountable for, at least, the re-localisation of Racl to 
the nuclei and areas o f cell-cell junctions; an effect that was confirmed using RNAi 
technology to knock-down (34-integrin. Downregulation o f (34-integrin has resulted in the 
mobilisation o f Racl from nuclei and cell-cell junctions back to the cytoplasm and to the cell 
periphery at the leading edge. Here Racl was found in large distinct vesicular structure. 
Likewise, knock-down o f (34-integrin in the CA1 cell line also resulted in the translocation of 
Racl from the nuclei to the cell periphery at the leading edge o f the cell. Tiam-1 is an
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important regulator o f Racl activity (Mertens et al., 2003) and could possibly be the 
downstream effector of the (34-integrin in this phenomenon.
Constitutively active Racl (RacV12) was shown to localise at the nuclei and at the cell-cell 
junctions o f the transfected cells; a similar distribution to the endogenously active Racl in 
the H376(34 E-cadherin, but not in the H376 E-cadherin, cell line. These results might be 
suggestive o f the possibility that (34-integrin might also contribute to the maturation of the 
adherens junction through the activation o f Racl. However, results o f pull-down assays were 
inconclusive; which I suspect might be ascribed to the fact that a large fraction o f active Racl 
is expressed in the nucleus and thus require nuclear lysis prior to detection.
Another critical observation was that, upon introduction o f the constitutively active Racl 
into both the H376 E-cadherin and the H376(34 E-cadherin cell lines, only the H376 E- 
cadherin cell line acquired a fan-shaped morphotype (described as motile by Sander et al., 
1998) but not the H376(34 E-cadherin cell line. Occurrence o f such a morphotype was 
abrogated when cells were allowed to grow on laminin-1 matrix, as compared to cells 
growing on a collagen I matrix (Sander et al., 1998). The fact that (34-integrin is a known 
laminin-1 receptor (Niessen et al., 1994) is strongly suggestive that these changes might be 
strongly linked to the expression o f (34-integrin.
Perhaps the activation pathway is defective in the H376 E-cadherin cell line and it requires 
(34-integrin in order to mediate this process.
In summary, these results suggest that (34-integrin expression in the H376(34 E-cadherin cell 
line is accountable for the maturation o f the E-cadherin dependent cell-cell junctions and for 
the development o f the epithelial morphotype, possibly signalling through the Racl member 
o f the Rho family GTPases. Activation of Racl owing to (34-integrin expression, with the 
possibility that (34-integrin instigates its actions through Tiam-1, should be investigated in- 
depth in future work.
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Results from this study, and results previously reported by Jones et al (1996 b), showed that 
neither the re-expression o f E-cadherin nor o f [34-integrin produced differentiation in these 
cell lines. However they resulted in the formation o f a more mature E-cadherin-dependent 
cell-cell junction; such a junction is vital for integrity and function of the epithelial basal cell 
layer. These results work in tandem with the old notion that cells committed to terminal 
differentiation become less adherent to the basement membrane as well as to one another 
(Watt, 1984). There appear to be cell-type-specific differences in how junctions are formed 
and it may well be that there are cadherin-specific differences. What is certain is that 
collaborative matrix- and intercellular adhesion regulation is a prerequisite for tissue 
rearrangements during morphogenesis and tissue remodelling (Marsden and DeSimone, 
2003) and it highly likely that similar mechanisms are operative in cancer cell growth and 
spread.
This thesis has generated more questions than it has provided answers but, there are many 
observations that can provide a good foundation for future research and the model system 
used herein will provides an ideal model to study the role of E-cadherin in OSCC.
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APPENDIX I 
Media, solutions and buffers
1. Tissue culture media and solutions 
Phosphate-Buffered Saline (PBSA) (Cancer Research UK Central Cell Services):
Made up to 1 litre with distilled water, titrated to pH 7.2 and autoclaved.
PBSABC consists o f PBS supplemented with ImM  CaCl2 (solution B) and ImM  MgCl2 
(solution C)
Standard Keratinocyte Growth Medium (KGM):
a MEM
10% Foetal Calf Serum (Globepharm, Surrey)
100  I U /I p e n ic i l l in
100 jig /1 streptomycin
1 .8 x 10"4M  a d en in e
5jig/m l insulin
1x10'8M cholera toxin
0.5jlg/ml hydrocortisone
lOng/ml epidermal growth factor (Sigma)
Selection Medium is KGM supplemented with 0.5jig/m l Puromycin (Sigma)
NaCl
KC1
Na2H P 0 4
k h 2p o 4
8g
0.25g
0.25g
0.25g
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2. Western Blotting
RIPA Lysis Buffet (2x):
2% Triton X-100 1ml
2% NaDOC lg
0.2% SDS 0.5ml
316mM NaCl 6.32ml
20mM Tris pH 7.3 1ml
20mM EGTA 200pl
2mM N a3V 04 5ml
lOmM NaF 0.5ml
Pro tease inhibitor (1:100) added fresh at time of use 
Protease Inhibitor:
PMSF (lOmg/ml) 1:100
Aprotinin (2mg/ml) 1:50
Leupeptin (1 Omg/ml) 1:5000
SDS-polyacrylamide gels 
Resolving Gel (10ml)
8% 10% 12.5% 15%
ddH20 4.6ml 4.0ml 3.3ml 2.3ml
Acrylamide Solution 2.7ml 3.3ml 4.0ml 5.0ml
1.5M Tris pH 8.8 2.5ml 2.5ml 2.5ml 2.5ml
20% SDS 50pl 50jll1 50pl 50pl
10% APS lOOpl lOOpl lOOpl lOOpl
TEM ED 6p 4pl 4jlx1 4pl
* APS = Ammonium persulphate
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Stacking Gel (5ml)
4%
d d H ,0 3.0ml
Acrylamide Solution 0.7ml
0.5M Tris pH 6.8 1.25ml
20% SDS 25 pi
10% APS 20pl
TEM ED lOpl
Running Buffer (xl) (500ml)
Tris base 
Glycine 
20% SDS
Fill up to 500ml with Distilled H 20
Transfer Buffer (xl) (500ml)
Tris base
Glycine
Methanol
Fill up to 500ml with Distilled H 20
Western Blot Blocking Buffer 1 (100ml)
Tween 20
Marvel skimmed milk powder 
PBS A
1.51g
7.3g
2.5ml
0.73g
3.6g
100ml
50pl
5g
100ml
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Western Blot Blocking Buffer 2 (100ml)
Tween 20 50pl
BSA lg
TBS 100ml
Western Blot Blocking Buffer 3 (100ml)
Tween 20 50 pi
Marvel skimmed milk powder 5g
TBS 100ml
Western Blot Blocking Buffer 4 (100ml)
Tween 20 50pl
Marvel skimmed milk powder 3g
PBSA 100ml
Western Blot Wash Buffer 1 (100ml)
Tween 20 250pl
PBS 500ml
Western Blot Wash Buffer 2 (100ml)
Tween 20 250pl
TBS 500ml
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3. Molecular Biology
2% Agarose Gel
Agarose 0.5g
ddH 20  22.5ml
Heat to 56°C until agarose dissolved, then add
TAE buffer (lOx) 2.5ml
Ethidium bromide (10 jig/ml) 1.25pi
DNA Loading Buffer (10ml)
Bromophenol blue 25mg
Xylene cyanol FF 25mg
100% Glycerol 3ml
ddH20  7ml
4. Pull-down assay 
Lysis Buffer (20ml)
50 mM Tris-HCl, pH  7.5 1ml (1 M stock)
1% Triton X-100 0.2ml
0.5% sodium deoxycolate O.lg
0.1 % SDS 0.2ml (10% stock)
10 mM MgCl2 0.2ml (1 M stock)
150mM NaCl 0.6ml (5 M stock)
ddH 20  17.7
Leupeptin, pepstatin, Pefabloc
PMSF (to 2 mM) and 1:1000 pro tease inhibitor mixture added fresh at time o f assay.
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Washing buffer (100ml)
50 mM Tris-HCl, pH  7.5 5ml (1 M stock)
1% Triton X-100 1ml
10 mM MgCl2 1ml (1 M stock)
150mM NaCl 3ml (5 M stock)
ddH20  17.7ml
Leupeptin, pepstatin, Pefabloc and PMFS added fresh at time
Laemmli Buffer (4 x reducing sample buffer)
1 M Tris-HCl, pH  6.8 2.5ml
20% SDS 2ml
Glycerol 4ml
Bromophenol blue 0.042g
Beta mercaptoethanol 2ml
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\ppendix  II
A P P E N D IX  II 
List o f A ntibodies
Table II.1: Primary antibodies used in FACS analysis
Antibody Clone Concentration Dilution Source
Anti-E-cadherin HECD-1
“Mouse”
1.8 mg/ml 1:200 M.Takeichi
Anti-al integrin FB12
“Mouse”
1 mg/ml 1:100 CHEMICON®
International
Anti-a2 integrin P1E6
“Mouse”
1 mg/ml 1:100 CHEMICON®
International
Anti-a3 integrin PIB5
“Mouse”
1 mg/ml 1:100 CHEMICON®
International
Anti-a4 integrin 7.2
“Mouse”
1.8 mg/ml 1:200 Made in-lab by 
J.F.Marshall
And-a5 integrin P1D6
“Mouse”
1 mg/ml 1:100 CHEMICON®
International
Anti-a6 integrin GoH3
“Rat”
1 mg/ml 1:100 SeroTec, Oxford, UK
Anti-a9 integrin Y9A8
“Mouse”
1 mg/ml 1:100 CHEMICON®
International
Anti-av integrin L230
“Mouse”
1.8 mg/ml 1:200 ATCC, Middlesex, 
UK
Anti-[31 integrin AIIB2
“Rat”
0.5 mg/ml 1:50 DSHB, IA, UK
Anti-[34 integrin 3E1
“Mouse”
1 mg/ml 1:100 CHEMICON®
International
Anti-avJ33 integrin LM609
“Mouse”
1 mg/ml 1:100 CHEMICON®
International
Anti-av[35 integrin P1F6
“Mouse”
4.1 mg/ml 1:400 CHEMICON®
International
* DSHB= Developmental Studies Hybridoma Bank, the University of Iowa
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Table II.2: Primary antibodies used in indirect im munocytochemical staining
Antibody Clone Concentration Dilution Source
Anti-E-cadherin HECD-1
“Mouse”
1.8 mg/ml 1:200 M.Takeichi
Anti-(3-catenin 14
“Mouse”
250 pl/ml 1:100 BD Transduction 
Laboratories
Anti-y-catenin 15
“Mouse”
250 pl/ml 1:200 BD Transduction 
Laboratories
And-[34 integrin 7
“Mouse”
250 pi/ml 1:50 BD Transduction 
Laboratories
Anti-Raci 23A8
“Mouse”
1:50 Upstate Cell Signaling 
Solutions
Alexa Fluor ® 647 goat 
anti-mouse
Secodary
antibody
2 mg/ml 1:400 Molecular Probes
Cy 3-anti-mouse Secondary
Antibody
Stratech Scientific Ltd. 
Cambridgeshire,UK
Table II.3: Primary and secondary antibodies used in Western Blot analysis
Antibody Clone Molecular
Weight
Dilution Source
Anti-E-cadherin HECD-1
“Mouse”
120 kDa 1:500 M.Takeichi
Anti-N-cadherin 32
“Mouse”
130 kDa 1:500 BD Transduction 
Laboratories
Anti-P-cadherin 56
“Mouse”
120 kDa 1:250 BD Transduction 
Laboratories
Anti-desmoglein 62
“Mouse”
165 kDa 1:500 BD Transduction 
Laboratories
Anti-a-catenin 5
“Mouse”
102 kDa 1:250 BD Transduction 
Laboratories
Anti-(3-catenin 14
“Mouse”
92 kDa 1:500 BD Transduction 
Laboratories
Anti-y-catenin 15
“Mouse”
82 kDa 1:1000 BD Transduction 
Laboratories
Anti-p 120-catenin 98
“Mouse”
120 kDa 1:500 BD Transduction 
Laboratories
Anti-(3 4 integrin 7
“Mouse”
200 kDa 1:250 BD Transduction 
Laboratories
Anti-Involucrin SY5
“Mouse”
120 kDa 1:500 Abeam Ltd., 
Cambridge, UK
Anti-Cytokeratin 14 B429 50 kDa 1:100 Abeam Ltd.
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“Mouse”
Anti-Bcl-2 100
“Mouse”
26 kDa 1:500 Upstate Cell Signalling 
Solutions
And-Akt-1 2H10
“Mouse”
60 kDa 1:1000 Cell Signaling
Anti-phospho-Akt (Thr 
308) “Rabbit”
60 kDa 1:1000 Cell Signaling
Anti-ILK 3
“Mouse”
50 kDa 1:500 BD Transduction 
Laboratories
Anti-Raci 23A8
“Mouse”
24 kDa 1:500 Upstate Cell Signalling 
Solutions
Anti-Cdc42 3707
“Mouse”
24 kDa 1:250 CHEMICON®
International
Anti-(3-actin AC-15
“Mouse”
42 kDa 1:2000 Sigma-Aldrich
Heat shock protein 
“Hsc-70”
B-6
“Mouse”
70 kDa 1:2000 Santa Cruz 
Biotechnology, UK
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A P P E N D IX  III
1. E-cadherin sequencing primers
Primers were obtained from the Cancer Research UK Oligonucleotide Synthesis Laboratory 
at Clare Hall
Sequence M.W %GC Annealing
Temp.
E l GCGCCCGGGCTCGAGTCGGCGTCCCCGGCCAGCCATGG 11722 81.58% 80.6°C
E2 GCGCCCGGGCTCGAGGCATTTCCCAGCACATGGGTCTGG 12064 69.23% 76.0°C
E3 GACTGGGTTATTCCTCCCATCAGC 7342 54.17% 59.0°C
E4 GACTGGGTTATTCCTCCCATCAGC 7984 53.85% 61.0°C
E5 CCGGACACTGGTGCCATTTCCACTCG 7945 61.54% 64.2°C
E6 GCTTTGCTAATTCTGATTCTGCTGC 7667 44.00% 55.9°C
2. siGENOM E SMARTpool
siRNA oligonucleotides were provided as 4 duplexes, 5nmol each (Dharmacon RNA
technologies, Chicago, IL, USA)
siGENOM E duplex (1)
Sense sequence
G .G .A A A .G A .G .C .U .G .C A .G .G .U .G A A .U .U  
Antisense sequence
5’-P.U.U.C.A.C.C.U.G.C.A.G.C.U.C.U.U.U.C.C.U.U
siGENOM E duplex (2)
Sense sequence
G.A.GA.G.C.A.G.C.U.U.C.CAAA.U.C.A.U.U  
Antisense sequence
5’-P.U.G.A.U.U.U.G.G.A.A.G.C.U.G.C.U.C.U.C.U.U
siGENOM E duplex (3)
Sense sequence
C.GA.C.U.A.CA.C.UA.U.U.G.G.A.U.U.U.U.U  
Antisense sequence
5’-P.A.A.A.U.C.C.A.A.U.A.G.U.G.U.A,G.U.C.G.U.U
siGENOM E duplex (4)
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Sense sequence
C.A.G.A.A.G.A.U.G.U.G.G.A.U.G.A.G.U.U.U.U 
Antisense sequence
5’-PA.A.C.U.C.A.U.C.C.A.CA.U.C.U.U.C.U.G.U.U
Scrambled sequence 
Sense sequence
CA.G.C.G.A.C.U.A.C.A.C.C.A.A.U.A.G.dT.dT 
Antisense sequence 
U.C.U.A.U.U.G.G.U.G.U.A.G.U.C.G.C.U.G.dT.dT
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A P P E N D IX  IV  
R esults
1. Sequencing results
The nucleic acid sequence of the isolated E-cadherin gene was matched with the E-cadherin 
gene sequence template, obtained from EMBL/Genbank Data Libraries under the accession 
number Z13009, using sequence matching software, Lalign Query, supplied by the 
GeneStream network server (GeneStream network server IGH, Motpellier, France).
Point mutations, resulting from substitution of Cytosine (C) with Thymidine (T), were 
detected at two different locations:
a) Using E4 primer
1 3 3 0  1 3 4 0  135 0  1 3 6 0  1 3 7 0  1380
1 7 0 8 2 8  TGATGCTGATGCCCCCAATACCCCAGCGTGGGAGGCTGTATACACCATATTGAATGATGA
TGATGCTGATGCCCCCAATACCCCAGCGTGGGAGGCTGTATACACCATATTGAATGATGA 
160 170  180  190  20 0  2 10
1 3 9 0  14 0 0  141 0  / ^ 20 143 0  1440
1 7 0 8 2 8  TGGTGGACAATTTGTCGTCACCACAAATCCAGTG^/CAACGATGGCATTTTGAAAACAGC
t g g t g g a c a a t t t g t c g t c a c c a c a a a t c c a g t g A t J a c g a t g g c a t t t t g a a a a c a g c  
220 2 3 0  24 0  2 50  \ S  260  2 70
b) Using E6 primer
2 2 8 0  2 2 9 0  2 3 0 0  2 3 1 0  2 3 2 0  2 3 3 0
3 5 6 9 3 1  TGTTTCTTCGGAGGAGAGCGGTGGTCAAAGAGCCCTTACTGCCCCCAGAGGATGACACCC
TGTTTCTTCGGAGGAGAGCGGTGGTCAAAGAGCCCTTACTGCCCCCAGAGGATGACACCC 
560 570  580  590  600 610
2 3 4 0  Z ^ 50 2 3 6 0  2 3 7 0  2 3 8 0  2 3 9 0
3 5 6 9 3 1  GGGAC^/caTTTATTACTATGATGAAGAAGGAGGCGGAGAAGAGGACCAGGACTTTGACT
GGGAcdvrjTTTATTACTATGATGAAGAAGGAGGCGGAGAAGAGGACCAGGACTTTGACT 
620 V /  630 640 650 660 670
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2. Characterisation of H376P4 and IA2 transfected cell lines
a) Catenin profile
a-catemn 
(102 kDa)
P-actin 
(42 kDa)
P-catenin 
(92 kDa)
P-actin 
(42 kDa)
y-catenin 
(82 kDa)
P-actin 
(42 kDa)
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b) N-cadherin profile
-a
■'S'caoi'~-
f O
N-cadherin  
(130 kDa)
H sc-70  
(70 kDa)
c) Invasion Assay
■  H376 (34 E-cadherin 
□  H376 (34 antisense
■  IA2 E-cadherin 
□  IA2 antisense
20000 n
15000
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t
I
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309
In
teg
rin
 
Le
ve
l 
(M
FI
) 
In
teg
rin
 
Le
ve
l 
(M
FI
)
A ppendix IV
d) Integrin profile
H37604 E-Cadherin
1000
100 -
al a2 a3 a4 a5 a6 a9 av pi P4 avP3 avP5
0.1 J Integrin Subunits
10000
H376P4 antiense
1000
100
10
al a2 a3 a4 a5 a6 a9 av pi P4 avP3 avp5
Integrin Subunits
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d) Integrin profile (Cont.)
1000
100
IA2 E-Cadherin
—
n r
al a2 a3 a4 a5 a6 a9 av pi P4 avP3 avP5
Integrin Subunits
IA2 antisense
1000
100
10
i— — r
al a2 a3 a4 a5 a6 a9 av pi p4
_j j |
avP3 avP5
0.1
Integrin Subunits
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3. 3-D presentation of E-cadherin-dependent-cell-cell junctions in H376 E- 
cadherin and H37604 E-cadherin OSCC cell lines
See attached CD
312
REFERENCES
Aberle, H., Butz, S., Stappert, J., Weissig, H., Kemler, R. and Hoschuetzky, H. (1994). 
Assembly of the cadherin-catenin complex in vitro with recombinant proteins. J  Cell 
Sri, 107, 3655-63.
Adams, C.L. and Nelson, W.J. (1998). Cytomechanics o f cadherin-mediated cell-cell 
adhesion. Curr Opin Cell Biol, 10, 572-7.
Adams, J.C. and Watt, F.M. (1990). Changes in keratinocyte adhesion during terminal 
differentiation: reduction in fibronectin binding precedes alpha 5 beta 1 integrin loss 
from the cell surface. Cell, 63, 425-35.
Adams, J.C. and Watt, F.M. (1991). Expression of beta 1, beta 3, beta 4, and beta 5 integrins 
by human epidermal keratinocytes and non-differentiating keratinocytes. J  Cell Biol, 
115, 829-41.
Adams, J.C. and Watt, F.M. (1993). Regulation of development and differentiation by the 
extracellular matrix. Development, 117, 1183-98.
Adams, J.M. and Cory, S. (2001). Life-or-death decisions by the Bcl-2 protein family. Trends 
Biochem Sri, 26, 61-6.
Agrez M., Chen A., Cone R.I., Pytela R., Sheppard D. (1994). The alpha v beta 6 integrin 
promotes proliferation o f colon carcinoma cells through a unique region o f the beta 
6 cytoplasmic domain. J  Cell Biol, 127, 547-56.
Agrez M.V., Bates R.C., Mitchell D., Wilson N., Ferguson N., Anseline P., Sheppard D. 
(1996). Multiplicity of fibronectin-binding alpha v integrin receptor in colorectal 
cancer. Br J  Cancer, 73, 887-92.
Albelda S.M., Mette S.A., Elder D.E., Stewart R., Damjannovich L., Herlyn M., Buck C.A. 
(1900). Integrin distribution in malignant melanoma: association o f the beta 3 subunit 
with tumor progression. Cancer Res., 50, 6757-64.
Alessi, D.R., Andjelkovic, M., Caudwell, B., Cron, P., Morrice, N., Cohen, P. and Hemmings, 
B.A. (1996). Mechanism of activation o f protein kinase B by insulin and IGF-1. Embo 
J, 15, 6541-51.
Allard, W.F., DeVol, E.B. and Te, O.B. (1999). Smokeless tobacco (shamma) and oral cancer 
in Saudi Arabia. Community Dent Oral Epidemiol, 27, 398-405.
Allen, M.V., Smith, G.J., Juliano, R., Maygarden, S.J. and Mohler, J.L. (1998). 
Downregulation o f the beta4 integrin subunit in prostatic carcinoma and prostatic 
intraepithelial neoplasia. Hum Pathol, 29, 311-8.
American Cancer Society (A.C.S.) (2005). Cancer Facts and Figures.
<http://w w w .cancer.org/docroot/STT/ stt O.asp >. ACS Inc.: Atlanta, GA, USA.
Anastasiadis, P.Z. and Reynolds, A.B. (2001). Regulation o f Rho GTPases by pl20-catenin. 
Curr Opin Cell Biol, 13, 604-10.
Andre, F., Rigot, V., Thimonier, J., Montixi, C., Parat, F., Pommier, G., Marvaldi, J. and Luis, 
J. (1999). Integrins and E-cadherin cooperate with IGF-I to induce migration of 
epithelial colonic cells. Int J  Cancer, 83, 497-505.
Andrews, N.A., Jones, A.S., Helliwell, T.R. and Kinsella, A.R. (1997). Expression o f the E- 
cadherin-catenin cell adhesion complex in primary squamous cell carcinomas o f the 
head and neck and their nodal metastases. Br J  Cancer, 75, 1474-80.
Angst, B.D., Marcozzi, C. and Magee, A.I. (2001). The cadherin superfamily. J  Cell Sri, 114, 
629-41.
313
Aoki, J., Umeda, M., Takio, K., Titani, K., Utsumi, H., Sasaki, M. and Inoue, K. (1991). 
Neural cell adhesion molecule mediates contact-dependent inhibition o f growth of 
near-diploid mouse fibroblast cell line m 5S/ 1M. J  Cell Biol, 115, 1751-61.
Aplin, A.E., Howe, A.K. and Juliano, R.L. (1999). Cell adhesion molecules, signal 
transduction and cell growth. Curr Opin Cell Biol,’ 11, 737-44.
Arora, S., Matta, A., Shukla, N.K., Deo, S.V. and Ralhan, R. (2005). Identification of 
differentially expressed genes in oral squamous cell carcinoma. Mol Carcinog, 42, 97- 
108.
Assoian, R.K. (1997). Anchorage-dependent cell cycle progression./ Cell Biol, 136, 1-4.
Attwell, S., Roskelley, C. and Dedhar, S. (2000). The integrin-linked kinase (ILK) suppresses 
anoikis. Oncogene, 19, 3811-5.
Aviezer, D., Hecht, D., Safran, M., Eisinger, M., David, G. and Yayon, A. (1994). Perlecan, 
basal lamina proteoglycan, promotes basic fibroblast growth factor-receptor binding, 
mitogenesis, and angiogenesis. Cell, 79, 1005-13.
Badaracco, G., Venuti, A., Bartolazzi, A., Morello, R., Marzetti, F. and Marcante, M.L. 
(2000). Overexpression o f p53 and bcl-2 proteins and the presence o f HPV infection 
are independent events in head and neck cancer. J  Oral Pathol Med, 29, 173-9.
Bagutti, C., Speight, P.M. and Watt, F.M. (1998). Comparison o f integrin, cadherin, and 
catenin expression in squamous cell carcinomas o f the oral cavity. J  Pathol, 186, 8-16.
Bankfalvi, A., Krassort, M., Buchwalow, I.B., Vegh, A., Felszeghy, E. and Piffko, J. (2002). 
Gains and losses o f adhesion molecules (CD44, E-cadherin, and beta-catenin) during 
oral carcinogenesis and tumour progression. J  Pathol, 198, 343-51.
Bankfalvi, A. and Piffko, J. (2000). Prognostic and predictive factors in oral cancer: the role 
o f the invasive tumour front. J  Oral Pathol Med, 29, 291-8.
Banks-Schlegel, S. and Green, H. (1981). Involucrin synthesis and tissue assembly by 
keratinocytes in natural and cultured human epithelia. J  Cell Biol, 90, 732-7.
Barrandon, Y. and Green, H. (1985). Cell size as a determinant o f the clone-forming ability 
of human keratinocytes. Proc N atl Acad Sci U S A ,  82, 5390-4.
Barth, A.I., Nathke, I.S. and Nelson, W.J. (1997). Cadherins, catenins and APC protein: 
interplay between cytoskeletal complexes and signaling pathways. Curr Opin Cell Biol, 
9, 683-90.
Batlle, E., Sancho, E., Franci, C., Dominguez, D., Monfar, M., Baulida, J. and Garcia De 
Herreros, A. (2000). The transcription factor snail is a repressor o f E-cadherin gene 
expression in epithelial tumour cells. N at Cell Biol, 2, 84-9.
Behrens, J. (1999). Cadherins and catenins: role in signal transduction and tumor
progression. Cancer Metastasis Rep, 18, 15-30.
Behrens, J., Mareel, M.M., Van Roy, F.M. and Birchmeier, W. (1989). Dissecting tumor cell 
invasion: epithelial cells acquire invasive properties after the loss of uvomorulin-
mediated cell-cell adhesion. J  Cell Biol, 108, 2435-47.
Behrens, J., Vakaet, L., Friis, R., Winterhager, E., Van Roy, F., Mareel, M.M. and Birchmeier, 
W. (1993). Loss o f epithelial differentiation and gain of invasiveness correlates with 
tyrosine phosphorylation of the E-cadherin/beta-catenin complex in cells 
transformed with a temperature-sensitive v-SRC gene. J  Cell Biol, 120, 757-66.
Bellacosa, A., de Feo, D., Godwin, A.K., Bell, D.W., Cheng, J.Q., Altomare, D.A., Wan, M., 
Dubeau, L., Scambia, G., Masciullo, V. and et al. (1995). Molecular alterations of the 
AKT2 oncogene in ovarian and breast carcinomas. Int J  Cancer, 64, 280-5.
Ben-Ze'ev, A. and Geiger, B. (1998). Differential molecular interactions of beta-catenin and 
plakoglobin in adhesion, signaling and cancer. Curr Opin Cell Biol, 10, 629-39.
314
Berx, G., Cleton-Jansen, A.M., Nollet, F., de Leeuw, W.J., van de Vijver, M., Comelisse, C. 
and van Roy, F. (1995). E-cadherin is a tumour /invasion suppressor gene mutated in 
human lobular breast cancers. Embo J , 14, 6107-15.
Berx, G., Nollet, F. and van Roy, F. (1998). Dysregulation of the E-cadherin/catenin 
complex by irreversible mutations in human carcinomas. Cell Adhes Commun, 6, 171- 
84.
Berx, G. and Van Roy, F. (2001). The E-cadherin/catenin complex: an important gatekeeper 
in breast cancer tumorigenesis and malignant progression. Breast Cancer Res, 3, 289-93. 
Epub 2001 Jun 28.
Birchmeier, W. and Behrens, J. (1994). Cadherin expression in carcinomas: role in the 
formation o f cell junctions and the prevention of invasiveness. Biochim Biophys Acta, 
1198, 11-26.
Bishop, A.L. and Hall, A. (2000). Rho GTPases and their effector proteins. Biochem J, 348, 
241-55.
Bissell, M.J. and Radisky, D. (2001). Putting tumours in context. N at Rev Cancer, 1, 46-54.
Bonkhoff, H. (1998). Analytical molecular pathology o f epithelial-stromal interactions in the 
normal and neoplastic prostate. A nal Quant Cytol Histol', 20, 437-42.
Borradori, L. and Sonnenberg, A. (1996). Hemidesmosomes: roles in adhesion, signaling and 
human diseases. Curr Opin Cell Biol.’ 8, 647-56.
Borradori, L. and Sonnenberg, A. (1999). Structure and function of hemidesmosomes: more 
than simple adhesion complexes. J  Invest Dermatol,’ 112, 411-8.
Bossy, B., Bossy-Wetzel, E. and Reichardt, L.F. (1991). Characterization o f the integrin alpha 
8 subunit: a new integrin beta 1-associated subunit, which is prominently expressed 
on axons and on cells in contact with basal laminae in chick embryos. Embo J , 10, 
2375-85.
Bowie, G.L., Caslin, A.W., Roland, N.J., Field, J.K., Jones, A.S. and Kinsella, A.R. (1993). 
Expression o f the cell-cell adhesion molecule E-cadherin in squamous cell carcinoma 
of the head and neck. Clin Otolaryngol Allied Sci, 18, 196-201.
Boyer, B., Valles, A.M. and Edme, N. (2000). Induction and regulation o f epithelial- 
mesenchymal transitions. Biochem Pharmacol', 60,1091-9.
Brabletz, T., Jung, A., Dag, S., Reu, S. and Kirchner, T. (2000). [beta-Catenin induces 
invasive growth by activating matrix metalloproteinases in colorectal carcinoma]. 
Verb Dtsch Ges Pathol, 84, 175-81.
Brady-Kalnay, S.M., Rimm, D.L. and Tonks, N.K. (1995). Receptor protein tyrosine 
phosphatase PTPmu associates with cadherins and catenins in vivo. J  Cell Biol’ 130, 
977-86.
Braga, V. (2000). Epithelial cell shape: cadherins and small GTPases. E xp Cell Res, 261, 83- 
90.
Braga, V.M. (1999). Small GTPases and regulation o f cadherin dependent cell-cell adhesion. 
Mol Pathol, 52, 197-202.
Braga, V.M. (2002). Cell-cell adhesion and signalling. Curr Opin Cell Biol, 14, 546-56.
Braga, V.M., Del Maschio, A., Machesky, L. and Dejana, E. (1999). Regulation o f cadherin 
function by Rho and Rac: modulation by junction maturation and cellular context. 
Mol Biol Cell’ 10, 9-22.
Braga, V.M., Machesky, L.M., Hall, A. and Hotchin, N.A. (1997). The small GTPases Rho 
and Rac are required for the establishment of cadherin-dependent cell-cell contacts. J  
Cell Biol, 137, 1421-31.
Brazil, D.P., Park, J. and Hemmings, B.A. (2002). PKB binding proteins. Getting in on the 
Akt. Cell, 111, 293-303.
315
Bremnes, R.M., Veve, R., Hirsch, F.R. and Franklin, W.A. (2002). The E-cadherin cell-cell 
adhesion complex and lung cancer invasion, metastasis, and prognosis. Lung Cancer, 
36, 115-24.
Breuss, J.M., Gallo, J., DeLisser, H.M., Klimanskaya, I.V., Folkesson, H.G., Pittet, J.F., 
Nishimura, S.L., Aldape, K., Landers, D.V., Carpenter, W. and et al. (1995). 
Expression o f the beta 6 integrin subunit in development, neoplasia and tissue repair 
suggests a role in epithelial remodeling. /  Cell Sri, 108, 2241-51.
Briggaman, R.A. and Wheeler, C.E., Jr. (1975). The epidermal-dermal junction. J  Invest 
Dermatol, 65, 71-84.
Bringuier, P.P., Umbas, R., Schaafsma, H.E., Karthaus, H.F., Debruyne, F.M. and Schalken, 
J.A. (1993). Decreased E-cadherin immunoreactivity correlates with poor survival in 
patients with bladder tumors. Cancer Res, 53, 3241-5.
Brognard, J., Clark, A.S., Ni, Y. and Dennis, P.A. (2001). A kt/protein kinase B is 
constitutively active in non-small cell lung cancer cells and promotes cellular survival 
and resistance to chemotherapy and radiation. Cancer Res, 61, 3986-97.
Brown, T.A. (2000). Preservation o f stock cultures. In Essential Molecular Biology, Brown, T.A. 
(ed) pp. 40-42. Oxford University Press: Oxford, UK.
Bryne, M., Boysen, M., Alfsen, C.G., Abeler, V.M., Sudbo, J., Nesland, J.M., Kdstensen, 
G.B., Piffko, J. and Bankfalvi, A. (1998). The invasive front o f carcinomas. The most 
important area for tumour prognosis? Anticancer Res, 18, 4757-64.
Bullions, L.C., Notterman, D.A., Chung, L.S. and Levine, A.J. (1997). Expression of wild- 
type alpha-catenin protein in cells with a mutant alpha-catenin gene restores both 
growth regulation and tumor suppressor activities. M ol Cell Biol, 17, 4501-8.
Bursch, W., Kleine, L. and Tenniswood, M. (1990). The biochemistry o f cell death by 
apoptosis. Biochem Cell Biol, 68, 1071-4.
Busk, M., Pytela, R. and Sheppard, D. (1992). Characterization o f the integrin alpha v beta 6 
as a fibronectin-binding protein. J  Biol Chem, 267, 5790-6.
Butz, S. and Kemler, R. (1994). Distinct cadherin-catenin complexes in Ca(2+)-dependent 
cell-cell adhesion. FEBS Lett, 355, 195-200.
Cano, A., Perez-Moreno, M.A., Rodrigo, I., Locascio, A., Blanco, M.J., del Barrio, M.G., 
Portillo, F. and Nieto, M.A. (2000). The transcription factor snail controls epithelial- 
mesenchymal transitions by repressing E-cadherin expression. N at Cell Biol, 2, 76-83.
Cantley, L.C. (2002). The phosphoinositide 3-kinase pathway. Science, 296, 1655-7.
Carey, T.E., Laurikainen, L., Nair, T.S., Reinke, T.S., Coling, D.E., Wolf, G.T., Van Waes, C., 
Liebert, M. and Marcelo, C. (1992). Regulation of expression and phosphorylation of 
A9/alpha 6 beta 4 integrin in normal and neoplastic keratinocytes. J  N atl Cancer Inst 
Monogr, 75-86.
Carico, E., French, D., Bucci, B., Falcioni, R., Vecchione, A. and Mariani-Costantini, R. 
(1993). Integrin beta 4 expression in the neoplastic progression o f cervical 
epithelium. Gynecol Oncol, 49, 61-6.
Carr, R.J. and Langdon, J.D. (1989). Multiple primaries in mouth cancer—the price of 
success. Br J  Oral Maxillofac Surg, 27, 394-9.
Carson, D.A. and Ribeiro, J.M. (1993). Apoptosis and disease. Lancet, 341, 1251-4.
Carter, W.G., Ryan, M.C. and Gahr, P.J. (1991). Epiligrin, a new cell adhesion ligand for 
integrin alpha 3 beta 1 in epithelial basement membranes. Cell, 65, 599-610.
Carter, W.G., Wayner, E.A., Bouchard, T.S. and Kaur, P. (1990). The role of integrins alpha 
2 beta 1 and alpha 3 beta 1 in cell-cell and cell-substrate adhesion o f human 
epidermal cells. J  Cell Biol, 110, 1387-404.
316
CavaUaro, U. and Chnstofori, G. (2004). Cell adhesion and signalling  by cadherins and Ig- 
CAMs in cancer. N at Rev Cancer, 4, 118-32.
Chang, H.W., Chow, V., Lam, K.Y., Wei, W.I. and Yuen, A. (2002). Loss o f E-cadherin 
expression resulting from promoter hypermethylation in oral tongue carcinoma and 
its prognostic significance. Cancer, 94, 386-92.
Charous, S.J., Stricklin, G.P., Nanney, L.B., Netterville, J.L. and Burkey, B.B. (1997). 
Expression o f matrix metalloproteinases and tissue inhibitor o f metalloproteinases in 
head and neck squamous cell carcinoma. A nn Otol RJoinol Earyngol, 106, 271-8.
Chen, C.S., Mrksich, M., Huang, S., Whitesides, G.M. and Ingber, D.E. (1997). Geometric
control o f cell life and death. Science, 276, 1425-8.
Chen, M.L., Yan, L.X. and Yu, G.Y. (2000). [Expression of P53, bcl-2 protein and
proliferating cell nuclear antigen in cutaneous squamous cell carcinoma]. Hunan Y i Ke
Da Xue Xue Bao, 25, 513-4.
Chen, Q., Lipkina, G., Song, Q. and Kramer, R.H. (2004). Promoter methylation regulates 
cadherin switching in squamous cell carcinoma. Biochem Biophys Res Commun, 315, 850- 
6 .
Chen, W.C. and Obrink, B. (1991). Cell-cell contacts mediated by E-cadherin (uvomorulin) 
restrict invasive behavior o f L-cells .J  Cell Biol, 114, 319-27.
Cheng, L.H. and Hudson, J. (2002). Ultrastructural changes in malignant transformation of 
oral mucosa. Br J  Oral Maxillofac Surg, 40, 207-12.
Chiquet-Ehrismann, R. (1991). Anti-adhesive molecules o f the extracellular matrix. Curr Opin 
Cell Biol, 3, 800-4.
Chitaev, N.A. and Troyanovsky, S.M. (1998). Adhesive but not lateral E-cadherin complexes 
require calcium and catenins for their formation. J  Cell Biol, 142, 837-46.
Christofori, G. (2003). Changing neighbours, changing behaviour: cell adhesion molecule- 
mediated signalling during tumour progression. Embo J, 22, 2318-23.
Christofori, G. and Semb, H. (1999). The role o f the cell-adhesion molecule E-cadherin as a 
tumour-suppressor gene. Trends Biochem Sci, 24, 73-6.
Clark, E.A. and Brugge, J.S. (1995). Integrins and signal transduction pathways: the road 
taken. Science, 268, 233-9.
Collins, J.E., Legan, P.K., Kenny, T.P., MacGarvie, J., Holton, J.L. and Garrod, D.R. (1991). 
Cloning and sequence analysis o f desmosomal glycoproteins 2 and 3 (desmocollins): 
cadherin-like desmosomal adhesion molecules with heterogeneous cytoplasmic 
domains. J  Cell Biol, 113, 381-91.
Comijn, J., Berx, G., Vermassen, P., Verschueren, K., van Grunsven, L., Bruyneel, E., 
Mareel, M., Huylebroeck, D. and van Roy, F. (2001). The two-handed E  box binding 
zinc finger protein SIP1 downregulates E-cadherin and induces invasion. Mol Cell, 7, 
1267-78.
Conacci-Sorrell, M., Zhurinsky, J. and Ben-Ze'ev, A. (2002). The cadherin-catenin adhesion 
system in signaling and cancer .J  Clin Invest, 109, 987-91.
Coppolino, M.G. and Dedhar, S. (2000). Bi-directional signal transduction by integrin 
receptors. Int J  Biochem Cell Biol, 32, 171-88.
Cortesina, G., Sacchi, M., Bussi, M., Panizzut, B., Ferro, S., Carlevato, M.T. and Marchisio, 
P.C. (1995). Integrin expression in head and neck cancers. Acta Otolaryngol, 115, 328- 
30.
Cos, S., Fernandez, R., Guezmes, A. and Sanchez-Barcelo, E.J. (1998). Influence of 
melatonin on invasive and metastatic properties of MCF-7 human breast cancer cells. 
Cancer Res, 58, 4383-90.
317
Cress, A.E., Rabinovitz, I., Zhu, W. and Nagle, R.B. (1995). The alpha 6 beta 1 and alpha 6 
beta 4 integrins in human prostate cancer progression. Cancer Metastasis Rev, 14, 219- 
28.
Cukierman, E., Pankov, R., Stevens, D.R. and Yamada, K.M. (2001). Taking cell-matrix 
adhesions to the third dimension. Science, 294, 1708-12.
Cukierman, E., Pankov, R. and Yamada, K.M. (2002). Cell interactions with three- 
dimensional matrices. Curr Opin Cell Biol\ 14, 633-9.
Dahlback, K., Lofberg, H., Alumets, J. and Dahlback, B. (1989). Immunohistochemical 
demonstration o f age-related deposition of vitronectin (S-protein o f complement) 
and terminal complement complex on dermal elastic fibers. J  Invest Dermatol’ 92, 727- 
33.
Datta, S.R., Brunet, A. and Greenberg, M.E. (1999). Cellular survival: a play in three Akts. 
Genes Dev, 13, 2905-27.
Day, M.L., Zhao, X., Vallorosi, C.J., Putzi, M., Powell, C.T., Lin, C. and Day, K.C. (1999). E- 
cadherin mediates aggregation-dependent survival o f prostate and mammary 
epithelial cells through the retinoblastoma cell cycle control pathway. J  Biol Chem, 
274, 9656-64.
De Luca, M., Tamura, R.N., Kajiji, S., Bondanza, S., Rossino, P., Cancedda, R., Marchisio, 
P.C. and Quaranta, V. (1990). Polarized integrin mediates human keratinocyte 
adhesion to basal lamina. Proc N atl Acad Sci U S A ,  87, 6888-92.
Dean, M. (1998). Cancer as a complex developmental disorder—nineteenth Cornelius P. 
Rhoads Memorial Award Lecture. Cancer Res, 58, 5633-6.
Dedhar, S., Williams, B. and Hannigan, G. (1999). Integrin-linked kinase (ILK): a regulator of 
integrin and growth-factor signalling. Trends Cell Biol, 9, 319-23.
Delcommenne, M., Tan, C., Gray, V., Rue, L., Woodgett, J. and Dedhar, S. (1998). 
Phosphoinositide-3-OH kinase-dependent regulation o f glycogen synthase kinase 3 
and protein kinase B /A K T by the integrin-linked kinase. Proc N atl Acad Sci U S A ,  
95,11211-6.
Dimanche-Boitrel, M.T., Genne, P., Duchamp, O. and Chauffert, B. (1994). Confluence 
dependent resistance (CDR) to doxorubicin and E-cadherin expression in murine 
mammary cells. Cancer Lett, 85,171-6.
Dorudi, S., Sheffield, J.P., Poulsom, R., Northover, J.M. and Hart, I.R. (1993). E-cadherin 
expression in colorectal cancer. An immunocytochemical and in situ hybridization 
study. A m  J  Pathol, 142, 981-6.
Downer, C.S. and Speight, P.M. (1993). E-cadherin expression in normal, hyperplastic and 
malignant oral epithelium. Eur J  Cancer B Oral Oncol, 29B, 303-5.
Downer, C.S., Watt, F.M. and Speight, P.M. (1993). Loss o f alpha 6 and beta 4 integrin 
subunits coincides with loss o f basement membrane components in oral squamous 
cell carcinomas. J  Pathol, 171, 183-90.
Eaton, S., Wepf, R. and Simons, K. (1996). Roles for Racl and Cdc42 in planar polarization 
and hair outgrowth in the wing of Drosophila. J  Cell Biol, 135, 1277-89.
Edelman, G.M., Gallin, W.J., Delouvee, A., Cunningham, B.A. and Thiery, J.P. (1983). Early 
epochal maps of two different cell adhesion molecules. Proc N atl Acad Sci U S A ,  80, 
4384-8.
Elias, P.M. and Menon, G.K. (1991). Structural and lipid biochemical correlates of the 
epidermal permeability barrier. A dv Lipid Res, 24, 1-26.
Engers, R., Springer, E., Michiels, F., Collard, J.G. and Gabbert, H.E. (2001). Rac affects 
invasion o f human renal cell carcinomas by up-regulating tissue inhibitor of
318
metalloproteinases (TIMP)-1 and TIMP-2 expression. J  Biol Chem, 276, 41889-97. 
Epub 2001 Sep 10.
Erickson, A.C. and Couchman, J.R. (2000). Still more complexity in mammalian basement 
membranes. /  Histochem Cytochem, 48, 1291-306.
Etienne-Manneville, S. and Hall, A. (2002). Rho GTPases in cell biology. Nature, 420, 629-35.
Felding-Habermann, B., Mueller, B.M., Romerdahl, C.A. and Cheresh, D.A. (1992). 
Involvement o f integrin alpha V gene expression in human melanoma 
tumorigenicity. J  Clin Invest, 89, 2018-22.
Fleckman, P., Dale, B.A. and Holbrook, K.A. (1985). Profilaggrin, a high-molecular-weight 
precursor o f filaggrin in human epidermis and cultured keratinocytes. J  Invest 
Dermatol’ 85, 507-12.
Fleischmajer, R. and Timpl, R. (1984). Ultrastructural localization of fibronectin to different 
anatomic structures of human skin. J  Histochem Cytochem, 32, 315-21.
Fleming, T.P., Javed, Q. and Hay, M. (1992). Epithelial differentiation and intercellular 
junction formation in the mouse early embryo. Dev Supply 105-12.
Fleming, T.P., Papenbrock, T., Fesenko, I., Hausen, P. and Sheth, B. (2000). Assembly of 
tight junctions during early vertebrate development. Semin Cell Dev Biol' 11, 291-9.
Fouquet, S., Lugo-Martinez, V.H., Faussat, A.M., Renaud, F., Cardot, P., Chambaz, J., 
Pincon-Raymond, M. and Thenet, S. (2004). Early loss of E-cadherin from cell-cell 
contacts is involved in the onset o f Anoikis in enterocytes. J  Biol Chem, 279, 43061-9. 
Epub 2004 Aug 2.
Fricke, E., Hermannstadter, C., Keller, G., Fuchs, M., Brunner, I., Busch, R., Hofler, H., 
Becker, K.F. and Luber, B. (2004). Effect o f wild-type and mutant E-cadherin on cell 
proliferation and responsiveness to the chemotherapeutic agents cisplatin, etoposide, 
and 5-fluorouracil. Oncology, 66, 150-9.
Friedrich, E.B., Liu, E., Sinha, S., Cook, S., Milstone, D.S., MacRae, C.A., Mariotti, M., 
Kuhlencordt, P.J., Force, T., Rosenzweig, A., St-Amaud, R., Dedhar, S. and 
Gerszten, R.E. (2004). Integrin-linked kinase regulates endothelial cell survival and 
vascular development. Mol Cell Biol, 24, 8134-44.
Frisch, S.M. and Francis, H. (1994). Disruption of epithelial cell-matrix interactions induces 
apoptosis. J  Cell Biol\ 124, 619-26.
Frisch, S.M. and Screaton, R.A. (2001). Anoikis mechanisms. Curr Opin Cell Biol, 13, 555-62.
Frixen, U.H., Behrens, J., Sachs, M., Eberle, G., Voss, B., Warda, A., Lochner, D. and 
Birchmeier, W. (1991). E-cadhenn-mediated cell-cell adhesion prevents invasiveness 
of human carcinoma cells. /  Cell Biol’ 113, 173-85.
Fuchs, E. (1990). Epidermal differentiation: the bare essential./ Cell Biol, 6, 2807-14.
Fuchs, E., Dowling, J., Segre, J., Lo, S.H. and Yu, Q.C. (1997). Integrators o f epidermal 
growth and differentiation: distinct functions for beta 1 and beta 4 integrins. Curr 
Opin Genet Dev, 7, 672-82.
Fujita, Y., Krause, G., Scheffner, M., Zechner, D., Leddy, H.E., Behrens, J., Sommer, T. and 
Birchmeier, W. (2002). Hakai, a c-Cbl-like protein, ubiquitinates and induces 
endocytosis o f the E-cadherin complex. N at Cell Biol, 4, 222-31.
Fukata, M. and Kaibuchi, K. (2001). Rho-family GTPases in cadherin-mediated cell-cell 
adhesion. N at Rev Mol Cell Biol’ 2, 887-97.
Fukata, M., Kuroda, S., Nakagawa, M., Kawajiri, A., Itoh, N., Shoji, I., Matsuura, Y., 
Yonehara, S., Fujisawa, H., Kikuchi, A. and Kaibuchi, K. (1999a). Cdc42 and Racl 
regulate the interaction o f IQGAP1 with beta-catenin. J  Biol Chem, 274, 26044-50.
Fukata, M., Nakagawa, M., Kuroda, S. and Kaibuchi, K. (1999b). Cell adhesion and Rho 
small GTPases. J  Cell Sci, 112, 4491-500.
319
Fukuda, T., Chen, K., Shi, X. and Wu, C. (2003). PINCH-1 is an obligate partner o f integrin- 
linked kinase (ILK) functioning in cell shape modulation, motility, and survival. J  Biol 
Chem, 278, 51324-33. Epub 2003 Oct 8.
Fukuyama, R. and Shimizu, N. (1991). Detection of epidermal growth factor receptors and 
E-cadherins in the basolateral membrane of A431 cells by laser scanning fluorescence 
microscopy. Jpn J  Cancer Res, 82, 8-11.
Fusenig, N.E., Breitkreutz, D., Dzarlieva, R.T., Boukamp, P., Bohnert, A. and Tilgen, W. 
(1983). Growth and differentiation characteristics of transformed keratinocytes from 
mouse and human skin in vitro and in vivo. J  Invest Dermatol’ 81, 168s-75s.
Fusenig, N.E., Limat, A., Stark, H.J. and Breitkreutz, D. (1994). Modulation o f the 
differentiated phenotype o f keratinocytes o f the hair follicle and from epidermis. J  
Dermatol Sci, 7, SI42-51.
Gage, J.P., Francis, M.J.O., Triffitt, J. T. (1989). Periodontal ligament, gingiva and oral 
mucosa. In Collagen and Dental Matrices,]. P. Gage, M.J.O.F.a.J.T.W. (ed) pp. 91-116: 
London.
Gagnoux-Palacios, L., Gache, Y., Ortonne, J.P. and Meneguzzi, G. (1997). Hemidesmosome 
assembly assessed by expression o f a wild-type integrin beta 4 cDNA in junctional 
epidermolysis bullosa keratinocytes. Dab Invest, 77, 459-68.
Galvin, S., Loomis, C., Manabe, M., Dhouailly, D. and Sun, T.T. (1989). The major pathways 
o f keratinocyte differentiation as defined by keratin expression: an overview. Adv 
Dermatol, 4, 277-99; discussion 300.
Garzino-Demo, P., Carrozzo, M., Trusolino, L., Savoia, P., Gandolfo, S. and Marchisio, P.C.
(1998). Altered expression o f alpha 6 integrin subunit in oral squamous cell 
carcinoma and oral potentially malignant lesions. Oral Oncol, 34, 204-10.
Geuijen, C.A. and Sonnenberg, A. (2002). Dynamics o f the alpha6beta4 integrin in 
keratinocytes. Mol Biol Cell, 13, 3845-58.
Ghosh, S., Munshi, H.G., Sen, R., Linz-McGillem, L.A., Goldman, R.D., Lorch, J., Green, 
K.J., Jones, J.C. and Stack, M.S. (2002). Loss o f adhesion-regulated proteinase 
production is correlated with invasive activity in oral squamous cell carcinoma. 
Cancer, 95, 2524-33.
Giancotti, F.G. and Ruoslahti, E. (1990). Elevated levels o f the alpha 5 beta 1 fibronectin 
receptor suppress the transformed phenotype o f Chinese hamster ovary cells. Cell, 
60, 849-59.
Giancotti, F.G., Stepp, M.A., Suzuki, S., Engvall, E. and Ruoslahti, E. (1992). Proteolytic 
processing o f endogenous and recombinant beta 4 integrin subunit. J  Cell Biol, 118, 
951-9.
Gomez, M., Navarro, P., Quintanilla, M. and Cano, A. (1992). Expression o f alpha 6 beta 4 
integrin increases during malignant conversion of mouse epidermal keratinocytes: 
association of beta 4 subunit to the cytokeratin fraction. Exp Cell Res, 201, 250-61.
Gonzalez, A.M., Otey, C., Edlund, M. and Jones, J.C. (2001). Interactions of a 
hemidesmosome component and actinin family members. J  Cell Sci, 114, 4197-206.
Gottardi, C.J., Wong, E. and Gumbiner, B.M. (2001). E-cadherin suppresses cellular 
transformation by inhibiting beta-catenin signaling in an adhesion-independent 
manner. J  Cell Biol, 153, 1049-60.
Graff, J.R., Gabrielson, E., Fujii, H., Baylin, S.B. and Herman, J.G. (2000). Methylation 
patterns o f the E-cadherin 5' CpG island are unstable and reflect the dynamic, 
heterogeneous loss o f E-cadherin expression during metastatic progression. J  Biol 
Chem, 275, 2727-32.
320
Gray, S.T., Wilkins, R.J. and Yun, K. (1992). Interstitial collagenase gene expression in oral 
squamous cell carcinoma. A m  J  Pathol, 141, 301-6.
Green, K.J., Bohringer, M., Gocken, T. and Jones, J.C. (2005). Intermediate filament 
associated proteins. A dv Protein Chem, 70,143-202.
Green, S.K., Karlsson, M.C., Ravetch, J.V. and Kerbel, R.S. (2002). Disruption of cell-cell 
adhesion enhances antibody-dependent cellular cytotoxicity: implications for 
antibody-based therapeutics o f cancer. Cancer Res, 62, 6891-900.
Greenlee, R.T., Hill-Harmon, M.B., Murray, T. and Thun, M. (2001). Cancer statistics, 2001. 
CA Cancer J  Clin, 51,15-36.
Grille, S.J., Bellacosa, A., Upson, J., Klein-S2anto, A.J., van Roy, F., Lee-Kwon, W., 
Donowitz, M., Tsichlis, P.N. and Larue, L. (2003). The protein kinase Akt induces 
epithelial mesenchymal transition and promotes enhanced motility and invasiveness 
of squamous cell carcinoma lines. Cancer Res, 63, 2172-8.
Grinnell, F. (2003). Fibroblast biology in three-dimensional collagen matrices. Trends Cell Biol, 
13, 264-9.
Grosheva, I., Shtutman, M., Elbaum, M. and Bershadsky, A.D. (2001). p l20  catenin affects 
cell motility via modulation of activity of Rho-family GTPases: a link between cell­
cell contact formation and regulation o f cell locomotion .J  Cell Sci, 114, 695-707.
Grossmann, J. (2002). Molecular mechanisms of "detachment-induced apoptosis—Anoikis". 
Apoptosis, 7, 247-60.
Gudjonsson, T., Ronnov-Jessen, L., Villadsen, R., Rank, F., Bissell, M.J. and Petersen, O.W.
(2002). Normal and tumor-derived myoepithelial cells differ in their ability to interact 
with luminal breast epithelial cells for polarity and basement membrane deposition. J  
Cell Sci, 115, 39-50.
Guerrero, S., Casanova, I., Farre, L., Mazo, A., Capella, G. and Mangues, R. (2000). K-ras 
codon 12 mutation induces higher level of resistance to apoptosis and predisposition 
to anchorage-independent growth than codon 13 mutation or proto-oncogene 
overexpression. Cancer Res, 60, 6750-6.
Guilford, P. (1999). E-cadherin downregulation in cancer: fuel on the fire? Mol Med Today, 5, 
172-7.
Guilford, P., Hopkins, J., Harraway, J., McLeod, M., McLeod, N., Harawira, P., Taite, H., 
Scoular, R., Miller, A. and Reeve, A.E. (1998). E-cadherin germline mutations in 
familial gastric cancer. Nature, 392, 402-5.
Gumbiner, B.M. (1995). Signal transduction o f beta-catenin. Curr Opin Cell Biol, 7, 634-40.
Gumbiner, B.M. (1996). Cell adhesion: the molecular basis o f tissue architecture and 
morphogenesis. Cell, 84, 345-57.
Gumbiner, B.M. (2000). Regulation of cadherin adhesive activity. J  Cell Biol, 148, 399-404.
Guo, M., Kim, L.T., Akiyama, S.K., Gralnick, H.R., Yamada, K.M. and Grinnell, F. (1991). 
Altered processing of integrin receptors during keratinocyte activation. Exp Cell Res, 
195, 315-22.
Haapasalmi, K., Zhang, K., Tonnesen, M., Olerud, J., Sheppard, D., Salo, T., Kramer, R., 
Clark, R.A., Uitto, V.J. and Larjava, H. (1996). Keratinocytes in human wounds 
express alpha v beta 6 integrin. J  Invest Dermatol,’ 106, 42-8.
Hajra, K.M. and Fearon, E.R. (2002). Cadherin and catenin alterations in human cancer. 
Genes Chromosomes Cancer, 34, 255-68.
Hall, A. (1998). G proteins and small GTPases: distant relatives keep in touch. Science, 280, 
2074-5.
Hall, P.A. and Watt, F.M. (1989). Stem cells: the generation and maintenance of cellular 
diversity. Development, 106, 619-33.
321
Hanahan, D. and Weinberg, R.A. (2000). The hallmarks of cancer. Cell, 100, 57-70.
Hannigan, G.E., Leung-Hagesteijn, C., Fitz-Gibbon, L., Coppolino, M.G., Radeva, G., 
Filmus, J., Bell, J.C. and Dedhar, S. (1996). Regulation o f cell adhesion and 
anchorage-dependent growth by a new beta 1-integrin-linked protein kinase. Nature, 
379, 91-6.
Hardy, M.H. and Vielkind, U. (1996). Changing patterns of cell adhesion molecules during 
mouse pelage hair follicle development. 1. Follicle morphogenesis in wild-type mice. 
Acta A nat (Basel), 157, 169-82.
Harris, C.C. (1987). Human tissues and cells in carcinogenesis research. Cancer Res, 47,1-10.
Hatta, K., Nose, A., Nagafuchi, A. and Takeichi, M. (1988). Cloning and expression of 
cDNA encoding a neural calcium-dependent cell adhesion molecule: its identity in 
the cadherin gene family. J  Cell Biol, 106, 873-81.
Hatta, K. and Takeichi, M. (1986). Expression of N-cadherin adhesion molecules associated 
with early morphogenetic events in chick development. Nature, 320, 447-9.
Hazan, R.B., Kang, L., Whooley, B.P. and Borgen, P.I. (1997). N-cadherin promotes 
adhesion between invasive breast cancer cells and the stroma. Cell Adhes Commun, 4, 
399-411.
Hazan, R.B. and Norton, L. (1998). The epidermal growth factor receptor modulates the 
interaction o f E-cadherin with the actin cytoskeleton. J  Biol Chem, 273, 9078-84.
Hazan, R.B., Phillips, G.R., Qiao, R.F., Norton, L. and Aaronson, S.A. (2000). Exogenous 
expression o f N-cadherin in breast cancer cells induces cell migration, invasion, and 
metastasis. J  Cell Biol, 148, 779-90.
Hazan, R.B., Qiao, R., Keren, R., Badano, I. and Suyama, K. (2004). Cadherin switch in 
tumor progression. A nn N  Y  Acad Sci, 1014, 155-63.
Helmlinger, G., Netti, P.A., Lichtenbeld, H.C., Melder, R.J. and Jain, R.K. (1997). Solid stress 
inhibits the growth of multicellular tumor spheroids. N at Biotechnol, 15, 778-83.
Hermiston, M.L. and Gordon, J.I. (1995). In vivo analysis of cadherin function in the mouse 
intestinal epithelium: essential roles in adhesion, maintenance o f differentiation, and 
regulation of programmed cell death. J  Cell Biol, 129, 489-506.
Hermiston, M.L., Wong, M.H. and Gordon, J.I. (1996). Forced expression o f E-cadherin in 
the mouse intestinal epithelium slows cell migration and provides evidence for 
nonautonomous regulation of cell fate in a self-renewing system. Genes Dev, 10, 985- 
96.
Herrenknecht, K., Ozawa, M., Eckerskorn, C., Lottspeich, F., Lenter, M. and Kemler, R. 
(1991). The uvomorulin-anchorage protein alpha catenin is a vinculin homologue. 
Proc N atl Acad Sci U S A ,  88, 9156-60.
Hertle, M.D., Adams, J.C. and Watt, F.M. (1991). Integrin expression during human 
epidermal development in vivo and in vitro. Development, 112,193-206.
Hieda, Y., Nishizawa, Y., Uematsu, J. and Owaribe, K. (1992). Identification of a new 
hemidesmosomal protein, HD1: a major, high molecular mass component of isolated 
hem idesmosomes./ Cell Biol, 116, 1497-506.
Higgins, J.M., Mandlebrot, D.A., Shaw, S.K., Russell, G.J., Murphy, E.A., Chen, Y.T., 
Nelson, W.J., Parker, C.M. and Brenner, M.B. (1998). Direct and regulated 
interaction o f integrin alphaEbeta7 with E-cadherin. /  Cell Biol, 140,197-210.
Hintermann, E., Yang, N., O'Sullivan, D., Higgins, J.M. and Quaranta, V. (2005). Integrin 
alpha6beta4-erbB2 complex inhibits haptotaxis by up-regulating E-cadherin cell-cell 
junctions in keratinocytes./ Biol Chem, 280, 8004-15. Epub 2004 Dec 3.
322
Hirano, S., Kimoto, N., Shimoyama, Y., Hirohashi, S. and Takeichi, M. (1992). Identification 
of a neural alpha-catenin as a key regulator o f cadherin function and multicellular 
organization. Cell, 70, 293-301.
Hiscox, S. and Jiang, W.G. (1999). Association o f the H G F/SF  receptor, c-met, with the cell- 
surface adhesion molecule, E-cadherin, and catenins in human tumor cells. Biochem 
Biophjs Res Commun, 261, 406-11.
Hobbs, S., Jitrapakdee, S. and Wallace, J.C. (1998). Development o f a bicistronic vector 
driven by the human polypeptide chain elongation factor 1 alpha promoter for 
creation o f stable mammalian cell lines that express very high levels o f recombinant 
proteins. Biochem Biophjs Res Commun, 252, 368-72.
Hodivala, K.J. and Watt, F.M. (1994). Evidence that cadherins play a role in the 
downregulation o f integrin expression that occurs during keratinocyte terminal 
differentiation. J  Cell Biol, 124, 589-600.
Hogervorst, F., Kuikman, I., von dem Borne, A.E. and Sonnenberg, A. (1990). Cloning and 
sequence analysis o f beta-4 cDNA: an integrin subunit that contains a unique 118 kd 
cytoplasmic domain. Embo J, 9, 765-70.
Hordijk, P.L., ten Klooster, J.P., van der Kammen, R.A., Michiels, F., Oomen, L.C. and 
Collard, J.G. (1997). Inhibition of invasion o f epithelial cells by Tiaml-Rac signaling. 
Science, 278,1464-6.
Hormia, M., Ylanne, J. and Virtanen, I. (1990). Expression of integrins in human gingiva. J  
Deni Res, 69,1817-23.
Hoschuetzky, H., Aberle, H. and Kemler, R. (1994). Beta-catenin mediates the interaction of 
the cadherin-catenin complex with epidermal growth factor receptor. J  Cell Biol, 127, 
1375-80.
Hotary, K.B., Allen, E.D., Brooks, P.C., Datta, N.S., Long, M.W. and Weiss, S.J. (2003). 
Membrane type I matrix metalloproteinase usurps tumor growth control imposed by 
the three-dimensional extracellular matrix. Cell, 114, 33-45.
Hotchin, N.A. and Hall, A. (1995). The assembly of integrin adhesion complexes requires 
both extracellular matrix and intracellular rho/rac GTPases. J  Cell Biol, 131, 1857-65.
Hotchin, N.A. and Hall, A. (1996). Regulation o f the actin cytoskeleton, integrins and cell 
growth by the Rho family of small GTPases. Cancer Surv, 27, 311-22.
Hotchin, N.A., Kovach, N.L. and Watt, F.M. (1993). Functional down-regulation o f alpha 5 
beta 1 integrin in keratinocytes is reversible but commitment to terminal 
differentiation is not. /  Cell Sci, 106, 1131-8.
Hoteiya, T., Hayashi, E., Satomura, K., Kamata, N. and Nagayama, M. (1999). Expression of 
E-cadherin in oral cancer cell lines and its relationship to invasiveness in SCID mice 
in vivo. J  Oral Pathol Med, 28, 107-11.
Howlett, A.R., Bailey, N., Damsky, C., Petersen, O.W. and Bissell, M.J. (1995). Cellular 
growth and survival are mediated by beta 1 integrins in normal human breast 
epithelium but not in breast carcinoma. J  Cell Sci, 108, 1945-57.
Hsu, M.Y., Meier, F.E., Nesbit, M., Hsu, J.Y., Van Belle, P., Elder, D.E. and Herlyn, M.
(2000). E-cadherin expression in melanoma cells restores keratinocyte-mediated 
growth control and down-regulates expression o f invasion-related adhesion 
receptors. A.m J  Pathol, 156, 1515-25.
Husmark, J., Heldin, N.E. and Nilsson, M. (1999). N-cadherin-mediated adhesion and 
aberrant catenin expression in anaplastic thyroid-carcinoma cell lines. Int J  Cancer, 83, 
692-9.
323
Huttenlocher, A., Lakonishok, M., Kinder, M., Wu, S., Truong, T., Knudsen, K.A. and 
Horwitz, A.F. (1998). Integrin and cadherin synergy regulates contact inhibition of 
migration and motile activity. /  Cell Biol, 141, 515-26.
Hyafil, F., Babinet, C. and Jacob, F. (1981). Cell-cell interactions in early embryogenesis: a 
molecular approach to the role of calcium. Cell, 26, 447-54.
Hynes, R.O. (1992). Integrins: versatility, modulation, and signaling in cell adhesion. Cell,, 69, 
11-25.
Hynes, R.O. (2002). Integrins: bidirectional, allosteric signaling machines. Cell’ 110, 673-87.
Imamura, Y., Itoh, M., Maeno, Y., Tsukita, S. and Nagafuchi, A. (1999). Functional domains 
o f alpha-catenin required for the strong state o f cadherin-based cell adhesion. J  Cell 
Biol, 144,1311-22.
Islam, S., Carey, T.E., Wolf, G.T., Wheelock, M.J. and Johnson, K.R. (1996). Expression of 
N-cadherin by human squamous carcinoma cells induces a scattered fibroblastic 
phenotype with disrupted cell-cell adhesion. J  Cell Biol, 135,1643-54. 
amora, C. and Fuchs, E. (2002). Intercellular adhesion, signalling and the cytoskeleton. N at 
Cell Biol, 4, E101-8.
iao, W., Miyazaki, K. and Kitajima, Y. (2001). Exogenous expression of E-cadherin in 
gallbladder carcinoma cell line G-415 restores its cellular polarity and differentiation. 
ln t J  Oncol, 19, 1099-107. 
ohansson, N., Airola, K., Grenman, R., Kanniemi, A.L., Saarialho-Kere, U. and Kahari, 
V.M. (1997). Expression of collagenase-3 (matrix metalloproteinase-13) in squamous 
cell carcinomas o f the head and neck. A m  J  Pathol, 151, 499-508. 
ohnson, N.W. and Wamakulasuriya, K.A. (1993). Epidemiology and aetiology of oral cancer 
in the United Kingdom. Community Dent Health, 10, 13-29. 
ones, J., Downer, C.S. and Speight, P.M. (1995). Changes in the expression o f integrins and 
basement membrane proteins in benign mucous membrane pemphigoid. Oral Dis, 1, 
159-65.
ones, J., Sugiyama, M., Giancotti, F., Speight, P.M. and Watt, F.M. (1996a). Transfection of 
beta 4 integrin subunit into a neoplastic keratinocyte line fails to restore terminal 
differentiation capacity or influence proliferation. CellAdhes Commun, 4, 307-16. 
ones, J., Sugiyama, M., Speight, P.M. and Watt, F.M. (1996b). Restoration of alpha v beta 5 
integrin expression in neoplastic keratinocytes results in increased capacity for 
terminal differentiation and suppression o f anchorage-independent growth. Oncogene, 
12,119-26.
ones, J. (1996). The Expression and Function of Integrins in Malignant Oral Epithelium. In 
PhD Thesis. Department of Oral Pathology. Eastman Dental Institute, Universit Collage 
London. London.
ones, J., Sugiyama, M., Watt, F.M. and Speight, P.M. (1993). Integrin expression in normal, 
hyperplastic, dysplastic, and malignant oral epithelium. J  Pathol, 169, 235-43. 
ones, J., Watt, F.M. and Speight, P.M. (1997). Changes in the expression o f alpha v integrins 
in oral squamous cell carcinomas. J  Oral Pathol Med, 26, 63-8. 
ones, J.C., Hopkinson, S.B. and Goldfinger, L.E. (1998). Structure and assembly of 
hemidesmosomes. Bioessays, 20, 488-94. 
ones, J.C., Kurpakus, M.A., Cooper, H.M. and Quaranta, V. (1991). A function for the 
integrin alpha 6 beta 4 in the hemidesmosome. Cell Regul, 2, 427-38. 
ordan, R.C., Catzavelos, G.C., Barrett, A.W. and Speight, P.M. (1996). Differential 
expression of bcl-2 and bax in squamous cell carcinomas of the oral cavity. Eur J  
Cancer B Oral Oncol, 32B, 394-400.
324
Juliano, R.L. (2002). Signal transduction by cell adhesion receptors and the cytoskeleton: 
functions of integrins, cadherins, selectins, and immunoglobulin-superfamily 
members. A.nnu Rev Pharmacol Toxicol,’ 42, 283-323.
Juliano, R.L. and Vamer, J.A. (1993). Adhesion molecules in cancer: the role o f integrins. 
Curr Opin Cell Biol, 5, 812-8.
Kaibuchi, K., Kuroda, S. and Amano, M. (1999). Regulation o f the cytoskeleton and cell 
adhesion by the Rho family GTPases in mammalian cells. Annu Rev Biochem, 68, 459- 
86 .
Kajiji, S., Tamura, R.N. and Quaranta, V. (1989). A novel integrin (alpha E beta 4) from 
human epithelial cells suggests a fourth family o f integrin adhesion receptors. Em bo J, 
8, 673-80.
Kalinin, A., Marekov, L.N. and Steinert, P.M. (2001). Assembly o f the epidermal comified 
cell envelope. J Cell Sci, 114, 3069-70.
Kanazawa, T., Watanabe, T., Kazama, S., Tada, T., Koketsu, S. and Nagawa, H. (2002). 
Poorly differentiated adenocarcinoma and mucinous carcinoma o f the colon and 
rectum show higher rates of loss o f heterozygosity and loss of E-cadherin expression 
due to methylation of promoter region. Ini J  Cancer, 102, 225-9.
Kandikonda, S., Oda, D., Niederman, R. and Sorkin, B.C. (1996). Cadherin-mediated 
adhesion is required for normal growth regulation o f human gingival epithelial cells. 
CellA.dhes Commun, 4, 13-24.
Kannan, S., Balaram, P., Chandran, G.J., Pillai, M.R., Mathew, B., Nalinakumari, K.R. and 
Nair, M.K. (1994). Alterations in expression of basement membrane proteins during 
tumour progression in oral mucosa. Histopathology, 24, 531-7.
Kantak, S.S. and Kramer, R.H. (1998). E-cadherin regulates anchorage-independent growth 
and survival in oral squamous cell carcinoma cells. J  Biol Chem, 273, 16953-61.
Kartenbeck, J., Schmelz, M., Franke, W.W. and Geiger, B. (1991). Endocytosis of junctional 
cadherins in bovine kidney epithelial (MDBK) cells cultured in low Ca2+ ion 
medium. J  Cell Biol, 113, 881-92.
Katayama, M., Hirai, S., Kamihagi, K., Nakagawa, K , Yasumoto, M. and Kato, I. (1994). 
Soluble E-cadherin fragments increased in circulation o f cancer patients. Br I Cancer, 
69,580-5.
Kawakita, M., Moroi, S., Kyotani, K., Kakehi, Y. and Yoshida, O. (1994). [Study on E- 
cadherin expression in relation to invasion and metastasis in urothelial cancer 
patients]. Hinjokika Kiyo, 40, 1077-80.
Keely, P., Parise, L. and Juliano, R. (1998). Integrins and GTPases in tumour cell growth, 
motility and invasion. Trends Cell Biol, 8,101-6.
Kemler, R. (1993). From cadherins to catenins: cytoplasmic protein interactions and 
regulation of cell adhesion. Trends Genet, 9, 317-21.
Kennel, S.J., Godfrey, V., Ch'ang, L.Y., Lankford, T.K., Foote, L.J. and Makkinje, A. (1992). 
The beta 4 subunit o f the integrin family is displayed on a restricted subset of 
endothelium in mice. J  Cell Sci, 101, 145-50.
Kim, S.H., Li, Z. and Sacks, D.B. (2000). E-cadherin-mediated cell-cell attachment activates 
Cdc42. J  Biol Chem, 275, 36999-7005.
King, W.G., Mattaliano, M.D., Chan, T.O., Tsichlis, P.N. and Brugge, J.S. (1997). 
Phosphatidylinositol 3-kinase is required for integrin-stimulated AKT and Raf- 
1/mitogen-activated protein kinase pathway activation. Mol Cell Biol, 17, 4406-18.
Kinsella, A.R., Bowie, G.L., Field, J.K. and Jones, A.S. (1994). Expression o f the cell-cell 
adhesion molecule E-cadherin in tongue carcinoma cell lines. J  Laryngol Otol, 108, 
957-61.
325
Klein, C.E., Steinmayer, T., Mattes, J.M., Kaufmann, R. and Weber, L. (1990). Integrins of 
normal human epidermis: differential expression, synthesis and molecular structure. 
Br J  Dermatol’ 123, 171-8.
Knudsen, K.A., Soler, A.P., Johnson, K.R. and Wheelock, M.J. (1995). Interaction o f alpha- 
actinin with the cadherin/catenin cell-cell adhesion complex via alpha-catenin. J  Cell 
Biol, 130, 67-77.
Kodama, A., Takaishi, K., Nakano, K., Nishioka, H. and Takai, Y. (1999). Involvement of 
Cdc42 small G protein in cell-cell adhesion, migration and morphology o f MDCK 
cells. Oncogene, 18, 3996-4006.
Kohya, N., Kitajima, Y., Jiao, W. and Miyazaki, K. (2003). Effects of E-cadherin transfection 
on gene expression o f a gallbladder carcinoma cell line: repression of MTS1/S100A4 
gene expression. Int J  Cancer, 104, 44-53.
Kopan, R. and Fuchs, E. (1989). A new look into an old problem: keratins as tools to 
investigate determination, morphogenesis, and differentiation in skin. Genes Dev, 3, 1- 
15.
Koretz, K., Schlag, P., Boumsell, L. and Moller, P. (1991). Expression of VLA-alpha 2, VLA- 
alpha 6, and VLA-beta 1 chains in normal mucosa and adenomas of the colon, and in 
colon carcinomas and their liver metastases. A.m J  Pathol, 138, 741-50.
Kovacs, E.M., Ali, R.G., McCormack, A.J. and Yap, A.S. (2002). E-cadherin homophilic 
ligation directly signals through Rac and phosphatidylinositol 3-kinase to regulate 
adhesive contacts. /  Biol Chem, 277, 6708-18. Epub 2001 Dec 13.
Kowalczyk, A.P., Bomslaeger, E.A., Norvell, S.M., Palka, H.L. and Green, K.J. (1999). 
Desmosomes: intercellular adhesive junctions specialized for attachment of 
intermediate filaments. Int Rev Cjtol, 185, 237-302.
Kudo, Y., Kitajima, S., Ogawa, I., Hiraoka, M., Sargolzaei, S., Keikhaee, M.R., Sato, S., 
Miyauchi, M. and Takata, T. (2004). Invasion and metastasis o f oral cancer cells 
require methylation of E-cadherin and/or degradation o f membranous beta-catenin. 
Clin Cancer Res, 10, 5455-63.
Kuroda, S., Fukata, M., Nakagawa, M., Fujii, K., Nakamura, T., Ookubo, T., Izawa, I., 
Nagase, T., Nomura, N., Tani, H., Shoji, I., Matsuura, Y., Yonehara, S. and Kaibuchi, 
K. (1998). Role of IQGAP1, a target of the small GTPases Cdc42 and Racl, in 
regulation of E-cadherin- mediated cell-cell adhesion. Science, 281, 832-5.
Kurpakus, M.A., Quaranta, V. and Jones, J.C. (1991). Surface relocation of alpha 6 beta 4 
integrins and assembly of hemidesmosomes in an in vitro model of wound healing. J  
Cell Biol, 115, 1737-50.
Kusukawa, J., Sasaguri, Y., Morimatsu, M. and Kameyama, T. (1995). Expression of matrix 
metalloproteinase-3 in stage I and II squamous cell carcinoma o f the oral cavity. J  
Oral Maxillofac Surg, 53, 530-4.
Kusukawa, J., Sasaguri, Y., Shima, I., Kameyama, T. and Morimatsu, M. (1992). Production 
of matrix metalloproteinase 2 (gelatinase/type IV collagenase) and 3 (stromelysin) by 
cultured oral squamous cell carcinoma. J  Oral Pathol Med, 21, 221-4.
Kusukawa, J., Sasaguri, Y., Shima, I., Kameyama, T. and Morimatsu, M. (1993). Expression 
of matrix metalloproteinase-2 related to lymph node metastasis o f oral squamous cell 
carcinoma. A clinicopathologic study. A.m J  Clin Pathol, 99, 18-23.
Lambert, M., Choquet, D. and Mege, R.M. (2002). Dynamics o f ligand-induced, Racl- 
dependent anchoring of cadherins to the actin cytoskeleton. J  Cell Biol, 157, 469-79. 
Epub 2002 Apr 22.
Lampugnani, M.G., Corada, M., Caveda, L., Breviario, F., Ayalon, O., Geiger, B. and Dejana, 
E. (1995). The molecular organization of endothelial cell to cell junctions: differential
326
association o f plakoglobin, beta-catenin, and alpha-catenin with vascular endothelial 
cadherin (VE-cadherin). J  Cell Biol, 129, 203-17.
Languino, L.R., Gehlsen, K.R., Wayner, E., Carter, W.G., Engvall, E. and Ruoslahti, E. 
(1989). Endothelial cells use alpha 2 beta 1 integrin as a laminin receptor. J  Cell Biol' 
109, 2455-62.
Larjava, H. (1991). Expression of beta 1 integrins in normal human keratinocytes. A m  J  Med 
Sci, 301, 63-8.
Lame, L., Ohsugi, M., Hirchenhain, J. and Kemler, R. (1994). E-cadherin null mutant 
embryos fail to form a trophectoderm epithelium. Proc N atl Acad Sci U S A ,  91, 8263- 
7.
Le, T.L., Joseph, S.R., Yap, A.S. and Stow, J.L. (2002). Protein kinase C regulates endocytosis 
and recycling of E-cadherin. A m  J  Physiol Cell Physiol, 283, C489-99.
Lee, J.W. and Juliano, R. (2004). Mitogenic signal transduction by integrin- and growth factor 
receptor-mediated pathways. Mol Cells, 17, 188-202.
Lee, Y.I., Kwon, Y.J. and Joo, C.K. (2004). Integrin-linked kinase function is required for 
transforming growth factor beta-mediated epithelial to mesenchymal transition. 
Biochem Biophys Res Commun, 316, 997-1001.
Li, G. and Herlyn, M. (2000). Dynamics of intercellular communication during melanoma 
development. Mol Med Today, 6,163-9.
Li, G., Satyamoorthy, K. and Herlyn, M. (2001). N-cadherin-mediated intercellular 
interactions promote survival and migration o f melanoma cells. Cancer Res, 61, 3819- 
25.
Li, K., Tamai, K., Tan, E.M. and Uitto, J. (1993). Cloning of type XVII collagen.
Complementary and genomic DNA sequences of mouse 180-kilodalton bullous
pemphigoid antigen (BPAG2) predict an interrupted collagenous domain, a 
transmembrane segment, and unusual features in the 5'-end of the gene and the 3'- 
untranslated region o f the mRNA. J  Biol Chem, 268, 8825-34.
Li, L., Backer, J., Wong, A.S., Schwanke, E.L., Stewart, B.G. and Pasdar, M. (2003). Bcl-2
expression decreases cadherin-mediated cell-cell adhesion. J  Cell Sci, 116, 3687-700.
Epub 2003 Jul 30.
Li, Z., Gallin, W.J., Lauzon, G. and Pasdar, M. (1998). L-CAM expression induces fibroblast- 
epidermoid transition in squamous carcinoma cells and down-regulates the 
endogenous N-cadherin. J  Cell Sci, 111, 1005-19.
Liebert, M. and Seigne, J. (1996). Characteristics of invasive bladder cancers: histological and 
molecular markers. Semin Urol Oncol, 14, 62-72.
Lim, L., Manser, E., Leung, T. and Hall, C. (1996). Regulation of phosphorylation pathways 
by p21 GTPases. The p21 Ras-related Rho subfamily and its role in phosphorylation 
signalling pathways. Eur J  Biochem, 242, 171-85.
Lipponen, P.K. and Eskelinen, M.J. (1995). Reduced expression of E-cadherin is related to 
invasive disease and frequent recurrence in bladder cancer. J  Cancer Res Clin Oncol, 
121, 303-8.
Lo, A.K., Yuen, P.W., Liu, Y., Wang, X.H., Cheung, A.L., Wong, Y.C. and Tsao, S.W.
(2001). Downregulation of hemidesmosomal proteins in nasopharyngeal carcinoma 
cells. CancerEett, 163,117-23.
Lo Muzio, L. (2001). A possible role for the WNT-1 pathway in oral carcinogenesis. Crit Rev 
Oral Biol Med, 12, 152-65.
Lo Muzio, L., Staibano, S., Pannone, G., Grieco, M., Mignogna, M.D., Cerrato, A., Testa, 
N.F. and De Rosa, G. (1999). Beta- and gamma-catenin expression in oral squamous 
cell carcinomas. Anticancer Res, 19, 3817-26.
327
Loro, L.L., Vintermyr, O.K. and Johannessen, A.C. (2003). Cell death regulation in oral 
squamous cell carcinoma: methodological considerations and clinical significance. /  
Oral PatholMed, 32, 125-38.
Lo2ano, E., Betson, M. and Braga, V.M. (2003). Tumor progression: Small GTPases and loss 
of cell-cell adhesion. Bioessays, 25, 452-63.
Lu, P.J., Lu, Q.L., Rughetti, A. and Taylor-Papadimitriou, J. (1995). bcl-2 overexpression 
inhibits cell death and promotes the morphogenesis, but not tumorigenesis o f human 
mammary epithelial cells. /  Cell Biol, 129, 1363-78.
Lu, Q.L., Abel, P., Foster, C.S. and Lalani, E.N. (1996). bcl-2: role in epithelial differentiation 
and oncogenesis. Hum Pathol, 27,102-10.
Lukashev, M.E. and Werb, Z. (1998). ECM signalling: orchestrating cell behaviour and 
misbehaviour. Trends Cell Biol, 8, 437-41.
Mackenzie, I.C. (2004). Growth o f malignant oral epithelial stem cells after seeding into 
organotypical cultures o f normal mucosa. /  Oral Pathol Med, 33, 71-8.
Mainiero, F., Pepe, A., Wary, K.K., Spinardi, L., Mohammadi, M., Schlessinger, J. and 
Giancotti, F.G. (1995). Signal transduction by the alpha 6 beta 4 integrin: distinct 
beta 4 subunit sites mediate recruitment of Shc/G rb2 and association with the 
cytoskeleton o f hemidesmosomes. Embo J, 14, 4470-81.
Mainiero, F., Pepe, A., Yeon, M., Ren, Y. and Giancotti, F.G. (1996). The intracellular 
functions o f alpha6beta4 integrin are regulated by EGF. J  Cell Biol, 134, 241-53.
Malliri, A., van Es, S., Huveneers, S. and Collard, J.G. (2004). The Rac exchange factor 
Tiaml is required for the establishment and maintenance o f cadherin-based 
adhesions. J  Biol Chem, 279, 30092-8. Epub 2004 May 11.
Marchisio, P.C., Bondanza, S., Cremona, O., Cancedda, R. and De Luca, M. (1991). Polarized 
expression of integrin receptors (alpha 6 beta 4, alpha 2 beta 1, alpha 3 beta 1, and 
alpha v beta 5) and their relationship with the cytoskeleton and basement membrane 
matrix in cultured human keratinocytes. J  Cell Biol, 112, 761-73.
Mareel, M., Bracke, M. and Van Roy, F. (1995). Cancer metastasis: negative regulation by an 
invasion-suppressor complex. Cancer Detect Prev, 19, 451-64.
Mareel, M.M., Behrens, J., Birchmeier, W., De Bruyne, G.K., Vleminckx, K., Hoogewijs, A., 
Fiers, W.C. and Van Roy, F.M. (1991). Down-regulation of E-cadherin expression in 
Madin Darby canine kidney (MDCK) cells inside tumors o f nude mice. Int J  Cancer, 
47, 922-8.
Margulis, A., Andriani, F., Fusenig, N., Hashimoto, K., Hanakawa, Y. and Garlick, J.A.
(2003). Abrogation o f E-cadherin-mediated adhesion induces tumor cell invasion in 
human skin-like organotypic culture./ Invest Dermatol, 121, 1182-90.
Marinkovich, M.P., Keene, D.R., Rimberg, C.S. and Burgeson, R.E. (1993). Cellular origin of 
the dermal-epidermal basement membrane. Dev Dyn, 197, 255-61.
Marsden, M. and DeSimone, D.W. (2003). Integrin-ECM interactions regulate cadherin- 
dependent cell adhesion and are required for convergent extension in Xenopus. Curr 
Biol, 13, 1182-91.
Marshall, D., Hardman, M.J., Nield, K.M. and Byme, C. (2001). Differentially expressed late 
constituents o f the epidermal cornified envelope. Proc N atl Acad Sci U S A ,  98, 
13031-6.
Marshall, J.F.a.D., D. (2000). The role of integrin-mediated processes in the biology of 
metastasis. In Cancer Metastasis, Molecular and Cellular Mechanisms and Clinical 
Interventions, Mansel, W.J.a.R. (ed) pp. 19-54. Kluwer Academics: Dordrecht, The 
Netherlands.
328
Marshall, J.F.a.H., I. (1999). The role of adhesion in metastasis: Potential mechanisms and 
modulation o f integrin activity. In Advances in Molecular and Cell Biology, E. E. Bittar, 
D.R.G., A. J. North, M. J. Chidgey (ed), Vol. 28. pp. 345-365.
Mary, S., Charrasse, S., Meriane, M., Comunale, F., Travo, P., Blangy, A. and Gauthier- 
Rouviere, C. (2002). Biogenesis o f N-cadherin-dependent cell-cell contacts in living 
fibroblasts is a microtubule-dependent kinesin-driven mechanism. Mol Biol Cell,’ 13, 
285-301.
Mattijssen, V., Peters, H.M., Schalkwijk, L., Manni, J.J., van 't Hof-Grootenboer, B., de 
Mulder, P.H. and Ruiter, D.J. (1993). E-cadherin expression in head and neck 
squamous-cell carcinoma is associated with clinical outcome. Int J  Cancer.; 55, 580-5.
Mehrel, T., Hohl, D., Rothnagel, J.A., Longley, M.A., Bundman, D., Cheng, C., Lichti, U., 
Bisher, M.E., Steven, A.C., Steinert, P.M. and et al. (1990). Identification o f a major 
keratinocyte cell envelope protein, loricrin. Cell\ 61,1103-12.
Meredith, J.E., Jr., Fazeli, B. and Schwartz, M.A. (1993). The extracellular matrix as a cell 
survival factor. Mol Biol Cell’ 4, 953-61.
Meredith, J.E., Jr., Winitz, S., Lewis, J.M., Hess, S., Ren, X.D., Renshaw, M.W. and Schwartz, 
M.A. (1996). The regulation of growth and intracellular signaling by integrins. Endocr 
Rev, 17, 207-20.
Mertens, A.E., Roovers, R.C. and Collard, J.G. (2003). Regulation o f Tiaml-Rac signalling. 
FEBS Lett, 546,11 -6.
Mialhe, A., Louis, J., Pasquier, D., Rambeaud, J.J. and Seigneurin, D. (1997). Expression of 
three cell adhesion molecules in bladder carcinomas: correlation with pathological 
features. A nal Cell Pathol’, 13, 125-36.
Miller, J.R. and Moon, R.T. (1996). Signal transduction through beta-catenin and 
specification o f cell fate during embryogenesis. Genes Dev, 10, 2527-39.
Miner, J.H. and Yurchenco, P.D. (2004). Laminin functions in tissue morphogenesis. Annu 
Rev Cell Dev Biol, 20, 255-84.
Miyaki, M. (1995). [Increased cell adhesiveness and decreased tumorigenicity induced in 
human colon carcinoma cells by transfection with E-cadherin cDNA]. Nippon Rinsho, 
53, 1585-9.
Miyaki, M., Tanaka, K., Kikuchi-Yanoshita, R., Muraoka, M., Konishi, M. and Takeichi, M. 
(1995). Increased cell-substratum adhesion, and decreased gelatinase secretion and 
cell growth, induced by E-cadherin transfection of human colon carcinoma cells. 
Oncogene, 11, 2547-52.
Miyazaki, J., Fujisawa, M., Arakawa, S. and Kamidono, S. (1995). [The expression o f the E- 
cadherin in human urinary bladder carcinoma]. Nippon Hinj/okika Gakkai Zasshi, 86, 
1208-15.
Moersig, W., Horn, S., Hilker, M., Mayer, E. and Oelert, H. (2002). Transfection o f E- 
cadherin cDNA in human lung tumor cells reduces invasive potential of tumors. 
Thorac Cardiovasc Surg, 50, 45-8.
Moll, R., Franke, W.W., Schiller, D.L., Geiger, B. and Krepler, R. (1982). The catalog of 
human cytokeratins: patterns of expression in normal epithelia, tumors and cultured 
cells. Cell, 31,11-24.
Moss-Salentijn, L.a.H.-K., M. (1980). Oral mucosa-connective tissue proper. In Dental and 
oral tissues, Kimpton, L.M.-S.a.M.H.-K.H. (ed) pp. p 53-74: London.
Muller, D., Wolf, C., Abecassis, J., Millon, R., Engelmann, A., Bronner, G., Rouyer, N., Rio, 
M.C., Eber, M., Methlin, G. and et al. (1993). Increased stromelysin 3 gene 
expression is associated with increased local invasiveness in head and neck squamous 
cell carcinomas. Cancer Res, 53, 165-9.
329
Munshi, H.G., Ghosh, S., Mukhopadhyay, S., Wu, Y.I., Sen, R., Green, K.J. and Stack, M.S.
(2002). Proteinase suppression by E-cadherin-mediated cell-cell attachment in 
premalignant oral keratinocytes. J  Biol Chem, 277, 38159-67. Epub 2002 Jul 23.
Nakagawa, M., Fukata, M., Yamaga, M., Itoh, N. and Kaibuchi, K. (2001). Recruitment and 
activation o f Racl by the formation of E-cadherin-mediated cell-cell adhesion sites. J  
Cell Sci, 114, 1829-38.
Nakayama, H., Ikebe, T., Beppu, M. and Shirasuna, K. (2001a). High expression levels of 
nuclear factor kappaB, IkappaB kinase alpha and Akt kinase in squamous cell 
carcinoma o f the oral cavity. Cancer, 92, 3037-44.
Nakayama, S., Sasaki, A., Mese, H., Alcalde, R.E., Tsuji, T. and Matsumura, T. (2001b). The 
E-cadherin gene is silenced by CpG methylation in human oral squamous cell 
carcinomas. Int J  Cancer, 93, 667-73.
Nass, S.J., Herman, J.G., Gabrielson, E., Iversen, P.W., Pari, F.F., Davidson, N.E. and Graff, 
J.R. (2000). Aberrant methylation of the estrogen receptor and E-cadherin 5' CpG 
islands increases with malignant progression in human breast cancer. Cancer Res, 60, 
4346-8.
Natali, P.G., Nicotra, M.R., Bigotti, A. and De Martino, C. (1992). Localization of ahe alpha 
6 and beta 4 integrin subunits in normal human non-lymphoid tissues. J  Cell Sci, 103, 
1243-7.
Navarro, P., Gomez, M., Pizarro, A., Gamallo, C., Quintanilla, M. and Cano, A. (1991). A 
role for the E-cadherin cell-cell adhesion molecule during tumor progression of 
mouse epidermal carcinogenesis . J  Cell Biol, 115, 517-33.
Navarro, P., Lozano, E. and Cano, A. (1993). Expression of E- or P-cadherin is not 
sufficient to modify the morphology and the tumorigenic behavior of murine spindle 
carcinoma cells. Possible involvement of plakoglobin. J  Cell Sci, 105, 923-34.
Nelson, W.J. (2003). Epithelial cell polarity from the outside looking in. News Physiol Sci, 18, 
143-6.
Nemes, Z. and Steinert, P.M. (1999). Bricks and mortar o f the epidermal barrier. E xp Mol 
Med, 31, 5-19.
Nieman, M.T., Prudoff, R.S., Johnson, K.R. and Wheelock, M.J. (1999). N-cadherin 
promotes motility in human breast cancer cells regardless o f their E-cadherin 
expression. J  Cell Biol, 147, 631-44.
Niessen, C.M., Hogervorst, F., Jaspars, L.H., de Melker, A.A., Delwel, G.O., Hulsman, E.H., 
Kuikman, I. and Sonnenberg, A. (1994). The alpha 6 beta 4 integrin is a receptor for 
both laminin and kalinin. Exp Cell Res, 211, 360-7.
Nievers, M.G., Schaapveld, R.Q., Oomen, L.C., Fontao, L., Geerts, D. and Sonnenberg, A.
(1998). Ligand-independent role of the beta 4 integrin subunit in the formation of 
hemidesmosomes. J  Cell Sci, 111, 1659-72.
Nikolopoulos, S.N. and Turner, C.E. (2001). Integrin-linked kinase (ILK) binding to paxillin 
LD1 motif regulates ILK localization to focal adhesions./ Biol Chem, 276, 23499-505. 
Epub 2001 Apr 13.
Noe, V., Chastre, E., Bruyneel, E., Gespach, C. and Mareel, M. (1999a). Extracellular 
regulation of cancer invasion: the E-cadherin-catenin and other pathways. Biochem Soc 
Symp, 65, 43-62.
Noe, V., Fingleton, B., Jacobs, K , Crawford, H.C., Vermeulen, S., Steelant, W., Bmyneel, E., 
Matrisian, L.M. and Mareel, M. (2001). Release o f an invasion promoter E-cadherin 
fragment by matrilysin and stromelysin-1. J  Cell Sci, 114, 111-118.
330
Noe, V., Willems, J., Vandekerckhove, J., Roy, F.V., Bruyneel, E. and Mareel, M. (1999b). 
Inhibition o f adhesion and induction of epithelial cell invasion by HAV-containing 
E-cadherin-specific peptides. J  Cell Sci, 112, 127-35.
Nojima, D., Nakajima, K., Li, L.C., Franks, J., Ribeiro-Filho, L., Ishii, N. and Dahiya, R.
(2001). CpG methylation o f promoter region inactivates E-cadherin gene in renal cell 
carcinoma. Mol Carcinog,, 32,19-27.
Nollet, F., Berx, G. and van Roy, F. (1999). The role of the E-cadherin/catenin adhesion 
complex in the development and progression o f cancer. Mol Cell Biol Res Commun, 2, 
77-85.
Noren, N.K., Liu, B.P., Burridge, K. and Kreft, B. (2000). p l20  catenin regulates the actin 
cytoskeleton via Rho family GTPases. J  Cell Biol.’ 150, 567-80.
Nose, A., Nagafuchi, A. and Takeichi, M. (1987). Isolation of placental cadherin cDNA: 
identification o f a novel gene family o f cell-cell adhesion molecules. Embo J, 6, 3655- 
61.
Novak, A., Hsu, S.C., Leung-Hagesteijn, C., Radeva, G., Papkoff, J., Montesano, R., 
Roskelley, C., Grosschedl, R. and Dedhar, S. (1998). Cell adhesion and the integrin- 
linked kinase regulate the LEF-1 and beta-catenin signaling pathways. Proc N atl Acad 
Sci U S  A , 95, 4374-9.
Ojakian, G.K. and Schwimmer, R. (1994). Regulation o f epithelial cell surface polarity 
reversal by beta 1 integrins. J  Cell Sci, 107, 561-76.
Okada, A., Bellocq, J.P., Rouyer, N., Chenard, M.P., Rio, M.C., Chambon, P. and Basset, P.
(1995). Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in 
stromal cells of human colon, breast, and head and neck carcinomas. Proc N atl Acad 
Sci U S  A , 92, 2730-4.
Oloumi, A., McPhee, T. and Dedhar, S. (2004). Regulation o f E-cadherin expression and 
beta-catenin/Tcf transcriptional activity by the integrin-linked kinase. Biochim Biophjs 
Acta, 1691, 1-15.
Office o f Population Censuses and Syrveys (OPCS) (1994). Cancer Statistics Registration: 
Series MBI No. 21. HMSO: London.
Owaribe, K., Kartenbeck, J., Stumpp, S., Magin, T.M., Krieg, T., Diaz, L.A. and Franke, 
W.W. (1990). The hemidesmosomal plaque. I. Characterization o f a major 
constituent protein as a differentiation marker for certain forms o f epithelia. 
Differentiation, 45, 207-20.
Ozawa, M., Baribault, H. and Kemler, R. (1989). The cytoplasmic domain o f the cell 
adhesion molecule uvomorulin associates with three independent proteins 
structurally related in different species. Em bo J, 8,1711-7.
Ozawa, M., Ringwald, M. and Kemler, R. (1990). Uvomorulin-catenin complex formation is 
regulated by a specific domain in the cytoplasmic region of the cell adhesion 
molecule. Proc N atl Acad Sci U S A ,  87, 4246-50.
Parkin, D.M. (1993). Studies of cancer in migrant populations. IA R C  Sci Publ, 1-10.
Partridge, M., Gullick, W.J., Langdon, J.D. and Sherriff, M. (1988). Expression o f epidermal 
growth factor receptor on oral squamous cell carcinoma. Br J  Oral Maxillofac Surg, 26, 
381-9.
Partridge, M., Kiguwa, S., Emilion, G., Pateromichelakis, S., A'Hem, R. and Langdon, J.D.
(1999). New insights into p53 protein stabilisation in oral squamous cell carcinoma. 
Oral Oncol, 35, 45-55.
Pece, S., Chiariello, M., Murga, C. and Gutkind, J.S. (1999). Activation o f the protein kinase 
A kt/PK B by the formation of E-cadherin-mediated cell-cell junctions. Evidence for
331
the association of phosphatidylinositol 3-kinase with the E-cadherin adhesion
complex. J  Biol Chem, 274, 19347-51.
Pece, S. and Gutkind, J.S. (2000). Signaling from E-cadherins to the MAPK pathway by the 
recruitment and activation o f epidermal growth factor receptors upon cell-cell 
contact formation. J  Biol Chem, 275, 41227-33.
Pece, S. and Gutkind, J.S. (2002). E-cadherin and Hakai: signalling, remodeling or
destruction? N at Cell Biol’ 4, E72-4.
Pecina-Slaus, N. (2003). Tumor suppressor gene E-cadherin and its role in normal and 
malignant cells. Cancer Cell Int, 3, 17.
Perez-Moreno, M., Jamora, C. and Fuchs, E. (2003). Sticky business: orchestrating cellular 
signals at adherens junctions. Cell, 112, 535-48.
Perez-Moreno, M.A., Locascio, A., Rodrigo, I., Dhondt, G., Portillo, F., Nieto, M.A. and 
Cano, A. (2001). A new role for E12/E47 in the repression of E-cadherin expression 
and epithelial-mesenchymal transitions. J  Biol Chem, 276, 27424-31. Epub 2001 Apr 
17.
Perl, A.K., Wilgenbus, P., Dahl, U., Semb, H. and Christofori, G. (1998). A causal role for E-
cadherin in the transition from adenoma to carcinoma. Nature, 392, 190-3.
Persad, S., Attwell, S., Gray, V., Delcommenne, M., Troussard, A., Sanghera, J. and Dedhar, 
S. (2000). Inhibition of integrin-linked kinase (ILK) suppresses activation of protein 
kinase B /A kt and induces cell cycle arrest and apoptosis o f PTEN-mutant prostate 
cancer cells. Proc N atl Acad Sci U S A ,  97, 3207-12.
Pignatelli, M. and Bodmer, W.F. (1990). Integrin cell adhesion molecules and colorectal 
cancer. J  Pathol, 162, 95-7.
Platz, H., Fries, R, Hudec, M. (1986). Prognoses o f oral cavity carcinomas: results o f a
multicentric retrospective observational study. Carl Hanser Verlag.: Munich.
Polette, M., Clavel, C., Birembaut, P. and De Clerck, Y.A. (1993). Localization by in situ 
hybridization o f mRNAs encoding stromelysin 3 and tissue inhibitors o f metallo- 
proteinases TIMP-1 and TIMP-2 in human head and neck carcinomas. Pathol Res 
Pract, 189, 1052-7.
Polette, M., Clavel, C., Muller, D., Abecassis, J., Binninger, I. and Birembaut, P. (1991). 
Detection o f mRNAs encoding collagenase I and stromelysin 2 in carcinomas of the 
head and neck by in situ hybridization. Invasion Metastasis, 11, 76-83.
Potten, C.S. (1981). Cell replacement in epidermis (keratopoiesis) via discrete units of 
proliferation. Int Rev Cytol, 69, 271-318.
Potts, A.J., Croall, D.E. and Hemler, M.E. (1994). Proteolytic cleavage o f the integrin beta 4 
subunit. E xp Cell Res, 212, 2-9.
Pozzi, A. and Zent, R. (2003). Integrins: sensors of extracellular matrix and modulators of 
cell function. Nephron Exp Nephrol, 94, e77-84.
Presland, R.B. and Dale, B.A. (2000). Epithelial structural proteins of the skin and oral cavity: 
function in health and disease. Crit Rev Oral Biol Med, 11, 383-408.
Presland, R.B. and Jurevic, R.J. (2002). Making sense o f the epithelial barrier: what molecular 
biology and genetics tell us about the functions o f oral mucosal and epidermal 
tissues. J  DentEduc, 66, 564-74.
Prime, S.S., Game, S.M., Matthews, J.B., Stone, A., Donnelly, M.J., Yeudall, W.A., Patel, V., 
Sposto, R., Silverthome, A. and Scully, C. (1994). Epidermal growth factor and 
transforming growth factor alpha characteristics of human oral carcinoma cell lines. 
Br J  Cancer, 69, 8-15.
332
Prime, S.S., Nixon, S.V., Crane, I.J., Stone, A., Matthews, J.B., Maitland, N.J., Remnant, L., 
Powell, S.K., Game, S.M. and Scully, C. (1990). The behaviour o f human oral 
squamous cell carcinoma in cell culture. J  Pathol, 160, 259-69.
Pyke, C., Ralfkiaer, E., Huhtala, P., Hurskainen, T., Dano, K. and Tryggvason, K. (1992). 
Localization o f messenger RNA for Mr 72,000 and 92,000 type IV collagenases in 
human skin cancers by in situ hybridization. Cancer Res, 52, 1336-41.
Quinlan, R.A., Schiller, D.L., Hatzfeld, M., Achtstatter, T., Moll, R., Jorcano, J.L., Magin, 
T.M. and Franke, W.W. (1985). Patterns of expression and organization of 
cytokeratin intermediate filaments. A nn N  Y  Acad Sci, 455, 282-306.
Rabinovitz, I. and Mercurio, A.M. (1996). The integrin alpha 6 beta 4 and the biology of 
carcinoma. Biochem Cell Biol, 74, 811-21.
Rabinovitz, I. and Mercurio, A.M. (1997). The integrin alpha6beta4 functions in carcinoma 
cell migration on laminin-1 by mediating the formation and stabilization o f actin- 
containing motility structures. /  Cell Biol, 139, 1873-84.
Raich, W.B., Agbunag, C. and Hardin, J. (1999). Rapid epithelial-sheet sealing in the 
Caenorhabditis elegans embryo requires cadherin-dependent filopodial priming. Curr 
Biol, 9, 1139-46.
Reed, J.C. (1998). Bcl-2 family proteins. Oncogene, 17, 3225-36.
Reed, J.C. (1999). Mechanisms of apoptosis avoidance in cancer. CurrOpin Oncol, 11, 68-75.
Reed, J.C., Zha, H., Aime-Sempe, C., Takayama, S. and Wang, H.G. (1996). Structure- 
function analysis of Bcl-2 family proteins. Regulators of programmed cell death. Adv 
Exp Med Biol, 406, 99-112.
Rheinwald, J.G. and Beckett, M.A. (1980). Defective terminal differentiation in culture as a 
consistent and selectable character of malignant human keratinocytes. Cell, 22, 629- 
32.
Ribeiro-Filho, L.A., Franks, J., Sasaki, M., Shiina, H., Li, L.C., Nojima, D., Arap, S., Carroll, 
P., Enokida, H., Nakagawa, M., Yonezawa, S. and Dahiya, R. (2002). CpG 
hypermethylation of promoter region and inactivation of E-cadherin gene in human 
bladder cancer. Mol Carcinog, 34, 187-98.
Rice, R.H. and Green, H. (1979). Presence in human epidermal cells o f a soluble protein 
precursor of the cross-linked envelope: activation o f the cross-linking by calcium 
ions. Cell, 18, 681-94.
Ridley, A.J. (1995). Microinjection of Rho and Rac into quiescent Swiss 3T3 cells. Methods 
Entymol, 256, 313-20.
Rieger-Christ, K.M., Lee, P., Zagha, R., Kosakowski, M., Moinzadeh, A., Stoffel, J., Ben- 
Ze'ev, A., Libertino, J.A. and Summerhayes, I.C. (2004). Novel expression of N- 
cadherin elicits in vitro bladder cell invasion via the Akt signaling pathway. Oncogene, 
23, 4745-53.
Riethmacher, D., Brinkmann, V. and Birchmeier, C. (1995). A targeted mutation in the 
mouse E-cadherin gene results in defective preimplantation development. Proc N atl 
Acad Sci U S  A , 92, 855-9.
Rimm, D.L., Koslov, E.R., Kebriaei, P., Cianci, C.D. and Morrow, J.S. (1995). Alpha 1(E)- 
catenin is an actin-binding and -bundling protein mediating the attachment of F-actin 
to the membrane adhesion complex. Proc N atl Acad Sci U S A ,  92, 8813-7.
Rousselle, P., Lunstrum, G.P., Keene, D.R. and Burgeson, R.E. (1991). Kalinin: an 
epithelium-specific basement membrane adhesion molecule that is a component of 
anchoring filam ents./ Cell Biol, 114, 567-76.
Ruoslahti, E. and Reed, J.C. (1994). Anchorage dependence, integrins, and apoptosis. Cell, 
77, 477-8.
333
Russell, A.J., Fincher, E.F., Millman, L., Smith, R., Vela, V., Waterman, E.A., Dey, C.N., 
Guide, S., Weaver, V.M. and Marinkovich, M.P. (2003). Alpha 6 beta 4 integrin 
regulates keratinocyte chemotaxis through differential GTPase activation and 
antagonism of alpha 3 beta 1 integrin. J  Cell Sci, 116, 3543-56. Epub 2003 Jul 15.
Ryniers, F., Stove, C., Goethals, M., Brackenier, L., Noe, V., Bracke, M., Vandekerckhove, J., 
Mareel, M. and Bruyneel, E. (2002). Plasmin produces an E-cadherin fragment that 
stimulates cancer cell invasion. Biol Chem, 383, 159-65.
Saito, Y., Takazawa, H., Uzawa, K., Tanzawa, H. and Sato, K. (1998). Reduced expression of 
E-cadherin in oral squamous cell carcinoma: relationship with DNA methylation of 
5' CpG island. Int J  Oncol, 12, 293-8.
Sakaki, T., Wato, M., Kaji, R., Mushimoto, K., Shirasu, R. and Tanaka, A. (1994). Correlation 
of E- and P-cadherin expression with differentiation grade and mode of invasion in 
gingival carcinoma. Pathol Int, 44, 280-6.
Sako, Y., Nagafuchi, A., Tsukita, S., Takeichi, M. and Kusumi, A. (1998). Cytoplasmic 
regulation o f the movement o f E-cadherin on the free cell surface as studied by 
optical tweezers and single particle tracking: corralling and tethering by the 
membrane skeleton./ Cell Biol, 140, 1227-40.
Sander, E.E., ten Klooster, J.P., van Delft, S., van der Kammen, R.A. and Collard, J.G.
(1999). Rac downregulates Rho activity: reciprocal balance between both GTPases 
determines cellular morphology and migratory behavior. J  Cell Biol, 147,1009-22.
Sander, E.E., van Delft, S., ten Klooster, J.P., Reid, T., van der Kammen, R.A., Michiels, F. 
and Collard, J.G. (1998). Matrix-dependent T iam l/R ac signaling in epithelial cells 
promotes either cell-cell adhesion or cell migration and is regulated by 
phosphatidylinositol 3-kinase./ Cell Biol, 143, 1385-98.
Sasaki, C.Y., Lin, H. and Passaniti, A. (2000). Expression o f E-cadherin reduces bcl-2 
expression and increases sensitivity to etoposide-induced apoptosis. Int J  Cancer, 86, 
660-6.
Sasaki, T., Fassler, R. and Hohenester, E. (2004). Laminin: the crux of basement membrane 
assembly. J  Cell Biol, 164, 959-63. Epub 2004 Mar 22.
Sasatomi, E., Tokunaga, O. and Miyazaki, K. (1996). Spontaneous apoptosis in gallbladder 
carcinoma. Relationships with clinicopathologic factors, expression of E-cadherin, 
bcl-2 protooncogene, and p53 oncosuppressor gene. Cancer, 78, 2101-10.
Schaapveld, R.Q., Borradori, L., Geerts, D., van Leusden, M.R., Kuikman, I., Nievers, M.G., 
Niessen, C.M., Steenbergen, R.D., Snijders, P.J. and Sonnenberg, A. (1998). 
Hemidesmosome formation is initiated by the beta4 integrin subunit, requires 
complex formation of beta4 and FIDl/plectin, and involves a direct interaction 
between beta4 and the bullous pemphigoid antigen 180. /  Cell Biol, 142, 271-84.
Schantz, S.P. (1993). Carcinogenesis, markers, staging, and prognosis o f head and neck 
cancer. Curr Opin Oncol, 5, 483-90.
Schipper, J.H., Frixen, U.H., Behrens, J., Unger, A., Jahnke, K. and Birchmeier, W. (1991). E- 
cadherin expression in squamous cell carcinomas of head and neck: inverse 
correlation with tumor dedifferentiation and lymph node metastasis. Cancer Res, 51, 
6328-37.
Schmeichel, K.L. and Bissell, M.J. (2003). Modeling tissue-specific signaling and organ 
function in three dimensions. J  Cell Sci, 116, 2377-88.
Schofield, O., Kist, D., Lucas, A., Wayner, E., Carter, W. and Zachary, C. (1998). Abnormal 
expression of epiligrin and alpha 6 beta 4 integrin in basal cell carcinoma. Dermatol 
Surg, 24, 555-9.
334
Scully, C. (1993). Oncogenes, tumor suppressors and viruses in oral squamous carcinoma. J  
Oral Pathol Med., 22, 337-47.
Scully, C. (2005). Cancers of the Oral Mucosa
< http://www.emedicine.com/derm/topic565.htm> . eMedicine.com, Inc.
Scully, C., Bagan, J.V., Black, M., Carrozzo, M., Eisen, D., Escudier, M., Farthing, P., Kuffer, 
R., Lo Muzio, L., Mignogna, M. and Porter, S.R. (2005). Epithelial biology. Oral Dls, 
11, 58-71.
Seftor, R.E., Seftor, E.A., Stetler-Stevenson, W.G. and Hendrix, M.J. (1993). The 72 kDa 
type IV collagenase is modulated via differential expression of alpha v beta 3 and 
alpha 5 beta 1 integrins during human melanoma cell invasion. Cancer Res, 53, 3411-5.
Sells, M.A., Knaus, U.G., Bagrodia, S., Ambrose, D.M., Bokoch, G.M. and Chemoff, J. 
(1997). Human p21-activated kinase (Pakl) regulates actin organization in 
mammalian cells. Curr Biol, 7, 202-10.
Shapiro, L., Fannon, A.M., Kwong, P.D., Thompson, A., Lehmann, M.S., Grubel, G., 
Legrand, J.F., Als-Nielsen, J., Colman, D.R. and Hendrickson, W.A. (1995). 
Structural basis of cell-cell adhesion by cadherins. Nature, 374, 327-37.
Shaw, L.M., Rabinovitz, I., Wang, H.H., Toker, A. and Mercurio, A.M. (1997). Activation of 
phosphoinositide 3-OH kinase by the alpha6beta4 integrin promotes carcinoma 
invasion. Cell, 91, 949-60.
Shen, X. and Kramer, R.H. (2004). Adhesion-mediated squamous cell carcinoma survival 
through ligand-independent activation of epidermal growth factor receptor. Mm J 
Pathol, 165, 1315-29.
Shibamoto, S., Hayakawa, M., Takeuchi, K., Hori, T., Miyazawa, K., Kitamura, N., Johnson, 
K.R., Wheelock, M.J., Matsuyoshi, N., Takeichi, M. and et al. (1995). Association of 
p i 20, a tyrosine kinase substrate, with E-cadherin/catenin complexes. J  Cell Biol, 128, 
949-57.
Shibata, T., Ochiai, A., Gotoh, M., Machinami, R. and Hirohashi, S. (1996a). Simultaneous 
expression o f cadherin-11 in signet-ring cell carcinoma and stromal cells o f diffuse- 
type gastric cancer. Cancer Lett, 99, 147-53.
Shibata, T., Ochiai, A., Kanai, Y., Akimoto, S., Gotoh, M., Yasui, N., Machinami, R. and 
Hirohashi, S. (1996b). Dominant negative inhibition o f the association between beta- 
catenin and c-erbB-2 by N-terminally deleted beta-catenin suppresses the invasion 
and metastasis of cancer cells. Oncogene, 13, 883-9.
Shimoyama, Y., Nagafuchi, A., Fujita, S., Gotoh, M., Takeichi, M., Tsukita, S. and Hirohashi, 
S. (1992). Cadherin dysfunction in a human cancer cell line: possible involvement of 
loss of alpha-catenin expression in reduced cell-cell adhesiveness. Cancer Res, 52, 
5770-4.
Shinohara, M., Hiraki, A., Ikebe, T., Nakamura, S., Kurahara, S., Shirasuna, K. and Garrod, 
D.R. (1998). Immunohistochemical study o f desmosomes in oral squamous cell 
carcinoma: correlation with cytokeratin and E-cadherin staining, and with tumour 
behav iour./Pathol, 184, 369-81.
Shinohara, M., Nakamura, S., Sasaki, M., Kurahara, S., Ikebe, T., Harada, T. and Shirasuna, 
K. (1999). Expression of integrins in squamous cell carcinoma of the oral cavity. 
Correlations with tumor invasion and metastasis. A m  J  Clin Pathol, 111, 75-88.
Siljander, P.R., Hamaia, S., Peachey, A.R., Slatter, D.A., Smethurst, P.A., Ouwehand, W.H., 
Knight, C.G. and Famdale, R.W. (2004). Integrin activation state determines 
selectivity for novel recognition sites in fibrillar collagens. J  Biol Chem, 279, 47763-72. 
Epub 2004 Sep 3.
335
Skalli, O., Jones, J.C., Gagescu, R. and Goldman, R.D. (1994). IFAP 300 is common to 
desmosomes and hemidesmosomes and is a possible linker o f intermediate filaments 
to these junctions./ Cell Biol, 125, 159-70.
Skubitz, A.P. (2002). Adhesion molecules. Cancer Treat Res, 107, 305-29.
Smola, H., Stark, H.J., Thiekotter, G., Mirancea, N., Krieg, T. and Fusenig, N.E. (1998). 
Dynamics o f basement membrane formation by keratinocyte-fibroblast interactions 
in organotypic skin culture. E xp Cell Res, 239, 399-410.
Soler, C., Rousselle, P. and Damour, O. (1998). Cadherin mediated cell-cell adhesion is 
regulated by tyrosine phosphatases in human keratinocytes. CellAdhes Commun, 5, 13- 
25.
Somasiri, A., Howarth, A., Goswami, D., Dedhar, S. and Roskelley, C.D. (2001). 
Overexpression of the integrin-linked kinase mesenchymally transforms mammary 
epithelial cells. J  Cell Sci, 114, 1125-36.
Sonnenberg, A. (1993). Integrins and their ligands. Curr Top Microbiol Immunol, 184, 7-35.
Sonnenberg, A., Linders, C.J., Daams, J.H. and Kennel, S.J. (1990). The alpha 6 beta 1 (VLA- 
6) and alpha 6 beta 4 protein complexes: tissue distribution and biochemical 
properties. J  Cell Sci, 96, 207-17.
Sorscher, S.M., Russack, V., Cagle, M., Feramisco, J.R. and Green, M.R. (1995). 
Immunolocalization o f E-cadherin in human head and neck cancer. Arch Pathol Tab 
Med, 119, 82-4.
Spinardi, L., Einheber, S., Cullen, T., Milner, T.A. and Giancotti, F.G. (1995). A recombinant 
tail-less integrin beta 4 subunit disrupts hemidesmosomes, but does not suppress 
alpha 6 beta 4-mediated cell adhesion to laminins. J  Cell Biol, 129, 473-87.
Squier, C.A. and Kremer, M.J. (2001). Biology of oral mucosa and esophagus. J  N atl Cancer 
Inst Monogr, 7-15.
St Croix, B. and Kerbel, R.S. (1997). Cell adhesion and drug resistance in cancer. Curr Opin 
Oncol, 9, 549-56.
St Croix, B., Sheehan, C., Rak, J.W., Florenes, V.A., Slingerland, J.M. and Kerbel, R.S. (1998). 
E-Cadherin-dependent growth suppression is mediated by the cyclin-dependent 
kinase inhibitor p27(KIPl). J  Cell Biol, 142, 557-71.
Stappenbeck, T.S. and Gordon, J.I. (2000). Racl mutations produce aberrant epithelial 
differentiation in the developing and adult mouse small intestine. Development, 127, 
2629-42.
Stark, H.J., Szabowski, A., Fusenig, N.E. and Maas-Szabowski, N. (2004). Organotypic 
cocultures as skin equivalents: A complex and sophisticated in vitro system. Biol 
Proced Online, 6, 55-60. Epub 2004 Apr 12.
Steinert, P.M. (2000). The complexity and redundancy of epithelial barrier function. J  Cell 
Biol, 151, F5-8.
Steinhusen, U., Weiske, J., Badock, V., Tauber, R., Bommert, K. and Huber, O. (2001). 
Cleavage and shedding of E-cadherin after induction o f apoptosis. J  Biol Chem, 276, 
4972-80. Epub 2000 Nov 13.
Stepp, M.A., Spurr-Michaud, S., Tisdale, A., Elwell, J. and Gipson, I.K. (1990). Alpha 6 beta 
4 integrin heterodimer is a component of hemidesmosomes. Proc N atl Acad Sci U S 
A , 87, 8970-4.
Stoffler, H.E., Honnert, U., Bauer, C.A., Hofer, D., Schwarz, H., Muller, R.T., Drenckhahn, 
D. and Bahler, M. (1998). Targeting of the myosin-I myr 3 to intercellular adherens 
type junctions induced by dominant active Cdc42 in HeLa cells. J  Cell Sci, 111, 2779- 
88 .
336
Strutt, D.I., Weber, U. and Mlodzik, M. (1997). The role o f RhoA in tissue polarity and 
Frizzled signalling. Nature, 387, 292-5.
Sugiyama, M., Speight, P.M., Prime, S.S. and Watt, F.M. (1993). Comparison of integrin 
expression and terminal differentiation capacity in cell lines derived from oral 
squamous cell carcinomas. Carcinogenesis, 14, 2171-6.
Sun, M., Wang, G., Paciga, J.E., Feldman, R.I., Yuan, Z.Q., Ma, X.L., Shelley, S.A., Jove, R., 
Tsichlis, P.N., Nicosia, S.V. and Cheng, J.Q. (2001). AKT1/PKBalpha kinase is 
frequently elevated in human cancers and its constitutive activation is required for 
oncogenic transformation in NIH3T3 cells. A m  J  Pathol' 159, 431-7.
Suzuki, S. and Naitoh, Y. (1990). Amino acid sequence o f a novel integrin beta 4 subunit and 
primary expression of the mRNA in epithelial cells. Emho J, 9, 757-63.
Takahashi, K. and Suzuki, K. (1996). Density-dependent inhibition o f growth involves 
prevention o f EG F receptor activation by E-cadherin-mediated cell-cell adhesion. 
Exp Cell Res, 226, 214-22.
Takahashi, N., Ishihara, S., Takada, S., Tsukita, S. and Nagafuchi, A. (2000). 
Posttranscriptional regulation o f alpha-catenin expression is required for Wnt 
signaling in L cells. Biochem Biophys Res Commun, 277, 691-8.
Takaishi, K., Sasaki, T., Kotani, H., Nishioka, H. and Takai, Y. (1997). Regulation of cell-cell 
adhesion by rac and rho small G proteins in MDCK cells. J  Cell Biol, 139, 1047-59.
Takata, K. and Singer, S.J. (1988). Phosphotyrosine-modified proteins are concentrated at the 
membranes of epithelial and endothelial cells during tissue development in chick 
embryos. J  Cell Biol, 106, 1757-64.
Takeichi, M. (1977). Functional correlation between cell adhesive properties and some cell 
surface proteins. J  Cell Biol, 75, 464-74.
Takeichi, M. (1993). Cadherins in cancer: implications for invasion and metastasis. Curr Opin 
Cell Biol, 5, 806-11.
Takeichi, M. (1995). Morphogenetic roles of classic cadherins. Curr Opin Cell Biol, 7, 619-27.
Takeichi, M., Watabe, M., Shibamoto, S., Ito, F., Oda, H., Uemura, T. and Shimamura, K. 
(1993). Dynamic control of cell-cell adhesion for muldcellular organization. C RAcad  
Sci III, 316, 813-21.
Tamai, K., Sawamura, D., Do, H.C., Tamai, Y., Li, K. and Uitto, J. (1993). The human 230- 
kD bullous pemphigoid antigen gene (BPAG1). Exon-intron organization and 
identification o f regulatory tissue specific elements in the promoter region. J Clin 
Invest, 92, 814-22.
Tamura, R.N., Rozzo, C., Starr, L., Chambers, J., Reichardt, L.F., Cooper, H.M. and 
Quaranta, V. (1990). Epithelial integrin alpha 6 beta 4: complete primary structure of 
alpha 6 and variant forms of beta 4 . /  Cell Biol, 111, 1593-604.
Tan, C., Costello, P., Sanghera, J., Dominguez, D., Baulida, J., de Herreros, A.G. and 
Dedhar, S. (2001). Inhibition o f integrin linked kinase (ILK) suppresses beta-catenin- 
Lef/Tcf-dependent transcription and expression of the E-cadherin repressor, snail, in 
A PC -/- human colon carcinoma cells. Oncogene, 20,133-40.
Tanaka, N., Odajima, T., Ogi, K., Ikeda, T. and Satoh, M. (2003). Expression o f E-cadherin, 
alpha-catenin, and beta-catenin in the process of lymph node metastasis in oral 
squamous cell carcinoma. Br J  Cancer, 89, 557-63.
Tandon, P., Pathak, V. P., Zaheer, A., Chatterjee, A., Walford, N. (1995). Cancer in the 
Gizan province o f Saudi Arabia: An eleven year study. A nn Saudi Med, 15, 14-20.
Teni, T., Pawar, S., Sanghvi, V. and Saranath, D. (2002). Expression of bcl-2 and bax in 
chewing tobacco-induced oral cancers and oral lesions from India. Pathol Oncol Res, 8, 
109-14.
337
Tennenbaum, T., Weiner, A.K., Belanger, A.J., Glick, A.B., Hennings, H. and Yuspa, S.H. 
(1993). The suprabasal expression of alpha 6 beta 4 integrin is associated with a high 
risk for malignant progression in mouse skin carcinogenesis. Cancer Res, 53, 4803-10.
Tennenbaum, T., Yuspa, S.H., Grover, A., Castronovo, V., Sobel, M.E., Yamada, Y. and De 
Luca, L.M. (1992). Extracellular matrix receptors and mouse skin carcinogenesis: 
altered expression linked to appearance of early markers of tumor progression. Cancer 
Res, 52, 2966-76.
Tepass, U., Truong, K., Godt, D., Ikura, M. and Peifer, M. (2000). Cadherins in embryonic 
and neural morphogenesis. N at Rev Mol Cell Biol, 1, 91-100.
Thiery, J.P. (2002). Epithelial-mesenchymal transitions in tumour progression. N at Rev 
Cancer, 2, 442-54.
Thiery, J.P. (2003). Epithelial-mesenchymal transitions in development and pathologies. Curr 
Opin Cell Biol, 15, 740-6.
Thomas, G.J., Hart, I.R., Speight, P.M., Marshall J.F. (2002). Binding of TGF-betal latency- 
associated peptide (LAP) to alpha(v)beta(6) integrin modulates behaviour of 
squamous carcinoma cells. B rJ Cancer, 87, 859-76.
Thomas, G.J., Jones, J. and Speight, P.M. (1997). Integrins and oral cancer. Oral Oncol, 33, 
381-8.
Thomas, G.J., Lewis, M.P., Whawell, S.A., Russell, A., Sheppard, D., Hart, I.R., Speight, P.M. 
and Marshall, J.F. (2001). Expression o f the alphavbeta6 integrin promotes migration 
and invasion in squamous carcinoma c e lls ./Invest Dermatol, 117, 67-73.
Thomas, G.J. and Speight, P.M. (2001). Cell adhesion molecules and oral cancer. Crit Rev 
Oral Biol Med, 12, 479-98.
Thomas, G.T., Lewis, M.P. and Speight, P.M. (1999). Matrix metalloproteinases and oral 
cancer. Oral Oncol, 35, 227-33.
Thompson, M. (1993). E-cadherin Expression and Function in Cell Lines Derived from Oral 
Squamous Cell Carcinomas. In Msc Thesis. Joint Department of Oral Pathology. The 
London Hospital Medical Collage and Insititute o f Dental Surgery: London.
Thoreson, M.A., Anastasiadis, P.Z., Daniel, J.M., Ireton, R.C., Wheelock, M.J., Johnson, 
K.R., Hummingbird, D.K. and Reynolds, A.B. (2000). Selective uncoupling of 
pl20(ctn) from E-cadherin disrupts strong adhesion. /  Cell Biol, 148, 189-202.
Timpl, R. and Brown, J.C. (1996). Supramolecular assembly o f basement membranes. 
Bioessays, 18, 123-32.
Tomita, K., van Bokhoven, A., van Leenders, G.J., Ruijter, E.T., Jansen, C.F., Bussemakers, 
M.J. and Schalken, J.A. (2000). Cadherin switching in human prostate cancer 
progression. Cancer Res, 60, 3650-4.
Tomson, A.M., Scholma, J., Meijer, B., Koning, J.G., de Jong, K.M. and van der Werf, M.
(1996). Adhesion properties, intermediate filaments and malignant behaviour o f head 
and neck squamous cell carcinoma cells in vitro. Clin E xp Metastasis, 14, 501-11.
Tran, N.L., Adams, D.G., Vaillancourt, R.R. and Heimark, R.L. (2002). Signal transduction 
from N-cadherin increases Bcl-2. Regulation o f the phosphatidylinositol 3- 
kinase/Akt pathway by homophilic adhesion and actin cytoskeletal organization. /  
Biol Chem, 277, 32905-14. Epub 2002 Jul 2.
Tran, N.L., Nagle, R.B., Cress, A.E. and Heimark, R.L. (1999). N-Cadherin expression in 
human prostate carcinoma cell lines. An epithelial-mesenchymal transformation 
mediating adhesion withStromal cells. A m  J  Pathol, 155, 787-98.
Trinkaus-Randall, V. and Gipson, I.K. (1984). Role o f calcium and calmodulin in 
hemidesmosome formation in vitro. J  Cell Biol’ 98, 1565-71.
338
Troussard, A.A., Mawji, N.M., Ong, C., Mui, A., St -Amaud, R. and Dedhar, S. (2003). 
Conditional knock-out o f integrin-linked kinase demonstrates an essential role in 
protein kinase B /A kt activation. J  Biol Chem, 278, 22374-8. Epub 2003 Apr 8.
Truong, K. and Ikura, M. (2002). The cadherin superfamily database. J  Struct Fund Genomics, 
2, 135-43.
Tsukatani, Y., Suzuki, K. and Takahashi, K. (1997). Loss of density-dependent growth 
inhibition and dissociation o f alpha-catenin from E-cadherin. J  Cell Physiol, 173, 54- 
63.
Tsukita, S., Furuse, M. and Itoh, M. (2001). Multifunctional strands in tight junctions. N at 
Rev Mol Cell Biol, 2, 285-93.
Tsukita, S., Oishi, K., Akiyama, T., Yamanashi, Y. and Yamamoto, T. (1991). Specific proto- 
oncogenic tyrosine kinases of src family are enriched in cell-to-cell adherens junctions 
where the level o f tyrosine phosphorylation is elevated. /  Cell Biol, 113, 867-79.
Tsuruta, D., Hopkinson, S.B., Lane, K.D., Werner, M.E., Cryns, V.L. and Jones, J.C. (2003). 
Crucial role o f the specificity-determining loop o f the integrin beta4 subunit in the 
binding o f cells to laminin-5 and outside-in signal transduction. J  Biol Chem, 278, 
38707-14. Epub 2003 Jul 16.
Uraguchi, M., Morikawa, M., Shirakawa, M., Sanada, K. and Imai, K. (2004). Activation of 
W NT family expression and signaling in squamous cell carcinomas o f the oral cavity. 
J  Dent Res, 83, 327-32.
Vallorosi, C.J., Day, K.C., Zhao, X., Rashid, M.G., Rubin, M.A., Johnson, K.R., Wheelock, 
M.J. and Day, M.L. (2000). Truncation o f the beta-catenin binding domain of E- 
cadherin precedes epithelial apoptosis during prostate and mammary involution. J  
Biol Chem, 275, 3328-34.
Van Aelst, L. and D'Souza-Schorey, C. (1997). Rho GTPases and signaling networks. Genes 
Dev, 11, 2295-322.
van der Flier, A. and Sonnenberg, A. (2001). Function and interactions of integrins. Cell 
Tissue Res, 305, 285-98.
van der Neut, R., Cachaco, A.S., Thorsteinsdottir, S., Janssen, H., Prins, D., Bulthuis, J., van 
der Valk, M., Calafat, J. and Sonnenberg, A. (1999). Partial rescue o f epithelial 
phenotype in integrin beta4 null mice by a keratin-5 promoter driven human integrin 
beta4 transgene./ Cell Sci, 112, 3911-22.
Vasioukhin, V., Bauer, C., Yin, M. and Fuchs, E. (2000). Directed actin polymerization is the 
driving force for epithelial cell-cell adhesion. Cell, 100, 209-19.
Vasioukhin, V. and Fuchs, E. (2001). Actin dynamics and cell-cell adhesion in epithelia. Curr 
Opin Cell Biol, 13, 76-84.
Verrando, P., Blanchet-Bardon, C., Pisani, A., Thomas, L., Cambazard, F., Eady, R.A., 
Schofield, O. and Ortonne, J.P. (1991). Monoclonal antibody GB3 defines a 
widespread defect of several basement membranes and a keratinocyte dysfunction in 
patients with lethal junctional epidermolysis bullosa. Fab Invest, 64, 85-92.
Vespa, A., Darmon, A.J., Turner, C.E., D'Souza, S.J. and Dagnino, L. (2003). Ca2+- 
dependent localization of integrin-linked kinase to cell junctions in differentiating 
keratinocytes. J  Biol Chem, 278, 11528-35. Epub 2003 Jan 23.
Vivanco, I. and Sawyers, C.L. (2002). The phosphatidylinositol 3-Kinase AKT pathway in 
human cancer. N at Rev Cancer, 2, 489-501.
Vleminckx, K., Vakaet, L., Jr., Mareel, M., Fiers, W. and van Roy, F. (1991). Genetic 
manipulation o f E-cadherin expression by epithelial tumor cells reveals an invasion 
suppressor role. Cell, 66, 107-19.
339
Walpita, D. and Hay, E. (2002). Studying actin-dependent processes in tissue culture. N at Rev 
Mol Cell Biol, 3,137-41.
Watt, F.M. (1984). Selective migration o f terminally differentiating cells from the basal layer 
o f cultured human epidermis. J  Cell Biol, 98, 16-21.
Watt, F.M. (1988). Proliferation and terminal differentiation o f human epidermal 
keratinocytes in culture. Biochem Soc Trans, 16, 666-8.
Watt, F.M. (2001). Stem cell fate and patterning in mammalian epidermis. Curr Opin Genet 
Dev, 11, 410-7.
Watt, F.M. (2002). Role o f integrins in regulating epidermal adhesion, growth and 
differentiation. Emho J, 21, 3919-26.
Watt, F.M. and Green, H. (1981). Involucrin synthesis is correlated with cell size in human 
epidermal cultures./ Cell Biol, 90, 738-42.
Watt, F.M. and Green, H. (1982). Stratification and terminal differentiation of cultured 
epidermal cells. Nature, 295, 434-6.
Watt, F.M. and Jones, P.H. (1993). Expression and function o f the keratinocyte integrins. Dev 
SuppL; 185-92.
Wayner, E.A. and Carter, W.G. (1987). Identification o f multiple cell adhesion receptors for 
collagen and fibronectin in human fibrosarcoma cells possessing unique alpha and 
common beta subunits. J  Cell Biol, 105, 1873-84.
Weaver, V.M., Petersen, O.W., Wang, F., Larabell, C.A., Briand, P., Damsky, C. and Bissell, 
M.J. (1997). Reversion of the malignant phenotype o f human breast cells in three- 
dimensional culture and in vivo by integrin blocking antibodies. J  Cell Biol, 137, 231- 
45.
Wehrle-Haller, B. and Imhof, B.A. (2003). Integrin-dependent pathologies. J  Pathol, 200, 481- 
7.
Weidner, K.M., Behrens, J., Vandekerckhove, J. and Birchmeier, W. (1990). Scatter factor: 
molecular characteristics and effect on the invasiveness o f epithelial cells. J  Cell Biol, 
111, 2097-108.
Weinacker, A., Ferrando, R., Elliott, M., Hogg, J., Balmes, J. and Sheppard, D. (1995). 
Distribution of integrins alpha v beta 6 and alpha 9 beta 1 and their known ligands, 
fibronectin and tenascin, in human airways. A m  J  Respir Cell Mol Biol, 12, 547-56.
Wheelock, M.J. and Johnson, K.R. (2003a). Cadherin-mediated cellular signaling. Curr Opin 
Cell Biol, 15, 509-14.
Wheelock, M.J. and Johnson, K.R. (2003b). Cadherins as modulators o f cellular phenotype. 
Annu Rev Cell Dev Biol, 19, 207-35.
Wheelock, M.J., Soler, A.P. and Knudsen, K.A. (2001). Cadherin junctions in mammary 
tumors. J  Mammary Gland Biol Neoplasia, 6, 275-85.
Whittard, J.D., Craig, S.E., Mould, A.P., Koch, A., Pertz, O., Engel, J. and Humphries, M.J.
(2002). E-cadherin is a ligand for integrin alpha2betal. M atrix Biol, 21, 525-32.
Wijnhoven, B.P., Dinjens, W.N. and Pignatelli, M. (2000). E-cadherin-catenin cell-cell 
adhesion complex and human cancer. Br J  Surg, 87, 992-1005.
Williams, H.K. (2000). Molecular pathogenesis o f oral squamous carcinoma. Mol Pathol, 53, 
165-72.
Williams, H.K., Sanders, D.S., Jankowski, J.A., Landini, G. and Brown, A.M. (1998). 
Expression of cadherins and catenins in oral epithelial dysplasia and squamous cell 
carcinoma. J  Oral Pathol Med, 27, 308-17.
Witkowski, C.M., Bowden, G.T., Nagle, R.B. and Cress, A.E. (2000). Altered surface 
expression and increased turnover o f the alpha6beta4 integrin in an undifferentiated 
carcinoma. Carcinogenesis, 21, 325-30.
340
Wolf, G.T., Carey, T.E., Schmaltz, S.P., McClatchey, K.D., Poore, J., Glaser, L., Hayashida, 
D.J. and Hsu, S. (1990). Altered antigen expression predicts outcome in squamous 
cell carcinoma o f the head and neck. J  N atl Cancer Inst, 82, 1566-72.
World Health Organization (WHO) (1997). Relative Frequency of Major Cancers in Men and 
Women Worlwide. Report o f the ad-hoc committee on health research relating to 
future intervention options. WHO: Geneva.
Wu, C. and Dedhar, S. (2001). Integrin-linked kinase (ILK) and its interactors: a new 
paradigm for the coupling o f extracellular matrix to actin cytoskeleton and signaling 
com plexes./ Cell Biol, 155, 505-10. Epub 2001 Nov 5.
Wu, C., Keightley, S.Y., Leung-Hagesteijn, C., Radeva, G., Coppolino, M., Goicoechea, S., 
McDonald, J.A. and Dedhar, S. (1998). Integrin-linked protein kinase regulates 
fibronectin matrix assembly, E-cadherin expression, and tumorigenicity. J  Biol Chem, 
273, 528-36.
Wymann, M.P. and Pirola, L. (1998). Structure and function of phosphoinositi.de 3-kinases. 
Biochim Biophys Acta, 1436,127-50.
Yamada, K., Jordan, R., Mori, M. and Speight, P.M. (1997). The relationship between E- 
cadherin expression, clinical stage and tumour differentiation in oral squamous cell 
carcinoma. Oral Dis, 3, 82-5.
Yamada, K.M. (1989). Fibronectins: structure, functions and receptors. Curr Opin Cell Biol, 1, 
956-63.
Yap, A.S., Brieher, W.M., Pruschy, M. and Gumbiner, B.M. (1997). Lateral clustering o f the 
adhesive ectodomain: a fundamental determinant of cadherin function. Curr Biol, 7, 
308-15.
Yap, A.S. and Kovacs, E.M. (2003). Direct cadherin-activated cell signaling: a view from the 
plasma membrane. J  Cell Biol, 160, 11-6. Epub 2002 Dec 30.
Yap, A.S., Niessen, C.M. and Gumbiner, B.M. (1998). The juxtamembrane region o f the 
cadherin cytoplasmic tail supports lateral clustering, adhesive strengthening, and 
interaction with p i 20cm ./ Cell Biol, 141, 779-89.
Yokosaki, Y., Palmer, E.L., Prieto, A.L., Crossin, K.L., Bourdon, M.A., Pytela, R. and 
Sheppard, D. (1994). The integrin alpha 9 beta 1 mediates cell attachment to a non- 
RGD site in the third fibronectin type III repeat of tenascin. J  Biol Chem, 269, 26691- 
6 .
Yokoyama, K., Kamata, N., Fujimoto, R., Tsutsumi, S., Tomonari, M., Taki, M., Hosokawa, 
H. and Nagayama, M. (2003). Increased invasion and matrix metalloproteinase-2 
expression by Snail-induced mesenchymal transition in squamous cell carcinomas. Int 
]  Oncol, 22, 891-8.
Yoshida-Noro, C., Suzuki, N. and Takeichi, M. (1984). Molecular nature o f the calcium- 
dependent cell-cell adhesion system in mouse teratocarcinoma and embryonic cells 
studied with a monoclonal antibody. Dev Biol, 101,19-27.
Yoshizaki, T., Sato, H., Mamyama, Y., Murono, S., Furukawa, M., Park, C.S. and Seiki, M.
(1997). Increased expression of membrane type 1-matrix metalloproteinase in head 
and neck carcinoma. Cancer, 79, 139-44.
Zambruno, G., Manca, V., Santantonio, M.L., Soligo, D. and Giannetti, A. (1991). VLA 
protein expression on epidermal cells (keratinocytes, Langerhans cells, melanocytes): 
a light and electron microscopic immunohistochemical study. Br J  Dermatol, 124, 135- 
45.
Zervas, C.G., Gregory, S.L. and Brown, N.H. (2001). Drosophila integrin-linked kinase is 
required at sites of integrin adhesion to link the cytoskeleton to the plasma 
membrane. /  Cell Biol, 152, 1007-18.
341
Zhang, Z., Vuori, K., Reed, J.C. and Ruoslahti, E. (1995). The alpha 5 beta 1 integrin 
supports survival o f cells on fibronectin and up-regulates Bcl-2 expression. Proc N atl 
Acad Sci U S A ,  92, 6161-5.
Zhu, A.J. and Watt, F.M. (1996). Expression o f a dominant negative cadherin mutant inhibits 
proliferation and stimulates terminal differentiation of human epidermal 
keratinocytes. J  Cell Sci, 109, 3013-23.
Zutter, M.M. and Santoro, S.A. (1990). Widespread histologic distribution of the alpha 2 beta
1 integrin cell-surface collagen receptor. A m  J  Pathol, 137,113-20.
Zutter, M.M., Santoro, S.A., Staatz, W.D. and Tsung, Y.L. (1995). Re-expression of the alpha
2 beta 1 integrin abrogates the malignant phenotype of breast carcinoma cells. Proc 
N atl Acad Sci U S A ,  92, 7411-5.
342
